<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>GNews Health</title><link>https://news.google.com/</link><description></description><generator>rfeed v1.1.1</generator><docs>https://github.com/svpino/rfeed/blob/master/README.md</docs><item><title>在犹他州的活动中，大约有2000人可能接触过麻疹-盐湖论坛报</title><link>https://www.sltrib.com/news/2025/09/09/four-utahns-infected-with-measles/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="article-head"&gt;&lt;h1 class="headline"&gt;About 2,000 people may have been exposed to measles at Utah event&lt;/h1&gt;&lt;h2 class="article-subheadline"&gt;Several attendees of a high school cycling event in August now have confirmed measles cases, Utah health officials say.&lt;/h2&gt;&lt;div class="image-rootLeft"&gt;&lt;p class="css-1ez1ofp"&gt;&lt;span class=" lazy-load-image-background "&gt;&lt;span class="image-img"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p class="caption-credit"&gt;(Centers for Disease Control and Prevention) An example of a measles virus.&lt;/p&gt;&lt;/div&gt;&lt;p id="f0fvPICkDdVr4HR" data-fusion-collection="features" data-fusion-type="article-byline/default" data-fusion-message="Could not render component [features:article-byline/default]"&gt;&lt;/p&gt;&lt;p id="f0fSQqI7MjYN5RL" data-fusion-collection="features" data-fusion-type="article-group-buttons/default" data-fusion-message="Could not render component [features:article-group-buttons/default]"&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="article-body-container" itemprop="articleBody"&gt;&lt;p class="body-raw"&gt;Several people have been infected with measles after they were exposed to the virus at an August cycling event at Soldier Hollow, the Utah Department of Health and Human Services reports.&lt;/p&gt;&lt;p class="body-raw"&gt;About 2,000 people attended the Utah High School Cycling League event on Aug. 16,&lt;b&gt; &lt;/b&gt;according to the department. Four measles cases have been confirmed among the attendees; none of them were vaccinated, the department said.&lt;/p&gt;&lt;p class="body-raw"&gt;The health department said it is working with the Utah High School Cycling League to inform families and race participants of their possible exposure to measles.&lt;/p&gt;&lt;p class="body-raw"&gt;The event was a competition for teen cyclists in the league’s region 6, whose teams come largely from southern Utah from St. George to Moab, and as far north as Utah County.&lt;/p&gt;&lt;p class="body-raw"&gt;The Wasatch County School District issued a statement Tuesday afternoon, saying that none of the participants of the cycling event were Wasatch County residents. “There are no known measles cases in Wasatch County and the event was not connected to WCSD,” the district said.&lt;/p&gt;&lt;p class="body-raw"&gt;The new cases bring the state’s confirmed total to 24, according to the health department. Only one of those was vaccinated.&lt;/p&gt;&lt;p class="body-raw"&gt;Even at outdoor events, measles remains highly contagious and can spread easily, Dr. Leisha Nolen, epidemiologist for the state of Utah, said in a statement issued by the health department. She urged anyone who attended&lt;b&gt; &lt;/b&gt;the event to check their measles-mumps-rubella vaccination status.&lt;/p&gt;&lt;p class="body-raw"&gt;The MMR vaccine is 97% effective against measles when people receive two doses, according to the state’s health department.&lt;/p&gt;&lt;p class="body-raw"&gt;Utah vaccination data among kindergarteners shows that despite the vaccine’s effectiveness, fewer and fewer students are receiving required vaccines as more parents seek exemptions for personal and religious reasons. &lt;/p&gt;&lt;p class="body-raw"&gt;During the 2024-25 school year, 11.2% of all Utah kindergarteners — and 9.9% of in-person kindergarten students — were not adequately vaccinated for measles, according to state data. &lt;/p&gt;&lt;p class="body-raw"&gt;Measles symptoms typically appear one to two weeks after exposure, according to the health department. They include a moderate fever accompanying a cough, runny nose and red, watery eyes. A few days later, the department said, the fever spikes to 101 degrees or higher and a rash appears along the hairline before spreading to the rest of the body. &lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Salt Lake Tribune</author><pubDate>Tue, 09 Sep 2025 20:01:15 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMifkFVX3lxTE8xaGxRWW5ST0NDNWxYY1lmS0xtblZsTnJJdUZNcmRtdlZnakJSZUgzOUNSY2I3NUhNYi1Zc0s0dTVkMGdscHlVRjhxaU00Wkk5ZzhKbGVCSjZVMHlDQ1NHSW80bTJla2xaRTZVT3g5em9UM05OdndCdndZemZ3QQ</guid></item><item><title>65岁以上精力充沛的人通常会发誓这7种爱好能让他们保持活力- VegOut</title><link>https://vegoutmag.com/lifestyle/z-people-over-65-who-stay-full-of-energy-usually-swear-by-these-7-hobbies-that-keep-them-moving/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="page__content mt-4"&gt;
							&lt;p data-start="320" data-end="370"&gt;Getting older doesn’t have to mean slowing down.&lt;/p&gt;
&lt;p data-start="372" data-end="638"&gt;In fact, I’ve met people in their seventies and eighties who are more active and full of life than some folks in their forties. The difference? They don’t sit still for long. They’ve built movement into their everyday routines through hobbies they genuinely enjoy.&lt;/p&gt;
&lt;p data-start="640" data-end="744"&gt;Here are seven that come up again and again when you ask energetic people over 65 how they keep going.&lt;/p&gt;
&lt;h2 data-start="751" data-end="781"&gt;1. Walking with intention&lt;/h2&gt;
&lt;p data-start="783" data-end="923"&gt;You might think walking is too simple to count, but that’s the beauty of it. It’s accessible, low-impact, and can be done almost anywhere.&lt;/p&gt;
&lt;p data-start="925" data-end="1137"&gt;The people I’ve seen turn walking into a hobby don’t just stroll aimlessly. They walk with intention—whether that’s exploring a new neighborhood, hiking a trail, or joining a walking group that makes it social.&lt;/p&gt;
&lt;p data-start="1139" data-end="1420"&gt;One man I know in his late seventies wakes up every morning, grabs his headphones, and sets out for a three-mile loop around his town. He treats it almost like meditation, syncing his steps with music or podcasts. It’s movement, yes, but also a daily ritual that keeps him sharp.&lt;/p&gt;
&lt;p data-start="1422" data-end="1688"&gt;As noted by the American Heart Association, regular walking &lt;a href="https://www.heart.org/en/healthy-living/fitness/walking/every-step-counts?.com"&gt;improves cardiovascular health&lt;/a&gt;, boosts mood, and even sharpens memory. And when older adults treat it as something to look forward to, not just “exercise,” it becomes the backbone of their energy routine.&lt;/p&gt;
&lt;p data-start="1690" data-end="1830"&gt;Even small variations—changing routes, adding inclines, or walking with friends—turn this simple act into something surprisingly powerful.&lt;/p&gt;
&lt;h2 data-start="1837" data-end="1852"&gt;2. Dancing&lt;/h2&gt;
&lt;p data-start="1854" data-end="2001"&gt;I once stumbled into a salsa class while traveling in Mexico City. Half the class was over sixty, and they were outdancing the twenty-somethings.&lt;/p&gt;
&lt;p data-start="2003" data-end="2180"&gt;That’s the thing about dancing—it works because it blends fun with movement. There’s rhythm, community, and a sense of play that makes people forget they’re exercising at all.&lt;/p&gt;
&lt;p data-start="2182" data-end="2506"&gt;And it’s not just about cardio. &lt;a href="https://www.sciencedirect.com/science/article/abs/pii/S0020748921001723?.com"&gt;Dancing challenges coordination&lt;/a&gt; and balance, keeping the brain sharp with every step and turn. Studies back this up: dance improves memory, coordination, and neuroplasticity—and is even linked to lower dementia risk.&lt;/p&gt;
&lt;p data-start="2508" data-end="2770"&gt;I’ve also noticed that older adults who keep dancing tend to be more socially connected. Whether it’s ballroom, line dancing, or just grooving in the living room, it’s hard not to smile when you’re moving to music. And that joy is part of why it works so well.&lt;/p&gt;
&lt;h2 data-start="2777" data-end="2794"&gt;3. Gardening&lt;/h2&gt;
&lt;p data-start="2796" data-end="2919"&gt;There’s something powerful about tending to plants. You bend, squat, lift, dig, and carry without even thinking about it.&lt;/p&gt;
&lt;p data-start="2921" data-end="3098"&gt;My grandmother used to say her roses kept her young. Looking back, I think she was right. Gardening gave her a daily reason to move, stretch, and stay outside in the sunshine.&lt;/p&gt;
&lt;p data-start="3100" data-end="3359"&gt;What fascinates me is how holistic gardening really is. Physically, it’s like a light workout spread across hours. Psychologically, it reduces stress and provides a sense of purpose. And spiritually—if you want to go there—it’s grounding in a literal sense.&lt;/p&gt;
&lt;p data-start="3361" data-end="3643"&gt;A growing body of research backs this up. A 2023 meta-analysis found that &lt;a href="https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2023.1142456/full?.com"&gt;horticultural therapy&lt;/a&gt; significantly reduces depressive symptoms in older adults, especially when activities are participatory and conducted in care-providing settings over 4 to 8 weeks.&lt;/p&gt;
&lt;p data-start="3645" data-end="3765"&gt;It’s not about having a perfect lawn. Even container gardens on a balcony or indoor plants can bring similar benefits.&lt;/p&gt;
&lt;h2 data-start="3772" data-end="3788"&gt;4. Swimming&lt;/h2&gt;
&lt;p data-start="3790" data-end="3888"&gt;If there’s a single activity that almost every energetic older person recommends, it’s swimming.&lt;/p&gt;
&lt;p data-start="3890" data-end="4007"&gt;Why? Because water takes the pressure off joints while still giving you resistance. It’s exercise without the pain.&lt;/p&gt;
&lt;p data-start="4009" data-end="4297"&gt;I’ve mentioned this before in another post, but I learned the value of swimming when I injured my knee a few years ago. It was the only thing that kept me moving pain-free. That same principle applies to people over 65—it allows them to stay active without worrying about wear and tear.&lt;/p&gt;
&lt;p data-start="4299" data-end="4462"&gt;One retired teacher I know swears by his morning laps. “The pool is the only place I feel completely free,” he told me. “It’s like the weight of age disappears.”&lt;/p&gt;
&lt;p data-start="4464" data-end="4711"&gt;Many community centers offer senior swim hours or aqua aerobics, making it a social outlet as well. And let’s not forget: swimming works almost every muscle in the body while building cardiovascular endurance. It’s hard to beat that combination.&lt;/p&gt;
&lt;h2 data-start="4718" data-end="4752"&gt;5. Practicing yoga or tai chi&lt;/h2&gt;
&lt;p data-start="4754" data-end="4899"&gt;“Stillness in movement, and movement in stillness.” That’s how a tai chi teacher once described it to me when I was visiting Beijing years ago.&lt;/p&gt;
&lt;p data-start="4901" data-end="5084"&gt;For older adults, practices like yoga and tai chi offer more than just flexibility. Tai chi, for instance, has been shown to significantly &lt;a href="https://www.health.harvard.edu/staying-healthy/tai-chi-the-winner-at-warding-off-falls?.com"&gt;reduce fall risk by up to 58%&lt;/a&gt; compared to stretching—and improve balance, stability, and muscle reaction times.&lt;/p&gt;
&lt;p data-start="5086" data-end="5285"&gt;Yoga, meanwhile, strengthens posture, flexibility, and mobility. A review of 33 randomized controlled studies found that &lt;a href="https://news.harvard.edu/gazette/story/2023/03/strong-evidence-that-yoga-protects-against-frailty-in-older-adults/?.com"&gt;yoga improves walking speed&lt;/a&gt;, leg strength, and other markers of frailty—hallmarks of sustained independence. &lt;/p&gt;
&lt;p data-start="5287" data-end="5537"&gt;I’ve seen seniors who’ve practiced yoga for decades hold poses with more grace and strength than younger people who only dabble in it. And they often say the mental benefits—reduced anxiety, clearer focus—are just as important as the physical ones.&lt;/p&gt;
&lt;p data-start="5539" data-end="5662"&gt;These practices prove that energy isn’t always about speed or intensity. Sometimes it’s about sustainability and harmony.&lt;/p&gt;
&lt;h2 data-start="5669" data-end="5684"&gt;6. Cycling&lt;/h2&gt;
&lt;p data-start="5686" data-end="5840"&gt;Cycling isn’t just for young commuters in Lycra shorts. I’ve seen retirees in California cruising on e-bikes or pedaling along coastal trails with ease.&lt;/p&gt;
&lt;p data-start="5842" data-end="6068"&gt;What makes cycling powerful is that it gets the heart rate up while being relatively gentle on the joints. Traditional bikes build endurance, while e-bikes allow older riders to scale their effort depending on how they feel.&lt;/p&gt;
&lt;p data-start="6070" data-end="6303"&gt;This combination of flexibility and freedom makes cycling an energy-boosting hobby that can be adapted as people age. And there’s something freeing about moving quickly under your own power—even if it’s with a little electric help.&lt;/p&gt;
&lt;p data-start="6305" data-end="6534"&gt;One couple in their seventies I met while traveling through Portugal told me cycling is what keeps their relationship strong. “We’ve ridden thousands of miles together,” the wife said. “It keeps us talking, keeps us exploring.”&lt;/p&gt;
&lt;p data-start="6536" data-end="6639"&gt;That social and exploratory element makes cycling more than just exercise. It’s adventure at any age.&lt;/p&gt;
&lt;h2 data-start="6646" data-end="6668"&gt;7. Playing sports&lt;/h2&gt;
&lt;p data-start="6670" data-end="6779"&gt;Pickleball, tennis, golf, even ping-pong—the specific sport doesn’t matter as much as the spirit behind it.&lt;/p&gt;
&lt;p data-start="6781" data-end="6982"&gt;Sports get people competing, laughing, and connecting. They provide structure (weekly games, friendly matches) that keep people accountable, and they engage muscles that don’t get used in daily life.&lt;/p&gt;
&lt;p data-start="6984" data-end="7267"&gt;Pickleball in particular has exploded in popularity among retirees. It’s less demanding than tennis but still offers a fast-paced game that keeps reflexes sharp. And it’s accessible—many community centers have converted tennis courts to pickleball courts because demand is so high.&lt;/p&gt;
&lt;p data-start="7269" data-end="7483"&gt;I’ve seen whole communities of retirees built around these games. They aren’t just exercising—they’re belonging to something bigger. And that sense of play might be the most underrated energy booster of them all.&lt;/p&gt;
&lt;p data-start="7485" data-end="7642"&gt;As psychologist Stuart Brown has said, “Play is not just an activity; it’s a state of mind that helps us stay resilient.” That’s doubly true in later life.&lt;/p&gt;
&lt;h2 data-start="7649" data-end="7669"&gt;The bottom line&lt;/h2&gt;
&lt;p data-start="7671" data-end="7783"&gt;Staying full of energy after 65 isn’t about grinding away on a treadmill or following strict fitness regimens.&lt;/p&gt;
&lt;p data-start="7785" data-end="7920"&gt;It’s about choosing hobbies that feel joyful, that bring movement naturally into the day, and that connect body, mind, and community.&lt;/p&gt;
&lt;p data-start="7922" data-end="8028"&gt;The people who stay active later in life don’t think of it as “working out.” They think of it as living.&lt;/p&gt;
&lt;p data-start="8030" data-end="8137"&gt;So maybe the better question isn’t &lt;em data-start="8065" data-end="8093"&gt;which hobby should I pick?&lt;/em&gt; but &lt;em data-start="8098" data-end="8135"&gt;which one makes me feel most alive?&lt;/em&gt;&lt;/p&gt;
&lt;div class="vegou-quiz-after-article" id="vegou-303646175"&gt;&lt;div&gt;
&lt;h2&gt;What’s Your Plant-Powered Archetype?&lt;/h2&gt;
&lt;p&gt;Ever wonder what your everyday habits say about your deeper purpose—and how they ripple out to impact the planet?&lt;/p&gt;
&lt;p&gt;This 90-second quiz reveals the plant-powered role you’re here to play, and the tiny shift that makes it even more powerful.&lt;/p&gt;
&lt;p&gt;12 fun questions. Instant results. Surprisingly accurate.&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;p&gt; &lt;/p&gt;
&lt;/div&gt;						&lt;/div&gt;
					&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>VegOut</author><pubDate>Tue, 09 Sep 2025 19:15:26 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMixwFBVV95cUxNdXVVUmVyLTNQWnA2MF9ORVU0R3lvSDk3TlQyVFZlcjFtWXFwc1NxaldEZU9KdGVPaHlRdXZ6WkRFZGluWDBnVHY2N0ltZUo5QlpLeFdaVW5BSGY2dmczRFBCSTBRNHVxUnUwejlPRk4zbHlqVlFmelFJUmc2akdIMXFmSlYyd0twVVlyQUE2Umh2WWxTMnozbW1qTmhBcm5nc0RLSUpyc2RiWFhMVi1ERkZvd0ZsWDg1RTFQVmxpYkRGdkdjN0Nj</guid></item><item><title>犹他州卫生部门确认士兵空心事件后麻疹暴露- KSLTV.com</title><link>https://ksltv.com/health/utah-health-department-confirms-measles-exposure-after-soldier-hollow-event/817496/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="story_body"&gt;

                        &lt;p&gt;SALT LAKE CITY – Several people were exposed to and infected with measles after attending an event at Soldier Hollow, the &lt;a href="https://dhhs.utah.gov/" target="_blank" rel="noopener"&gt;Utah Department of Health &amp;amp; Human Services&lt;/a&gt; confirmed Tuesday.&lt;/p&gt;
&lt;p&gt;On Aug. 16, the Utah DHHS reported that approximately 2,000 people attended a Utah High School Cycling League event at Soldier Hollow. The department said it “has confirmed that several people were exposed to and infected with measles,” but did not disclose how many people, or the origin of the spread.&lt;/p&gt;
&lt;p&gt;“Measles is highly contagious and spreads easily, even at outdoor events,” Dr. Leisha Nolen, epidemiologist for the State of Utah, said in a release from the department.&lt;/p&gt;
&lt;p&gt;Nolen advised that attendees and participants of upcoming cycling league events check their MMR vaccination status to prevent measles.&lt;/p&gt;
&lt;p&gt;The department said it is working to inform people of possible exposure.&lt;/p&gt;
&lt;blockquote&gt;&lt;p&gt;Utah public health is working with the Utah High School Cycling League to inform families of race participants who attended the Soldier Hollow event on August 16, 2025. We are also working collaboratively to help prevent spread at ongoing practices and upcoming events.&lt;/p&gt;&lt;/blockquote&gt;
&lt;h2&gt;Measles symptoms&lt;/h2&gt;
&lt;p&gt;The Utah HHS said symptoms usually begin within one or two weeks after initial exposure. Those symptoms can include:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Mild to moderate fever with a cough that later spikes,&lt;/li&gt;
&lt;li&gt;runny nose,&lt;/li&gt;
&lt;li&gt;red, watery eyes,&lt;/li&gt;
&lt;li&gt;blotchy rash appearing first along the hairline and behind the ears.&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;The department advised that if you develop symptoms, it’s important to protect others from exposure by staying away from other people and calling your healthcare provider before going to a clinic or hospital.&lt;/p&gt;
&lt;p&gt;For more &lt;a href="https://protect.checkpoint.com/v2/r01/___https:/utah.us20.list-manage.com/track/click?u=ed508d0fee9a2d592f5274e9c&amp;amp;id=e1be701d23&amp;amp;e=871f6cea93___.YzJ1OmJvbm5ldmlsbGVpbnRlcm5hdGlvbmFsOmM6bzphMzhhZTQzNDZjZDNjZDRkMTQxMDVkMjM0M2NhMWYyZjo3OmM4NjM6YzFkODc5YWMzNjRiNmM3YTcwYjcyMjM1OWJkMjY0NmExYzM1NTYzNjI4MzE4ODk3OTQwNGE5MTM4MWQ0NDdkMTpoOlQ6Tg" target="_blank" rel="noopener"&gt;information on measles in Utah, click here.&lt;/a&gt;&lt;/p&gt;

&lt;hr&gt;
&lt;p&gt;&lt;em&gt;This is a breaking news story. It may be updated.&lt;/em&gt;&lt;/p&gt;
                        
                        
                        
    


                        
                        
                        
                    &lt;/div&gt;

                &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>KSLTV.com</author><pubDate>Tue, 09 Sep 2025 19:00:01 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMirAFBVV95cUxNVWhGSGx1UjJLNjdiNzRiZXczbll2MVdYdlEwQUFmSG5JdHppanR1YVl6SWpJTHlXV0ZiUDRnaFR2amk3eXViNU9mLTdRWUVWRnN1SVRJcEwzUkdWelNPd1VRWWIzWjhpcldIUlJPVXJaT2ZQemtYemRlU3FyVGlsSHFqcjJ2VGxRcEVkeUg2MVpFVkJFT3A0MkhaSmdQV0NWUFdKc0c3bFpSQXhy</guid></item><item><title>领先的流行病学家迈克尔·奥斯特霍尔姆（ Michael Osterholm ）说： “我们基本上摧毁了我们应对大流行病的能力。”</title><link>https://www.livescience.com/health/viruses-infections-disease/we-have-basically-destroyed-what-capacity-we-had-to-respond-to-a-pandemic-says-leading-epidemiologist-michael-osterholm</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div id="article-body" class="text-copy bodyCopy auto"&gt;
&lt;p id="25e52957-7aa0-4399-9a1c-5603f3713521"&gt;COVID-19 has claimed the lives of more than 7 million people across the world, to date, including over 1 million people in the U.S., &lt;a data-analytics-id="inline-link" href="https://data.who.int/dashboards/covid19/deaths" target="_blank" data-url="https://data.who.int/dashboards/covid19/deaths" referrerpolicy="no-referrer-when-downgrade" data-hl-processed="none"&gt;&lt;u&gt;according to the World Health Organization&lt;/u&gt;&lt;/a&gt;. In addition to this staggering death toll, the disease has unleashed a &lt;a data-analytics-id="inline-link" href="https://www.livescience.com/health/coronavirus/1-in-22-covid-survivors-develop-debilitating-chronic-syndrome" data-before-rewrite-localise="https://www.livescience.com/health/coronavirus/1-in-22-covid-survivors-develop-debilitating-chronic-syndrome"&gt;&lt;u&gt;wave of chronic illness&lt;/u&gt;&lt;/a&gt;, and at the peak of the &lt;a data-analytics-id="inline-link" href="https://www.livescience.com/tag/pandemic" data-auto-tag-linker="true" data-before-rewrite-localise="https://www.livescience.com/tag/pandemic"&gt;pandemic&lt;/a&gt;, it triggered widespread disruptions in supply chains and health care services that ultimately threatened or &lt;a data-analytics-id="inline-link" href="https://www.livescience.com/health/coronavirus/covid-pandemic-knocked-16-years-off-global-life-expectancy-study-finds" data-before-rewrite-localise="https://www.livescience.com/health/coronavirus/covid-pandemic-knocked-16-years-off-global-life-expectancy-study-finds"&gt;&lt;u&gt;ended people's lives&lt;/u&gt;&lt;/a&gt;.&lt;/p&gt;&lt;p id="ad-unit-1" class="ad-unit"&gt;&lt;/p&gt;&lt;p&gt;Since its emergence in 2019, the novel coronavirus SARS-CoV-2 has had a tremendous impact on society. And yet, the next pandemic could potentially be even worse.&lt;/p&gt;&lt;a id="elk-seasonal" data-url="" href="" data-hl-processed="none"&gt;&lt;/a&gt;&lt;p id="25e52957-7aa0-4399-9a1c-5603f3713521-2"&gt;That's the argument of a new book by &lt;a data-analytics-id="inline-link" href="https://www.cidrap.umn.edu/michael-t-osterholdm-phd-mph" target="_blank" data-url="https://www.cidrap.umn.edu/michael-t-osterholdm-phd-mph" referrerpolicy="no-referrer-when-downgrade" data-hl-processed="none"&gt;&lt;u&gt;Michael Osterholm&lt;/u&gt;&lt;/a&gt;, founding director of the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, and award-winning author &lt;a data-analytics-id="inline-link" href="https://www.simonandschuster.com/authors/Mark-Olshaker/1135640" target="_blank" data-url="https://www.simonandschuster.com/authors/Mark-Olshaker/1135640" referrerpolicy="no-referrer-when-downgrade" data-hl-processed="none"&gt;&lt;u&gt;Mark Olshaker&lt;/u&gt;&lt;/a&gt;. The text doesn't just serve as a warning. As suggested by its title — &lt;a data-analytics-id="inline-link" href="https://www.hachettebookgroup.com/titles/michael-t-osterholm-phd-mph/the-big-one/9780316258340/?lens=little-brown-spark" target="_blank" data-url="https://www.hachettebookgroup.com/titles/michael-t-osterholm-phd-mph/the-big-one/9780316258340/?lens=little-brown-spark" referrerpolicy="no-referrer-when-downgrade" data-hl-processed="none"&gt;&lt;u&gt;"The Big One: How We Must Prepare for Future Deadly Pandemics"&lt;/u&gt;&lt;/a&gt; (Little Brown Spark, 2025) — the book lays out lessons learned during past pandemics and points to actions that could be taken to mitigate harm and save lives when the next infectious disease outbreak tears across the globe.&lt;/p&gt;&lt;p id="mid-article-leaderboard" class="ad-unit sm:hidden block"&gt;&lt;/p&gt;&lt;p id="08fa5795-89c3-4dc8-8a39-e38cf6e80779"&gt;Notably, the text was finalized before President Donald Trump began his second term.&lt;/p&gt;&lt;p id="ad-unit-2" class="ad-unit"&gt;&lt;/p&gt;&lt;p&gt;Since then, "we have basically destroyed what capacity we had to respond to a pandemic," Osterholm told Live Science. "The office that normally did this work in the White House has been totally disbanded."&lt;/p&gt;&lt;p&gt;Live Science spoke with Osterholm about the new book, what we should expect from the next &lt;a data-analytics-id="inline-link" href="https://www.livescience.com/pandemic.html" data-before-rewrite-localise="https://www.livescience.com/pandemic.html"&gt;&lt;u&gt;pandemic&lt;/u&gt;&lt;/a&gt;&lt;strong&gt; &lt;/strong&gt;and how we might prepare — both under ideal circumstances and under the current realities facing the U.S.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Related: &lt;/strong&gt;&lt;a data-analytics-id="inline-link" href="https://www.livescience.com/health/flu/rfks-proposal-to-let-bird-flu-spread-through-poultry-could-set-us-up-for-a-pandemic-experts-warn" data-before-rewrite-localise="https://www.livescience.com/health/flu/rfks-proposal-to-let-bird-flu-spread-through-poultry-could-set-us-up-for-a-pandemic-experts-warn"&gt;&lt;u&gt;&lt;strong&gt;RFK's proposal to let bird flu spread through poultry could set us up for a pandemic, experts warn&lt;/strong&gt;&lt;/u&gt;&lt;/a&gt;&lt;/p&gt;&lt;div id="slice-container-newsletterForm-articleInbodyContent-WNbzdbamYCxKMAHNou4oxK" class="slice-container newsletter-inbodyContent-slice newsletterForm-articleInbodyContent-WNbzdbamYCxKMAHNou4oxK slice-container-newsletterForm"&gt;&lt;div data-hydrate="true" class="newsletter-form__wrapper newsletter-form__wrapper--inbodyContent"&gt;&lt;div class="newsletter-form__container"&gt;&lt;section class="newsletter-form__main-section"&gt;&lt;p class="newsletter-form__strapline"&gt;Get the world’s most fascinating discoveries delivered straight to your inbox.&lt;/p&gt;&lt;/section&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;hr id="f91c963f-bd32-41e4-932e-e134028151f5"&gt;&lt;p id="c92f66f0-8c79-46a7-aab4-6ef8e0325ef2"&gt;&lt;strong&gt;Nicoletta Lanese: Given the book's title — "The Big One" — I figured we could start by defining what you mean by that phrase.&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Michael Osterholm: &lt;/strong&gt;Having worked, as I have, with coronaviruses, there are two characteristics that become very important: One is, how infectious are they? How relatively able are they to transmit? And [two], how lethal are they? How serious is the illness that they create, and the number of deaths?&lt;/p&gt;&lt;p&gt;I worked on both SARS and MERS before COVID came along. [&lt;a data-analytics-id="inline-link" href="https://www.bcm.edu/departments/molecular-virology-and-microbiology/emerging-infections-and-biodefense/specific-agents/sars-mers" target="_blank" data-url="https://www.bcm.edu/departments/molecular-virology-and-microbiology/emerging-infections-and-biodefense/specific-agents/sars-mers" referrerpolicy="no-referrer-when-downgrade" data-hl-processed="none"&gt;&lt;u&gt;SARS and MERS&lt;/u&gt;&lt;/a&gt; are severe coronavirus infections that predate COVID-19.] Those were two viruses that basically had the ability to kill 15% to 35% of the people that it infected, but they weren't nearly as infectious because they didn't have the &lt;a data-analytics-id="inline-link" href="https://theconversation.com/what-is-the-ace2-receptor-how-is-it-connected-to-coronavirus-and-why-might-it-be-key-to-treating-covid-19-the-experts-explain-136928" target="_blank" data-url="https://theconversation.com/what-is-the-ace2-receptor-how-is-it-connected-to-coronavirus-and-why-might-it-be-key-to-treating-covid-19-the-experts-explain-136928" referrerpolicy="no-referrer-when-downgrade" data-hl-processed="none"&gt;&lt;u&gt;ACE receptor&lt;/u&gt;&lt;/a&gt; capacity. [SARS-CoV-2, in comparison, plugs into the ACE2 receptor on human cells.]&lt;/p&gt;&lt;p&gt;But then along comes COVID, which basically has this highly infectious characteristic but fortunately, the case-fatality rate and serious illness was substantially lower than what we saw with MERS and SARS. Just in the last six months, there's actually been the isolation of new coronaviruses from bats in &lt;a data-analytics-id="inline-link" href="https://www.livescience.com/tag/china" data-auto-tag-linker="true" data-before-rewrite-localise="https://www.livescience.com/tag/china"&gt;China&lt;/a&gt; that actually have both [high infectiousness and high lethality] now. They actually have the ACE receptor capacity as well as that segment of the virus that was responsible for causing such severe illness.&lt;/p&gt;&lt;p&gt;So imagine a next pandemic where it's as infectious as COVID was, but instead of killing 1% to 2% of the people [it infected], it killed 15% to 35% of the people. That's exactly the example we're talking about with The Big One.&lt;/p&gt;&lt;p&gt;The same thing is true with influenza. You know, we've not seen a really severe influenza pandemic &lt;a data-analytics-id="inline-link" href="https://www.livescience.com/spanish-flu.html" data-before-rewrite-localise="https://www.livescience.com/spanish-flu.html"&gt;&lt;u&gt;dating back to 1918&lt;/u&gt;&lt;/a&gt;, relative to what it could be. And clearly there are influenza pandemics there, in a sense, waiting to happen. In the future, someday, that could easily be similar to or worse than what we saw with 1918 flu.&lt;/p&gt;&lt;p&gt;So we're trying to give people a sense that nobody's dismissing how severe COVID was, or what it did. It was devastating. But devastating with a "small d," not a "capital D," when you compare it to what could happen.&lt;/p&gt;&lt;figure class="van-image-figure pull-right inline-layout" data-bordeaux-image-check id="5ff90948-f751-478e-a622-4ef88c19f6ac"&gt;&lt;figcaption itemprop="caption description" class="pull-right inline-layout"&gt;&lt;span class="caption-text"&gt;Michael Osterholm, author of the book "The Big One: How We Must Prepare for Future Deadly Pandemics," warns that America is not prepared for the next pandemic. &lt;/span&gt;&lt;span class="credit" itemprop="copyrightHolder"&gt;(Image credit: Courtesy of the University of Minnesota)&lt;/span&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;p id="db3e9cbf-b45a-4576-82c8-f14f12f71ef4"&gt;&lt;strong&gt;NL: You mentioned both coronaviruses and influenza. Do you think the pathogen that sparks the next pandemic will belong to one of those groups?&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;MO: &lt;/strong&gt;We refer to these as "viruses with wings" in our book — you have to have a "virus with wings" to really make it into the pandemic category. I don't think there's a bacteria right now that would fit that characteristic; it really is in the virus family.&lt;/p&gt;&lt;p&gt;The greatest likelihood is going to be an influenza [virus] or coronavirus. Sure, there could be a surprise infection that comes up, but it'll have to have characteristics like flu and coronavirus in the sense of respiratory transmission.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;NL: Could you clarify what you mean by "virus with wings?" What gives a virus pandemic potential?&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;MO: &lt;/strong&gt;One of the things that made, for example, SARS and MERS easier to contain was for many of the [infected] individuals, they did not become highly infectious until after they're already clinically ill. But with COVID, we saw clearly a number of people who were actually infecting others when they were still asymptomatic, or they remained asymptomatic.&lt;/p&gt;&lt;p&gt;It [a "virus with wings"] has to have the airborne transmission capability, and that's the key one right there. … It would also be a virus that is novel to the society and that wouldn't have pre-existing immunity.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;NL: You make the case in the book that you can't necessarily prevent a pandemic pathogen from taking off, but you can mitigate its harm. Why is that?&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;MO: &lt;/strong&gt;I think exactly why we give the reader the scenario, because you can see the conditions on the ground in Somalia. [&lt;em&gt;Editor's note: Throughout "The Big One," the authors return to a thought experiment in which a pandemic virus emerges in Somalia and then spreads around the world, despite efforts by health officials to contain it.&lt;/em&gt;]&lt;/p&gt;&lt;p&gt;Every city, every camp, every clinic, every health care-related event is actually real. But you can see very quickly how a virus that emerged from an animal population — in this case camels — got into humans and how fast it moved around the world before anybody recognized it.&lt;/p&gt;&lt;figure id="71969cc9-4482-4ba6-80db-dfe5b554d5a4"&gt;&lt;blockquote class="vanilla-quoteblock"&gt;&lt;p&gt;mRNA technology offered us a real hope that we could actually, in the first year, have enough [vaccine] for the world. And of course you saw that was all just taken off the shelf by the White House.&lt;/p&gt;&lt;figcaption&gt;&lt;cite&gt;Michael Osterholm, University of Minnesota&lt;/cite&gt;&lt;/figcaption&gt;&lt;/blockquote&gt;&lt;/figure&gt;&lt;p id="e0ff69d0-f797-42db-b93a-b4f02b6eab39"&gt;These viruses are by nature highly infectious, and in a very mobile society, they are going to move. It just again illustrates that once that leaks out, it's out, it's gone. You can't unring a bell. Whereas other diseases that may be much slower to emerge and less likely to cause widespread transmission, you might be able to get to, but not easily with the pandemic. It's just gone. That's "wings," right there.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;NL: And when you talk about mitigating pandemics, you make the point that governments must be involved, that industry can't do it alone. Why?&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;MO: &lt;/strong&gt;Let me just say: I regret we didn't have six more months on this book. So many things have changed even from the time that the last manuscript went in at the end of last year and now, just because of what's happened in the Trump administration. We have basically destroyed what capacity we had to respond to a pandemic. The office that normally did this work in the White House has &lt;a data-analytics-id="inline-link" href="https://www.statnews.com/2025/07/30/white-house-pandemic-preparedness-office-leaderless-unprepared/" target="_blank" data-url="https://www.statnews.com/2025/07/30/white-house-pandemic-preparedness-office-leaderless-unprepared/" referrerpolicy="no-referrer-when-downgrade" data-hl-processed="none"&gt;&lt;u&gt;been totally disbanded&lt;/u&gt;&lt;/a&gt; [that being the Office of Pandemic Preparedness and Response Policy]. And there's no expertise there.&lt;/p&gt;&lt;p&gt;Today, if we had a major influenza pandemic and we needed vaccine, we'd be using the &lt;a data-analytics-id="inline-link" href="https://www.livescience.com/why-does-the-flu-shot-have-low-effectiveness" data-before-rewrite-localise="https://www.livescience.com/why-does-the-flu-shot-have-low-effectiveness"&gt;&lt;u&gt;embryonated chicken egg&lt;/u&gt;&lt;/a&gt;, which is the only means we have for any large-volume production of vaccine. Novavax has a cell-based one, but it's very limited how much can be produced. Even with all the global capacity, we could only make enough vaccine in the first 12 to 18 months for about one-fourth of the world. So three-quarters of the world in the first year of the pandemic wouldn't even see a vaccine, and it would take several years more.&lt;/p&gt;&lt;p&gt;Well, mRNA technology offered us a real hope that we could actually, in the first year, have enough for the world. And of course you saw that was all just taken off the shelf by the White House. HHS [the Department of Health and Human Services] said no more, $500 million is down. The money had been given to Moderna to actually develop prototypes ready to go so that if we needed them, we wouldn't have to go through the long laborious process of getting them approved. We get them approved now with the strain change issue [left for when a pandemic virus emerges].&lt;/p&gt;&lt;p&gt;And suddenly, that is like losing one of your wings at 30,000 feet [9,100 meters] — it's a devastating situation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Related: &lt;/strong&gt;&lt;a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/these-decisions-were-completely-reckless-funding-cuts-to-mrna-vaccines-will-make-america-more-vulnerable-to-pandemics" data-before-rewrite-localise="https://www.livescience.com/health/medicine-drugs/these-decisions-were-completely-reckless-funding-cuts-to-mrna-vaccines-will-make-america-more-vulnerable-to-pandemics"&gt;&lt;u&gt;&lt;strong&gt;'These decisions were completely reckless': Funding cuts to mRNA vaccines will make America more vulnerable to pandemics&lt;/strong&gt;&lt;/u&gt;&lt;/a&gt;&lt;/p&gt;&lt;figure class="van-image-figure inline-layout" data-bordeaux-image-check id="1206135f-df01-4c28-af6f-cf512132018d"&gt;&lt;figcaption itemprop="caption description" class=" inline-layout"&gt;&lt;span class="caption-text"&gt;Government funding cuts to mRNA vaccine technology are like "losing one of your wings at 30,000 feet," Osterholm said. &lt;/span&gt;&lt;span class="credit" itemprop="copyrightHolder"&gt;(Image credit: SOPA Images via Getty Images)&lt;/span&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;p id="c2b7ca87-15a3-4a31-a755-10dba3a1fd3b"&gt;&lt;strong&gt;NL: To push the point on mRNA: Do you see its main advantage being the speed of vaccine production?&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;MO: &lt;/strong&gt;What's important here with mRNA technology is in fact the speed, and you nailed that. Both in terms of not only designing the vaccine, but making it.&lt;/p&gt;&lt;p&gt;The second thing about it, though, is because of the way you can insert specific antigens into these vaccines [proteins that look foreign to the immune system]. You can take any one piece or several pieces, and actually now there's work going on on multiple antigens into mRNA vaccine, and that would be even better.&lt;/p&gt;&lt;p&gt;So it's much easier [than conventional vaccine manufacturing]. It's like a plug-and-play. Before, we didn't have anything like that. And clearly, we've demonstrated the mRNA approach does cause the human immune system to respond just as we want it to.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;NL: You also spend a lot of time in the book on the topic of communications — namely, how to better communicate key information in an unfolding pandemic. What do you think is a central takeaway for communicators?&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;MO: &lt;/strong&gt;Science is not truth; science is the pursuit of truth. So expect that we're going to learn a lot over the course of time. And I wish I could say to you today what I'll know three years from now, but I'm not. So the best I can do is keep you informed.&lt;/p&gt;&lt;p&gt;You know, I wrote an &lt;a data-analytics-id="inline-link" href="https://www.washingtonpost.com/opinions/2020/03/21/facing-covid-19-reality-national-lockdown-is-no-cure/" target="_blank" data-url="https://www.washingtonpost.com/opinions/2020/03/21/facing-covid-19-reality-national-lockdown-is-no-cure/" referrerpolicy="no-referrer-when-downgrade" data-hl-processed="none"&gt;&lt;u&gt;op-ed piece in the Washington Post&lt;/u&gt;&lt;/a&gt; early in the pandemic response before lockdowns even got going and I urged not to do lockdowns. "They won't work, don't do them. When are you going to release the lockdown, because this is going to last for months to years?"&lt;/p&gt;&lt;p&gt;What I suggested was something more akin to a snow day. The most important thing we could do to minimize the number of severe illnesses and deaths was to keep our health care system functioning and to be able to provide that care. Well, we didn't do that well because we have these big bursts of cases. What if we had really had the data on hospital capacity in every community, and we put those numbers up every day? And when we approached, you know, 95% of beds full: "Please, just like we do for snow days, for the next week, if you can back off public interaction, we can get those bed numbers back down." We were in this for the long haul.&lt;/p&gt;&lt;p&gt;We should have done a much better job of communicating that and not just jumping to "lockdowns" because when they ended, then what the hell do you do? We didn't paint this as, "This is going to be a battle for potentially three or four years." We were approaching this far too much like a hurricane situation. "It's going to blow through, it's going to be horrible, but in six hours, 12 hours, we'll be able to get to recovery mode." This wasn't going to happen that way.&lt;/p&gt;&lt;p&gt;One of things I find, throughout my 50 years in the business, is that people want truth. Don't sugarcoat things. At the same time, don't exaggerate; give people the reason as to how you got there.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;NL: Given how complicated our information ecosystem is now, I'm not sure if you have an impression of where most people got their updates? Or if it was highly mixed? &lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;MO: &lt;/strong&gt;I think that's a very important point. And I would say that no one's talking about having one single unified voice, because there's going to be differences when you're pursuing [solutions] and they'll change over time.&lt;/p&gt;&lt;p&gt;That's where we needed more humility. I keep coming back to that word humility — to say what we know and what we don't know and how it could change. I think had we done that, we'd be in much better shape in terms of public credibility. When you don't know, say you don't know.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;NL: You close the book noting that you're often asked what the average person can do. Is there anything?&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;MO: &lt;/strong&gt;Actually this has come into sharper focus with regard to the vaccine issue right now.&lt;/p&gt;&lt;p&gt;On our website, for example, &lt;a data-analytics-id="inline-link" href="https://www.cidrap.umn.edu/osterholm-update" target="_blank" data-url="https://www.cidrap.umn.edu/osterholm-update" referrerpolicy="no-referrer-when-downgrade" data-hl-processed="none"&gt;&lt;u&gt;when I do the podcast&lt;/u&gt;&lt;/a&gt;, we in the show notes list organizations that are working in the community on vaccines and to help support availability, education, etc. Get engaged with them. One of the things we didn't do is use our citizen public health army during the pandemic that we could have. There were some limited outreaches, for example, to the religious, to pastors and so forth, but I think we could do much, much more. Information will not stop the pandemic, but information may minimize the horrible impact that it has.&lt;/p&gt;&lt;p id="05c9bcae-ba28-4f0d-bb2e-10eb96132bb8"&gt;When I talk about citizen involvement, they can't go and make vaccines, but they can surely reach out to their elected officials. They can make sure that [harmful] policies are not being made at school boards, or at city councils or in state legislatures. We just had a bill introduced in Minnesota that's starting to get some legs to it, that would &lt;a data-analytics-id="inline-link" href="https://www.revisor.mn.gov/bills/bill.php?b=House&amp;amp;f=HF3219&amp;amp;ssn=0&amp;amp;y=2025" target="_blank" data-url="https://www.revisor.mn.gov/bills/bill.php?b=House&amp;amp;f=HF3219&amp;amp;ssn=0&amp;amp;y=2025" referrerpolicy="no-referrer-when-downgrade" data-hl-processed="none"&gt;&lt;u&gt;outlaw mRNA technology as a criminal activity&lt;/u&gt;&lt;/a&gt;. Literally, if you gave a vaccine, you could go to prison.&lt;/p&gt;&lt;p&gt;Having citizens be able to track this, maintain contact and be able to testify I think is really important. … We have to do more and more, to have citizen watch groups that are alerting people.&lt;/p&gt;&lt;p&gt;VIP [&lt;a data-analytics-id="inline-link" href="https://www.cidrap.umn.edu/vaccine-integrity-project" target="_blank" data-url="https://www.cidrap.umn.edu/vaccine-integrity-project" referrerpolicy="no-referrer-when-downgrade" data-hl-processed="none"&gt;&lt;u&gt;Vaccine Integrity Project&lt;/u&gt;&lt;/a&gt;, an initiative aimed at safeguarding vaccine use in the U.S.] is a good example of this. One of the individuals who presented yesterday at our big meeting is a woman with three kids, who is a mother, a department chief, all these different things — I don't know which 29 hours a day she works, but she's amazing. I said to her, "You know, you've got to take some time off." And she said, "This is too important."&lt;/p&gt;&lt;p&gt;This is what's giving me hope, you know. That's what we have to tap into.&lt;/p&gt;&lt;div id="slice-container-freeText-WNbzdbamYCxKMAHNou4oxK-RuHuXk9Q9ta7rRiZCUBFPFIYlzW0pkfQ" class="slice-container freeText-wrapper freeText-WNbzdbamYCxKMAHNou4oxK-RuHuXk9Q9ta7rRiZCUBFPFIYlzW0pkfQ slice-container-freeText"&gt;&lt;div class="info-block"&gt;&lt;p class="infoDisclaimer"&gt;This article is for informational purposes only and is not meant to offer medical advice.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;a id="elk-5a8b052e-90a8-4b73-9824-3af034c4c713" data-url="" href="" data-hl-processed="none"&gt;&lt;/a&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Live Science</author><pubDate>Tue, 09 Sep 2025 18:45:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMijgJBVV95cUxPd3ZDMU05V29wSjBRUlZ5WUpkN0laSWNDQ3lsc09xbTRGSlF6LUlVejF3MzhSY2otSGRFMmg4UW8tTVlmaEhfaER5WU53X1hYQThFcFNyVHNqVVJjQVQ1RlZiUXdPdnQ2VVlONzVPSS1DZzhrRXB4YzZ4Rkp3YlI2VnZGRGtFWkt1WWkyZy1UUWF5QnV0cmJsYWpDZXdKa3l3eEExTWZoSmV6UVNiWW9LVHVURFJlalRpb0FtMnBscWdOX3hRWVhDSklOdWpQellIRnF1RkdUUkhVRkt4MmxsMm9ueEpidmxzMFVOS3BpdmFMalJEenZwYzhnMDBXUkpRd2ZNWlhsaC1nVXp4ckE</guid></item><item><title>今年秋天你能接种新冠疫苗吗？这取决于一个荒谬的因素。-石板</title><link>https://slate.com/technology/2025/09/covid-vaccine-flu-shots-2025-florida-new-york-robert-f-kennedy-jr.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="article__content" itemprop="mainEntityOfPage"&gt;
          &lt;p class="slate-paragraph slate-graf" data-word-count="21" data-uri="slate.com/_components/slate-paragraph/instances/cmfcvbb3e008o3b7am7zy5wct@published"&gt;&lt;em&gt;&lt;a href="https://slate.com/theslatest?utm_source=slate&amp;amp;utm_medium=article&amp;amp;utm_campaign=article_plain_text_topper"&gt;Sign up for the Slatest&lt;/a&gt; to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily.&lt;/em&gt;&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="50" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv2eis0042t1ktjno3svcg@published"&gt;Last week, &lt;a href="https://slate.com/news-and-politics/2025/09/rfk-robert-kennedy-senate-hearing-bill-cassidy.html"&gt;U.S. senators spent three hours in a hearing room&lt;/a&gt; grappling with an urgent problem. The problem is that even though most Americans trust vaccines and feel safer when they and their families have access to them, the Trump appointee in charge of distributing America’s shots has his doubts.&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="119" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv2rsk000o3b7a899l0dvz@published"&gt;This hearing was &lt;em&gt;supposed&lt;/em&gt; to be about the president’s plan to “make America healthy again.” But for Democrats, Robert F. Kennedy Jr.’s actions as the secretary of Health and Human Services changed the agenda. We’ve known from the beginning, of course, how Robert F. Kennedy &lt;em&gt;feels&lt;/em&gt; about vaccines. But it’s worth talking about what he’s &lt;em&gt;done&lt;/em&gt;. So far, he has fired members of a crucial vaccine advisory committee—something he promised senators he would not do. His Food and Drug Administration has tried to &lt;a href="https://www.nytimes.com/2025/08/27/health/fda-covid-vaccines-rfk-jr.html"&gt;limit&lt;/a&gt; who can get COVID shots this fall. The secretary booted the head of the Centers for Disease Control and Prevention after a disagreement over immunization practices. Then, more than 1,000 government scientists demanded Kennedy’s resignation.&lt;/p&gt;

  

  &lt;p class="slate-paragraph slate-graf" data-word-count="44" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv2rxa000p3b7axu14l6z2@published"&gt;On a &lt;a href="https://link.chtbl.com/WNTranscript982025"&gt;recent episode&lt;/a&gt;&lt;strong&gt; &lt;/strong&gt;of What Next, Mary Harris spoke to Apoorva Mandavilli, a science and global health reporter at the New York Times, about how RFK Jr. put himself between Americans and their vaccines. This transcript has been edited and condensed for clarity.&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="68" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv3b3o00193b7axy5d7gbg@published"&gt;&lt;strong&gt;Mary Harris: Some of the former members of the Advisory Committee on Immunization Practices who were fired talked to &lt;/strong&gt;&lt;a href="https://www.statnews.com/2025/09/04/cdc-vaccine-policy-acip-covid-choice/" rel="noopener noreferrer" target="_blank"&gt;&lt;strong&gt;Stat News&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;, and they said Americans are losing the ability to choose vaccination. I thought that was an interesting way of phrasing things, because it’s not like your vaccine is being taken away. It’s your choice to have a vaccine. Can you just lay out how this is working? &lt;/strong&gt;&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="42" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv38xa000z3b7axlkmpv57@published"&gt;&lt;strong&gt;Apoorva Mandavilli: &lt;/strong&gt;Their word choice, “choose to,” is also very important because that’s what RFK Jr. has always said. He wants to give Americans a choice, and he believes they should be able to choose whether they want a vaccine or not.&lt;/p&gt;

  


  


  


  


  &lt;p class="slate-paragraph slate-graf" data-word-count="76" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv3cvt001j3b7aic5luyjv@published"&gt;But the FDA said from the start, as soon as the new leaders came on board, that they were not going to approve vaccines for anybody under 65 without new evidence. And sure enough, that is what has happened. They have approved the vaccine only for people who are older than 65 or for some people who have other health conditions that may put them at high risk. They’re not approving them for healthy pregnant women.&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="92" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv3fv7001t3b7avv9re3nn@published"&gt;RFK Jr.’s &lt;a href="https://www.npr.org/sections/shots-health-news/2025/05/27/nx-s1-5413179/covid-vaccine-children-pregnant-rfk-cdc#:~:text=All%20Things%20Considered-,CDC%20to%20stop%20recommending%20COVID%20vaccine%20for%20kids%2C%20pregnant%20women,pregnant%20women%20and%20healthy%20children."&gt;announcement&lt;/a&gt; in May that the CDC would no longer recommend the vaccines also means that insurance companies won’t cover them. So now you have a situation where, let’s say, there is a 50-year-old person who does not have any health conditions but wants to get the vaccine because they believe in it, and maybe they don’t want to expose anyone else to it. Maybe they want it because the vaccine does provide benefits, and they don’t want to get sick, or they don’t want to end up in the hospital.&lt;/p&gt;

  


  

  &lt;p class="slate-paragraph slate-graf" data-word-count="51" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv3l8n00233b7aa2ow7vw1@published"&gt;&lt;strong&gt;If we look at the example of the COVID vaccine, how is policy trickling down to actual access?&lt;/strong&gt;&lt;br&gt;These people will not be able to get the vaccine without finding a doctor who is willing to do that for them off-label, and they might have to pay for it out of pocket.&lt;/p&gt;

  


  &lt;p class="slate-paragraph slate-graf" data-word-count="81" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv4s2e002d3b7anawztfhy@published"&gt;Some pharmacies, like CVS and Walgreens, give out tons of shots for adults. They’re actually now saying that they won’t carry the COVID vaccine at all in certain states because of what’s going on. Even in states where you are, in theory, able to get it, the reality is that when you have these kinds of rules, pharmacies are just reluctant to carry the vaccine. They don’t want to get involved in this kind of thing because it’s just too difficult.&lt;/p&gt;

  


  &lt;p class="slate-paragraph slate-graf" data-word-count="33" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv4tpg002n3b7ad5og6b46@published"&gt;RFK Jr. has also threatened doctors who go against the guidelines, saying that they will not be protected from liability if they don’t follow ACIP recommendations. That’s a real deterrent for any doctor.&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="7" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv4vif002x3b7avfdffbds@published"&gt;&lt;strong&gt;How does it compare to policies worldwide? &lt;/strong&gt;&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="108" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv4wy400373b7ak3w13rse@published"&gt;One thing that a lot of the COVID vaccine skeptics point to is that the guidelines now are closer to what they are in other countries. Of course, they very conveniently leave out the fact that in those countries, the vaccine is still approved for everyone. So they do actually have a real choice. They can still get it if they want. And many of these countries have national health care. So they’re not worried about the cost for themselves if they want the vaccine. The circumstances are very different, partly because they have a safety net. They have a health care network that takes care of them.&lt;em&gt; &lt;/em&gt;&lt;/p&gt;

  


  


  


  &lt;p class="slate-paragraph slate-graf" data-word-count="86" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv4yqp003h3b7apfpvb15u@published"&gt;&lt;strong&gt;Last week, Florida came out and &lt;/strong&gt;&lt;a href="http://google.com/search?q=florida+rids+vaccine+mandate&amp;amp;oq=florida+rids+vaccine+mandate&amp;amp;gs_lcrp=EgZjaHJvbWUyBggAEEUYOTIJCAEQIRgKGKABMgkIAhAhGAoYoAEyCQgDECEYChigATIHCAQQIRiPAtIBCDMzNDRqMGo3qAIAsAIA&amp;amp;sourceid=chrome&amp;amp;ie=UTF-8"&gt;&lt;strong&gt;said&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt; it will no longer require vaccines to participate in public life, whether that means going to school or whatever else. This is striking because vaccine mandates have been around for a long time and have been controversial for a long time. But they’re definitely a tool of public health to keep all kinds of people safe. So when you heard about what was happening in Florida, what was your reaction? And can you tell that story a little bit? &lt;/strong&gt;&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="114" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv51jr003r3b7a7ooso5h6@published"&gt;Florida has a surgeon general who has been very anti-vaccine for quite a while now. He has said many, many things about COVID vaccines that are not true. Even when there was a measles outbreak, he said that kids could come into school without being vaccinated. It’s not surprising that states are starting to go their own way. States have always decided for themselves what to do with various health policies. But what has been important for them is to have this central voice, the CDC, saying, “This is what we think is right,” and then they can just follow that. Maybe they make minor tweaks here and there, but they essentially follow that.&lt;/p&gt;

  


  


  


  &lt;p class="slate-paragraph slate-graf" data-word-count="134" data-uri="slate.com/_components/slate-paragraph/instances/cmfcvtb1d0007357bhacxymmn@published"&gt;But when you have a situation where they can no longer trust what’s coming from the federal government, then they are sort of forced to make their own decisions at a whole other level, where they have to actually review the evidence themselves or entrust their own judgment in a way that they haven’t had to. That’s when you see Florida saying, “Well, I’m trusting my judgment and I don’t think anybody needs to be vaccinated to come to school.” But you’re also seeing West Coast states—Washington, Oregon, and California—saying they’re going to review the evidence on their own. We’re hearing about Northeast states doing that. New York is apparently going to follow its own thing. So this mishmash was predictable when the CDC stops being the central voice that they all listen to.&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="44" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv5cw700413b7ark9l421t@published"&gt;&lt;strong&gt;Next week, when ACIP meets, are they going to give further guidance? And how do you think their guidance is going to be viewed, given the fact that RFK Jr. just showed up on the Hill and got beaten about the head by senators? &lt;/strong&gt;&lt;/p&gt;

  


  &lt;p class="slate-paragraph slate-graf" data-word-count="52" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv5f34004b3b7aass7a1pq@published"&gt;Insurance companies are still going to cover what ACIP recommends. And there are many states whose state-level recommendations are very tied up with ACIP. Their laws will say that they follow the ACIP guidelines pretty much as they are. So for anybody to break with those recommendations, it would require some work.&lt;/p&gt;

  


  


  &lt;p class="slate-paragraph slate-graf" data-word-count="53" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv5h5o004l3b7acy6vtilw@published"&gt;&lt;strong&gt;I wonder if we’re going to see a future where people travel to get vaccines, where one state looks very different than another state, and what that will mean, because of course, we’re all interconnected. States border each other. And so an outbreak in one place doesn’t necessarily stay in one place, right?&lt;/strong&gt;&lt;/p&gt;


  &lt;p class="slate-paragraph slate-graf" data-word-count="89" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv5j6k004v3b7awnsjdms3@published"&gt;It doesn’t at all. It doesn’t stay in one state, in one country. The thing to remember also is that a lot of the money that state health departments have comes from the CDC. So when that budget is cut, which it has been, they have less money. And they have had to lay people off. So at the same time that they’re being asked to make more decisions on their own, or they’re having to make decisions on their own, they have fewer people to do the work.&lt;/p&gt;

  


  


  &lt;p class="slate-paragraph slate-graf" data-word-count="52" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv5kjm00553b7av146xm20@published"&gt;&lt;strong&gt;Vaccines are all about prevention, and you don’t see the benefit of them for a really long time. You’re preventing a negative. So when an outbreak does happen, it may happen years after the vaccines are no longer available. Would it then be harder to draw the connection of why it happened?&lt;/strong&gt;&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="38" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv5m3r005f3b7akkluc786@published"&gt;Yeah. Something public health people say a lot is, “When we’re doing our job right, you don’t see us.” So when we start to see more measles outbreaks, or polio, that’s when it’ll become clear what was needed.&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="45" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv5nj3005p3b7ali31wz9t@published"&gt;It’ll also become clearer how intricate this network is. Things go across states, across countries. So you can’t dismantle global health, and you can’t dismantle federal health structures, and still expect things to function OK at the local level. That’s just not how it works.&lt;/p&gt;

  
  &lt;p class="slate-paragraph slate-graf" data-word-count="32" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv5otw005z3b7aeopzhwxe@published"&gt;&lt;strong&gt;When you’ve spoken to people about what happens now, is there anyone who has a vision for how to get out of the mess that we’re in with vaccines at this moment? &lt;/strong&gt;&lt;/p&gt;

  


  &lt;p class="slate-paragraph slate-graf" data-word-count="77" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv5qxc00693b7afevqipke@published"&gt;One hard solution that I think has some hope of working, at least to some extent, is that there are medical organizations that are banding together. They are forming a coalition, of sorts, to issue guidance. Essentially, they’re forming a shadow ACIP. The American Academy of Pediatrics and the American College of Obstetricians and Gynecologists are two of the organizations that are really important here. They have both said that they don’t agree with the ACIP recommendations.&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="60" data-uri="slate.com/_components/slate-paragraph/instances/cmfcv5soa006j3b7amtu6wqi0@published"&gt;One hope is that there are enough of these organizations that are respected, that they will band together and that states will be able to look to them for guidance. Of course, it still won’t solve the issue of insurance coverage. But that’s the best we can look at, at this point. And there are many efforts along those &lt;span class="slate-paragraph--tombstone"&gt;lines.&lt;/span&gt;&lt;/p&gt;

  &lt;section class="newsletter-signup   " data-list="The Slatest" data-uri="slate.com/_components/newsletter-signup/instances/cmfcv2eis0045t1ktoeb7wgga@published"&gt;


    &lt;div class="newsletter-signup__intro newsletter-signup__intro--centered"&gt;
          &lt;img alt="" class="newsletter-signup__img" hidden data-src-light="https://dot.cdnslate.com/static/media/components/newsletter-signup/the-slatest.49f353b.png" data-src-dark="https://dot.cdnslate.com/static/media/components/newsletter-signup/the-slatest-dark.ca73d21.png"&gt;
&lt;h1 class="newsletter-signup__headline"&gt;Get the best of news and politics&lt;/h1&gt;
      &lt;span class="newsletter-signup__description"&gt;Sign up for Slate's evening newsletter.&lt;/span&gt;
    &lt;/div&gt;
    



&lt;/section&gt;

  

&lt;/div&gt;

      &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Slate</author><pubDate>Tue, 09 Sep 2025 18:38:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiqwFBVV95cUxQdG5ZZlRKY0ZPcmJfOXZjd1pjWGcxbFIweGZtVFNKLWEwUWNad29MUXUzbUNlbE9iRkZNc3AtaS1IOXdKcURnYUxiaGtWLU1JSUwxZnY5ZG1sRGVVZG1KWUFMNUlReHZoUjlIVjlFRGNxMldzMEZaYnk1UG1VS092eEtHc3FUZ3UwR1JxZVNrZ2N6eG1Gak54N0QyYjFnM3hBMXVGanhhRzByYm8</guid></item><item><title>奥斯汀医生被停职，被指控与患者发生性关系-达拉斯新闻</title><link>https://www.dallasnews.com/business/health-care/2025/09/09/austin-doctor-suspended-accused-of-sexual-relationships-with-patients/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;section&gt;&lt;p class="body-text-paragraph"&gt;The Texas Medical Board has suspended a family medicine doctor in Austin after finding the physician used medical appointments for sexual encounters with patients. &lt;/p&gt;&lt;p class="body-text-paragraph"&gt;The medical board on Sept. 3 temporarily suspended Dr. Jared Kealy’s medical license, citing a threat to public welfare. The suspension was effective immediately.&lt;/p&gt;&lt;p class="body-text-paragraph"&gt;Through his attorney, Kealy denied the allegations.&lt;/p&gt;&lt;p class="body-text-paragraph"&gt;Kealy worked at an Austin location of Lone Star Circle of Care, which is a federally qualified health center. Such centers provide medical care to underserved communities, often focusing on uninsured and low-income patients.&lt;/p&gt;&lt;div class="dmnc_features-cta-social-article-cta-social-module__sI3E3 p-7 mb-6 w-full h-64 border-t border-b border-black flex flex-col gap-7"&gt;&lt;div class="dmnc_features-cta-social-article-cta-social-module__2nIGz flex items-center justify-center gap-x-7"&gt;&lt;div class="dmnc_features-cta-social-article-cta-social-module__VBR0d flex-auto w-full flex flex-col"&gt;&lt;p class="dmnc_features-cta-social-article-cta-social-module__jO6ca secondaryBold secondaryBold-8 text-center"&gt;Business Briefing&lt;/p&gt;&lt;p class="dmnc_features-cta-social-article-cta-social-module__3beff secondaryRoman secondaryRoman-20 text-center text-gray-dark"&gt;Become a business insider with the latest news.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="dmnc_features-cta-social-article-cta-social-module__WpP95 flex flex-col gap-7 items-center"&gt;&lt;p class="dmnc_features-cta-social-article-cta-social-module__8MgJa flex flex-wrap text-gray-dark secondaryRoman secondaryRoman-20 text-center justify-center"&gt;By signing up, you agree to our &lt;a class="dmnc_features-cta-social-article-cta-social-module__lU9-l border-b border-gray-dark hover_border-0 focus_border-0 active_border-0" href="/help/terms-of-service/"&gt;Terms of Service&lt;/a&gt; and &lt;a class="dmnc_features-cta-social-article-cta-social-module__lU9-l border-b border-gray-dark hover_border-0 focus_border-0 active_border-0" href="/help/privacy-policy"&gt;Privacy Policy.&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p class="body-text-paragraph"&gt;In the suspension announcement, the Texas Medical Board wrote that Kealy had initiated sexual relationships with two patients. The family medicine doctor, according to the announcement, also “used scheduled medical encounters to engage in, and continue, sexual acts with the patients.”&lt;/p&gt;&lt;p class="body-text-paragraph"&gt;Kealy’s attorney, Louis Leichter of the Austin-based &lt;a href="https://www.leichterlaw.com/attorneys/louis-leichter/" target="_self" rel="" title="https://www.leichterlaw.com/attorneys/louis-leichter/"&gt;Leichter Law Firm&lt;/a&gt;, rejected the allegations. &lt;/p&gt;&lt;p class="body-text-paragraph"&gt;“He denies sexual involvement with the two patients,” Leichter said of his client.&lt;/p&gt;&lt;p class="body-text-paragraph"&gt;The attorney said Kealy was not given proper due process at his hearing before the board.&lt;/p&gt;&lt;p class="body-text-paragraph"&gt;“It was almost as if they had made up their mind before we walked into the hearing,” Leichter said, “and without being able to hear the relevant testimony, nothing could persuade them from changing their mind.”&lt;/p&gt;&lt;p class="body-text-paragraph"&gt;Lone Star Circle of Care said in a statement, sent by spokesperson Ashley Wild, that the organization could not comment on specific patient cases.&lt;/p&gt;&lt;p class="body-text-paragraph"&gt;“Lone Star Circle of Care prioritizes the safety and well-being of its patients and takes any allegations of professional misconduct very seriously,” the statement said. &lt;/p&gt;&lt;p class="body-text-paragraph"&gt;“We can confirm that Dr. Jared Kealy has not provided medical services at Lone Star Circle of Care for some time, and is no longer an employee of the organization.”&lt;/p&gt;&lt;p class="body-text-paragraph"&gt;In response to questions about the time frame and nature of Kealy’s separation from the organization, Wild referred back to the original statement.&lt;/p&gt;&lt;p class="body-text-paragraph"&gt;Kealy is no longer listed on &lt;a href="https://lonestarcares.org/providers/" target="_self" rel="" title="https://lonestarcares.org/providers/"&gt;Lone Star Circle of Care’s website&lt;/a&gt;. An archived version of the website includes Kealy on the provider list &lt;a href="https://web.archive.org/web/20250715005509/https://lonestarcares.org/providers/" target="_self" rel="" title="https://web.archive.org/web/20250715005509/https://lonestarcares.org/providers/"&gt;as recently as July&lt;/a&gt;. The location that Kealy worked at is also no longer listed on the website.&lt;/p&gt;&lt;/section&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Dallas News</author><pubDate>Tue, 09 Sep 2025 18:22:30 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiyAFBVV95cUxNcl9HcHB0SU11MUNLR3RjN0tIX0F5azBqMTE5aXdRcldENFVHeXh5Vzh5MFZpYjYxbldPbDBCTjVYTlQ1eXdNTDVxaGJHelhfb1E3NE9pWmVPMjg3akxtNHVGaktHUWdYVzYzNzU2M0JJN2JhWEFIOVpBWTVqV295R1k1RlAzdkhteDNneS14UGF1cnVSejBkLVlSbVNSZFJ0SW5sZ1hsZ3lzeDRjdktRTzhZaS1uM0FucXBHQkxUMl8zdmxYblpncA</guid></item><item><title>研究表明，常用产品正被用于青少年前期的自我伤害- CNN</title><link>https://www.cnn.com/2025/09/09/health/medication-preteen-self-harm-wellness</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="article__content" data-editable="content" itemprop="articleBody" data-reorderable="content"&gt;
                  &lt;div data-uri="cms.cnn.com/_components/action-bar/instances/cmfckmaja001s26qc4gub29m7@published" data-label-id-prefix="action-bar-start-of-article" class="action-bar" data-dynamic-breakpoint-placement='{"extraLarge":{"placement":".layout-article-elevate__left"}}' data-expand-conditions='{"follow":{"extraLarge":{"alwaysExpand":true}},"shareOptions":{"large":{"maxNumOfActions":1},"medium":{"maxNumOfActions":1},"extraLarge":{"withAction":"follow","maxNumOfActions":2}}}'&gt;
    &lt;p class="action-bar__overlay"&gt;&lt;/p&gt;
    &lt;div class="action-bar__action-sheet" tabindex="-1"&gt;
        
            
            &lt;div class="action-bar__action-sheet--action" data-title="share options"&gt;
                  &lt;div data-uri="cms.cnn.com/_components/social-share/instances/cmfckmaja001v26qc9wxv2ro7@published" class="social-share_labelled-list"&gt;
    &lt;div class="social-share_labelled-list__share-links vossi-social-share_labelled-list" data-type="share-links"&gt;
        &lt;button class="social-share_labelled-list__share" data-url="https://www.facebook.com/dialog/share?app_id=80401312489&amp;amp;href=https%3A%2F%2Fwww.cnn.com%2F2025%2F09%2F09%2Fhealth%2Fmedication-preteen-self-harm-wellness&amp;amp;display=popup" data-type="facebook" aria-label="share with facebook" title="Share with Facebook"&gt;
                &lt;svg class="icon-facebook-circle" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 16 16" fill="none"&gt;
&lt;path d="M8.04139 1.33301C11.7458 1.33301 14.7488 4.33601 14.7488 8.04042C14.7488 11.3884 12.296 14.1632 9.08943 14.6663V9.97928H10.6523L10.9497 8.04042H9.08943V6.78225C9.08943 6.25182 9.34934 5.73475 10.1825 5.73475H11.0283V4.08409C11.0283 4.08409 10.2607 3.95309 9.52685 3.95309C7.99476 3.95309 6.99336 4.88165 6.99336 6.56269V8.04042H5.29031V9.97928H6.99336V14.6663C3.78677 14.1632 1.33398 11.3882 1.33398 8.04042C1.33398 4.33601 4.33699 1.33301 8.04139 1.33301Z" fill="#0C0C0C"&gt;&lt;/path&gt;
&lt;/svg&gt;

                &lt;span class="social-share_labelled-list__share-links--label"&gt;Facebook&lt;/span&gt;
        &lt;/button&gt;
        &lt;button class="social-share_labelled-list__share" data-url="https://twitter.com/intent/tweet?text=Check%20out%20this%20article%3A&amp;amp;url=https%3A%2F%2Fwww.cnn.com%2F2025%2F09%2F09%2Fhealth%2Fmedication-preteen-self-harm-wellness" data-type="x" aria-label="share with x" title="Share with X"&gt;
                &lt;svg class="icon-x-share" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 16 16" fill="none"&gt;
&lt;path fill-rule="evenodd" clip-rule="evenodd" d="M5.99386 8.11503L0 0.666992H4.74756L8.44753 5.27039L12.4004 0.687719H15.0151L9.71175 6.84331L16 14.667H11.2666L7.2603 9.6887L2.98317 14.6532H0.354296L5.99386 8.11503ZM11.9565 13.287L2.91105 2.04698H4.0571L13.0912 13.287H11.9565Z" fill="#0C0C0C"&gt;&lt;/path&gt;
&lt;/svg&gt;

                &lt;span class="social-share_labelled-list__share-links--label"&gt;Tweet&lt;/span&gt;
        &lt;/button&gt;
        &lt;a class="social-share_labelled-list__share" href="mailto:?subject=CNN%20content%20share&amp;amp;body=Check%20out%20this%20article%3A%0Ahttps%3A%2F%2Fwww.cnn.com%2F2025%2F09%2F09%2Fhealth%2Fmedication-preteen-self-harm-wellness" data-type="email" target="_blank" rel="noopener noreferrer" aria-label="share with email" title="Share with email"&gt;
                &lt;svg class="icon-email-share" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 24 24" fill="none"&gt;
&lt;path fill-rule="evenodd" clip-rule="evenodd" d="M2 6C2 4.89543 2.89543 4 4 4H20C21.1046 4 22 4.89543 22 6V18C22 19.1046 21.1046 20 20 20H4C2.89543 20 2 19.1046 2 18V6ZM4 6H20V9.11604L12 11.9396L4 9.11604V6ZM4 11.237V18H20V11.237L12.3328 13.943C12.1174 14.019 11.8825 14.019 11.6672 13.943L4 11.237Z" fill="#0C0C0C"&gt;&lt;/path&gt;
&lt;/svg&gt;

                &lt;span class="social-share_labelled-list__share-links--label"&gt;Email&lt;/span&gt;
        &lt;/a&gt;
        &lt;button class="social-share_labelled-list__share" data-url="https://www.cnn.com/2025/09/09/health/medication-preteen-self-harm-wellness" data-type="copy" aria-label="copy link to clipboard" title="Copy link to clipboard"&gt;
                &lt;svg class="icon-hyperlink" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 16 16" fill="none"&gt;
&lt;path fill-rule="evenodd" clip-rule="evenodd" d="M5.64373 10.3574C5.38338 10.0971 5.38338 9.67496 5.64373 9.41461L9.88637 5.17197C10.1467 4.91162 10.5688 4.91162 10.8292 5.17197C11.0895 5.43232 11.0895 5.85443 10.8292 6.11478L6.58654 10.3574C6.32619 10.6178 5.90408 10.6178 5.64373 10.3574Z" fill="#0C0C0C"&gt;&lt;/path&gt;
&lt;path d="M4.22952 8.94321L5.64373 7.52899C5.90408 7.26865 5.90408 6.84654 5.64373 6.58619C5.38338 6.32584 4.96127 6.32584 4.70092 6.58619L3.28671 8.0004C1.98496 9.30215 1.98496 11.4127 3.28671 12.7144C4.58846 14.0162 6.69901 14.0162 8.00075 12.7144L9.41497 11.3002C9.67532 11.0399 9.67532 10.6178 9.41497 10.3574C9.15462 10.0971 8.73251 10.0971 8.47216 10.3574L7.05795 11.7716C6.2769 12.5527 5.01057 12.5527 4.22952 11.7716C3.44847 10.9906 3.44847 9.72426 4.22952 8.94321Z" fill="#0C0C0C"&gt;&lt;/path&gt;
&lt;path d="M8.94356 4.22916L7.52935 5.64338C7.269 5.90373 6.84689 5.90373 6.58654 5.64338C6.32619 5.38303 6.32619 4.96092 6.58654 4.70057L8.00075 3.28635C9.3025 1.98461 11.4131 1.98461 12.7148 3.28635C14.0165 4.5881 14.0165 6.69865 12.7148 8.0004L11.3006 9.41461C11.0402 9.67496 10.6181 9.67496 10.3578 9.41461C10.0974 9.15426 10.0974 8.73215 10.3578 8.4718L11.772 7.05759C12.553 6.27654 12.553 5.01021 11.772 4.22916C10.9909 3.44812 9.72461 3.44811 8.94356 4.22916Z" fill="#0C0C0C"&gt;&lt;/path&gt;
&lt;/svg&gt;

                &lt;span class="social-share_labelled-list__share-links--label"&gt;Link&lt;/span&gt;
        &lt;/button&gt;
        
    &lt;/div&gt;
    &lt;button class="social-share_labelled-list__open" data-type="open" aria-label="open social share" title="Open social share"&gt;
        &lt;svg class="icon-ui-share-os" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M19 12c.394 0 .714.32.714.714v8.572c0 .394-.32.714-.714.714H4.714A.715.715 0 014 21.286v-8.572a.715.715 0 011.429 0v7.857h12.857v-7.857c0-.394.32-.714.714-.714zm-7.664-9.79a.73.73 0 011.024 0l.076.075 4.916 4.854c.183.18.27.449.188.69a.734.734 0 01-1.216.314L12.57 4.5v11.786c0 .357-.357.714-.714.714s-.714-.359-.714-.714V4.5L7.372 8.143a.73.73 0 01-1.102-.091c-.21-.289-.149-.694.106-.946l4.884-4.821z"&gt;&lt;/path&gt;&lt;/svg&gt;

    &lt;/button&gt;
    &lt;button class="social-share_labelled-list__close" data-type="close" aria-label="close social share" title="Close social share"&gt;
        &lt;svg class="icon-ui-close" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M19.787 18.758l-6.792-6.781 6.746-6.735a.728.728 0 00-1.028-1.03l-6.747 6.737-6.711-6.7a.728.728 0 00-1.028 1.03l6.71 6.698-6.723 6.712a.727.727 0 101.027 1.03l6.725-6.714 6.793 6.782a.725.725 0 001.028 0 .727.727 0 000-1.03"&gt;&lt;/path&gt;&lt;/svg&gt;

    &lt;/button&gt;
&lt;/div&gt;

            &lt;/div&gt;
    &lt;/div&gt;
    
&lt;/div&gt;

  
&lt;p data-uri="cms.cnn.com/_components/editor-note/instances/cmfcny7tn00033b6ned604knj@published" data-editable="text" data-component-name="editor-note" class="editor-note-elevate vossi-editor-note inline-placeholder " data-article-gutter="true"&gt;
    &lt;span class="editor-note__prefix"&gt;EDITOR’S NOTE:&lt;/span&gt;  If you or someone you know is struggling with suicidal thoughts or mental health matters, please call the 988 Suicide &amp;amp; Crisis Lifeline by dialing 988 to connect with a trained counselor, or visit the &lt;a href="https://988lifeline.org/" target="_blank"&gt;988 Lifeline website&lt;/a&gt;. For exposures to medication or a drug, you can call the National Poison Helpline at 1-800-222-1222 or visit www.poison.org.
&lt;/p&gt;


    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckmaja001u26qc1qvhccbn@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            Children ages 6 to 12 are experiencing a dramatic increase in instances of self-harm –– and they are using common items available around the house, according to a new study.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a00083b6n5q2w5rc6@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            The rate of instances reported to poison control centers of children being exposed to substances has risen by more than 50% since 2000, said study coauthor Dr. Hannah Hays, chief of toxicology at Nationwide Children’s Hospital and medical director of the Central Ohio Poison Center.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a00093b6npkrfu3k9@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            But the number of those cases with suspected suicide or self-harm intent increased up to fourfold, she added.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000a3b6nbjgt5om3@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            “These cases were far more likely to result in serious medical outcomes or hospitalization for these children,” Hays said.
    &lt;/p&gt;

  





    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000b3b6nbdy368bi@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            Hays said she noticed seeing more and younger kids experiencing self-harm and suicidality, and she wanted to understand whether there was a real trend borne out in the data. To investigate, researchers analyzed more than 1.5 million reports of substance exposures to US poison control centers across the country.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000c3b6nfv449lyw@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            Reports to poison control with suspected self-harm intent among 11-year-olds increased by 398% since 2000. The increase was 343% in 12-year-olds, according to the study &lt;a href="https://publications.aap.org/pediatrics/article-abstract/doi/10.1542/peds.2024-069753/203713/Poison-Center-Calls-About-Self-Harm-or-Suicidal" target="_blank"&gt;published Monday by Pediatrics&lt;/a&gt;, a journal of the American Academy of Pediatrics.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000d3b6npxpuvi5r@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            The substances in the reports included common household products such as pain relievers, antihistamines, cold medicines and vitamins, the study said.
    &lt;/p&gt;

  

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000e3b6ny1j7v1zw@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            Researchers have analyzed data about toddlers accidentally ingesting medications and teenagers taking them for harm or recreational purposes, but this study offers important data on the ages in between, said Dr. Jennifer Hoffmann, assistant professor of pediatrics at Northwestern University and attending physician in pediatric emergency medicine at Ann and Robert H. Lurie Children’s Hospital of Chicago. She was not involved in the study.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000f3b6n8zt1ufnj@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            And although the data is stronger because of the large number of reports researchers analyzed, instances of ingestion are likely underreported to poison control centers — because families have to think to make the report after something bad happens, Hays said. That means the rates are likely even higher.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000g3b6ngbykpd83@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            The increases of ingestions with harmful intent are concerning, but they make sense given the rise in reports of suicidal feelings in younger kids, said psychologist Dr. Christopher Willard, a lecturer in psychiatry at Harvard Medical School. He was not involved in the study.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000h3b6n7z7q2xlg@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            “With younger kids, it’s always hard to know if they fully understand the consequences of their behaviors, and what their true intentions are,” he said in an email.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000i3b6nystx2moa@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            The other problem is that many homes have more poisonous substances easily available than in the past, Willard said. Those include medication, cleaning products, supplements and recreational marijuana products.
    &lt;/p&gt;

  

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000j3b6ngsfbqq81@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            One of the most important lessons to come out of the data is that families should lock away over-the-counter and prescription medications and dispose of old products safely, Hoffmann said.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000k3b6naatj8thk@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            “With increased access comes increased exposures to all things,” Hays said.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000l3b6nbq46et01@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            The decision-making and planning part of the brain doesn’t develop until a person is in their mid-20s, so if kids can access potentially harmful medications, they may make an impulsive choice without fully thinking it through, she added.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000m3b6nnonp1wq8@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            Policymakers can have an impact on access by limiting package sizes for high-risk drugs and expanding the use of blister packages that require a person to pop out each pill individually, Hays said.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000n3b6npaf4bpmj@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            “Just those few minutes to pop the pills out of the blister pack can be enough to make a child think about what they’re doing, stop, and it can therefore save their life,” she added.
    &lt;/p&gt;

  

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000o3b6nxjqkpjqh@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            Health care providers can also make a difference by screening for suicide risk and doing routine mental health checks, Hoffmann said.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000p3b6n02gxu78n@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            And families need to know what to look for, Hays said.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000q3b6n81s2u55f@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            “Children don’t always look at you and say, ‘I’m feeling depressed. I’m feeling like I want to harm myself,’” she said. “Parents can look for changes in their children.”
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000r3b6nm5awdp1m@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            Signs that something is wrong can include changes in mood, like increased irritability, hopelessness or tearfulness. Changes in behavior such as refusing to go to school and body cues like headaches, sleep or appetite changes can also be a signal to investigate, Hays said.
    &lt;/p&gt;

  





    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000s3b6nzwu9q55u@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            “If your gut says something’s off, the next best step would be to ask kids directly,” she said. “Then go from there by looping in your safety nets, your school, your counselors, your pediatrician, to make safety plans and get concrete directions on next best steps.”
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000t3b6nuoa8utjs@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            Suicide in children is often an impulsive act precipitated by a stressful event, yet many reports show cases of children without a known mental health condition, Hoffmann said. That means there needs to be more universal prevention efforts, she added.
    &lt;/p&gt;

    &lt;p class="paragraph-elevate inline-placeholder vossi-paragraph" data-uri="cms.cnn.com/_components/paragraph/instances/cmfckof5a000u3b6ns4c0rvy5@published" data-editable="text" data-component-name="paragraph" data-article-gutter="true"&gt;
            If you or a loved one has been exposed to a medication or drug, you can call the National Poison Helpline at 1-800-222-1222 for free, confidential advice from experts, 24 hours per day, seven days per week.
    &lt;/p&gt;

              &lt;/div&gt;
                &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>CNN</author><pubDate>Tue, 09 Sep 2025 18:00:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMigAFBVV95cUxOSlRJMGdNUDJSam9HbUtkN2x2dDJrWWJCekxPS3N4eHJPVEtDSVVFYXZRX1V6RU5HS21ESTNaOHF0cWNRS3lWSGFxdnUwS0dSam5yaDJFaVB5VWhHX3h6ZmRLdnZUS2hxVS0xWHhPXzV5dlF2cGFqQVRPZWVNbXRTNQ</guid></item><item><title>俄勒冈州医生对在医疗指导真空中分发最新的COVID-19疫苗犹豫不决- OregonLive.com</title><link>https://www.oregonlive.com/health/2025/09/oregon-doctors-hesitate-to-dispense-latest-covid-19-vaccines-in-vacuum-of-medical-guidance.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="entry-content   "&gt;&lt;p class="article__paragraph article__paragraph--left" id="UNK5DDOZGRDWBIRXDDY3XEOGKU"&gt;The latest COVID-19 vaccines are only available to Oregonians with a prescription for the time being, but the state’s doctors are hesitant to order the inoculations. &lt;/p&gt;&lt;p id="inarticle-1" data-gaid="inarticle-1"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="MDWXWF7LAJHU7HNIGOZZ2VKEVY"&gt;The U.S. Food and Drug Administration cleared the updated COVID-19 shots for seniors and younger Americans with certain health conditions — excluding healthy children and young adults — but the Centers for Disease Control and Prevention’s vaccine advisory committee has not yet issued recommendations on who should receive them. &lt;/p&gt;&lt;p id="inarticle-2" data-gaid="inarticle-2"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="P7CBISORY5BYFNJ5SCZASGYBPI"&gt;Until the committee issues its recommendation, state policy bars pharmacists from giving the shots to anyone without a prescription, even to those for whom the drug is approved. &lt;/p&gt;&lt;p id="inarticle-3" data-gaid="inarticle-3"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="RT5ZJUL4GVF43DRASXZPNUAJJY"&gt;So go see a doctor, then? It might not be so simple. &lt;/p&gt;&lt;p id="inarticle-4" data-gaid="inarticle-4"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="6KN7FEHBDFF5RNGWUIFU5LNLFM"&gt;Doctors, too, are hesitant to prescribe or administer the new COVID-19 vaccine without the CDC’s official recommendation on the shot.&lt;/p&gt;&lt;p id="inarticle-5" data-gaid="inarticle-5"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="MAEIYQDN6NCJDEQULD4JCFLQLU"&gt;Courtni Dresser, the Oregon Medical Association’s vice president of government relations, said the doctors’ hesitation to prescribe the vaccine “comes from a place of caution and concern” due to the lack of clear guidance from the federal government and from the state.&lt;/p&gt;&lt;p id="inarticle-6" data-gaid="inarticle-6"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="EFCAIMN4FVENFNKHLTQJZZCQ64"&gt;Dresser said physicians are concerned about liability and insurance coverage issues when prescribing it for those eligible, as well as for what would be considered off-label use to those who don’t fit under the U.S. Food and Drug Administration’s narrower approval. &lt;/p&gt;&lt;p id="inarticle-7" data-gaid="inarticle-7"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="VSKJUN6QDJCTTE5MFJO4WYQJXA"&gt;“The lack of guidance from the CDC has created an unnecessary mess,” Dresser said. “For one, this is the first time that doctors are having to prescribe the vaccine. … For those who aren’t eligible for the shot under the FDA’s criteria, it’s even harder for physicians to make the call on whether to prescribe it.”&lt;/p&gt;&lt;p id="inarticle-8" data-gaid="inarticle-8"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="XCDGEDG7V5CVNPUXZORSERR2J4"&gt;The CDC’s guidance was delayed this year after Health and Human Services Secretary Robert F. Kennedy Jr. &lt;a href="https://www.oregonlive.com/health/2025/06/rfk-jr-removes-every-member-of-cdcs-vaccine-advisory-committee.html" target="_blank" rel=""&gt;dismissed the entire advisory committee&lt;/a&gt;, and replacements appointed by Kennedy — among them vaccine skeptics and &lt;a href="https://apnews.com/article/cdc-acip-vaccine-committee-9f58e1f004075b081718ff078de88d76" target="_blank" rel=""&gt;people who have spread misinformation about vaccines&lt;/a&gt; — have yet to make recommendations on the new COVID-19 formulations.&lt;/p&gt;&lt;p id="inarticle-9" data-gaid="inarticle-9"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="SSU4SRO32ZGRFHP4O5MC2B4G3A"&gt;In the absence of clear federal guidance, Oregon has joined California, Washington and Hawaii in forming a West Coast Health Alliance to issue its own recommendations. But Oregon health officials have yet to issue state-level guidance.&lt;/p&gt;&lt;p id="inarticle-10" data-gaid="inarticle-10"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="MQX2WFDMSBCTXCPO35FWDAPMPY"&gt;Physicians at Providence Health &amp;amp; Services, one of the region’s largest health providers, have turned away some patients seeking COVID-19 vaccinations, several of the patients told The Oregonian/OregonLive.&lt;/p&gt;&lt;p id="inarticle-11" data-gaid="inarticle-11"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="RSAE2HSLS5DPJMPXBHJTUKCCH4"&gt;Asked whether its physicians were prescribing the updated COVID-19 vaccines, Providence Health &amp;amp; Services Oregon said in an email that it is “carefully evaluating revised guidance from the FDA on the updated COVID-19 vaccines and is awaiting further recommendations from the CDC and state public health authorities to understand how this may or may not affect our family of organizations.”&lt;/p&gt;&lt;p id="inarticle-12" data-gaid="inarticle-12"&gt;&lt;/p&gt;&lt;p id="fusion-static-enter:F3P6QTWEKNBLVGE5EPOPWRAXBQ" data-fusion-component="F3P6QTWEKNBLVGE5EPOPWRAXBQ"&gt;&lt;/p&gt;&lt;p id="fusion-static-exit:F3P6QTWEKNBLVGE5EPOPWRAXBQ" data-fusion-component="F3P6QTWEKNBLVGE5EPOPWRAXBQ"&gt;&lt;/p&gt;&lt;p id="inarticle-13" class="middleParagraph" data-gaid="inarticle-13"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="OG3AWZ7T6JAE5M5RJZ7GSF5G3Q"&gt;Jonathan Modie, a spokesperson for the Oregon Health Authority, said his agency, the state Board of Pharmacy, the governor’s office and the Oregon Department of Justice are reviewing “existing statutes and rules to determine next steps needed to support continued access to vaccines throughout the state, including at pharmacies.”&lt;/p&gt;&lt;p id="inarticle-14" data-gaid="inarticle-14"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="WGDF3NROEFDORO4S63DCPTO7YA"&gt;Modie said the state has only limited control over vaccine eligibility. He said the health authority can set eligibility for its own vaccine programs, but state-supplied doses make up a small fraction of what’s given in Oregon. He said most people get vaccines that are bought by pharmacies, clinics or hospitals directly.&lt;/p&gt;&lt;p id="inarticle-15" data-gaid="inarticle-15"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="72KFHAEECRBLRCCXSCP2Q6B444"&gt;Modie said doctors and other clinicians already have the authority to recommend and give the new COVID-19 vaccine to their patients as they see fit, as long as it’s within their professional scope.&lt;/p&gt;&lt;p id="inarticle-16" data-gaid="inarticle-16"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="6RPB3MBUUNA4TED7ZB7AGYOC6Y"&gt;Modie said the state supports COVID-19 vaccine recommendations from the American Academy of Pediatrics for children and the American College of Obstetricians and Gynecologists for pregnant people. He said Oregon recommends COVID-19 vaccination for adults aged 18 to 64 who are at higher risk or live in group settings, and supports making the shots available to all adults in that age group who want it.&lt;/p&gt;&lt;p id="inarticle-17" data-gaid="inarticle-17"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="O2ZO7EPPFZF7LCNKV2B6JKKEVU"&gt;He said Oregon expects to reach agreement with other West Coast Health Alliance states soon on recommendations for COVID-19 and other respiratory virus vaccines. &lt;/p&gt;&lt;p id="inarticle-18" data-gaid="inarticle-18"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="2DKGQNGT2FEWZA5GQYTRQNUWXA"&gt;Meanwhile, providers can vaccinate anyone 6 months or older using an FDA-approved COVID-19 vaccine formulation, Modie said, adding that the state health authority “recommends health care and vaccine providers discuss this issue with their own risk management or counsel.” &lt;/p&gt;&lt;p id="inarticle-19" data-gaid="inarticle-19"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="6IR7CMEWPRHZDABLSGTMXCE2EE"&gt;He said prescribing “off-label” vaccines is a common, lawful practice in the U.S., as long as it is within a provider’s scope. That means even if a patient doesn’t fit the FDA’s narrow criteria, their doctor may still be able to give them the shot.&lt;/p&gt;&lt;p id="inarticle-20" data-gaid="inarticle-20"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="DC3FZSPCBNE5VEQ47XSUEFKSTM"&gt;Dresser said the state medical association is waiting for more guidance from Oregon officials on whether physicians prescribing or administering the vaccine will be legally protected and reimbursed by insurers for doing so.&lt;/p&gt;&lt;p id="inarticle-21" data-gaid="inarticle-21"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="6GQQXIYI7ZH5LOIMLRHED4BVW4"&gt;“There’s also a risk for physicians. They need clear direction from the state on who they can prescribe and give the vaccine to, and whether there will be protection and coverage,” she said. “Oregon hasn’t done that, and it’s frustrating for everybody, including physicians and their patients.”&lt;/p&gt;&lt;p id="inarticle-22" data-gaid="inarticle-22"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="3BPKDDX4BVBKDBCJMRGMVINS3Q"&gt;Dresser said Oregon should follow its northern neighbor, which signed a &lt;a href="https://doh.wa.gov/sites/default/files/2025-09/COVID19VaccineStandingOrder.pdf" target="_blank" rel=""&gt;standing order&lt;/a&gt; into effect last week allowing anyone in the state 6 months or older to receive the vaccine without a prescription through pharmacists or nurses. &lt;/p&gt;&lt;p id="inarticle-23" data-gaid="inarticle-23"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="DXOEZE6R35DFRIWRBGDNFDJ3BU"&gt;Washington State Department of Health’s standing order provides legal protection for providers administering the COVID-19 vaccine and allows residents to get vaccinated without first needing to consult a doctor.&lt;/p&gt;&lt;p id="inarticle-24" data-gaid="inarticle-24"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="TU36PKARKFGLFNZTTIFOQWQLOE"&gt;Other states have taken measures to expand access to the new COVID-19 vaccines. &lt;a href="https://governorsoffice.colorado.gov/governor/news/governor-polis-cdphe-take-swift-action-ensure-easy-access-covid-19-vaccines-coloradans-fall" target="_blank" rel=""&gt;Colorado&lt;/a&gt;, &lt;a href="https://content.govdelivery.com/attachments/MNGOV/2025/09/08/file_attachments/3381381/Executive%2520Order%252025-09.pdf" target="_blank" rel=""&gt;Minnesota&lt;/a&gt; and &lt;a href="https://www.governor.ny.gov/executive-order/no-52-declaring-disaster-state-new-york-due-federal-actions-related-vaccine-access" target="_blank" rel=""&gt;New York&lt;/a&gt; have issued standing orders to allow pharmacists to give COVID-19 shots without a prescription. &lt;a href="https://www.pa.gov/governor/newsroom/2025-press-releases/state-board-of-pharmacy-votes-to-protect-vaccine-access-across-p.html" target="_blank" rel=""&gt;Pennsylvania’s board of pharmacy&lt;/a&gt; voted to allow pharmacists to follow recommendations from trusted medical organizations without requiring a doctor’s prescription.&lt;/p&gt;&lt;p id="inarticle-25" data-gaid="inarticle-25"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="D7ELUMTATJDXHN6J24FISWW6YU"&gt;&lt;i&gt;-- Kristine de Leon is a reporter for The Oregonian/OregonLive focusing on consumer health and data enterprise stories. Contact her at &lt;/i&gt;&lt;a href="mailto:kdeleon@oregonian.com" target="_blank" rel=""&gt;&lt;i&gt;kdeleon@oregonian.com&lt;/i&gt;&lt;/a&gt;&lt;i&gt;.&lt;/i&gt;&lt;/p&gt;&lt;p id="inarticle-26" data-gaid="inarticle-26"&gt;&lt;/p&gt;&lt;/div&gt;&lt;p class="article__paragraph article__paragraph--center skimlinks"&gt;If you purchase a product or register for an account through a link on our site, we may receive compensation.&lt;span&gt; By using this site, you consent to our &lt;a href="https://www.advancelocal.com/advancelocalUserAgreement/user-agreement.html" target="_blank" rel="noopener noreferrer"&gt;User Agreement&lt;/a&gt; and agree that your clicks, interactions, and personal information may be collected, recorded, and/or stored by us and social media and other third-party partners in accordance with our &lt;a href="https://www.advancelocal.com/advancelocalUserAgreement/privacy-policy.html" target="_blank" rel="noopener noreferrer"&gt;Privacy Policy.&lt;/a&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>OregonLive.com</author><pubDate>Tue, 09 Sep 2025 17:13:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">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</guid></item><item><title>这项巧妙的新测试可以预测您是否会患上痴呆症-每日邮报</title><link>https://www.dailymail.co.uk/health/article-15080677/tests-predict-dementia-iron-mri-john-hopkins.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div itemprop="articleBody"&gt;&lt;p class="mol-para-with-font"&gt;A special brain imaging technique could help predict if a person will develop dementia later in life, a new study has revealed. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Researchers from Johns Hopkins University used a special MRI technique called quantitative susceptibility mapping (QSM) in a long-term investigation to measure levels of iron in the brain.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;&lt;a target="_self" href="/sciencetech/alzheimers-disease/index.html" id="mol-adac0980-8d92-11f0-9b8b-b99cc5759f02"&gt;Alzheimer's disease&lt;/a&gt;, the leading cause of dementia that affects 7million Americans, is thought to be caused by the accumulation of harmful amyloid plaque and tau proteins, which disrupt brain cell function and obstruct communication between neurons.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;But scientists have begun to research how elevated levels of iron in the brain could impact cognition.  &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;'Iron overload,' or extremely high levels of the mineral, disrupt the balance of free radicals - harmful molecules in the body - and antioxidants - substances that fight free radicals. This exacerbates nerve cell death. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Iron levels are typically measured in the brain post-mortem by analyzing brain tissue samples, but QSM allows scientists to measure the mineral non-invasively while a patient is still alive. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;In the study, researchers looked at QSM MRI data from 158 cognitively unimpaired patients and established baseline readings for iron for each subject. Then, the scientists followed participants for 7.7 years, collecting updated readings throughout. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Findings revealed that higher levels of brain iron in the initial readings, especially in the brain regions important to memory and other cognitive function, were linked to an increased risk of mild cognitive impairment later in life.&lt;/p&gt;&lt;div class="artSplitter mol-img-group"&gt;  &lt;p class="imageCaption" aria-label="To enrich screen reader interactions, please activate Accessibility in Grammarly extension settings"&gt;Alzheimer's disease, which affects more than 7million Americans, is caused by the abnormal build-up of proteins in and around brain cells. And previous research has linked abnormally high levels of iron in the brain (stock image) &lt;/p&gt;&lt;/div&gt;
    
    
    &lt;p class="mol-para-with-font"&gt;This is a transitional stage preceding Alzheimer’s disease-related dementia. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The researchers say that their findings provide further evidence of QSM being a promising non-invasive diagnostic tool for Alzheimer's Disease, detecting abnormal iron accumulation in the brain linked to disease progression before people start to show symptoms.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;&lt;span&gt;This will allow for earlier detection and targeted intervention for the disease.&lt;/span&gt;&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;There isn't a single 'normal' brain iron level, as iron distribution varies across brain regions and increases with age, but typical ranges exist for specific areas.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Currently there is no cure for dementia or Alzheimer's but the team behind the new study say that&lt;span&gt; clinical trials could test iron-targeted therapies. &lt;/span&gt;&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Commenting on the findings, the study's senior author and associate professor of radiology at Johns Hopkins University Dr Xu Li said: 'QSM can detect small differences in iron levels across different brain regions, providing a reliable and non-invasive way to map and quantify iron in patients, which is not possible with conventional MR approaches.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;'Using QSM, we found higher brain iron in some memory related regions that are linked to a higher risk of developing cognitive impairment and faster cognitive decline.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;'We can use this kind of tool to help identify patients at higher risk of developing Alzheimer's disease and potentially guide early interventions as new treatments become available.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;'Also, besides serving as a biomarker, brain iron may become a future therapeutic target.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;'At the same time, we hope to make the QSM technology more standardized, faster and more widely accessible in clinical practice.'&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The findings were published in Radiology, a journal of the &lt;a class="" rel="noreferrer noopener" target="_blank" href="https://pubs.rsna.org/journal/radiology"&gt;Radiological Society of North America (RSNA).&lt;/a&gt;&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;High levels of iron were first reported in the brains of people with Alzheimer's disease in 1953 in a postmortem study.&lt;/p&gt;&lt;div class="artSplitter mol-img-group"&gt;  &lt;p class="imageCaption"&gt;Natalie Ive (pictured) was diagnosed with primary progressive aphasia, a type of frontotemporal dementia, in 2021 at age 48&lt;/p&gt;&lt;/div&gt;&lt;div class="artSplitter mol-img-group"&gt;  &lt;p class="imageCaption"&gt;Gemma Illingworth, from Manchester, was 28-years-old when she was diagnosed with a rare form of dementia called posterior cortical atrophy (PCA). She died three years later&lt;/p&gt;&lt;/div&gt;&lt;p class="mol-para-with-font"&gt;Iron is a prevalent element in the human body and is needed for major biochemical processes such as oxygen transport and DNA synthesis.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The human body obtains iron through various foods, with red meat being one of the best sources, and it is absorbed through the small intestine.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;It is important to maintain a delicate balance of iron in the brain; both deficiency and overload can be detrimental. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Abnormal iron accumulation has been reported in numerous neurodegenerative disorders such as Parkinson's disease, Huntington's disease, and Multiple Sclerosis, but it's unclear if increased iron deposition contributes to the development of these diseases or is a secondary effect or by-product.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Previous studies have identified that iron accumulation correlates with amyloid beta – the protein that clumps together in the brains of people with Alzheimer's.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;These clumps form 'plaques' that collect between neurons, otherwise known as nerve cells, and disrupt cell function. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Associations have also been found between iron and neurofibrillary tangles – abnormal accumulations of a protein called tau that collect inside neurons.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;These tangles block the neuron's transport system, which harms the communication between neurons.&lt;/p&gt;&lt;div class="artSplitter mol-img-group"&gt;  &lt;p class="imageCaption"&gt;Brain maps of healthy control participants and participants with Alzheimer disease. Iron accumulation was associated with cognitive deterioration independently of brain volume loss. (Alzheimer's disease is associated with higher rates of brain tissue loss than normal ageing.)&lt;/p&gt;&lt;/div&gt;&lt;div class="artSplitter mol-img-group"&gt;  &lt;p class="imageCaption"&gt;Alzheimer's disease is the most common cause of dementia. The disease can cause anxiety, confusion and short-term memory loss&lt;/p&gt;&lt;/div&gt;&lt;p class="mol-para-with-font"&gt;It is known that deep grey matter structures of patients with Alzheimer's disease contain higher brain iron concentrations.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Grey matter of the brain is high in neural cell bodies and plays a major part in the central nervous system.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;But less is known about the neocortex, the deeply grooved outer layer of the brain that is involved with language, conscious thought and other important functions.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Impaired iron stability for people with Alzheimer's disease indicates that iron chelation therapy, giving patients drugs that rid the body of iron via urine, in clinical trials might be a promising treatment.&lt;/p&gt;&lt;/div&gt;
            

            
            
            
            
            &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Daily Mail</author><pubDate>Tue, 09 Sep 2025 17:12:05 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiowFBVV95cUxOTTZMYWZxRDVCRmZjZWJCWXFEc1haMEtzODFwS1gtRjJqeFdUcy03V09abG9Ocms2dXFTd3JMd1RNM29Cc01JdHpsWWpNWTdBbFh1UndWeV9HMWVPSUxUYkFHQ2FpY3RldnpGWmZwWTFVaWFlMnppejlERkh1OWQ3OHhzS2VlSjBLcUJXLXRGSmRwVzE5MTBfR19lV1JqTndHNXBr0gGoAUFVX3lxTE8taHJzdV9kdTZqUC03T1lSN2lnQ3JoMDMyZDlTXy1EMVl0MGdwVGl6dEFlUVJYeWN3UExVeWgyaVE0NkRYb0x5Nm1hTnRiczZoODdodFpKTmEyMmhBQ0RUVWJyRjhLOWpZMS0xWXk3b1hsLVRDWi01RmNuczlZTE04YTBJWTNnTGh6ckZ6LWN3YzZ2UU02NkJQSE50M3BsX3FpaHgxVGhPaw</guid></item><item><title>它是您身体的重要组成部分。这也是Health TikTokkers最可怕的噩梦。我们是如何到达这里的？ - Slate</title><link>https://slate.com/technology/2025/09/cortisol-belly-face-cleanse-tiktok.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="article__content" itemprop="mainEntityOfPage"&gt;
          &lt;p class="slate-paragraph slate-graf" data-word-count="21" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpd8rg000w3b79d3q81096@published"&gt;&lt;em&gt;&lt;a href="https://slate.com/theslatest?utm_source=slate&amp;amp;utm_medium=article&amp;amp;utm_campaign=article_plain_text_topper"&gt;Sign up for the Slatest&lt;/a&gt; to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily.&lt;/em&gt;&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="43" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpcv0d00bb9bm7lwu7jsqk@published"&gt;Shana used to love training for triathlons. As a nurse working in the ICU of the University of Chicago Medical Center, she’d often finish a night shift at 7 a.m. and then squeeze in a run on the lake before heading to bed.&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="52" data-uri="slate.com/_components/slate-paragraph/instances/cmfcphari001r3b79c5e52dvd@published"&gt;She even completed the infamous Escape From Alcatraz Triathlon—a 1.5-mile swim from Alcatraz Island to the shoreline, an 18-mile hilly bike ride, and an 8-mile run. She’d had asthma since she was a child, but it rarely interfered with her training, usually only flaring up once a year when she had a cold.&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="56" data-uri="slate.com/_components/slate-paragraph/instances/cmfcphari001s3b79et42jtff@published"&gt;Then her asthma suddenly worsened. One night on the ward, she had a bad attack. She recovered, but had another the next day. And the next. Soon she was nebulizing her medication throughout the day and struggling to walk up stairs. Her doctor put her on heavy doses of steroids to try to calm her lungs.&lt;/p&gt;

  

  &lt;p class="slate-paragraph slate-graf" data-word-count="68" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpharj001t3b79peu9edfj@published"&gt;She finally found relief, but it was short-lived. She gained so much weight from the steroids so rapidly—almost 60 pounds in a month—that she had a hard time moving. “Imagine going to the gym, picking up a barbell, and stacking on 60 pounds of plates, then carrying that around with you all day. In the shower, walking down the street, lying in bed. It was horrible,” she says.&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="88" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpharj001u3b79penjo9hl@published"&gt;As a nurse, she understood the physiology behind what was happening to her. She knew her throbbing knees and elbows meant fluid was leaking out of her joints. She understood that the pain in her chest was her diaphragm muscle being stretched away from the bone underneath as fluid filled her abdominal wall. And as her face started to swell, she looked in the mirror and recognized the moon face that is a hallmark of Cushing’s syndrome, a condition that happens when your body has too much cortisol.&lt;/p&gt;

  


  


  


  


  &lt;p class="slate-paragraph slate-graf" data-word-count="111" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpharj001v3b79swm1bdjs@published"&gt;Shana and I met in an online support group. We both have severe asthma, which 8 percent to 10 percent of asthmatics develop: The condition suddenly worsens without a clear reason and stops responding to most medications. Like many patients with severe asthma, we both developed adrenal diseases after having to take huge doses of steroids to manage our frequent attacks. Unlike Shana, I never developed Cushing’s syndrome, which is when your cortisol is too high. Instead, I developed adrenal insufficiency, which is when your cortisol is too low. I can no longer make cortisol on my own and must now take a synthetic form called hydrocortisone several times a day.&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="133" data-uri="slate.com/_components/slate-paragraph/instances/cmfcphark001w3b797gt57420@published"&gt;Fortunately, true disorders of cortisol like Cushing’s syndrome and adrenal insufficiency are incredibly rare: According to the Cleveland Clinic, 40–70 people in 1 million have cortisol that is too high and 100–140 people in 1 million have cortisol that is too low. This rarity is why Shana and I, and many members of our support group, are baffled by the “high cortisol” posts flooding social media, and TikTok in particular, which has more than &lt;a href="https://www.medscape.com/viewarticle/round-face-viral-terms-real-diagnostic-implications-2024a1000kia?form=fpf"&gt;800 million views&lt;/a&gt; of videos tagged #CortisolTok. According to these posts, high cortisol is to blame for a slew of health issues including fatigue, a puffy face, waking up at night, and weight gain (commonly called “cortisol belly”). Many of the influencers posting about cortisol call themselves hormone or weight loss coaches, though they typically don’t have medical qualifications.&lt;/p&gt;

  


  


  &lt;p class="slate-paragraph slate-graf" data-word-count="98" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpharm001x3b79hz63yd4u@published"&gt;It’s hard to overstate how essential cortisol is to our bodies. Adrenal insufficiency, also known as Addison’s disease, was a fatal condition until hydrocortisone was invented in the 1930s. Nowadays, people with adrenal insufficiency have mostly normal lifespans. But it is still a dangerous disease that can quickly flare into an adrenal crisis, which is when your body doesn’t have enough cortisol, and your organ systems begin to fail. Some studies show that up to 1 in 4 people &lt;a href="https://my.clevelandclinic.org/health/diseases/23948-adrenal-crisis"&gt;die from an adrenal crisis&lt;/a&gt;, a tragic reality Shana and I see all too often in our support group.&lt;/p&gt;

  


  &lt;p class="slate-paragraph slate-graf" data-word-count="55" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpharm001y3b79wuc8o9no@published"&gt;You wouldn’t know that sad truth from the posts that tend to prescribe the standard wellness remedies of the moment: matcha tea, bone broth, celery juice, and cold plunges. Some are even pricier, like a &lt;a href="https://www.instagram.com/reel/DNp4XWrOzrT/"&gt;$184 weighted pillow&lt;/a&gt; that promises to help you “say goodbye to cortisol” and a $1,000 &lt;a href="https://yourhealthcoachbiz.com/3-month-cortisol-recovery-program-rachel-feldman/"&gt;three-month online “cortisol recovery” program&lt;/a&gt;.&lt;/p&gt;

  


  &lt;p data-uri="slate.com/_components/slate-section-div/instances/cmfcphavg002e3b79x2zr1zmt@published" class="section-div"&gt;&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="80" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpharm001z3b79ok2nyexk@published"&gt;Cortisol is a hormone produced by the adrenal glands, two tiny organs, each the size of half a walnut, that sit on top of the kidneys. It regulates our blood pressure, helps us digest food, keeps our blood sugar stable, and controls our circadian rhythm. Cortisol is also critical to our immune system. It repairs tissues and acts as our body’s most powerful anti-inflammatory, which is why Shana’s doctor gave her such high doses of steroids—synthetic cortisol—to treat her asthma.&lt;/p&gt;

  


  


  &lt;p class="slate-paragraph slate-graf" data-word-count="42" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpharn00203b79jq7vh4g3@published"&gt;Perhaps the biggest danger of this trend is that people are panicking about their cortisol for no reason. Dr. Rachel Pessah-Pollack, an endocrinologist at the NYU School of Medicine, has seen a surge in patients requesting cortisol tests in the past year.&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="79" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpharn00213b794xf4fc0p@published"&gt;One of her first priorities is to help her patients understand that cortisol not only fluctuates throughout the day, but is different on a day-to-day basis. Our cortisol peaks around 8 a.m. and then falls throughout the rest of the day, increasing in little bumps when we eat, drink coffee, or feel stress. It increases with bad stress like a difficult meeting or a stomach bug, as well as good stress like a family reunion or a birthday party.&lt;/p&gt;

  


  &lt;p class="slate-paragraph slate-graf" data-word-count="16" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpharn00223b79mevq8bsv@published"&gt;“But those bumps are almost always transient and quickly go back to a baseline,” Pessah-Pollack says.&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="48" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpharn00233b79hrzvzdsm@published"&gt;That is why she emphasizes to her patients that cortisol testing needs to be handled and interpreted by specialists. Otherwise, if they use saliva tests at home, as is commonly encouraged on TikTok, they might be unnecessarily spooked when they see their cortisol is all over the map.&lt;/p&gt;

  


  &lt;p class="slate-paragraph slate-graf" data-word-count="79" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpharo00243b79fuqy7lqs@published"&gt;Pessah-Pollack is deeply empathetic to her patients’ concerns and tries to get to the root cause of why they’re worried their cortisol is too high. Many of her patients say it’s because they are exhausted or have gained weight. These are two common features of an underactive thyroid, a condition that is thousands of times more common than cortisol disorders, which is why one of her first steps is typically to order blood work to check their thyroid function.&lt;/p&gt;

  


  &lt;p class="slate-paragraph slate-graf" data-word-count="85" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpharo00253b79s8pd8x74@published"&gt;If they’re waking up at night, she considers other factors like whether they may have undiagnosed sleep apnea or are drinking alcohol shortly before bedtime. And if they’re worried about weight gain, she helps them analyze their activity level and how their exercise and nutrition needs may be changing with age. Unless she sees the telltale signs of Cushing’s, like stretchmarks on a patient’s thighs and stomach, central obesity, high blood pressure, and high blood sugar, she doesn’t worry that their cortisol is too high.&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="7" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpharo00263b79v5mh6epk@published"&gt;So, how did cortisol get so misunderstood?&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="76" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpharo00273b79d2x8w5ct@published"&gt;Cortisol took off as a buzzword associated with stress after the publication of naturopath James Lee Wilson’s 2001 book, &lt;em&gt;Adrenal Fatigue: The 21&lt;/em&gt;&lt;sup&gt;&lt;em&gt;st&lt;/em&gt;&lt;/sup&gt;&lt;em&gt; Century Stress Syndrome&lt;/em&gt;. In the book, Wilson argued chronic stress damages the adrenal glands, which means a lot of people don’t have enough cortisol and feel exhausted and foggy as a result. He coined this condition “adrenal fatigue,” and although it is not a recognized medical diagnosis, it became popular in wellness communities.&lt;/p&gt;

  


  &lt;p class="slate-paragraph slate-graf" data-word-count="60" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpharp00283b79nbcg3mzf@published"&gt;For years, Google search trends show about equal interest in low and high cortisol. Then, in 2022, searches for “high cortisol” skyrocketed. Around that time, several studies came out linking stress about the COVID-19 pandemic with increased levels of cortisol in health care workers and the general population. Perhaps this contributed to the sudden spike of interest in high cortisol.&lt;/p&gt;

  


  


  


  
  &lt;p class="slate-paragraph slate-graf" data-word-count="66" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpharp00293b79xjpw67lt@published"&gt;It makes sense that this interest has endured. Who &lt;em&gt;doesn’t&lt;/em&gt; need a word to describe the constant panic many of us feel in today’s world, where we are constantly bombarded with anxiety-provoking headlines about climate change, A.I. taking over jobs, and unstable democracies? How could we not be seduced by the hope that an allegedly cortisol-lowering matcha tea or magnesium footbath might quiet our inner turmoil?&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="27" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpharp002a3b79vsc7duzw@published"&gt;But cortisol is not a synonym for stress. It is a hormone we need to survive. And this misunderstanding is deeply frustrating to people with adrenal diseases.&lt;/p&gt;

  



  &lt;p class="slate-paragraph slate-graf" data-word-count="61" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpharp002b3b79cspf1p99@published"&gt;When I asked my support group what they wished people knew about cortisol, one woman said she wished people knew how similar Addison’s disease is to Type 1 diabetes, and that if she doesn’t take medication daily, she will die. Another said she wished her friends and family would stop telling her how lucky she is that she can’t make cortisol.&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="98" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpharp002c3b79lszfem65@published"&gt;Shana recently switched to a lower dose of a gentler steroid, and her doctor says her Cushing’s should be gone within the year. Her face is still swollen, however, and she is growing weary of posts about “cortisol face.” She’s seen many reasons people have puffy faces in her line of work: too much salt in their diet, alcohol, allergies, even sleeping face down. She hopes that by sharing her story, she can encourage people who are experiencing any unusual symptoms and are worried about their cortisol to seek medical care instead of trying remedies they find online.&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="28" data-uri="slate.com/_components/slate-paragraph/instances/cmfcpharq002d3b79acwpi8w9@published"&gt;She’s already dreaming of her next triathlon, perhaps the Alpe d’Huez in the French Alps. Yesterday she ran 200 yards. She hopes to run a little farther &lt;span class="slate-paragraph--tombstone"&gt;today.&lt;/span&gt;&lt;/p&gt;

  &lt;section class="newsletter-signup   " data-list="The Slatest" data-uri="slate.com/_components/newsletter-signup/instances/cmfcpcv0d00be9bm733p2gfhg@published"&gt;


    &lt;div class="newsletter-signup__intro newsletter-signup__intro--centered"&gt;
          &lt;img alt="" class="newsletter-signup__img" hidden data-src-light="https://dot.cdnslate.com/static/media/components/newsletter-signup/the-slatest.49f353b.png" data-src-dark="https://dot.cdnslate.com/static/media/components/newsletter-signup/the-slatest-dark.ca73d21.png"&gt;
&lt;h1 class="newsletter-signup__headline"&gt;Get the best of news and politics&lt;/h1&gt;
      &lt;span class="newsletter-signup__description"&gt;Sign up for Slate's evening newsletter.&lt;/span&gt;
    &lt;/div&gt;
    



&lt;/section&gt;

  

&lt;/div&gt;

      &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Slate</author><pubDate>Tue, 09 Sep 2025 16:17:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiggFBVV95cUxNSDNQMGVOY3BueDRRcjFkdmRfV0NYSkdWd1J5eHN5Rm5kVFN5TE5kSkNWSDhtZ0k2cTNZYXYtd1JOUzNuamdTU1JzS2syN1d4RkRDdXlob1JXU095V3p5bVlaNjQ3SU9GZnBoSTQ1VDQtWG9sNXZ6cXQ3SVBMY3FaYTV3</guid></item><item><title>致命的“接吻虫”疾病在美国流行： CDC - FOX 5 DC</title><link>https://www.fox5dc.com/news/deadly-kissing-bug-disease-becoming-endemic-us</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="article-body" data-v-7f0a623e&gt;&lt;div original-article-post="" class="big-top featured article-ct" data-v-7d0efd03 data-v-7f0a623e&gt;&lt;div class="m featured-img" data-v-7d0efd03&gt;&lt;img src="https://images.foxtv.com/static.fox5dc.com/www.fox5dc.com/content/uploads/2025/09/764/432/gettyimages-2214281234.jpg?ve=1&amp;amp;tl=1" alt="" data-v-7d0efd03&gt; &lt;span class="overlay" data-v-7d0efd03&gt;article&lt;/span&gt;&lt;/div&gt; &lt;div class="info" data-v-7d0efd03&gt;&lt;div class="caption" data-v-7d0efd03&gt;&lt;p data-v-7d0efd03&gt;&lt;span data-v-7d0efd03&gt;MADRID, SPAIN - 2025/05/09: Panstrongylus megistus displayed in Faunia zoo. Panstrongylus megistus is a blood-drinking insect in the subfamily Triatominae, is an important vector of Trypanosoma cruzi, the causative agent of Chagas disease. (Photo by &lt;/span&gt; &lt;/p&gt; &lt;/div&gt;&lt;/div&gt; &lt;/div&gt;  &lt;p data-v-7f0a623e&gt;Chagas disease, also known as the "kissing bug" disease, is spreading across the United States, and some researchers believe it should now be classified as endemic.&lt;/p&gt; &lt;p id="taboola-mid-article-thumbnails" data-v-7f0a623e&gt;&lt;/p&gt; &lt;p id="taboola-mid-article-thumbnails-js" data-v-7f0a623e&gt;&lt;/p&gt; &lt;p data-ad-pos="inread" data-ad-size="1x1" class="ad gpt" data-v-7f0a623e&gt;&lt;/p&gt;&lt;p original-article-post="" data-v-ec26887a data-v-7f0a623e&gt;What we know:&lt;/p&gt; &lt;p data-v-7f0a623e&gt;Human cases of the deadly disease have been reported in eight states, including Texas, California, Arizona, Tennessee, Louisiana, Missouri, Mississippi and Arkansas.&lt;/p&gt;  &lt;p data-v-7f0a623e&gt;However, the blood-sucking insects that cause Chagas disease have been found in 32 states over the past decade.&lt;/p&gt;  &lt;p data-v-7f0a623e&gt;In a report published last month for the &lt;a href="https://wwwnc.cdc.gov/eid/article/31/9/24-1700_article" target="_blank" rel="noopener"&gt;CDC's Emerging Infectious Diseases&lt;/a&gt; journal, researchers argued that Chagas disease should be considered endemic in the U.S.&lt;/p&gt; &lt;h2 data-v-7f0a623e&gt;What does endemic mean?&lt;/h2&gt; &lt;p data-v-7f0a623e&gt;A disease is endemic if it regularly occurs within a certain area or community.&lt;/p&gt; &lt;p data-v-7f0a623e&gt;It's different from an epidemic, which describes a sudden increase in the number of cases, or a pandemic, which has spread throughout several countries or continents.&lt;/p&gt; &lt;p original-article-post="" data-v-ec26887a data-v-7f0a623e&gt;What they're saying:&lt;/p&gt; &lt;p data-v-7f0a623e&gt;"Labeling the United States as non–Chagas disease–endemic perpetuates low awareness and underreporting," researchers stated in the CDC report. "The Classification of Chagas disease as endemic, in particular as hypoendemic, to the United States could improve surveillance, research, and public health responses."&lt;/p&gt; &lt;p data-v-7f0a623e&gt;The deadly disease is already endemic to 21 countries in the Americas.&lt;/p&gt; &lt;h2 data-v-7f0a623e&gt;What is Chagas disease?&lt;/h2&gt; &lt;p original-article-post="" data-v-ec26887a data-v-7f0a623e&gt;Dig deeper:&lt;/p&gt; &lt;p data-v-7f0a623e&gt;&lt;a href="https://www.cdc.gov/chagas/about/index.html" target="_blank" rel="noopener"&gt;Chagas disease&lt;/a&gt; is a potentially deadly disease caused by Trypanosoma cruzi parasites, which is carried by triatomine or "kissing bugs."&lt;/p&gt; &lt;p data-v-7f0a623e&gt;If the "kissing bug" sucks the blood of an infected host, then it becomes a carrier and can pass the parasite through its feces.&lt;/p&gt; &lt;div original-article-post="" class="full-width-image" data-v-0dea8073 data-v-7f0a623e&gt;&lt;img src="https://images.foxtv.com/static.fox5dc.com/www.fox5dc.com/content/uploads/2025/09/932/524/gettyimages-2214281234.jpg?ve=1&amp;amp;tl=1" alt="" data-v-0dea8073&gt; &lt;div class="info" data-v-0dea8073&gt;&lt;p data-v-0dea8073&gt;&lt;span data-v-0dea8073&gt;MADRID, SPAIN - 2025/05/09: Panstrongylus megistus displayed in Faunia zoo. Panstrongylus megistus is a blood-drinking insect in the subfamily Triatominae, is an important vector of Trypanosoma cruzi, the causative agent of Chagas disease. (Photo by &lt;/span&gt; &lt;/p&gt; &lt;/div&gt;&lt;/div&gt; &lt;p data-v-7f0a623e&gt;The CDC says about 8 million people globally, including an estimated 280,000 in the United States, have the disease without knowing it.&lt;/p&gt; &lt;p data-v-7f0a623e&gt;Chagas disease can be life-threatening without proper treatment.&lt;/p&gt; &lt;h2 data-v-7f0a623e&gt;Symptoms and treatments&lt;/h2&gt; &lt;p original-article-post="" data-v-ec26887a data-v-7f0a623e&gt;What you can do:&lt;/p&gt; &lt;p data-v-7f0a623e&gt;Health officials say Chagas disease has two stages; the acute phase and the chronic phase.&lt;/p&gt; &lt;p data-v-7f0a623e&gt;The acute phase happens in the first weeks and months after getting infected, and could include these symptoms:&lt;/p&gt; &lt;ul original-article-post="" data-v-03e8ff79 data-v-7f0a623e&gt;&lt;li class="article-ct" data-v-03e8ff79&gt;&lt;span data-v-03e8ff79&gt;Fever&lt;/span&gt;&lt;/li&gt;&lt;li class="article-ct" data-v-03e8ff79&gt;&lt;span data-v-03e8ff79&gt;Feeling tired&lt;/span&gt;&lt;/li&gt;&lt;li class="article-ct" data-v-03e8ff79&gt;&lt;span data-v-03e8ff79&gt;Body aches&lt;/span&gt;&lt;/li&gt;&lt;li class="article-ct" data-v-03e8ff79&gt;&lt;span data-v-03e8ff79&gt;Headache&lt;/span&gt;&lt;/li&gt;&lt;li class="article-ct" data-v-03e8ff79&gt;&lt;span data-v-03e8ff79&gt;Rash&lt;/span&gt;&lt;/li&gt;&lt;li class="article-ct" data-v-03e8ff79&gt;&lt;span data-v-03e8ff79&gt;Loss of appetite&lt;/span&gt;&lt;/li&gt;&lt;li class="article-ct" data-v-03e8ff79&gt;&lt;span data-v-03e8ff79&gt;Diarrhea&lt;/span&gt;&lt;/li&gt;&lt;li class="article-ct" data-v-03e8ff79&gt;&lt;span data-v-03e8ff79&gt;Vomiting&lt;/span&gt;&lt;/li&gt;&lt;li class="article-ct" data-v-03e8ff79&gt;&lt;span data-v-03e8ff79&gt;Eyelid swelling&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt; &lt;p data-v-7f0a623e&gt;The chronic phase can last many years, or the rest of your life, without any symptoms. However, the CDC says about 20–30 % of those infected can develop some serious health issues:&lt;/p&gt; &lt;ul original-article-post="" data-v-03e8ff79 data-v-7f0a623e&gt;&lt;li class="article-ct" data-v-03e8ff79&gt;&lt;span data-v-03e8ff79&gt;Heart issues, such as an enlarged heart, heart failure, altered heart rate or rhythm, or sudden death.&lt;/span&gt;&lt;/li&gt;&lt;li class="article-ct" data-v-03e8ff79&gt;&lt;span data-v-03e8ff79&gt;Digestive problems, such as an enlarged esophagus or colon, leading to trouble eating or going to the bathroom.&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt; &lt;p data-v-7f0a623e&gt;Treatment for Chagas disease includes antiparasitic and symptomatic methods.&lt;/p&gt; &lt;p data-v-7f0a623e&gt;Antiparasitic treatment uses medication to kill the parasite that causes the disease, while symptomatic treatment helps manage the symptoms and signs of the infection.&lt;/p&gt; &lt;div original-article-post="" class="group-source-title" data-v-4fbf7207 data-v-7f0a623e&gt;&lt;p class="group-source-paragraph" data-v-4fbf7207&gt;&lt;b data-v-4fbf7207&gt;The Source:&lt;/b&gt; Information from this article was sourced from the Centers for Disease Control and Prevention.&lt;/p&gt;&lt;/div&gt;     &lt;p data-uid="fts-ar-17" class="vendor-unit" data-v-7f0a623e&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>FOX 5 DC</author><pubDate>Tue, 09 Sep 2025 15:01:36 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMif0FVX3lxTE5iaW9jb0lCb3JGanNyQm9KMWt5NkN4S2RmSS0yWnNXV0JfMHBnbmhkYk03RVBZNDZSTlEyamc0VnlXc2paVGh3ZUhIRlVrREp0TVMyS1RtUThEZFBWX2FXMU1GaUEtcDBFU2RldGZjaGxoaUo2c3FKV1lrQVRiQWvSAYQBQVVfeXFMUHZ6U3VheG1JMnZvdGdoMHFEcEZVVks2QmplWE5qbG5WMVItZFRDMThicWx2MDNXSVRpWEhLRGs1YndEaDJaWklMbTBuZS1FTnVvRnBFbHduMUF5YXdmallaQy1iLWFHVklfenlWUU9fb1Jna1RwNElnUGVzeWdmUDM4LVVq</guid></item><item><title>您应该在什么时候就睡眠问题去看医生？ -《纽约时报》</title><link>https://www.nytimes.com/2025/09/09/well/sleep-medicine-appointment.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;body id="readabilityBody"&gt;&lt;p id="cmsg"&gt;Please enable JS and disable any ad blocker&lt;/p&gt;&lt;/body&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The New York Times</author><pubDate>Tue, 09 Sep 2025 15:00:09 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMie0FVX3lxTE5aZHhreGlRTF83Zzh4Q1E5NkdrZXVpMU82MHdMTFowZ1BqQ1Q0cThFTEpXd0ZZdzRJRDI0V3hvMVk3ckg3UHQyQnRzeVNJWkJ4TVVRa3N3UTE5ZE5Da0h3QlpvUG9xQUtxRHl1cVA3NVB6RVNOcGxLZ3NKOA</guid></item><item><title>我是一名物理治疗师，现在就开始做这四个练习--否则就有可能成为一个虚弱、虚弱和虚弱的老人--《每日邮报》</title><link>https://www.dailymail.co.uk/health/article-15080791/physiotherapist-exercises-old-age-pensioner-longevity-strength.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div itemprop="articleBody"&gt;&lt;p class="mol-para-with-font"&gt;Adding just four exercises to your fitness routine in midlife can help prevent muscle loss and preserve strength, according to a leading physiotherapist. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Research has long suggested that strength training, using just bodyweight, can help significantly slash the risk of a number of health conditions and turn back the biological clock. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The &lt;a target="_self" href="/news/nhs/index.html" id="mol-8a6c2220-8d83-11f0-9a53-a98349360cc8"&gt;NHS&lt;/a&gt; recommends that adults should be active everyday and undertake at least 150 minutes of moderately intense activity or 75 minutes if vigorous activity a week. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;But as we age, muscle mass gradually deteriorates, and joints become stiffer and weaker over time. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;To combat this, the health service also recommends strengthening exercises that work all major muscle groups including the legs, back and abdomen at least two days a week. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;But now Fikri Fikriev, a physiotherapist at Physiotherapy Matters has shared four simple exercises to implement in midlife to make ageing easier, reducing back pain and supporting muscle growth. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;'As we age, naturally the joints can become stiffer and our muscles lose strength,' he told the &lt;a class="class" rel="noreferrer noopener" target="_blank" href="https://www.mirror.co.uk/news/health/people-aged-30s-40s-should-35863189"&gt;Mirror&lt;/a&gt;. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;'The rate of muscle mass loss depends on age and lifestyle, but we gradually begin to lose muscle mass from around our 30-40s.' &lt;/p&gt;&lt;div class="artSplitter mol-img-group"&gt;  &lt;p class="imageCaption"&gt;Studies have previously shown that vigorous activity — such as running, swimming or tennis — at least once a week is needed to ward off musculoskeletal pain in the long-term &lt;/p&gt;&lt;/div&gt;&lt;p class="mol-para-with-font"&gt;From around 65-years-old, this process can speed up––in some cases reaching around 8 per cent muscle mass per decade.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Mr Fikriev added: 'This can have an effect on your mobility and energy levels, hence why it is essential to have a balanced routine that helps to preserve strength and mobility as we age.' &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;To do this and ease the effects of ageing, Mr Fikriev shared four simple exercises to perform around three to four times a week in midlife for maximum health benefits, stressing that 'consistency is key'. &lt;/p&gt;&lt;h2 class="mol-para-with-font mol-style-subhead"&gt;Two leg bridge &lt;/h2&gt;&lt;p class="mol-para-with-font"&gt;This straightforward exercise is an easy way to ease back pain, whilst building core stability which helps with everything from posture to bladder control. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;To perform the exercise simply lie on your back with your knees bent and feet firmly planted on the ground, hip-width apart. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Push your hips towards the sky to form a bridge shape with your body, making sure to push down through your heels and being careful to keep your tailbone tucked in. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;'Bridge exercises and hip thrusts can improve back pain, as well as hip, hamstring and glute strength,' Mr Fikriev explained. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;'Additionally, bridge exercises can help strengthen the core and pelvic floor. This is very important, especially in women who struggle with bladder control, such as older adults, after pregnancy, or due to stress.' &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;This exercise can also be modified for more of a challenge, with the option to incorporate weights, add pulses or lift one leg as you thrust upwards. &lt;/p&gt;&lt;div class="artSplitter mol-img-group"&gt;  &lt;p class="imageCaption"&gt;Glute bridges can help ease back pain and improve posture, as well as strengthening the core&lt;/p&gt;&lt;/div&gt;&lt;h2 class="mol-para-with-font mol-style-subhead"&gt;Wall push-ups &lt;/h2&gt;&lt;p class="mol-para-with-font"&gt;'Push up exercises are a great way to improve posture and upper body strength, such as in your back, chest and core,' the physiotherapist explained. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;For people who are just starting out on their fitness journey, a wall-push up is a great alternative to the classic exercise. Place your hands against the wall, shoulder-width apart, and bring your chest towards the wall and then push it away. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;For more of a burn, try and keep your elbows tucked in close to your body. As you build strength, try adding more reps or position yourself further away from the wall to build resistance. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;'Push-ups also help to improve heart health, lose body weight and fat, and lower blood pressure and cholesterol', Mr Fikriev added.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;It has long been proven that exercise strengthens the heart and lowers blood pressure, reducing the risk of heart disease. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;By minimising metabolic risk factors, exercising in midlife can have a preventative effect preserving muscle mass and slowing down biological ageing. &lt;/p&gt;&lt;div class="artSplitter mol-img-group"&gt;  &lt;p class="imageCaption"&gt;These simple exercises can then be modified once you have built a good base level of core strength and mobility  &lt;/p&gt;&lt;/div&gt;&lt;h2 class="mol-para-with-font mol-style-subhead"&gt;Sit to stand &lt;/h2&gt;&lt;p class="mol-para-with-font"&gt;Whilst it might sound overly simple, moving from a sitting position to standing can help strengthen muscles we rely on for everyday movement. This functional conditioning helps to keep joints flexible, reducing risk of inflammation and joint pain. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;As you progress, you can also start adding in squats and lunges to increase your range of motion. &lt;/p&gt;&lt;h2 class="mol-para-with-font mol-style-subhead"&gt;Calf raises &lt;/h2&gt;&lt;p class="mol-para-with-font"&gt;'Calf raises offer several benefits, including improved balanced, improved ankle stability and mobility, and enhanced strength,' Mr Fikriev explained. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The simple movement involves alternating between a tip-toe stance and being flat footed on the ground. Again, this exercise can be modified with the addition of weights, or by performing the exercise on one leg and then the other. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt; The physiotherapist added: 'This exercise can also improve lower limb blood circulation, which reduces sprains and helps prevent falls. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;It can also help reduce the risk of tendonitis––where a tendon becomes inflamed causing pain and joint stiffness. &lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Daily Mail</author><pubDate>Tue, 09 Sep 2025 14:35:23 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">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</guid></item><item><title>根据营养师的说法，您应该吃的6种降低血压的方便食品- AOL.com</title><link>https://www.aol.com/6-convenience-foods-eat-lower-000000368.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="caas-body"&gt;&lt;p&gt;&lt;strong&gt;Reviewed by Dietitian Katey Davidson, M.Sc.FN, RD, CPT&lt;/strong&gt;&lt;/p&gt;&lt;figure class="caas-figure"&gt;&lt;div class="caption-wrapper caption-aligned-with-image"&gt;&lt;figcaption class="caption-collapse"&gt;&lt;p&gt;Design elements: Getty Images. EatingWell design.&lt;/p&gt;&lt;/figcaption&gt;&lt;/div&gt;&lt;/figure&gt;&lt;h3&gt;Key Points&lt;/h3&gt;&lt;ul class="caas-list caas-list-bullet"&gt;&lt;li&gt;&lt;p&gt;Convenience foods can be nutritious and help support healthy blood pressure.&lt;/p&gt;&lt;/li&gt;&lt;li&gt;&lt;p&gt;Stock up on black beans, edamame, canned tuna, Greek yogurt, beets and prewashed greens.&lt;/p&gt;&lt;/li&gt;&lt;li&gt;&lt;p&gt;Start with small, gradual changes and swaps to support your heart health.&lt;/p&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;If you’re managing high blood pressure, you might assume “convenience food” is off-limits. After all, it often brings to mind greasy takeout, salty snacks or sugary treats. But here’s the truth: convenience doesn’t always mean unhealthy. In fact, supporting your heart health doesn’t require hours in the kitchen—many quick and easy foods can be part of a heart-healthy diet. “Convenience foods get a bad rap, but we often underestimate how many options actually fall into this category beyond chips or doughnut holes,” says &lt;a href="https://www.artofappetite.com/about" rel="nofollow noopener" target="_blank" data-ylk="slk:Bree Phillips, M.S., RD;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;Bree Phillips, M.S., RD&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;The key is choosing foods rich in nutrients that support healthy blood pressure—like fiber, potassium and magnesium—while &lt;a class="link rapid-noclick-resp" href="https://www.eatingwell.com/article/7981788/low-sodium-foods-list/" rel="nofollow noopener" target="_blank" data-ylk="slk:limiting sodium;elm:context_link;itc:0;sec:content-canvas"&gt;limiting sodium&lt;/a&gt;, which can increase blood pressure. The good news? Grocery stores are full of simple, convenient, &lt;a class="link rapid-noclick-resp" href="https://www.eatingwell.com/article/7872995/complete-list-of-heart-healthy-foods/" rel="nofollow noopener" target="_blank" data-ylk="slk:heart-healthy options;elm:context_link;itc:0;sec:content-canvas"&gt;heart-healthy options&lt;/a&gt;. Here are six dietitian-approved convenience foods to add to your list.&lt;/p&gt;&lt;h2&gt;1. Canned Black Beans&lt;/h2&gt;&lt;p&gt;“A great convenience food for better blood pressure is canned no-salt-added black beans,” says &lt;a href="https://drlisayoung.com/about/" rel="nofollow noopener" target="_blank" data-ylk="slk:Lisa Young, Ph.D., RDN;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;Lisa Young, Ph.D., RDN&lt;/a&gt;. “They’re quick and ready to use, packed with potassium and magnesium—two minerals that help relax blood vessels and lower blood pressure. They’re also high in fiber, which supports heart health.” If you can’t find a sodium-free version, she recommends giving them a rinse before eating to reduce any excess sodium.&lt;/p&gt;&lt;p&gt;When you’re short on time, having these in your pantry means you can have a nourishing meal in just minutes. Try tossing them into a salad for a satisfying lunch, mashing them with spices for a quick bean dip, or adding them to soups and tacos for an easy dinner.&lt;/p&gt;&lt;h2&gt;2. Steamed &amp;amp; Peeled Beets&lt;/h2&gt;&lt;p&gt;Beets are nutritional powerhouses, but preparing them from scratch can be a messy and time-consuming process. That’s why canned beets are an excellent choice. “This convenient option lets you enjoy all the benefits without any of the purple-stained fingers, making it simple to add a vibrant, earthy and healthy component to any meal. They’re such a time-saver and spare the mess of preparing fresh beets,” says &lt;a href="https://www.rachellemallik.com/meetrachelle" rel="nofollow noopener" target="_blank" data-ylk="slk:Rachelle Mallik, M.A., RD;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;Rachelle Mallik, M.A., RD&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;&lt;a href="https://www.christinaychu.com/about" rel="nofollow noopener" target="_blank" data-ylk="slk:Christina Chu, M.S., RD, CSSD;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;Christina Chu, M.S., RD, CSSD&lt;/a&gt;, a sports dietitian, points to their added nutritional benefits. “Beets contain nitrates, which convert to nitric oxide, a natural vasodilator that opens up your blood vessels, thus improving blood flow and improving blood pressure,” she explains. Steamed beets are also a &lt;a href="https://www.eatingwell.com/gallery/11369/healthy-recipes-for-potassium-rich-foods/" rel="nofollow noopener" target="_blank" data-ylk="slk:good source of potassium;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;good source of potassium&lt;/a&gt; and folate, both of which contribute to cardiovascular health.&lt;/p&gt;&lt;p&gt;You can slice them into a salad with goat cheese and walnuts, blend them into a smoothie for a nutrient boost, or simply enjoy them as a side dish drizzled with a little balsamic glaze.&lt;/p&gt;&lt;h2&gt;3. Canned Tuna&lt;/h2&gt;&lt;p&gt;“Canned tuna with no salt added can be a great choice for someone looking to regulate their blood pressure,” shares &lt;a href="https://www.thedietitiandish.com/about-me" rel="nofollow noopener" target="_blank" data-ylk="slk:Patricia Kolesa, M.S., RDN;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;Patricia Kolesa, M.S., RDN&lt;/a&gt;. “Not only is it low in sodium, but it is a lean source of protein and high in omega-3s.”&lt;/p&gt;&lt;p&gt;&lt;a href="https://www.eatingwell.com/article/8035578/omega-3-supplements-benefits/" rel="nofollow noopener" target="_blank" data-ylk="slk:Omega-3 fats;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;Omega-3 fats&lt;/a&gt; are celebrated for their anti-inflammatory properties and their ability to &lt;a class="link rapid-noclick-resp" href="https://www.eatingwell.com/surprising-nutrient-for-better-heart-health-8686588" rel="nofollow noopener" target="_blank" data-ylk="slk:support overall heart health;elm:context_link;itc:0;sec:content-canvas"&gt;support overall heart health&lt;/a&gt;, including managing healthy blood pressure. Studies suggest that they help blood vessels relax and improve how they function, which reduces strain on the heart and arteries. Tuna also contains selenium, a trace mineral linked with better blood pressure.&lt;/p&gt;&lt;p&gt;Try adding canned tuna on top of a salad, in a sandwich or in a delicious pasta.&lt;/p&gt;&lt;h2&gt;4. Frozen Cooked Edamame&lt;/h2&gt;&lt;p&gt;Found in the freezer aisle, edamame is one of the most underrated convenience foods. These green soybeans are “loaded with plant protein, potassium, isoflavones (plant compounds) and fiber; all components that support healthy blood pressure levels,” explains &lt;a href="https://whitnessnutrition.com/contact/" rel="nofollow noopener" target="_blank" data-ylk="slk:Whitney Stuart, M.S., RDN;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;Whitney Stuart, M.S., RDN&lt;/a&gt;. In fact, studies have found that eating soybeans and soy products is associated with lower blood pressure.&lt;/p&gt;&lt;p&gt;Keep a bag in your freezer and steam them for a simple side dish, toss them into stir-fries or salads for extra protein, or puree them with garlic and lemon juice to make a nutritious dip.&lt;/p&gt;&lt;h2&gt;5. Plain Strained (Greek-Style) Yogurt&lt;/h2&gt;&lt;p&gt;Keeping a container of plain strained (Greek-style) yogurt in your fridge is a convenient way to boost nutrition at any meal. It’s thicker and higher in protein than regular yogurt, providing a satisfying base for countless creations. It’s also linked with better blood pressure, thanks to its quality protein and nutrients like potassium, magnesium and calcium that help support healthy blood vessels and flush out excess sodium.&lt;/p&gt;&lt;p&gt;The high protein content can also aid in weight management, which is another key factor in &lt;a class="link rapid-noclick-resp" href="https://www.eatingwell.com/how-to-lower-blood-pressure-8611460" rel="nofollow noopener" target="_blank" data-ylk="slk:maintaining healthy blood pressure;elm:context_link;itc:0;sec:content-canvas"&gt;maintaining healthy blood pressure&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;Use it as a base for a heart-healthy parfait with berries and nuts, as a healthier substitute for sour cream on baked potatoes, or as a creamy foundation for sauces and dressings.&lt;/p&gt;&lt;h2&gt;6. Prewashed Leafy Greens&lt;/h2&gt;&lt;p&gt;Eating more vegetables rich in natural nitrates, like leafy greens, is linked to lower blood pressure. They’re also rich in potassium, magnesium and an &lt;a class="link rapid-noclick-resp" href="https://www.eatingwell.com/foods-as-many-antioxidants-as-green-tea-11761365" rel="nofollow noopener" target="_blank" data-ylk="slk:array of antioxidants;elm:context_link;itc:0;sec:content-canvas"&gt;array of antioxidants&lt;/a&gt; like lutein that support heart health. In fact, one study found that a greater intake of leafy greens is associated with lower blood pressure and a &lt;a class="link rapid-noclick-resp" href="https://www.eatingwell.com/article/7894073/these-7-things-could-make-you-more-likely-to-get-heart-disease-according-to-the-american-heart-association/" rel="nofollow noopener" target="_blank" data-ylk="slk:reduced risk of heart disease;elm:context_link;itc:0;sec:content-canvas"&gt;reduced risk of heart disease&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;While salad kits can sometimes come with high-sodium dressings, a simple bag of prewashed spinach, kale or arugula offers pure convenience. These greens are ready to use right out of the bag, cutting down on prep time and making it incredibly easy to add to any meal. Use these greens in salads, soups, sauces, smoothies or sandwiches to easily boost your nutrition.&lt;/p&gt;&lt;h2&gt;Our Expert Take&lt;/h2&gt;&lt;p&gt;Adopting a diet that supports healthy blood pressure doesn’t have to mean an expensive grocery list or a complicated meal plan. Simple changes and smart choices can make a big difference. By including &lt;a class="link rapid-noclick-resp" href="https://www.eatingwell.com/processed-and-ultra-processed-foods-dietitian-approved-11770154" rel="nofollow noopener" target="_blank" data-ylk="slk:nutrient-rich convenience foods;elm:context_link;itc:0;sec:content-canvas"&gt;nutrient-rich convenience foods&lt;/a&gt; like the ones on this list, you can build &lt;a class="link rapid-noclick-resp" href="https://www.eatingwell.com/small-habits-for-heart-health-11796620" rel="nofollow noopener" target="_blank" data-ylk="slk:heart-healthy habits;elm:context_link;itc:0;sec:content-canvas"&gt;heart-healthy habits&lt;/a&gt; without adding stress to your busy life.&lt;/p&gt;&lt;p&gt;Remember that you don’t have to buy everything at once or completely overhaul your diet. Start by adding one or two items to your weekly routine—swap a salty snack for edamame, or replace a complicated side dish with some steamed beets. Small, easy adjustments like these let you take control of your health one delicious meal at a time.&lt;br&gt;&lt;/p&gt;&lt;p&gt;Read the original article on &lt;a href="https://www.eatingwell.com/best-convenience-foods-to-lower-blood-pressure-11801985" rel="nofollow noopener" target="_blank" data-ylk="slk:EatingWell;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;EatingWell&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>AOL.com</author><pubDate>Tue, 09 Sep 2025 14:19:49 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMickFVX3lxTFBjRjdpUE9kd0hyTmJ5TkpIZ0wxekV4dE9UWXQ5VUJQMGpOUnZ1X1c1Z0ZPTEdRNXl2T29kdmFCNDI4WmVYb0doVTI4MzlIU0k2U09LSkV1R2xKZXA2QU9vUW9odmVIRGEzbjJ4MVV5d2pVdw</guid></item><item><title>Parkview遗传学项目现已向公众开放- WINE 15</title><link>https://www.wane.com/news/local-news/parkview-genetics-program-now-open-to-the-public/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="article-content article-body rich-text "&gt;
		
		


&lt;p&gt;FORT WAYNE, Ind. (WANE) – A program that until now has only been available for Parkview Health patients and staff is opening to anyone interested in knowing their genetic health risks.&lt;/p&gt;



&lt;p&gt;DNA Insights, a free community health research program, is now available to anyone ages 18 and older with a Parkview MyChart account. Created in partnership with &lt;a href="https://www.parkview.com/news/results/01152025-parkview-health-joins-helix-research-network-to-advance" target="_blank" rel="noreferrer noopener"&gt;Helix Research Network&lt;/a&gt;, the program aims to help participants understand how their ancestry has impacted their traits and risk of certain diseases, according to a press release from Parkview. &lt;/p&gt;



&lt;p&gt;Those who enroll will take the following steps:&lt;/p&gt;
&lt;p hidden data-minutemedia-viewport="mobile" data-player-id="hfzyf2ay" data-stn-player="" data-s2n-api="minuteMediaS2NApi"&gt;&lt;/p&gt;


&lt;ul class="wp-block-list"&gt;
&lt;li&gt;Complete an online informed consent form&lt;/li&gt;



&lt;li&gt;Visit a Parkview laboratory for a simple blood draw&lt;/li&gt;



&lt;li&gt;Receive no-cost genetic screening to learn about their inherited risk for:
&lt;ul class="wp-block-list"&gt;
&lt;li&gt;Certain hereditary cancers, including breast, ovarian and colorectal.&lt;/li&gt;



&lt;li&gt;A hereditary form of high cholesterol (familial hypercholesterolemia) that increases risk for heart attack and stroke&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;



&lt;li&gt;Gain insights into regional ancestry and selected genetic traits, such as caffeine sensitivity and sleep patterns&lt;/li&gt;
&lt;/ul&gt;



&lt;p&gt;Approximately 1-2% of program participants are expected to have a genetic variant that may put them at risk for one of the above conditions. According to the press release, those with positive results are offered a no-cost genetic counseling session with a Parkview counselor to understand their results and discuss proactive, preventative care planning. Results may also help guide testing for other family members who could be affected.&lt;/p&gt;
&lt;p hidden data-minutemedia-viewport="desktop" data-player-id="hfzyf2ay" data-stn-player="" data-s2n-api="minuteMediaS2NApi"&gt;&lt;/p&gt;


&lt;p&gt;“Integrating genetic information into everyday care is the future of medicine,” said Dr. Michael Mirro, chief academic research officer for Parkview Health. “Our goal is to make precision health accessible to more people, which in turn will help us design smarter, more effective programs for prevention and treatment across our region.”&lt;/p&gt;





&lt;p&gt;Over the next several years, Parkview aims to enroll 100,000 participants in the program.&lt;/p&gt;





&lt;p&gt;Participants are also contributing to what the release describes as groundbreaking research, which could help Parkview and other Helix Research Network members develop targeted health programs for communities, improve outcomes while reducing total cost of care through early detection, and advance the integration of genomics into routine care, according to the release.&lt;/p&gt;



&lt;p&gt;Participants who aren’t Parkview patients can &lt;a href="https://mychart.parkview.com/mychart/signup" target="_blank" rel="noreferrer noopener"&gt;create a MyChart account online.&lt;/a&gt; Health insurance is not required to be part of the program. Learn more about DNA insights &lt;a href="https://www.parkview.com/dnainsights" target="_blank" rel="noreferrer noopener"&gt;on the website.&lt;/a&gt; &lt;/p&gt;

		&lt;p class="article-content-cta-group"&gt;
					&lt;/p&gt;
	&lt;/div&gt;

	
&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>WANE 15</author><pubDate>Tue, 09 Sep 2025 14:18:24 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMijwFBVV95cUxOS2ZWeVBYZGpaVG9SWENQOXp1VEFJek5ReDI3MjQ5am9McjBIVzFIbjZ6NnlHVG52TnpaaWpKRTFBVTQ5UEZOZVVWbEJDSG9XcXRoOEhxMVdQVDF4TzhwcVlWNE1ZcE1fTjBOT3g1amc2WDY5NHRadFVjMUdvc2tFcU83YnpQOFJjdENfQ00yb9IBlAFBVV95cUxNTWVpOF80RHhuNURfeHZ0aEJVRHQyMGRxbXEtdThFZEZzbUs4UnlzRWtoeFFDX3BvcU03ejhpZmR1ZXJoTUEtUm5QSzlFT0lGWVFfbU9wRFBxdlhMYUp1NmhyY0RzT1dkcjdSOXZSZ3htTGtMcHA3OERQeDBlTWlMUVV1eDlHbzM4SGpJazBVNXBfN01l</guid></item><item><title>我现在该怎么处理我家人的疫苗接种？ - vox.com</title><link>https://www.vox.com/health/460528/vaccine-recommendations-rfk-hhs-new-guidance-covid</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div id="zephr-anchor" class="_1agbrix10"&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;&lt;em&gt;We’re making this story accessible to all readers as a public service. At Vox, our mission is to help everyone access essential information that empowers them. Support our journalism by &lt;a href="/support-membership?itm_campaign=jan-2025-critical&amp;amp;itm_medium=site&amp;amp;itm_source=in-article" target="_blank" rel="noreferrer noopener"&gt;becoming a member today&lt;/a&gt;.&lt;/em&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;Every cold and flu season, you probably find yourself thinking about vaccinations for your kids: flu, Covid, the works. Maybe you’re at a routine checkup and you’re wondering if you should ask your doctor for the shots; maybe the pediatric clinic is running a vaccine clinic and you’re considering stopping by with the whole family. Either way, it has become a routine part of every autumn.&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;But this year, it’s different.&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;Any parent who reads the news or logs onto social media has probably heard that the &lt;a href="https://www.npr.org/sections/shots-health-news/2025/08/27/nx-s1-5515503/fda-covid-vaccines-restricted"&gt;US government has changed its vaccine guidance&lt;/a&gt;. They may also have learned that some of the leading doctor organizations in the country &lt;a href="/health/459226/rfk-jr-trump-covid-vaccine-ban"&gt;are &lt;em&gt;opposed&lt;/em&gt;&lt;/a&gt; to those changes, as are a growing number of states.&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;I am lucky to have three healthy children under age 7, but I have still found myself wondering particularly about the value of Covid-19 shots for them the past few years. Like many parents, I have a lot of questions: &lt;em&gt;Is the government going to change what vaccines we can get? Are Covid and flu shots going to be accessible anymore? Will they be covered by health insurance? How do I even know anymore which vaccines are safe for my child?&lt;/em&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;It used to be simple: The federal government, professional medical societies, your personal physician would all tell you the same thing about which vaccines you should get. And then your health insurance company — following that guidance — would usually cover the cost. But perhaps not anymore.&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;Robert F. Kennedy Jr., the US health secretary, is making a lot of changes to the government’s vaccine policy.&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;He has unilaterally &lt;a href="https://www.axios.com/2025/08/27/covid-vaccine-2025-fda-recommendation-rfk"&gt;declared&lt;/a&gt; that healthy children and healthy pregnant women should not receive a dose of the Covid vaccines — a move that has spurred uproar among staff at the Centers for Disease Control and Prevention and &lt;a href="/health/459768/trump-cdc-director-monarez-robert-kennedy-jr"&gt;led to an exodus of its leaders&lt;/a&gt;, including director Susan Monarez. There have been &lt;a href="https://www.thedailybeast.com/donald-trump-and-robert-f-kennedy-junior-to-ban-covid-19-vaccine-within-months/"&gt;reports&lt;/a&gt; that the Trump administration may pull the Covid vaccines from the market entirely. He has &lt;a href="https://www.npr.org/sections/shots-health-news/2025/06/25/nx-s1-5445254/cdc-review-vaccine-schedule-children"&gt;ordered&lt;/a&gt; a review of all of the vaccines that children receive when they’re growing up, and Kennedy has &lt;a href="https://www.politico.com/news/2025/09/03/kennedy-prepares-to-name-new-acip-members-00542750"&gt;put vaccine skeptics&lt;/a&gt; in important positions in the administration.&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;Now, the medical establishment has started pushing back forcefully. In the past few weeks, the &lt;a href="https://www.wsj.com/health/healthcare/leading-pediatrics-group-recommends-covid-19-shots-for-young-children-differing-from-cdc-5ed971a6?mod=djemHL_t"&gt;American Academy of Pediatrics&lt;/a&gt; and the &lt;a href="https://www.bloomberg.com/news/articles/2025-08-22/ob-gyns-clash-with-rfk-jr-to-back-covid-shots-during-pregnancy?cmpid=BBD082525_prognosis&amp;amp;utm_medium=email&amp;amp;utm_source=newsletter&amp;amp;utm_term=250825&amp;amp;utm_campaign=prognosis&amp;amp;embedded-checkout=true"&gt;American College of Obstetrics and Gynecologists&lt;/a&gt; have said that children and pregnant women should receive the Covid vaccine.&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;There is a group of &lt;a href="https://www.cidrap.umn.edu/vaccine-integrity-project"&gt;infectious disease experts at the University of Minnesota&lt;/a&gt; who are working on alternative vaccine recommendations, in consultation with a range of medical organizations. Groups of states &lt;a href="https://www.opb.org/article/2025/09/03/vaccines-oregon-washington-california-cdc/"&gt;on the West Coast&lt;/a&gt; and &lt;a href="https://www.bostonglobe.com/2025/08/22/metro/vaccine-public-health-massachusetts-pennsylvania-rhode-island-vermont-connecticut-maine-kennedy-trump/"&gt;across New England&lt;/a&gt; are teaming up with their neighbors to potentially issue their own vaccine recommendations. &lt;a href="https://www.bostonglobe.com/2025/09/04/metro/covid-vaccines-kennedy-cdc-healey/"&gt;Massachusetts will require health insurers&lt;/a&gt; to cover state-endorsed vaccines, and more states may follow suit.&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;Here are some essential things to know about where vaccine access stands right now: The Trump administration has granted more limited approval for the latest update of the Covid shots. Healthy adults under 65 and children are not technically covered by the new Food and Drug Administration approval, and it’s not clear how widely available the vaccines will be at pharmacies and doctors offices in the fall. And the CDC will release its own recommendations for the Covid vaccines later in September, which could match the FDA approval — but could not. We’re in uncharted territory.&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;So far, other vaccines have not yet been affected, but we have already seen Kennedy make changes to the vaccine guidance outside of the normal process. The government could still make changes to who is recommended to get flu shots and RSV shots, and, in the long term, they could change the recommendations around measles shots, hepatitis shots, and all of the other vaccines that make up the childhood immunization schedule.&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;And in this new normal, where the government and medical establishment are at odds, whenever Kennedy walks back a recommendation for a specific vaccine, professional medical organizations may recommend the exact opposite. So, what are parents, trying to do the best for their children, supposed to do?&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;First, know which sources can help you find your bearings. Even though many experts in the public health establishment are pushing back on the federal government right now, it’s still worth understanding what the CDC recommends. You can find this &lt;a href="https://www.cdc.gov/vaccines/index.html"&gt;on the CDC’s website&lt;/a&gt;. After that, you want to get the bigger picture: Understand what the relevant professional medical societies recommend. Some of the big ones are: the &lt;a href="https://publications.aap.org/redbook/resources/15585/AAP-Immunization-Schedule?autologincheck=redirected&amp;amp;utm_source=substack&amp;amp;utm_medium=email"&gt;American Academy of Pediatrics&lt;/a&gt;, the &lt;a href="https://www.acog.org/news/news-releases/2025/08/acog-releases-updated-maternal-immunization-guidance-covid-influenza-rsv"&gt;American College of Obstetricians and Gynecologists&lt;/a&gt;, and the &lt;a href="https://www.idsociety.org/ID-topics/special-topics/immunization/"&gt;Infectious Diseases Society of America&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;But you’re not on your own in the labyrinth of the internet, either.&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;Your family physician, primary care doctor, and pharmacist will also be able to walk you through the best available information. They may also be able to tell you about any recent changes to the federal policy and what’s being communicated to the public about why they were made.&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;If both the CDC and the doctors’ groups agree on their vaccine guidance — as they might for, for example, the flu shot — then you can feel good about which shots to get, and you can be confident that your health insurance will cover it. Federal law mandates that most insurers cover the vaccines that are recommended by the federal government.&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;But what if the CDC and the doctor groups disagree, as they seem to on the value of Covid shots at the moment? This is a situation where it is valuable to have a doctor you can trust.&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;Unfortunately, finding a primary care doctor is &lt;a href="/23817170/family-doctor-primary-care-physician-general-practitioner-shortage"&gt;more difficult&lt;/a&gt; than it should be in the United States. But something most families can do is pose these questions even to a nurse at a pharmacy or health care worker at a vaccine clinic, for your own knowledge and peace of mind:&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;&lt;em&gt;What are the benefits of receiving the vaccine? What are the potential risks? How common are serious side effects?&lt;/em&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;And, in their opinion, &lt;em&gt;Do the benefits outweigh the risks or vice versa? Is one vaccine preferable over the other?&lt;/em&gt; The Pfizer vaccine, for example, is approved for children ages 6 and older, while the Moderna shot is approved for kids 6 &lt;em&gt;months&lt;/em&gt; and older.&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;The next major question we’re all going to have to face is: &lt;em&gt;If I want to get a vaccine for myself or my child, will it cost me any money?&lt;/em&gt; This largely depends on your health insurance, if you have it.&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;As of today, none of the major health insurers have made significant changes to their vaccine coverage policies. But that could change.&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;Your doctor likely deals with insurance coverage in these situations all the time. Use them as an ally when trying to figure out if you can get your health insurance to cover a vaccine in a scenario where it is not federally required. They should also know about any state-level mandates that could require a health plan to cover you or your child’s shots.&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 xkp0cg1"&gt;Doctors may even be able to help you file a claim with your health insurer, and they might be aware of other public and private programs that are available to help cover the cost of vaccines. The &lt;a href="https://www.pbs.org/newshour/health/fda-approves-updated-covid-19-shots-with-some-restrictions-for-kids-and-adults"&gt;new FDA approvals&lt;/a&gt; do allow for kids with underlying health conditions to receive the vaccine in consultation with a doctor, which could ensure insurance coverage. Adults may also want to ask if any of their preexisting medical conditions allow them to qualify under the new criteria. In general, &lt;a href="https://www.cdc.gov/covid/hcp/clinical-care/underlying-conditions.html"&gt;the list of qualifying conditions&lt;/a&gt; is quite long, but it includes things like asthma, diabetes, heart disease, mental health conditions, and immunodeficiencies.&lt;/p&gt;&lt;/div&gt;&lt;div class="duet--article--article-body-component"&gt;&lt;p class="duet--article--dangerously-set-cms-markup duet--article--standard-paragraph _1agbrixi lg8ac51 lg8ac50 lg8ac5a xkp0cg1"&gt;Making health care decisions might not be as easy as it used to be. But your best allies are your health care provider — and yourself. Learn as much information as you can, try to find a doctor you trust, and you can be more confident in your health care decisions for yourself and your family.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>vox.com</author><pubDate>Tue, 09 Sep 2025 13:30:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMijAFBVV95cUxOZFo5REVDWHBwc2hSQVpoVnF5VFBxcGJET2VIT2NFVHpfVGRBTWdpdTZ6MFZ6RjdkNkJKNXh6WF9DN1ltRnBEbk9EQV8xd3ZDZFoxV0lzLUQyZjdWZ1RoXzk3RmV4RFVyMlRieTVxSGg0NjRBb1dXV0VqSjV5MlZ5TFNkZktzUnpCa1VXZg</guid></item><item><title>每日服用欧米茄-3补充剂对女性有什么好处- Verywell Health</title><link>https://www.verywellhealth.com/omega-3-benefits-for-women-11802684</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div id="health-sc-page_1-0" class="comp health-sc-page mntl-sc-page mntl-block structured-content article-content expert-content right-rail__offset lock-journey" data-sc-sticky-offset="60" data-sc-ad-label-height="24" data-sc-ad-track-spacing="100" data-sc-min-track-height="250" data-sc-max-track-height="600" data-sc-breakpoint="50em" data-sc-load-immediate="4" data-sc-content-positions="[400, 1400, 1400, 1700, 2000, 2200, 2400, 2600, 2800]" data-bind-scroll-on-start="true"&gt;&lt;div id="health-sc-block-callout--key-takeaway_1-0" class="comp health-sc-block-callout--key-takeaway health-sc-block-callout-base mntl-sc-block-callout mntl-block theme-key-takeaway theme-key-takeaway" data-tracking-id="mntl-sc-block-callout" data-tracking-container="true"&gt;&lt;h3 id="mntl-sc-block-callout-heading_1-0" class="comp mntl-sc-block-callout-heading mntl-text-block"&gt;Key Takeaways&lt;/h3&gt;
&lt;div id="mntl-sc-block-callout-body_1-0" class="comp mntl-sc-block-callout-body mntl-text-block expert-content"&gt;&lt;ul&gt;&lt;li&gt;A new study shows that omega-3 deficiency could put women at greater risk for Alzheimer's disease.&lt;/li&gt;&lt;li&gt;Omega-3 fatty acids are important for everyone's health.&lt;/li&gt;&lt;li&gt;Prioritize eating omega-3-rich foods whenever possible, and talk with your doctor about taking a supplement.&lt;br&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p id="mntl-sc-block_2-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Omega-3 fatty acids, a family of &lt;a class="recommendation-inline-link-ai" href="https://www.verywellhealth.com/foods-high-in-omega-3-11686761" link-destination-recommendation-ai="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;essential fats found in foods&lt;/a&gt; like salmon, walnuts, and chia seeds, are critical for many aspects of health. Now, a new study has found that omega-3 deficiency could put women at greater risk for Alzheimer’s disease.
&lt;/p&gt;
&lt;p id="mntl-sc-block_3-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-what-the-study-says"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_4-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text"&gt; What the Study Says &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_5-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; The study, published in &lt;em&gt;Alzheimer's and Dementia&lt;/em&gt;, found that women with Alzheimer’s showed a notable decrease in unsaturated lipids—especially those containing omega fatty acids—compared to healthy women and men with Alzheimer's.&lt;span class="ql-inline-citation" data-cite="2"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_6-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_7-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; This suggests there may be sex-specific differences between how Alzheimer's develops and progresses in women versus men, which may help explain why women are more frequently diagnosed with the disease, said &lt;a href="https://www.houstonmethodist.org/doctor/doha-ayish/" data-component="link" data-source="inlineLink" data-type="externalLink" data-ordinal="1"&gt;Doha Ayish, MD&lt;/a&gt;, a neurologist at Houston Methodist West Hospital.
&lt;/p&gt;
&lt;p id="mntl-sc-block_8-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_9-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; It also suggests that a &lt;a class="recommendation-inline-link-ai" href="https://www.verywellhealth.com/foods-with-more-omega-3-than-sardines-11745099" link-destination-recommendation-ai="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;diet rich in omega-3s&lt;/a&gt; could help protect against Alzheimer's disease.&lt;br&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_10-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_11-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; "Women make up almost two-thirds of people with Alzheimer’s in America, so this could be a potential breakthrough in prevention and treatment that is much needed, as Alzheimer’s is the sixth leading cause of death for Americans," said &lt;a href="https://www.eatrightpro.org/about-us/for-media/meet-our-spokespeople/vanessa-king" data-component="link" data-source="inlineLink" data-type="externalLink" data-ordinal="1"&gt;Vanessa King, RD&lt;/a&gt;, a registered dietitian and spokesperson for the Academy of Nutrition and Dietetics.
&lt;/p&gt;
&lt;p id="mntl-sc-block_12-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_13-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; While King said more research is needed before any firm recommendations can be made about Alzheimer's specifically, research shows that there are health benefits to an omega-3-rich diet — especially for women.&lt;br&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_14-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;

&lt;p id="mntl-sc-block_16-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-1-you-may-support-brain-health"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_17-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text"&gt; 1. You May Support Brain Health &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_18-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; In addition to the new Alzheimer's study, other research has suggested that omega-3s are particularly &lt;a class="recommendation-inline-link-ai" href="https://www.verywellhealth.com/omega-3s-brain-benefits-alzheimers-gene-8741587" link-destination-recommendation-ai="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;critical for brain health&lt;/a&gt; in women as they age.
&lt;/p&gt;
&lt;p id="mntl-sc-block_19-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_20-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; A 2010 study found that omega-3s may help the brain work better, reduce inflammation and cell damage, and play a role in slowing changes linked to Alzheimer’s disease.&lt;span class="ql-inline-citation" data-cite="1"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_21-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_22-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; This may be particularly important for women, who have a higher life expectancy and therefore a &lt;a class="recommendation-inline-link-ai" href="https://www.verywellhealth.com/cognitive-decline-8382821" link-destination-recommendation-ai="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;higher lifetime risk of cognitive decline&lt;/a&gt; and dementia.&lt;br&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_23-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-2-you-could-get-bone-and-joint-health-benefits"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_24-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text"&gt; 2. You Could Get Bone and Joint Health Benefits &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_25-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Omega-3s may also &lt;a class="recommendation-inline-link-ai" href="https://www.verywellhealth.com/foods-for-bone-health-osteoporosis-month-5184304" link-destination-recommendation-ai="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;help keep bones healthy&lt;/a&gt;. A 2025 study found that women who ate more omega-3s had a lower risk of osteoporosis, especially younger women.&lt;span class="ql-inline-citation" data-cite="3"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_26-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_27-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; A 2023 meta-analysis also found that omega-3 supplementation can help relieve pain and improve joint function in patients with osteoarthritis.&lt;span class="ql-inline-citation" data-cite="4"&gt;&lt;/span&gt;&lt;br&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_28-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;

&lt;p id="mntl-sc-block_30-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-3-youll-improve-your-heart-health"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_31-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text"&gt; 3. You'll Improve Your Heart Health &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_32-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Omega-3s have long been touted for their protective effects against cardiovascular disease.
&lt;/p&gt;
&lt;p id="mntl-sc-block_33-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_34-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; A report that reviewed over 7,000 studies found that getting omega-3s from fish or fish oil supplements can &lt;a class="recommendation-inline-link-ai" href="https://www.verywellhealth.com/simple-steps-to-increase-your-life-expectancy-11776679" link-destination-recommendation-ai="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;lower the risk of dying early&lt;/a&gt; and protect against heart disease.&lt;span class="ql-inline-citation" data-cite="5"&gt;&lt;/span&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_35-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_36-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; "In women specifically, omega-3 has been found to partially compensate for reduced estrogen’s heart-protective effects in post-menopausal women," Ayish added.
&lt;/p&gt;
&lt;p id="mntl-sc-block_37-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-4-you-could-boost-your-hormones-and-fertility"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_38-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text"&gt; 4. You Could Boost Your Hormones and Fertility &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_39-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; A 2024 study review found that omega-3s can improve fertility by boosting pregnancy and fertilization rates, including for women doing IVF. Another study showed that omega-3s may also help women with PCOS by lowering testosterone levels and regulating periods.&lt;span class="ql-inline-citation" data-cite="7"&gt;&lt;/span&gt;&lt;span class="ql-inline-citation" data-cite="6"&gt;&lt;/span&gt;&lt;br&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_40-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-5-you-may-support-a-healthy-pregnancy"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_41-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text"&gt; 5. You May Support a Healthy Pregnancy &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_42-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Omega-3s may help support a healthy pregnancy and fetal development for younger women.&lt;span class="ql-inline-citation" data-cite="8"&gt;&lt;/span&gt;&lt;br&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_43-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_44-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; "Omega-3s have been shown to support healthy fetal eye and brain development in pregnant women," Ayesh explained. "Adequate intake is also linked with lower risk of preterm birth and postpartum depression."&lt;br&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_45-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;span class="heading-toc" id="toc-know-the-sources-of-omega-3s"&gt;&lt;/span&gt;&lt;h2 id="mntl-sc-block_46-0" class="comp mntl-sc-block health-sc-block-heading mntl-sc-block-heading"&gt; &lt;span class="mntl-sc-block-heading__text"&gt; Know the Sources of Omega-3s &lt;/span&gt; &lt;/h2&gt;
&lt;p id="mntl-sc-block_47-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; Our bodies don't produce omega-3s naturally, so the only way to get them is through diet or supplements.
&lt;/p&gt;
&lt;p id="mntl-sc-block_48-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_49-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; &lt;strong&gt;Foods that are rich in Omega-3s include:&lt;/strong&gt;
&lt;/p&gt;
&lt;p id="mntl-sc-block_50-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;ul id="mntl-sc-block_51-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; &lt;li&gt;&lt;strong&gt;Salmon&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Walnuts&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Chia seeds&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Flax seeds&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Omega-3 fortified eggs and dairy&lt;/strong&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;p id="mntl-sc-block_52-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_53-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; "Whenever possible, &lt;a class="recommendation-inline-link-ai" href="https://www.verywellhealth.com/foods-with-more-omega-3-than-fish-11715846" link-destination-recommendation-ai="true" data-component="link" data-source="inlineLink" data-type="internalLink" data-ordinal="1"&gt;getting omega-3s from food&lt;/a&gt; should be the first choice," King said.
&lt;/p&gt;
&lt;p id="mntl-sc-block_54-0" class="comp mntl-sc-block mntl-sc-block-adslot mntl-block"&gt;&lt;/p&gt;
&lt;p id="mntl-sc-block_55-0" class="comp mntl-sc-block mntl-sc-block-html"&gt; "That said, if you don’t eat much fish, nuts, or seeds, or simply struggle to meet your omega-3 needs through food alone, a high-quality supplement can help fill the gap. Just make sure to choose one that’s third-party tested," she added.
&lt;/p&gt;&lt;/div&gt;
&lt;div id="post-article_1-0" class="comp post-article mntl-block"&gt;
&lt;div id="sources_1-0" class="comp sources mntl-block"&gt;&lt;div id="mntl-article-sources_1-0" class="comp mntl-article-sources mntl-expandable-block" data-scroll-offset="70"&gt;&lt;div class="loc expandable-content"&gt;&lt;div id="source-guidelines_1-0" class="comp source-guidelines mntl-text-block"&gt;&lt;p&gt;Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our &lt;/p&gt;&lt;a href="/verywell-editorial-process-4777042"&gt;editorial process&lt;/a&gt;&lt;p&gt; to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.&lt;/p&gt;&lt;/div&gt;
&lt;div id="mntl-article-sources__citation-sources_1-0" class="comp mntl-article-sources__citation-sources mntl-citation-sources mntl-sources" data-tracking-container="true"&gt; &lt;ol class="mntl-sources__content"&gt;
&lt;li class="mntl-sources__source" id="citation-2"&gt;&lt;p&gt;Wretlind A, Xu J, Chen W, et al. &lt;a href="https://doi.org/10.1002/alz.70512" data-component="link" data-source="inlineLink" data-type="externalLink" data-ordinal="1"&gt;Lipid profiling reveals unsaturated lipid reduction in women with Alzheimer’s disease&lt;/a&gt;. &lt;em&gt;Alzheimer’s &amp;amp;amp; Dementia&lt;/em&gt;. 2025;21(8):e70512.doi:10.1002/alz.70512&lt;/p&gt;&lt;/li&gt;
&lt;li class="mntl-sources__source" id="citation-1"&gt;&lt;p&gt;Robinson JG, Ijioma N, Harris W. &lt;a href="https://doi.org/10.2217/WHE.09.75" data-component="link" data-source="inlineLink" data-type="externalLink" data-ordinal="1"&gt;Omega-3 fatty acids and cognitive function in women&lt;/a&gt;. &lt;em&gt;Womens Health (Lond Engl)&lt;/em&gt;. 2010;6(1):119-134.doi:10.2217/WHE.09.75&lt;/p&gt;&lt;/li&gt;
&lt;li class="mntl-sources__source" id="citation-3"&gt;&lt;p&gt;Liu Z, Cai S, Chen Y, et al. &lt;a href="https://doi.org/10.3389/fnut.2024.1467559" data-component="link" data-source="inlineLink" data-type="externalLink" data-ordinal="1"&gt;The association between dietary omega-3 intake and osteoporosis: a NHANES cross-sectional study&lt;/a&gt;. &lt;em&gt;Front Nutr&lt;/em&gt;. 2025;11:1467559.doi:10.3389/fnut.2024.1467559&lt;/p&gt;&lt;/li&gt;
&lt;li class="mntl-sources__source" id="citation-4"&gt;&lt;p&gt;Deng, W., Yi, Z., Yin, E. &lt;em&gt;et al.&lt;/em&gt; &lt;a href="https://doi.org/10.1186/s13018-023-03855-w" data-component="link" data-source="inlineLink" data-type="externalLink" data-ordinal="1"&gt;Effect of omega-3 polyunsaturated fatty acids supplementation for patients with osteoarthritis: a meta-analysis&lt;/a&gt;. &lt;em&gt;J Orthop Surg Res&lt;/em&gt; 18, 381 (2023).doi:10.1186/s13018-023-03855-w&lt;/p&gt;&lt;/li&gt;
&lt;li class="mntl-sources__source" id="citation-5"&gt;&lt;p&gt;Tufts-New England Medical Center EPC, Boston, Massachusetts. &lt;a href="https://archive.ahrq.gov/downloads/pub/evidence/pdf/o3cardio/o3cardio.pdf" data-component="link" data-source="inlineLink" data-type="externalLink" data-ordinal="1"&gt;Effects of Omega-3 Fatty Acids on&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="https://archive.ahrq.gov/downloads/pub/evidence/pdf/o3cardio/o3cardio.pdf" data-component="link" data-source="inlineLink" data-type="externalLink" data-ordinal="2"&gt;Cardiovascular Disease.&lt;/a&gt;&lt;/p&gt;&lt;/li&gt;
&lt;li class="mntl-sources__source" id="citation-7"&gt;&lt;p&gt;Nadjarzadeh A, Dehghani Firouzabadi R, Vaziri N, Daneshbodi H, Lotfi MH, Mozaffari-Khosravi H. &lt;a href="https://pubmed.ncbi.nlm.nih.gov/24639805/" data-component="link" data-source="inlineLink" data-type="externalLink" data-ordinal="1"&gt;The effect of omega-3 supplementation on androgen profile and menstrual status in women with polycystic ovary syndrome: A randomized clinical trial&lt;/a&gt;. Iran J Reprod Med. 2013;11(8):665-672.&lt;/p&gt;&lt;/li&gt;
&lt;li class="mntl-sources__source" id="citation-6"&gt;&lt;p&gt;Trop-Steinberg S, Gal M, Azar Y, Kilav-Levin R, Heifetz EM. &lt;a href="https://doi.org/10.1016/j.heliyon.2024.e29324" data-component="link" data-source="inlineLink" data-type="externalLink" data-ordinal="1"&gt;Effect of omega-3 supplements or diets on fertility in women: A meta-analysis&lt;/a&gt;. &lt;em&gt;Heliyon&lt;/em&gt;. 2024;10(8):e29324.doi:10.1016/j.heliyon.2024.e29324&lt;/p&gt;&lt;/li&gt;
&lt;li class="mntl-sources__source" id="citation-8"&gt;&lt;p&gt;Coletta JM, Bell SJ, Roman AS. &lt;a href="https://pubmed.ncbi.nlm.nih.gov/21364848/" data-component="link" data-source="inlineLink" data-type="externalLink" data-ordinal="1"&gt;Omega-3 fatty acids and pregnancy&lt;/a&gt;. &lt;em&gt;Reviews in Obstetrics and Gynecology&lt;/em&gt;. 2010;3(4):163.&lt;/p&gt;&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;div id="author-bio_1-0" class="comp author-bio"&gt;

&lt;p class="author-bio__bio-text"&gt;
&lt;span class="author-bio__bio-title"&gt;By &lt;a href="https://www.verywellhealth.com/mira-miller-5202407"&gt;Mira Miller&lt;/a&gt;&lt;/span&gt;
&lt;br&gt;
Miller is a journalist specializing in mental health, women's health, and culture. Her work is published in outlets ranging from Vice to Healthnews.
&lt;/p&gt;
&lt;/div&gt;
&lt;div id="trust-ribbon_1-0" class="comp trust-ribbon trust-ribbon-expandable-block"&gt; 
&lt;div class="loc expandable-content"&gt;&lt;div id="trust-ribbon__feedback-block_1-0" class="comp trust-ribbon__feedback-block article-feedback mntl-article-feedback"&gt; 
&lt;div class="article-feedback__success-section js-success-section is-hidden"&gt;
&lt;p class="article-feedback__heading"&gt;Thanks for your feedback!&lt;/p&gt;
&lt;/div&gt;
&lt;div class="article-feedback__feedback-section js-feedback-section is-hidden"&gt;
&lt;p class="article-feedback__heading"&gt;What is your feedback?&lt;/p&gt;
&lt;button id="helpful-button_1-0" class="comp helpful-button mntl-button article-feedback__feedback-button"&gt; Helpful
&lt;/button&gt;
&lt;button id="report-error-button_1-0" class="comp report-error-button mntl-button article-feedback__feedback-button"&gt; Report an Error
&lt;/button&gt;
&lt;button id="other-button_1-0" class="comp other-button mntl-button article-feedback__feedback-button"&gt; Other
&lt;/button&gt;
&lt;svg class="icon icon-x close-button"&gt;
&lt;use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-x" href="#icon-x"&gt;&lt;/use&gt;
&lt;/svg&gt; 
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Verywell Health</author><pubDate>Tue, 09 Sep 2025 13:04:56 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMidEFVX3lxTE9PSEJjSG1UY1BYT1lTQ19ybElZbGVQQThHZE96XzJ0ZVczektwMnhIcExqZnlCSXJpMnFaUE1qQTUtU21ieUE5a29wMF9mYWh6MFkySWpMd2g0NlRJMk9TNWljVlVjT2RCN3NwUkdncnpuTDJo</guid></item><item><title>研究发现，近一半的糖尿病患者未确诊- yahoo.com</title><link>https://www.yahoo.com/news/article/nearly-half-of-people-with-diabetes-are-undiagnosed-study-finds-125244067.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="" data-article-body="true"&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Good morning, all. Fall is nearing. Embrace the changing seasons by trying out this anti-inflammatory &lt;a data-i13n="cpos:1;pos:1" href="https://www.yahoo.com/lifestyle/articles/anti-inflammatory-fall-salad-ll-170000705.html" data-ylk="slk:roasted squash and kale salad;cpos:1;pos:1;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;" class="link  yahoo-link"&gt;roasted squash and kale salad&lt;/a&gt;. Now, on to the news.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;&lt;a data-i13n="cpos:2;pos:1" href="https://news.yahoo.com/newsletters/the-yodel" data-ylk="slk:Subscribe;cpos:2;pos:1;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;Subscribe&lt;/a&gt; to get this newsletter in your inbox each morning.&lt;/p&gt;&lt;hr class="my-4"&gt;&lt;h2 class="mb-4 text-xl font-bold md:text-2xl" data-jump-link-target="" id="need-to-know"&gt;&lt;strong&gt;NEED TO KNOW&lt;/strong&gt;&lt;/h2&gt;&lt;figure class="relative mb-4"&gt;&lt;figcaption class="relative text-sm mt-1 pr-2.5"&gt;&lt;p&gt;Getty Images&lt;/p&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;New studies released this week revealed a surprising relationship between warmer weather and sugar consumption, and that many people with diabetes may be unaware that they have the condition.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;&lt;strong&gt;What to know: &lt;/strong&gt;One study found that Americans were far likelier to &lt;a data-i13n="cpos:3;pos:1" href="https://www.yahoo.com/news/articles/world-gets-hotter-americans-turning-150243174.html" data-ylk="slk:reach for sugary products;cpos:3;pos:1;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;" class="link  yahoo-link"&gt;reach for sugary products&lt;/a&gt;, particularly sweetened drinks like soda and juice, when temperatures climbed. The trend was higher among low-income families. [AP]&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;&lt;strong&gt;Check your blood sugar: &lt;/strong&gt;A separate study found that 44% of people worldwide are living with undiagnosed diabetes, according to new data analysis — with the figure higher among those under 35. Here’s &lt;a data-i13n="cpos:4;pos:1" href="https://www.yahoo.com/news/articles/nearly-half-people-diabetes-don-225851604.html" data-ylk="slk:what to look out for;cpos:4;pos:1;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;" class="link  yahoo-link"&gt;what to look out for&lt;/a&gt;. [CNN]&lt;/p&gt;&lt;hr class="my-4"&gt;&lt;h2 class="mb-4 text-xl font-bold md:text-2xl" data-jump-link-target="" id="in-case-you-missed-it"&gt;&lt;strong&gt;IN CASE YOU MISSED IT&lt;/strong&gt;&lt;/h2&gt;&lt;figure class="relative mb-4"&gt;&lt;figcaption class="relative text-sm mt-1 pr-2.5"&gt;&lt;p&gt;AP Photo/Kevin Wolf&lt;/p&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;h3 class="mb-4 text-lg font-bold" data-jump-link-target="" id="epstein-documents-drop"&gt;&lt;strong&gt;Epstein documents drop&lt;/strong&gt;&lt;/h3&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;House Democrats released a birthday letter to disgraced financier Jeffrey Epstein that was allegedly signed by Donald Trump. The White House quickly denied its authenticity. See &lt;a data-i13n="cpos:5;pos:1" href="https://www.yahoo.com/news/articles/gop-led-house-oversight-committee-165151951.html" data-ylk="slk:the letter;cpos:5;pos:1;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;" class="link  yahoo-link"&gt;the letter&lt;/a&gt; and &lt;a data-i13n="cpos:6;pos:1" href="https://www.yahoo.com/news/articles/5-takeaways-epstein-documents-080005997.html" data-ylk="slk:read other takeaways;cpos:6;pos:1;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;" class="link  yahoo-link"&gt;read other takeaways&lt;/a&gt;. [ABC News/CNN]&lt;/p&gt;&lt;h3 class="mb-4 text-lg font-bold" data-jump-link-target="" id="operation-midway-blitz"&gt;&lt;strong&gt;Operation Midway Blitz&lt;/strong&gt;&lt;/h3&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The Trump administration &lt;a data-i13n="cpos:7;pos:1" href="https://www.yahoo.com/news/articles/president-donald-trump-administration-announces-022200241.html" data-ylk="slk:confirmed;cpos:7;pos:1;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;" class="link  yahoo-link"&gt;confirmed&lt;/a&gt; that it’s launching immigration raids in Chicago, hours after the Supreme Court &lt;a data-i13n="cpos:8;pos:1" href="https://www.yahoo.com/news/articles/carte-blanche-anyone-immigrants-fearful-002430418.html" data-ylk="slk:allowed it to resume;cpos:8;pos:1;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;" class="link  yahoo-link"&gt;allowed it to resume&lt;/a&gt; what some have called “indiscriminate” immigration stops in L.A. [Chicago Tribune/Los Angeles Times]&lt;/p&gt;&lt;h3 class="mb-4 text-lg font-bold" data-jump-link-target="" id="real-life-succession-saga"&gt;&lt;strong&gt;Real-life ‘Succession’ saga&lt;/strong&gt;&lt;/h3&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;After years of infighting, media mogul Rupert Murdoch’s children &lt;a data-i13n="cpos:9;pos:1" href="https://finance.yahoo.com/news/lachlan-wins-murdoch-succession-war-202118512.html" data-ylk="slk:struck a deal;cpos:9;pos:1;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;" class="link  yahoo-link"&gt;struck a deal&lt;/a&gt; to allow his son Lachlan to eventually control Fox Corporation and News Corp, while his siblings will walk away with major buyouts. [Hollywood Reporter]&lt;/p&gt;&lt;h3 class="mb-4 text-lg font-bold" data-jump-link-target="" id="cma-awards-nominations"&gt;&lt;strong&gt;CMA Awards nominations&lt;/strong&gt;&lt;/h3&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Women were the frontrunners among the nominees for the &lt;a data-i13n="cpos:10;pos:1" href="https://www.yahoo.com/entertainment/music/articles/cma-awards-nominations-led-lainey-173000385.html" data-ylk="slk:Country Music Association Awards;cpos:10;pos:1;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;" class="link  yahoo-link"&gt;Country Music Association Awards&lt;/a&gt;, released last night, with six nods each for stars Lainey Wilson, Ella Langley and Megan Moroney. The awards show will air on Nov. 19. [Variety]&lt;/p&gt;&lt;h3 class="mb-4 text-lg font-bold" data-jump-link-target="" id="an-incredible-turnaround"&gt;&lt;strong&gt;An incredible turnaround&lt;/strong&gt;&lt;/h3&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Minnesota Vikings QB J.J. McCarthy’s NFL debut got off to a rough start before he rebounded in the fourth quarter, leading his team to a comeback 27-24 victory over the Chicago Bears. &lt;a data-i13n="cpos:11;pos:1" href="https://sports.yahoo.com/nfl/breaking-news/live/jj-mccarthy-vikings-storm-back-to-beat-bears-as-qb-rallies-from-ugly-start-in-nfl-debut-230128689.html" data-ylk="slk:Watch the highlights;cpos:11;pos:1;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;" class="link  yahoo-link"&gt;Watch the highlights&lt;/a&gt;. [Yahoo Sports]&lt;/p&gt;&lt;hr class="my-4"&gt;&lt;h2 class="mb-4 text-xl font-bold md:text-2xl" data-jump-link-target="" id="whats-happening-today"&gt;&lt;strong&gt;WHAT’S HAPPENING TODAY&lt;/strong&gt;&lt;/h2&gt;&lt;figure class="relative mb-4"&gt;&lt;figcaption class="relative text-sm mt-1 pr-2.5"&gt;&lt;p&gt;Valerie Macon for AFP/Getty Images&lt;/p&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;h3 class="mb-4 text-lg font-bold" data-jump-link-target="" id="now-streaming"&gt;&lt;strong&gt;Now streaming&lt;/strong&gt;&lt;/h3&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The first three episodes of Season 5 of&lt;em&gt; Only Murders in the Building &lt;/em&gt;are now on Hulu. &lt;a data-i13n="cpos:12;pos:1" href="https://www.yahoo.com/entertainment/tv/articles/only-murders-building-end-season-110100296.html" data-ylk="slk:Could this be the end;cpos:12;pos:1;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;" class="link  yahoo-link"&gt;Could this be the end&lt;/a&gt; of the mystery comedy series? “You have to live season by season,” star Selena Gomez said. [USA Today]&lt;/p&gt;&lt;h3 class="mb-4 text-lg font-bold" data-jump-link-target="" id="on-bookshelves"&gt;&lt;strong&gt;On bookshelves&lt;/strong&gt;&lt;/h3&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Charlie Sheen’s tell-all memoir, &lt;a data-i13n="cpos:13;pos:1" href="https://www.yahoo.com/entertainment/celebrity/articles/charlie-sheen-talks-road-sobriety-041630723.html" data-ylk="slk:The Book of Sheen;cpos:13;pos:1;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;" class="link  yahoo-link"&gt;&lt;em&gt;The Book of Sheen&lt;/em&gt;&lt;/a&gt;, and &lt;a data-i13n="cpos:14;pos:1" href="https://www.yahoo.com/entertainment/celebrity/article/bruce-williss-wife-emma-heming-willis-opens-up-about-their-life-together-since-his-dementia-diagnosis-ftd-doesnt-scream-it-whispers-222551514.html" data-ylk="slk:The Unexpected Journey;cpos:14;pos:1;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;" class="link  yahoo-link"&gt;&lt;em&gt;The Unexpected Journey&lt;/em&gt;&lt;/a&gt;, Emma Heming Willis’s book about caring for loved ones with dementia — written after husband Bruce Willis’s diagnosis — are now available. [AP/Yahoo Entertainment]&lt;/p&gt;&lt;h3 class="mb-4 text-lg font-bold" data-jump-link-target="" id="in-cupertino-calif"&gt;&lt;strong&gt;In Cupertino, Calif.&lt;/strong&gt;&lt;/h3&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Apple is expected to reveal new iPhones and Apple Watches during its “awe dropping” event at 1 p.m. ET on YouTube. &lt;a data-i13n="cpos:15;pos:1" href="https://news.yahoo.com/finance/news/an-iphone-air-new-watches-and-heart-rate-tracking-airpods-what-to-expect-at-apples-sept-9-event-182148742.html" data-ylk="slk:Here’s what to expect;cpos:15;pos:1;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;" class="link  yahoo-link"&gt;Here’s what to expect&lt;/a&gt;. [Yahoo Finance]&lt;/p&gt;&lt;h3 class="mb-4 text-lg font-bold" data-jump-link-target="" id="on-the-field"&gt;&lt;strong&gt;On the field&lt;/strong&gt;&lt;/h3&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;With the MLB postseason just around the corner, the Brewers — who are in line to be &lt;a data-i13n="cpos:16;pos:1" href="https://sports.yahoo.com/mlb/article/mlb-playoffs-2025-tracker-standings-schedule-clinch-scenarios-and-more-204808538.html" data-ylk="slk:the first team to secure a spot;cpos:16;pos:1;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;" class="link  yahoo-link"&gt;the first team to secure a spot&lt;/a&gt; — face the Rangers at 8:05 p.m. ET on the MLB app. [Yahoo Sports]&lt;/p&gt;&lt;h3 class="mb-4 text-lg font-bold" data-jump-link-target="" id="on-the-court"&gt;&lt;strong&gt;On the court&lt;/strong&gt;&lt;/h3&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;The Sparks, potentially &lt;a data-i13n="cpos:17;pos:1" href="https://sports.yahoo.com/article/kelsey-plum-gets-worrisome-injury-021448436.html" data-ylk="slk:without star Kelsey Plum;cpos:17;pos:1;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;" class="link  yahoo-link"&gt;without star Kelsey Plum&lt;/a&gt;, face the Mercury at 10 p.m. ET on WNBA League Pass. The matchup could determine whether the Sparks make the playoffs. [ClutchPoints]&lt;/p&gt;&lt;h3 class="mb-4 text-lg font-bold" data-jump-link-target="" id="and-dont-forget-to"&gt;&lt;strong&gt;And don’t forget to…&lt;/strong&gt;&lt;/h3&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Read your daily &lt;a data-i13n="cpos:18;pos:1" href="https://www.yahoo.com/lifestyle/horoscope/" data-ylk="slk:horoscope;cpos:18;pos:1;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;horoscope&lt;/a&gt;. Play the &lt;a data-i13n="cpos:19;pos:1" href="https://www.yahoo.com/games/play/crossword/?ncid=yahooproperties_yodelnewsl_clcywstk18m" data-ylk="slk:crossword;cpos:19;pos:1;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;crossword&lt;/a&gt;. Check the &lt;a data-i13n="cpos:20;pos:1" href="https://www.yahoo.com/news/weather/forecast/12763119" data-ylk="slk:forecast;cpos:20;pos:1;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;forecast&lt;/a&gt; in your area.&lt;/p&gt;&lt;hr class="my-4"&gt;&lt;h2 class="mb-4 text-xl font-bold md:text-2xl" data-jump-link-target="" id="today-in-history"&gt;&lt;strong&gt;TODAY IN HISTORY&lt;/strong&gt;&lt;/h2&gt;&lt;figure class="relative mb-4"&gt;&lt;figcaption class="relative text-sm mt-1 pr-2.5"&gt;&lt;p&gt;Matthew West/MediaNews Group/Boston Herald via Getty Images&lt;/p&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;In 2007, the New England Patriots were caught secretly recording the New York Jets’ coaching signals — a scandal that became known as Spygate and resulted in a $500,000 fine for head coach Bill Belichick. Read about four other &lt;a data-i13n="cpos:21;pos:1" href="https://sports.yahoo.com/article/5-most-shocking-nfl-scandals-020000378.html" data-ylk="slk:scandals that rocked the NFL;cpos:21;pos:1;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;" class="link  yahoo-link"&gt;scandals that rocked the NFL&lt;/a&gt;. [Sportsnaut]&lt;/p&gt;&lt;hr class="my-4"&gt;&lt;h2 class="mb-4 text-xl font-bold md:text-2xl" data-jump-link-target="" id="feel-good-moment"&gt;&lt;strong&gt;FEEL-GOOD MOMENT&lt;/strong&gt;&lt;/h2&gt;&lt;figure class="relative mb-4"&gt;&lt;figcaption class="relative text-sm mt-1 pr-2.5"&gt;&lt;p&gt;St. Louis Zoo&lt;/p&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;Dot and Samson, a pair of critically endangered Amur leopards at the St. Louis Zoo, recently welcomed a new litter of cubs. The zoo said that while mom and the cubs are thriving, it’ll be a few months before their first appearance. &lt;a data-i13n="cpos:22;pos:1" href="https://www.yahoo.com/news/articles/2-rare-leopard-cubs-born-013000625.html" data-ylk="slk:Take a look;cpos:22;pos:1;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;" class="link  yahoo-link"&gt;Take a look&lt;/a&gt; at them bonding. [People]&lt;/p&gt;&lt;hr class="my-4"&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;&lt;strong&gt;💡 P.S. Before you go, your daily advice: &lt;/strong&gt;If you use a sleep tracker, &lt;a data-i13n="cpos:23;pos:1" href="https://health.yahoo.com/wellness/sleep/articles/quest-perfect-sleep-keeping-awake-165145120.html" data-ylk="slk:experts say;cpos:23;pos:1;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;" class="link  yahoo-link"&gt;experts say&lt;/a&gt; it’s better to check it weekly for bigger trends rather than day-to-day. [Time]&lt;/p&gt;&lt;hr class="my-4"&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;&lt;strong&gt;About The Yodel:&lt;/strong&gt; The Yodel is a morning newsletter from Yahoo News.&lt;/p&gt;&lt;p class="mb-4 text-lg md:leading-8 break-words"&gt;&lt;a data-i13n="cpos:24;pos:1" href="https://news.yahoo.com/newsletters/the-yodel/" data-ylk="slk:Start your day with The Yodel;cpos:24;pos:1;elm:context_link;itc:0;sec:content-canvas" class="link "&gt;Start your day with The Yodel&lt;/a&gt; to get caught up on weather, national news, politics, entertainment and sports — in four minutes or less.&lt;/p&gt;&lt;hr class="my-4"&gt;&lt;div class=""&gt;&lt;div class="mx-auto mb-5 flex flex-col overflow-hidden rounded-xl pb-5 shadow-[0_0_1px_rgba(200,160,251,.63),0_2px_6px_1px_#F3E6FE] md:mx-2"&gt;&lt;h3 class="m-auto block px-4 pb-4 pt-2 text-lg font-bold leading-6"&gt;Get The Yodel right in your inbox&lt;/h3&gt;&lt;p class="m-auto px-4 pb-4 !text-sm font-normal"&gt;Did you like this morning’s newsletter? Subscribe to have it sent to you on weekdays.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>yahoo.com</author><pubDate>Tue, 09 Sep 2025 12:52:44 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiswFBVV95cUxNOGxuRXFyOXVPY0FqY01XTW9VQUZTeGlnamV0dE1kTkpqUnN1QVF4QXU1WW1PQm1LYUN6UmJoSkhJSVR5eFBRejlIcGhmWGg5MU9yMVBiY2duYUxXLXo5ck9hVENldzdudWlYTVUyeVBlaEk2QTFaNlFMNUlmR2VaTUZ0REc0VFVnZ3ZyekxObmVSaWJJMENNT1Y0VVUxaWRRYjJmUXdCejc0VFU1ckxCb01FUQ</guid></item><item><title>小金毛小狗造型牛仔帽和靴子偷人心- AOL.com</title><link>https://www.aol.com/tiny-golden-retriever-puppy-modeling-202000931.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="caas-body"&gt;&lt;p&gt;Some pups were born to be stars, and others just naturally know how to work an outfit. This little &lt;strong&gt;Golden Retriever&lt;/strong&gt; falls squarely into the second category.&lt;/p&gt;&lt;p&gt;In a delightfully cute video, the sweet puppy shows off his really cool cowboy hat and tiny boots, grinning like he owns the Wild West. It’s impossible not to fall in love instantly, and it will paint a feel-good smile across your face.&lt;/p&gt;&lt;p&gt;On August 20, 2025, @lilgoldenmoose shared a video of the sweet Golden Retriever pup who is ready for his cowboy way of living, and he fits right in.&lt;/p&gt;&lt;p&gt;Moose has a giant smile on his face, happy to show off the boots that are basically taller than he is, and is welcomed to the world of the cowboy, and our hearts are full of all the happy feels.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;a href="https://paradepets.com/pet-news/golden-retriever-sneaks-into-neighbors-house-to-see-house-sitter" rel="nofollow noopener" target="_blank" data-ylk="slk:Related: Golden Retriever Goes Viral After Sneaking Into Neighbor's Home To See House Sitter;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;Related: Golden Retriever Goes Viral After Sneaking Into Neighbor's Home To See House Sitter&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;In the comments, others couldn't contain their excitement at seeing this tiny &lt;a href="https://paradepets.com/pet-news/golden-retriever-meets-tiny-bunny-on-walk-and-instantly-claims-him-as-family" rel="nofollow noopener" target="_blank" data-ylk="slk:Golden Retriever;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;Golden Retriever&lt;/a&gt; in his cowboy getup, just like us.&lt;/p&gt;&lt;p&gt;One person wrote, "Well, that’s just one of the cutest things I’ve seen all day."&lt;/p&gt;&lt;p&gt;Another shared, "He’s got some big shoes to fill."&lt;/p&gt;&lt;p&gt;Someone else added, "Omg, this is the best thing I've ever seen!"&lt;/p&gt;&lt;p&gt;Others wrote, "Aww, such a cute cowboy," "The cutest cowboy ever," "So adorable, cute," "You are so cute," "Oh my goodness," and "Cutie patootie."&lt;/p&gt;&lt;p&gt;&lt;a href="https://emojipedia.org/dog-face" rel="nofollow noopener" target="_blank" data-ylk="slk:🐶;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;🐶&lt;/a&gt;&lt;a href="https://parade.com/newsletters/parade-pets" rel="nofollow noopener" target="_blank" data-ylk="slk:SIGN UP to get “pawsitivity” delivered right to your inbox with inspiring &amp;amp; entertaining stories about our furry &amp;amp; feathered friends;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;&lt;strong&gt;SIGN UP to get “pawsitivity” delivered right to your inbox with inspiring &amp;amp; entertaining stories about our furry &amp;amp; feathered friends&lt;/strong&gt;&lt;/a&gt;&lt;a href="https://emojipedia.org/paw-prints" rel="nofollow noopener" target="_blank" data-ylk="slk:🐾🐾;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;🐾🐾&lt;/a&gt;&lt;/p&gt;&lt;h2&gt;Moose the Golden Retriever Has Been Having Lots of Fun&lt;/h2&gt;&lt;p&gt;Watching a tiny &lt;a href="https://paradepets.com/dogs/golden-retriever-puppy-who-sleeps-like-a-human-is-giving-people-the-feels" rel="nofollow noopener" target="_blank" data-ylk="slk:Golden Retriever puppy;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;Golden Retriever puppy&lt;/a&gt; grow into a big, beautiful, and full-grown dog is one of the cutest things you can witness. And looking at Lil Golden Mooses's social media presence, we can see this little dude is growing quickly, and he's having so much fun.&lt;/p&gt;&lt;p&gt;In several updates, we can see the little guy taking naps in the car, sitting on his human's lap, watching a new episode of his favorite television show, getting hugs and cuddles, trying new foods, taking a bath, and soaking in all the joys of the world.&lt;/p&gt;&lt;p&gt;We're having the best time watching this 12-week-old Golden from Florida growing and exploring, and we can't wait for the next new clip!&lt;/p&gt;&lt;p&gt;&lt;i&gt;This story was originally reported by &lt;a href="https://paradepets.com/pet-news/tiny-golden-retriever-puppy-modeling-cowboy-hat-and-boots" rel="nofollow noopener" target="_blank" data-ylk="slk:Parade Pets;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;Parade Pets&lt;/a&gt; on Sep 8, 2025, where it first appeared in the &lt;a href="https://paradepets.com/pet-news" rel="nofollow noopener" target="_blank" data-ylk="slk:Pet News;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;Pet News&lt;/a&gt; section. Add Parade Pets as a &lt;a href="https://google.com/preferences/source?q=paradepets.com" rel="nofollow noopener" target="_blank" data-ylk="slk:Preferred Source by clicking here.;elm:context_link;itc:0;sec:content-canvas" class="link rapid-noclick-resp"&gt;Preferred Source by clicking here.&lt;/a&gt;&lt;/i&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>AOL.com</author><pubDate>Tue, 09 Sep 2025 12:51:43 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMie0FVX3lxTE85a04yUzY0UEN1cTJNYm5BTDFmUkExZmpqd2stZWlJT1ZDekp3Vkx6VGV1dllmM0ZOM3pHZUprT3VxQ3pZRHlkcjBOWUR4RnR1ZElSSzFJc2licmpVb0U1WUpXSkVfSmdmc3hpVHZuNVpTS3A5dS1BemJobw</guid></item><item><title>治疗棘手癌症的有前途的新疗法- statnews.com</title><link>https://www.statnews.com/2025/09/09/health-news-lung-cancer-florida-trump-fda-pig-kidney/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="entry-content the-content wp-block-post-content is-layout-flow wp-block-post-content-is-layout-flow"&gt;&lt;p&gt;&lt;em&gt;Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. &lt;a href="https://www.statnews.com/signup/morning-rounds/"&gt;Sign up here&lt;/a&gt;.&lt;/em&gt;&lt;/p&gt;



&lt;p&gt;Good morning, and happy tenth anniversary to STAT! That’s a decade of incredible, award-winning journalism, wonderful colleagues, and delicious snacks shared at the office. We’ll be celebrating for the rest of the year and have some some cool stuff coming soon that I won’t spoil yet. Watch this space.&lt;/p&gt;



&lt;h2 class="wp-block-heading" id="h-the-next-maha-commission-report-will-publish-today"&gt;The next MAHA Commission report will publish today&lt;/h2&gt;



&lt;p&gt;This afternoon, the MAHA Commission, led by health secretary Robert F. Kennedy Jr., will release its report on how to reduce chronic disease among children. It’s a long-awaited follow-up to a controversial May &lt;a href="https://www.statnews.com/2025/05/22/rfk-jr-maha-commission-report-key-takeaways-ultraprocessed-foods-environmental-toxins-overmedicalization/"&gt;report&lt;/a&gt; that contained &lt;a href="https://www.statnews.com/2025/05/29/white-house-acknowledges-problems-rfk-jr-maha-report/"&gt;citations&lt;/a&gt; to nonexistent studies and &lt;a href="https://www.statnews.com/2025/06/20/maha-children-health-report-citations-errors-sloppy/"&gt;mis-cited&lt;/a&gt; others. We’ll have more details on the new report later today, but here’s a recap of what we know so far: &lt;/p&gt;



&lt;p&gt;STAT reporters reviewed a &lt;a href="https://www.statnews.com/2025/08/15/maha-report-rfk-tiptoes-on-pesticides-ultraprocessed-foods/"&gt;leaked draft&lt;/a&gt; of the report in mid-August, which the White House referred to as “speculative literature.” That draft called for more research on familiar topics like childhood vaccine schedule reform and nutrition, largely steering clear of explicit policy recommendations. There were some surprises, including a call to look into the “potential benefits of select high-quality supplements,” as well as for research on electromagnetic radiation, which is more of a fringe concern.&lt;/p&gt;



&lt;p&gt;Keep an eye on STAT for more coverage on what was kept in the final version of the draft and what may have gotten cut.&lt;/p&gt;



&lt;h2 class="wp-block-heading" id="h-fda-greenlights-trial-of-gene-edited-pig-kidneys"&gt;FDA greenlights trial of gene-edited pig kidneys&lt;/h2&gt;



&lt;p&gt;It’s been almost three months since Bill Stewart received a kidney transplant from a pig. He’s back at home, at work, and has even been able to go e-biking on a lakeside trail with his wife, untethered to the grueling schedules of dialysis for the first time in years. He’s the latest of a small number of people who’ve gotten a kidney from a donor pig that’s been CRISPR’d to make its organs more human-friendly. &lt;/p&gt;



&lt;p&gt;“My pig kidney and I had a little conversation while I was laying there,” Stewart told STAT. “I just basically said, ‘I’m going to do everything I can to make sure that you stay healthy, and I appreciate you doing everything you can to keep me upright and breathing.’” &lt;/p&gt;



&lt;p&gt;These experiments and others like them have proceeded through an expanded access program at the FDA that’s focused on patients with life-threatening conditions. But that’s about to change. Yesterday, eGenesis, a Cambridge-based biotechnology company, announced that it had been cleared by the FDA to begin a broader trial of kidneys from the CRISPR’d pigs. &lt;a href="https://www.statnews.com/2025/09/08/pig-organ-transplant-egenesis-revivicor-human-trials-fda/"&gt;Read more&lt;/a&gt; from STAT’s Eric Boodman and Megan Molteni on what’s ahead.  &lt;/p&gt;



&lt;h2 class="wp-block-heading" id="h-florida-vs-trump-vs-rfk-jr"&gt;Florida vs. Trump vs. RFK Jr.&lt;/h2&gt;



&lt;p&gt;Last week, Florida became the first state in the country to plan to eliminate school vaccination requirements. Kennedy has a long history of opposing such mandates, and both NIH director Jay Bhattacharya and CMS administrator Mehmet Oz praised the decision out of Florida. But President Trump offered a different view. “I think we have to be very careful,” he told reporters in the White House on Friday. &lt;/p&gt;



&lt;p&gt;It’s another example of the growing public divide between Trump and his health secretary over vaccines, which could threaten Kennedy’s plan to upend business as usual at the federal health agencies, especially for vaccines, STAT’s Chelsea Cirruzzo and Daniel Payne report. &lt;a href="https://www.statnews.com/2025/09/08/vaccine-policy-cracks-showing-between-trump-kennedy/"&gt;Read more&lt;/a&gt; on what’s at stake. &lt;/p&gt;



&lt;p&gt;In the meantime, two local public health officials — one from Texas, another from Ohio — write  in a new &lt;a href="https://www.statnews.com/2025/09/09/school-vaccine-requirements-florida-red-states-public-health/"&gt;First Opinion&lt;/a&gt; essay that they’re worried their states could be next to drop the mandates. &lt;/p&gt;



&lt;p&gt;“We have seen firsthand in our communities how viruses do not respect borders,” the authors write. During the last school year, state laws exempted 3.6% of children nationwide from vaccine requirements. But in parts of Texas and Ohio, that rate is often even higher. Some Texas schools at the epicenter of the state’s measles outbreak had MMR vaccination rates under 50%. In Ohio, only 85% of kindergartners received MMR vaccines last year. &lt;a href="https://www.statnews.com/2025/09/09/school-vaccine-requirements-florida-red-states-public-health/"&gt;Read more&lt;/a&gt; on what public health authorities are bracing for if more states follow Florida’s lead.&lt;/p&gt;



&lt;h2 class="wp-block-heading" id="h-why-do-men-die-so-much-earlier-than-women"&gt;Why do men die so much earlier than women?&lt;/h2&gt;



&lt;p&gt;Two principal reasons that often get cited when it comes to lower life expectancies for men are Covid-19 and “deaths of despair” such as suicide and drug overdoses. But this isn’t a new problem — government data shows that in 1921, the life expectancy at birth was 1.8 years longer for women than men. The disparity ballooned to nearly 8 years by 1979, then began falling, reaching under 5 years in 2010. By 2023, it had shot up again, at just over 5 years. &lt;/p&gt;



&lt;p&gt;The gap has myriad causes, including men’s higher smoking rates and reluctance to go to the doctor. You might notice the element of personal responsibility in those two examples. “We think about men’s health as a problem of men’s misbehavior,” population health professor Derek Griffith told STAT’s Olivia Goldhill. “We haven’t looked at the social and structural drivers, and commercial and political drivers. We have to broaden the way we think about it.” In her latest story, Olivia digs into these societal influences. &lt;a href="https://www.statnews.com/2025/09/09/how-research-ignores-men-dying-younger" rel=""&gt;Read more&lt;/a&gt;. &lt;/p&gt;



&lt;h2 class="wp-block-heading" id="h-a-promising-new-treatment-for-a-tough-cancer"&gt;&lt;strong data-stringify-type="bold"&gt;A promising new treatment for a tough cancer&lt;/strong&gt;&lt;/h2&gt;



&lt;p&gt;Small cell lung cancer is a bleak diagnosis with a dismal survival rate. But finally, researchers might be making some progress. On Monday, BioNTech &lt;a data-stringify-link="https://cattendee.abstractsonline.com/meeting/21151/Session/243" data-sk="tooltip_parent" href="https://cattendee.abstractsonline.com/meeting/21151/Session/243" target="_blank" rel="noopener noreferrer"&gt;presented&lt;/a&gt; at the World Conference on Lung Cancer some promising Phase 2 data on a novel immunotherapy that targets two key proteins, PDL1 and VEGF.&lt;/p&gt;



&lt;p&gt;During the trial, the tumors of all 43 patients either shrank or did not progress, and 76.3% of patients saw significant tumor reduction. The average amount that tumors shrank was 56.7% in the trial. “These are impressive but small numbers,” said Roy Herbst, deputy director of the Yale Cancer Center, who did not work on the study, adding that it will be key to see whether the benefits persist. “But good forward progress so far.”&lt;/p&gt;



&lt;p&gt;BioNTech presented data showing that the same treatment was also effective in treating &lt;a href="https://www.statnews.com/2024/12/10/triple-negative-breast-cancer-biontech-immunotherapy-bispecific/" rel="" data-stringify-link="https://www.statnews.com/2024/12/10/triple-negative-breast-cancer-biontech-immunotherapy-bispecific/" data-sk="tooltip_parent"&gt;triple negative breast cancer&lt;/a&gt; last year. With the combined early successes in difficult cancer types, the company believes that the drug may be the future “&lt;a href="https://www.statnews.com/2025/01/22/cancer-therapy-gold-rush-bispecific-antibodies-summit-biontech/" rel="" data-stringify-link="https://www.statnews.com/2025/01/22/cancer-therapy-gold-rush-bispecific-antibodies-summit-biontech/" data-sk="tooltip_parent"&gt;immune-oncology backbone&lt;/a&gt; across tumors,” said Özlem Türeci, the company’s cofounder and CMO. —&lt;i data-stringify-type="italic"&gt; Angus Chen&lt;/i&gt;&lt;/p&gt;



&lt;h2 class="wp-block-heading" id="h-what-we-re-reading"&gt;What we’re reading&lt;/h2&gt;



&lt;ul class="wp-block-list"&gt;
&lt;li&gt;&lt;p id="link-394c56e9" data-testid="headline"&gt;This is what could happen to a child who doesn’t get vaccinated, &lt;a href="https://www.npr.org/sections/goats-and-soda/2025/09/08/g-s1-87121/vaccines-measles-diarrhea-pneumonia-sudan" rel="noopener" target="_blank"&gt;NPR&lt;/a&gt;&lt;/p&gt;&lt;/li&gt;



&lt;li&gt;&lt;p data-flatplan-title="true"&gt;NY attorney general will intervene in Texas abortion pill access lawsuit, &lt;a href="https://www.texastribune.org/2025/09/08/exas-new-york-abortion-pill-access-lawsuit-shield-law/" rel="noopener" target="_blank"&gt;Texas Tribune&lt;/a&gt;&lt;/p&gt;&lt;/li&gt;



&lt;li&gt;Epic must face claims it used monopoly power to harm a rival business, judge rules, &lt;a href="https://www.statnews.com/2025/09/08/epic-particle-health-monopoly-antitrust-discovery-ehr/" rel=""&gt;STAT&lt;/a&gt;&lt;/li&gt;



&lt;li&gt;She started the debate about kids and phones. Now she wants to end it, &lt;a href="https://www.nytimes.com/2025/09/06/well/family/jean-twenge-social-media-screens-teens.html" rel="noopener" target="_blank"&gt;New York Times&lt;/a&gt;&lt;/li&gt;



&lt;li&gt;Former top FDA digital leader lands at Mayo Clinic, &lt;a href="https://www.statnews.com/2025/09/08/fda-mayo-clinic-digital-health-leader-leaves/" rel=""&gt;STAT&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/div&gt;

		&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>statnews.com</author><pubDate>Tue, 09 Sep 2025 12:11:15 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMikwFBVV95cUxOcFlUS1R5dVFkbGJOdndXRHRscXNZN1VPYjRvWHVOaWxWVzlndWpNcFhqY3VWRlEtQUJwT3BNRFhyR0hzdDJHaEJDMngwUUhQX0FIZVdlR015ZHhXSHlIcWYxeTdzcnZfOWdPMm5lRC1iVGlxNTNndFlVZktwWDdjR0Vzd1ZWZ1ZMbU5WemNrMlhOQ0E</guid></item><item><title>如何接种新冠肺炎疫苗，以及世卫组织在接种受限情况下是否符合资格-《华盛顿邮报》</title><link>https://www.washingtonpost.com/health/2025/09/09/covid-vaccine-without-prescription-cdc/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="wpds-c-PJLV article-body type-text" data-qa="article-body"&gt;&lt;p data-apitype="text" data-contentid="P2LB22K6FFEBLIRW3ZH54UTVOQ" data-el="text" class="wpds-c-heFNVF wpds-c-heFNVF-iPJLV-css overrideStyles font-copy" dir="null"&gt;Getting an updated coronavirus vaccine can be particularly challenging this year.&lt;/p&gt;&lt;/div&gt;&lt;div class="wpds-c-PJLV article-body type-text" data-qa="article-body"&gt;&lt;p data-apitype="text" data-contentid="C4VU2FSLQJHFVBJCM4S3FSO5YA" data-el="text" class="wpds-c-heFNVF wpds-c-heFNVF-iPJLV-css overrideStyles font-copy" dir="null"&gt;The Food and Drug Administration&lt;a href="https://www.washingtonpost.com/health/2025/08/27/fda-approves-covid-vaccines/" target="_blank"&gt; approved&lt;/a&gt; those shots for people who are 65 and older or have underlying conditions that elevate their risk of severe disease, narrowing the pool of Americans who have easy access to the shots.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Washington Post</author><pubDate>Tue, 09 Sep 2025 11:31:38 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMikgFBVV95cUxQR3Itc2RtU0pBb1RaVFZkQnU0S2JDeDBQa3F0bE8xd0pKSjYxUWl5QjJQakdaZzhCVFlFNnpJOU9iUjh3Z0E1S3paUHliR1VqY25GTGxra3prUkwyNmwwOG84LS1NUXU1MlV2WEhIdVBWWkY1ckVROERJRl9GNU9MdDg1QURiUC1EbjlqSHU2Z2lLdw</guid></item><item><title>生牡蛎和食肉细菌的注意事项-《华盛顿邮报》</title><link>https://www.washingtonpost.com/wellness/2025/09/09/raw-oysters-vibrio-flesh-eating-bacteria/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div id="topper-text-elems" class="wpds-c-kebnqj wpds-c-kebnqj-iPJLV-css"&gt;&lt;div data-testid="article-topper" class="wpds-c-cBzrLX wpds-c-cBzrLX-cmVlgk-isCenterNS-false wpds-c-cBzrLX-iyHTpF-useUATStyles-true wpds-c-cBzrLX-ieuxqEo-css"&gt;&lt;h1 id="main-content" data-qa="headline" data-testid="headline" class="wpds-c-eRlesA wpds-c-eRlesA-dHdMuz-isOnSplitTopper-false wpds-c-eRlesA-bAbYzz-isStyle-false wpds-c-eRlesA-iPJLV-css"&gt;What to know about raw oysters and flesh-eating bacteria&lt;/h1&gt;&lt;p data-qa="subheadline" data-testid="subheadline" class="wpds-c-ckOSsQ wpds-c-ckOSsQ-iPJLV-css"&gt;Multiple states have reported cases of a deadly bacteria that, in rare cases, can be spread by raw oysters.&lt;/p&gt;&lt;div data-testid="timestamp" class="wpds-c-bEimne wpds-c-bEimne-dyECYW-theme-default"&gt;&lt;time datetime="2025-09-09T10:00:00.000Z" class="wpds-c-gRBhEF wpds-c-gRBhEF-idbzzBd-css overrideStyles"&gt;&lt;p class="wpds-c-eUMOSL"&gt;&lt;span data-testid="published-date" class="wpds-c-bASIGw wpds-c-bASIGw-ilmVsQY-css overrideStyles"&gt;September 9, 2025 at 6:00 a.m. EDT&lt;/span&gt;&lt;span data-testid="relative-date" class="wpds-c-bASIGw wpds-c-bASIGw-idUCtvg-css overrideStyles"&gt;Today at 6:00 a.m. EDT&lt;/span&gt;&lt;/p&gt;&lt;/time&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Washington Post</author><pubDate>Tue, 09 Sep 2025 11:31:10 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMilwFBVV95cUxNdjVCUU02bE5jcTNoaTl6anZjTTZKWmZHZkJCaWFmcEt6UDZQOXBibTdsUzRFUEU3TGhaSmRycHRWOVd5OUNvbUdKNDJXWmUwWTFHd1o1ei04MjJNaTVnb1Q0eV9RbHRiMXQzN2gzaHAxczN4eEl5dkFGMndlSXlYTl9ZQ2lnMjZEemp2cUVuVWtDbVVLTHBF</guid></item><item><title>随着医生透露副作用- LADbible ， “阴囊毒性”手术正在增加</title><link>https://www.ladbible.com/news/health/scrotox-botox-injections-men-surgery-side-effects-465197-20250908</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div&gt;&lt;p class="text_text__nEn66"&gt;A doctor has revealed the concerning side effects of a 'scrotox' medical procedure as searches are reportedly on the rise.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;Typically, people get work done because they want to feel more confident by fixing things they &lt;a class="anchor_link__6t7IO" href="https://www.ladbible.com/news/uk-news/woman-5k-forehead-surgery-before-after-transformation-238848-20250814"&gt;don't like about their appearance&lt;/a&gt;.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;Whether it's to reduce wrinkles to look younger, or to change facial features they're unhappy with, the point of it is to make people feel better in their own skin.&lt;/p&gt;&lt;p class="floating-video-player_container__u4D9_"&gt;&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;And I guess all the above can apply to a procedure like scrotox, which involves injecting Botox (botulinum toxin) into the scrotum.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;According &lt;a class="anchor_link__6t7IO" target="_blank" rel="noopener" href="https://www.indy100.com/viral/men-getting-scrotox-botox-scrotum"&gt;to&lt;/a&gt; a report by Indy100, 'Google searches have shot up to 46,000', but why?&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;Mike Tee, a senior doctor at the &lt;a class="anchor_link__6t7IO" target="_blank" rel="noopener" href="https://www.harleystreetskinclinic.com/"&gt;Harley Street Skin Clinic&lt;/a&gt;, says that around '80 percent' of patients are 'seeking an aesthetic result, rather than addressing a purely medical concern', as was the case before 2015.&lt;/p&gt;&lt;div class="article-image_articleImage__eyzAn"&gt;&lt;cite class="image-credit_imageCredit__YMlqS"&gt;Searches for scrotox are reportedly on the rise (Getty Stock Images)&lt;/cite&gt;&lt;/div&gt;&lt;h2&gt;&lt;strong&gt;Why are people having scrotox?&lt;/strong&gt;&lt;/h2&gt;&lt;p class="text_text__nEn66"&gt;According to Dr Tee, patients usually get it done for at least one of these three reasons:&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;1) To reduce wrinkles or creases in the scrotal skin, making it appear smoother.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;2) To treat hyperhidrosis (sweating of the skin) which causes discomfort or irritation from constant moisture, as well as chafing or skin infections.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;3) Temporarily increasing scrotal size or sag, because relaxing the muscles allows the scrotum to hang lower.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;"In adult men, an overactive cremasteric muscle can cause involuntary and frequent tight contractions, which can be very painful," Dr Tee told the outlet.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;"Once again, both physical activity and sexual activity can be affected."&lt;/p&gt;&lt;h2&gt;&lt;strong&gt;Scrotox side effects&lt;/strong&gt;&lt;/h2&gt;&lt;div class="article-image_articleImage__eyzAn"&gt;&lt;cite class="image-credit_imageCredit__YMlqS"&gt;Any medical procedure can have side effects (Getty Stock Images)&lt;/cite&gt;&lt;/div&gt;&lt;p class="text_text__nEn66"&gt;While the &lt;a class="anchor_link__6t7IO" href="https://www.ladbible.com/health"&gt;health&lt;/a&gt; professional notes that 'botulinum toxin is generally safe', it's important to undergo treatment via a qualified doctor to minimise the chances of anything going wrong.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;Less common, but equally as concerning side effects include asymmetry, as well as allergic reactions such as rashes and dizziness.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;There's also a small chance you could get anaphylaxis, consisting of urinary or sexual dysfunction if the toxin spreads too deeply, Dr Tee warned.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;But as is the case with most cosmetic procedures, the more common issues include tenderness, sensitivity and bruising.&lt;/p&gt;&lt;h2&gt;&lt;strong&gt;What is the recovery like?&lt;/strong&gt;&lt;/h2&gt;&lt;p class="text_text__nEn66"&gt;Dr Tee explained: "Recovery is typically quick, with most patients returning to normal daily activities immediately after treatment. There may be some tenderness and redness in the first 24 to 48 hours. I advise patients to avoid sexual activity, hot baths, or exercise during this time.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;"It’s important to wear loose clothing, keep the area clean, and take general care for the following seven days. Effects will begin to appear gradually, with full results visible between two and four weeks."&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>LADbible</author><pubDate>Tue, 09 Sep 2025 11:04:29 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMipAFBVV95cUxOOVJoSjRtQ3RGQmNoNjFIZEJ0LW40Zy1xRHVMQld2dmFTOHMyYVdaY0RZbGt4UjJPMzBPZTMwanVHTGtjRFo4bXRObVNXMFlfa0k4aTRmRDRSOTQxOWNxRzQ5WWJGazdZUjJ4Y3FCbmdIWURmY3FmZkpNdDlENmQ3Nl8zbGhKbjY2OGpISFJjamw5NnZ0WEc4ZVlITHVicVd1el9FQw</guid></item><item><title>关于新冠肺炎，医生现在最担心的是什么- HuffPost</title><link>https://www.huffpost.com/entry/covid-vaccines-experts-what-to-know_l_68bb3c15e4b0a78951966045</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;section class="entry__content-list js-entry-content js-cet-subunit"&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;a href="https://www.huffpost.com/news/topic/coronavirus" role="link" class=" js-entry-link cet-internal-link" data-vars-item-name="COVID-19" data-vars-item-type="text" data-vars-unit-name="68bb3c15e4b0a78951966045" data-vars-unit-type="buzz_body" data-vars-target-content-id="/news/topic/coronavirus" data-vars-target-content-type="feed" data-vars-type="web_internal_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="0"&gt;COVID-19&lt;/a&gt; is making headlines in several ways right now. &lt;a href="https://www.huffpost.com/entry/covid-surge-west-center-states_l_68b1c4aae4b072bf6d64617e" role="link" class=" js-entry-link cet-internal-link" data-vars-item-name="Infections are up in" data-vars-item-type="text" data-vars-unit-name="68bb3c15e4b0a78951966045" data-vars-unit-type="buzz_body" data-vars-target-content-id="68b1c4aae4b072bf6d64617e" data-vars-target-content-type="buzz" data-vars-type="web_internal_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="1"&gt;Infections are up in&lt;/a&gt; multiple parts of the country, and COVID vaccines are not available for many people who could get them last year.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;All of this is colliding with the upcoming colder weather, when more and more people will spend time — and share germs — indoors, raising fears that controlling cases will become even harder than it already is.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;In short, it’s chaos ― and this current state of affairs is worrying experts. Below, doctors share what’s alarming them most about COVID right now.&lt;/p&gt;&lt;/div&gt;&lt;p class="primary-cli cli cli-text "&gt;&lt;h2&gt;&lt;strong&gt;Fewer people may get the COVID vaccine because of confusing regulations. &lt;/strong&gt;&lt;/h2&gt;&lt;/p&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;Last year, everyone 6 months and older &lt;a href="https://www.huffpost.com/entry/covid-shots-fda-approved-limits_l_68a74310e4b0cfb9a82aa596" role="link" class=" js-entry-link cet-internal-link" data-vars-item-name="was eligible for a COVID shot" data-vars-item-type="text" data-vars-unit-name="68bb3c15e4b0a78951966045" data-vars-unit-type="buzz_body" data-vars-target-content-id="68a74310e4b0cfb9a82aa596" data-vars-target-content-type="buzz" data-vars-type="web_internal_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="2"&gt;was eligible for a COVID shot&lt;/a&gt;. This year, there are tighter restrictions in place; only those 65 and older or people younger than 65 with a qualifying &lt;a href="https://www.cdc.gov/covid/hcp/clinical-care/underlying-conditions.html" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="underlying condition" data-vars-item-type="text" data-vars-unit-name="68bb3c15e4b0a78951966045" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.cdc.gov/covid/hcp/clinical-care/underlying-conditions.html" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="3"&gt;underlying condition&lt;/a&gt; (such as having certain lung conditions, being a smoker, having asthma and more) can get the shot. However, the guidelines vary from place to place, making the eligibility extremely confusing.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“It’s a horrible mess. With these new restricted eligibility criteria from the [Food and Drug Administration], getting a COVID vaccine has now become a chaotic, constantly shifting scavenger hunt that depends on what state you’re in,” &lt;a href="https://www.healthjustice.co/our-team/" target="_blank" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="Dr. Oni Blackstock" data-vars-item-type="text" data-vars-unit-name="68bb3c15e4b0a78951966045" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.healthjustice.co/our-team/" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="4"&gt;Dr. Oni Blackstock&lt;/a&gt;, a primary care physician and executive director of Health Justice, a racial and health equity consultancy, told HuffPost via email.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;Some states, like New York, have granted residents permission to get their shot, no matter if they meet the FDA’s eligibility requirements or not. Other states, like &lt;a href="https://www.atlantanewsfirst.com/2025/09/06/government-is-tying-our-hands-covid-19-vaccine-confusion-building-georgia/" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="Georgia " data-vars-item-type="text" data-vars-unit-name="68bb3c15e4b0a78951966045" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.atlantanewsfirst.com/2025/09/06/government-is-tying-our-hands-covid-19-vaccine-confusion-building-georgia/" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="5"&gt;Georgia &lt;/a&gt;and &lt;a href="https://www.wdsu.com/article/new-rules-restrict-covid-19-vaccine-access-in-louisiana/65986602" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="Louisiana," data-vars-item-type="text" data-vars-unit-name="68bb3c15e4b0a78951966045" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.wdsu.com/article/new-rules-restrict-covid-19-vaccine-access-in-louisiana/65986602" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="6"&gt;Louisiana,&lt;/a&gt; may require prescriptions from a doctor. And across the country, some pharmacies aren’t even offering the shot because of the current confusion, Blackstock noted. And the rules in place now may change as time goes on.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“These restricted eligibility criteria and the patchwork of policies are going to cause major obstacles for the public trying to access an effective and safe vaccine,” she said.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;You can try to get a COVID shot, but you should check your individual state laws and potentially even talk to your doctor to see what you need to do to get vaccinated. The confusing rules may only make people more hesitant to get a vaccine that &lt;a href="https://www.cidrap.umn.edu/covid-19/low-covid-flu-vaccine-uptake-noted-us-healthcare-workers" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="has a small uptake" data-vars-item-type="text" data-vars-unit-name="68bb3c15e4b0a78951966045" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.cidrap.umn.edu/covid-19/low-covid-flu-vaccine-uptake-noted-us-healthcare-workers" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="7"&gt;has a small uptake&lt;/a&gt; as it is.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“To make things worse, all of this is happening just as COVID cases are rising, heading to the usual fall season surge,” Blackstock said.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p class="primary-cli cli cli-text "&gt;&lt;h2&gt;&lt;strong&gt;Children under 2, who now have limited access to the vaccine, could face serious health consequences. &lt;/strong&gt;&lt;/h2&gt;&lt;/p&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;“As a pediatrician, what concerns me the greatest is the children that are less than 2, because those children ... are also at risk of severe disease,” said &lt;a href="https://www.instagram.com/anitakpatelmd/?hl=en" target="_blank" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="Dr. Anita Patel" data-vars-item-type="text" data-vars-unit-name="68bb3c15e4b0a78951966045" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.instagram.com/anitakpatelmd/?hl=en" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="8"&gt;Dr. Anita Patel&lt;/a&gt;, a pediatric critical care doctor in Washington, D.C.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;Children, across the board, already have low COVID vaccine uptake, Patel added. “And every single year we see these children under 2 get admitted to the hospital, either to the ICU ... or to the regular inpatient units, requiring oxygen [or] noninvasive forms of breathing support. And in severe cases, they need to be on a ventilator,” Patel explained.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;a href="https://www.huffpost.com/entry/covid-shots-fda-approved-limits_l_68a74310e4b0cfb9a82aa596" role="link" class=" js-entry-link cet-internal-link" data-vars-item-name="Children 6 months and older" data-vars-item-type="text" data-vars-unit-name="68bb3c15e4b0a78951966045" data-vars-unit-type="buzz_body" data-vars-target-content-id="68a74310e4b0cfb9a82aa596" data-vars-target-content-type="buzz" data-vars-type="web_internal_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="9"&gt;Children 6 months and older&lt;/a&gt; with an underlying condition are eligible for the Moderna vaccine, but not the Pfizer of Novavax versions. Kids without an underlying condition are not part of the FDA’s eligibility requirements.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;Vaccination can help protect folks of all ages, incuding kids, from severe disease, death and hospitalization. &lt;/p&gt;&lt;/div&gt;&lt;figure class="cli cli-image js-no-inject"&gt;&lt;p class="cli-image__spacer"&gt;&lt;/p&gt;&lt;div class="cli-image__source-wrapper"&gt;&lt;div class="cli-image__credit" aria-label="Image Credit: Yuichiro Chino via Getty Images"&gt;&lt;p class="credit-container"&gt;&lt;span class="credit"&gt;Yuichiro Chino via Getty Images&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;figcaption class="cli-image__caption caption-cli"&gt;As COVID surges across the country, doctors worry what confusing vaccine rules mean for future infections. &lt;/figcaption&gt;&lt;/div&gt;&lt;/figure&gt;&lt;p class="primary-cli cli cli-text "&gt;&lt;h2&gt;&lt;strong&gt;Vaccine hesitancy could lead to more long COVID infections, in addition to long-term complications. &lt;/strong&gt;&lt;/h2&gt;&lt;/p&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;“What we do know about the COVID vaccines is that they really are proven to be effective at preventing those long-term complications like long COVID,” Patel said.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;a href="https://www.yalemedicine.org/news/covid-vaccines-reduce-long-covid-risk-new-study-shows" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="Research shows" data-vars-item-type="text" data-vars-unit-name="68bb3c15e4b0a78951966045" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.yalemedicine.org/news/covid-vaccines-reduce-long-covid-risk-new-study-shows" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="10"&gt;Research shows&lt;/a&gt; that getting a COVID vaccine can protect you against long COVID, an oft-debilitating condition that’s associated with chronic symptoms like fatigue, coughing, headaches and chest pain. Long COVID can persist for weeks or years after a COVID infection.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;“And when you look at the complications for children with underlying health conditions and elderly individuals, there are also risk of &lt;a href="https://www.hopkinsmedicine.org/news/articles/2022/06/preventing-life-threatening-blood-clots-in-children-with-serious-cases-of-covid-19" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="clotting disorders" data-vars-item-type="text" data-vars-unit-name="68bb3c15e4b0a78951966045" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.hopkinsmedicine.org/news/articles/2022/06/preventing-life-threatening-blood-clots-in-children-with-serious-cases-of-covid-19" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="11"&gt;clotting disorders&lt;/a&gt; and strokes,” Patel added.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;Vaccination can help prevent long COVID and long-term effects of an infection, Patel noted. “So my major concern is that, because of this confusion, patients are just going to opt out of getting the COVID vaccine, because if physicians and pharmacies are confused as to who is eligible to get it, you can bet that the lay people are even more confused. That confusion is going to lead to an increase in vaccine hesitancy,” she said.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;Not getting the shot could mean someone ends up with long COVID after infection or another severe consequence. &lt;/p&gt;&lt;/div&gt;&lt;p class="primary-cli cli cli-text "&gt;&lt;h2&gt;&lt;strong&gt;There could be a big disparity in who actually has access to the vaccines.&lt;/strong&gt;&lt;/h2&gt;&lt;/p&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;As mentioned above, you may need a prescription from a doctor for vaccine access in some states. This creates a big health disparity, said &lt;a href="https://www.instagram.com/eric2687/?hl=en" target="_blank" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="Dr. Eric Burnett" data-vars-item-type="text" data-vars-unit-name="68bb3c15e4b0a78951966045" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.instagram.com/eric2687/?hl=en" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="12"&gt;Dr. Eric Burnett&lt;/a&gt;, an internal medicine doctor at an academic medical center in New York and a &lt;a href="https://www.tiktok.com/@dr.eric.b?lang=en" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="health communicator on social media" data-vars-item-type="text" data-vars-unit-name="68bb3c15e4b0a78951966045" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.tiktok.com/@dr.eric.b?lang=en" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="13"&gt;health communicator on social media&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;“That brings up the point where not everyone in this country has access to a primary care doctor where they can just go get a prescription and go to CVS or go to their doctor to get vaccinated at the office,” he said.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;“We have so many people who just don’t have primary care doctors, who are underinsured or uninsured and can’t have access to these things,” Burnett said.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;This creates a divide in who has access to the vaccines, Burnett explained, which is worrisome and could cause worse health outcomes in groups that are already underinsured or uninsured. &lt;/p&gt;&lt;/div&gt;&lt;p class="primary-cli cli cli-text "&gt;&lt;h2&gt;&lt;strong&gt;As we enter cold and flu season, hospitals could deal with overcrowding.&lt;/strong&gt;&lt;/h2&gt;&lt;/p&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;“We’re entering cold and flu season, and our hospitals are already very, very busy,” Burnett said. “Just last month in August, hospitals were overflowing with patients, and that’s concerning because August is typically the season where we don’t have much activity in the hospital.”&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;Burnett is worried that hospitals will be even busier during respiratory virus season as vaccine access is fragmented and there’s much confusion about who can actually get the COVID shot.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;“I’m already starting to see more and more ER visits,” Burnett said. “I haven’t seen too much COVID, I’m starting to see more of it now, but it’s just busy in general, and I think a lot of it has to do with the fact that there’s so much impact from the pandemic.”&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;“A lot of people got sick during COVID, a lot of which resulted in a lot of chronic illness, not just from COVID itself, but just from people having interruption in their health care,” Burnett continued.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;Think about it: Many people were afraid to leave their homes to go to doctors’ appointments during the pandemic, which allowed symptoms to worsen and left underlying conditions untreated. &lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;“People don’t realize that we’re still dealing with the ramifications of the pandemic and how it disrupted health care,” he added.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;Even if you aren’t at risk of severe COVID or flu, you may need to go to the hospital for another reason, such as a broken leg or a bad cut, and you might be met with long wait times because of the crowding at the hospital, Burnett explained.&lt;/p&gt;&lt;/div&gt;&lt;div id="support-huffpost-entry-support-huffpost-mid-article" class="cli support-huffpost-mid-article primary-cli cli cli-text cli-support-huffpost hidden"&gt;&lt;div class="cli-support-huffpost__content-wrapper"&gt;&lt;p class="cli-support-huffpost__title default-title"&gt;&lt;span class="cli-support-huffpost__title--first"&gt;20 Years Of&lt;/span&gt;&lt;span class="cli-support-huffpost__title--second"&gt;Free&lt;/span&gt;&lt;span class="cli-support-huffpost__title--third"&gt;Journalism&lt;/span&gt;&lt;/p&gt;&lt;div class="contributor-once-variation"&gt;&lt;p class="cli-support-huffpost__title"&gt;&lt;span class="cli-support-huffpost__title--first"&gt;Your Support&lt;/span&gt;&lt;span class="cli-support-huffpost__title--second"&gt;Fuels&lt;/span&gt;&lt;span class="cli-support-huffpost__title--third"&gt;Our Mission&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="contributor-canceled-variation"&gt;&lt;p class="cli-support-huffpost__title"&gt;&lt;span class="cli-support-huffpost__title--first"&gt;Your Support&lt;/span&gt;&lt;span class="cli-support-huffpost__title--second"&gt;Fuels&lt;/span&gt;&lt;span class="cli-support-huffpost__title--third"&gt;Our Mission&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="cli-support-huffpost__container"&gt;&lt;div class="cli-support-huffpost__message-container"&gt;&lt;div class="cli-support-huffpost__message support-huffpost__message--main"&gt;&lt;p&gt;For two decades, HuffPost has been fearless, unflinching, and relentless in pursuit of the truth. Support our mission to keep us around for the next 20 — we can't do this without you.&lt;/p&gt;&lt;p class="cli-support-huffpost__sub-headline"&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="cli-support-huffpost__message variation contributor-once-variation"&gt;&lt;p&gt;We remain committed to providing you with the unflinching, fact-based journalism everyone deserves.&lt;/p&gt;&lt;p&gt;Thank you again for your support along the way. We’re truly grateful for readers like you! Your initial support helped get us here and bolstered our newsroom, which kept us strong during uncertain times. Now as we continue, we need your help more than ever. &lt;a href="https://www.huffpost.com/support" class="cli-support-huffpost__message__link js-entry-link" data-vars-item-name="we're offering an ad-free experience" data-vars-item-type="text" data-vars-unit-name="main" data-vars-unit-type="buzz_body" data-vars-target-content-id="/support" data-vars-target-content-type="feed" data-vars-type="web_internal_link" data-vars-subunit-name="support-huffpost-mid-article" data-vars-subunit-type="component" data-vars-position-in-subunit="15"&gt;We hope you will join us once again&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;&lt;div class="cli-support-huffpost__message variation contributor-canceled-variation"&gt;&lt;p&gt;We remain committed to providing you with the unflinching, fact-based journalism everyone deserves.&lt;/p&gt;&lt;p&gt;Thank you again for your support along the way. We’re truly grateful for readers like you! Your initial support helped get us here and bolstered our newsroom, which kept us strong during uncertain times. Now as we continue, we need your help more than ever. &lt;a href="https://www.huffpost.com/support" class="cli-support-huffpost__message__link js-entry-link" data-vars-item-name="we're offering an ad-free experience" data-vars-item-type="text" data-vars-unit-name="main" data-vars-unit-type="buzz_body" data-vars-target-content-id="/support" data-vars-target-content-type="feed" data-vars-type="web_internal_link" data-vars-subunit-name="support-huffpost-mid-article" data-vars-subunit-type="component" data-vars-position-in-subunit="15"&gt;We hope you will join us once again&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;a class="cli-support-huffpost__support-button accent-button" href="https://www.huffpost.com/support?utm_campaign=mid-article-web" data-vars-item-name-overwritable="support-huffpost" data-vars-item-name="Support HuffPost" data-vars-item-type="button" data-vars-unit-name="main" data-vars-unit-type="buzz_body" data-vars-target-content-id="/support" data-vars-target-content-type="feed" data-vars-type="web_internal_link" data-vars-subunit-name="support-huffpost-mid-article" data-vars-subunit-type="component" data-vars-position-in-subunit="14"&gt;Support HuffPost&lt;/a&gt;&lt;p class="support-huffpost-login"&gt;Already contributed? &lt;a class="js-entry-link-no-impression" href="https://login.huffpost.com/login?dest=https%3A%2F%2Fwww.huffpost.com%2Fentry%2Fcovid-vaccines-experts-what-to-know_l_68bb3c15e4b0a78951966045%3Fhp_auth_done%3D1" data-vars-item-name="Log in to hide these messages" data-vars-item-type="text" data-vars-unit-name="68bb3c15e4b0a78951966045" data-vars-unit-type="buzz_body" data-vars-target-content-id="/login" data-vars-target-content-type="utility" data-vars-type="web_internal_link" data-vars-subunit-name="support-huffpost-mid-article" data-vars-subunit-type="component"&gt;Log in to hide these messages.&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;There’s currently a lot of strain on the health care system, “which is going to directly negatively impact public health as a whole, and that’s something that I’m very much concerned about as we move forward into this administration,” he added.&lt;/p&gt;&lt;/div&gt;&lt;/section&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>HuffPost</author><pubDate>Tue, 09 Sep 2025 11:00:18 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMimAFBVV95cUxOSGEwS2dBSFJfLS1NRkhZcy11TFNkTnNiT2xjMmtxRjJ5VzE0NnlKN1h5elI3YXhRU0VpYk4wcGdTMDRmSHVfanhqWFdKRWt6VGZCcWJGRDJVVWR2UE9mUDRzYW9SazhJb2pOcUQ2QldrMkhWVHkzdXBfLVBRNlRFS25VQVJ5NmhGcEVsUWJoMVBadnB2akpaetIBngFBVV95cUxPcHZ6amNQTTlmOHpuWE4wVkJoUUFtRWhfcHVod3lVRGpEamVReXdXUzFBSTh6ZW5mckR6Nzg1QWNXa3VPT1o2QU5OYTNuNlNCVnRFQmE1SmY4Y3JuM2dHTExqeGhKa2lLWVRLQUtYa0IxOURwNkZUUEVLQzBIdHdaODdjZFg2MVR5UGdBTWJldEkyQ2hwYllBZm5fdlNrQQ</guid></item><item><title>疾病预防控制中心表示， “接吻虫”疾病现在在美国流行。这是什么？ -《华盛顿邮报》</title><link>https://www.washingtonpost.com/health/2025/09/09/kissing-bug-disease-chagas-endemic/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="wpds-c-PJLV article-body type-text" data-qa="article-body"&gt;&lt;p data-apitype="text" data-contentid="JVJCOEV73JFERJQPRCDEQ2AENQ" data-el="text" class="wpds-c-heFNVF wpds-c-heFNVF-iPJLV-css overrideStyles font-copy" dir="null"&gt;“Kissing bug” disease, also known as Chagas disease, is now considered an endemic illness in the United States, the Centers for Disease Control and Prevention said &lt;a href="https://wwwnc.cdc.gov/eid/article/31/9/24-1700_article" target="_blank"&gt;earlier this month&lt;/a&gt;. Scientists have long warned that the potentially deadly disease is spreading, especially across southern states.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Washington Post</author><pubDate>Tue, 09 Sep 2025 09:53:47 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMijAFBVV95cUxNRHlRZGRVQ18zeTFvdE9jZERHVGhJbXc3aFRGU1EyRFlUTHdRNThrSk5uTDNSaERCRWFHY3RiZEhKQ2lsTTJFVmk2M2p3U0h2MmZmVkdSTW1udWdFOElPU290Mk5xNkQzcTVPb1ljblBndG1Zcjdvdjg0cU1CeDM3ZGE3T1J6aTUwMkJlNA</guid></item><item><title>使用因果神经网络对治疗摄动进行组合预测-自然</title><link>https://www.nature.com/articles/s41551-025-01481-x</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="c-article-section__content" id="Sec10-content"&gt;&lt;h3 class="c-article__sub-heading" id="Sec11"&gt;Preliminaries&lt;/h3&gt;&lt;p&gt;A calligraphic letter &lt;span class="mathjax-tex"&gt;\({\mathcal{X}}\)&lt;/span&gt; indicates a set, an italic uppercase letter &lt;i&gt;X&lt;/i&gt; denotes a graph, uppercase &lt;b&gt;X&lt;/b&gt; denotes a matrix, lowercase &lt;b&gt;x&lt;/b&gt; denotes a vector, and a monospaced letter &lt;span class="u-monospace"&gt;X&lt;/span&gt; indicates a tuple. Uppercase letter &lt;span class="mathjax-tex"&gt;\({\mathsf{X}}\)&lt;/span&gt; indicates a random variable, and lowercase letter &lt;span class="mathjax-tex"&gt;\({\mathsf{x}}\)&lt;/span&gt; indicates its corresponding value; bold uppercase &lt;span class="mathjax-tex"&gt;\({\boldsymbol{\mathsf{X}}}\)&lt;/span&gt; denotes a set of random variables, and lowercase letter &lt;span class="mathjax-tex"&gt;\({\boldsymbol{\mathsf{x}}}\)&lt;/span&gt; indicates its corresponding values. We denote &lt;span class="mathjax-tex"&gt;\(P({\boldsymbol{\mathsf{X}}})\)&lt;/span&gt; as a probability distribution over a set of random variables &lt;span class="mathjax-tex"&gt;\({\boldsymbol{\mathsf{X}}}\)&lt;/span&gt; and &lt;span class="mathjax-tex"&gt;\(P({\boldsymbol{\mathsf{X}}}={\boldsymbol{\mathsf{x}}})\)&lt;/span&gt; as the probability of &lt;span class="mathjax-tex"&gt;\({\boldsymbol{\mathsf{X}}}\)&lt;/span&gt; that is equal to the value of &lt;span class="mathjax-tex"&gt;\({\boldsymbol{\mathsf{x}}}\)&lt;/span&gt; under the distribution &lt;span class="mathjax-tex"&gt;\(P({\boldsymbol{\mathsf{X}}})\)&lt;/span&gt;. For simplicity, &lt;span class="mathjax-tex"&gt;\(P({\boldsymbol{\mathsf{X}}}={\boldsymbol{\mathsf{x}}})\)&lt;/span&gt; is abbreviated as &lt;span class="mathjax-tex"&gt;\(P({\boldsymbol{\mathsf{x}}})\)&lt;/span&gt;. This section uses terminology and concepts from the framework of casual inference&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 67" title="Neal, B. Introduction to Causal Inference. Course Lecture Notes (draft). (Department of Statistics, Harvard University, 2020); 
                https://www.bradyneal.com/Introduction_to_Causal_Inference-Dec17_2020-Neal.pdf
                
              " href="/articles/s41551-025-01481-x#ref-CR67" id="ref-link-section-d254919041e2638"&gt;67&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec12"&gt;Problem formulation for combinatorial prediction of targets&lt;/h3&gt;&lt;p&gt;Intuitively, given a diseased cell line sample, we would like to predict the set of therapeutic genes that need to be targeted to reverse the effects of disease, that is, the genes that need to be perturbed to shift the cell gene expression state as close as possible to the healthy state. Next, we formalize our problem formulation. Let &lt;span class="mathjax-tex"&gt;\({\mathtt{M}}= &amp;lt; {\boldsymbol{\mathsf{E}}},{\boldsymbol{\mathsf{V}}},{\mathcal{F}},P(\boldsymbol{{\mathsf{E}}}) &amp;gt;\)&lt;/span&gt; be a structural causal model (SCM; see the description of related works in Supplementary Note &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41551-025-01481-x#MOESM1"&gt;4&lt;/a&gt;) associated with causal graph &lt;i&gt;G&lt;/i&gt;, where &lt;span class="mathjax-tex"&gt;\({\boldsymbol{\mathsf{E}}}\)&lt;/span&gt; is a set of exogenous variables affecting the system, &lt;span class="mathjax-tex"&gt;\({\boldsymbol{\mathsf{V}}}\)&lt;/span&gt; are the system variables, &lt;span class="mathjax-tex"&gt;\({\mathcal{F}}\)&lt;/span&gt; are structural equations encoding causal relations between variables and &lt;span class="mathjax-tex"&gt;\(P({\boldsymbol{\mathsf{E}}})\)&lt;/span&gt; is a probability distribution over exogenous variables. Let &lt;span class="mathjax-tex"&gt;\({\mathcal{T}}=\{{{\mathtt{T}}}_{1},\ldots ,{{\mathtt{T}}}_{m}\}\)&lt;/span&gt; be a dataset of paired healthy and diseased samples (namely, disease intervention data), where each element is a triplet &lt;span class="mathjax-tex"&gt;\({\mathtt{T}}= &amp;lt; {{\boldsymbol{\mathsf{v}}}}^{\rm{h}},{\boldsymbol{\mathsf{U}}},{{\boldsymbol{\mathsf{v}}}}^{\rm{d}} &amp;gt;\)&lt;/span&gt; with &lt;span class="mathjax-tex"&gt;\({{\boldsymbol{\mathsf{v}}}}^{\rm{h}}\in {[0,1]}^{N}\)&lt;/span&gt; being normalized gene expression values of a healthy cell line (variable states before perturbation), &lt;span class="mathjax-tex"&gt;\({{\boldsymbol{\mathsf{V}}}}_{{\boldsymbol{\mathsf{U}}}}\)&lt;/span&gt; being the disease-causing perturbed variable (gene) set in &lt;span class="mathjax-tex"&gt;\({\boldsymbol{\mathsf{V}}}\)&lt;/span&gt;, and &lt;span class="mathjax-tex"&gt;\({{\boldsymbol{\mathsf{v}}}}^{\rm{d}}\in {[0,1]}^{N}\)&lt;/span&gt; being gene expression values of a diseased cell line (variable states after perturbation). Our goal is to find, for each sample &lt;span class="mathjax-tex"&gt;\({\mathtt{T}}= &amp;lt; {{\boldsymbol{\mathsf{v}}}}^{\rm{h}},{\boldsymbol{\mathsf{U}}},{{\boldsymbol{\mathsf{v}}}}^{\rm{d}} &amp;gt;\)&lt;/span&gt;, the variable set &lt;span class="mathjax-tex"&gt;\({{\boldsymbol{\mathsf{U}}}}^{{\prime} }\)&lt;/span&gt; with the highest likelihood of shifting variable states from diseased &lt;span class="mathjax-tex"&gt;\({{\boldsymbol{\mathsf{v}}}}^{\rm{d}}\)&lt;/span&gt; to healthy &lt;span class="mathjax-tex"&gt;\({{\boldsymbol{\mathsf{v}}}}^{\rm{h}}\)&lt;/span&gt; state. To increase generality, we refer to the desired variable states as treated (&lt;span class="mathjax-tex"&gt;\({{\boldsymbol{\mathsf{v}}}}^{\rm{t}}\)&lt;/span&gt;). Our goal can then be expressed as:&lt;/p&gt;&lt;div id="Equ1" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${\rm{argmax}}_{{{\boldsymbol{\mathsf{U}}}}^{{\prime} }}{P}^{\;{G}^{{\boldsymbol{\mathsf{U}}}}}({\boldsymbol{\mathsf{V}}}={{\boldsymbol{\mathsf{v}}}}^{\rm{t}}\,| \,{\rm{do}}({{\boldsymbol{\mathsf{U}}}}^{{\prime} })),$$&lt;/span&gt;&lt;/p&gt;&lt;p class="c-article-equation__number"&gt;
                    (1)
                &lt;/p&gt;&lt;/div&gt;&lt;p&gt;where &lt;span class="mathjax-tex"&gt;\({P}^{\;{G}^{{\boldsymbol{\mathsf{U}}}}}\)&lt;/span&gt; represents the probability on the graph &lt;i&gt;G&lt;/i&gt; mutilated by perturbations in variables in &lt;span class="mathjax-tex"&gt;\({\boldsymbol{\mathsf{U}}}\)&lt;/span&gt;. Under the assumption of no unobserved confounders, the above interventional probability can be expressed as a conditional probability on the mutilated graph &lt;span class="mathjax-tex"&gt;\({G}^{{{\boldsymbol{\mathsf{U}}}}^{{\prime} }}\)&lt;/span&gt;:&lt;/p&gt;&lt;div id="Equ2" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${\rm{argmax}}_{{{\boldsymbol{\mathsf{U}}}}^{{\prime} }}{P}^{\;{G}^{{{\boldsymbol{\mathsf{U}}}}^{{\prime} }}}({\boldsymbol{\mathsf{V}}}={{\boldsymbol{\mathsf{v}}}}^{\rm{t}}\,| \,{{\boldsymbol{\mathsf{U}}}}^{{\prime} }),$$&lt;/span&gt;&lt;/p&gt;&lt;p class="c-article-equation__number"&gt;
                    (2)
                &lt;/p&gt;&lt;/div&gt;&lt;p&gt;which under the causal Markov condition is:&lt;/p&gt;&lt;div id="Equ3" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${\rm{argmax}}_{{{\boldsymbol{\mathsf{U}}}}^{{\prime} }}\prod _{i}P\left({{{\mathsf{V}}}}_{i}={{{\mathsf{v}}}}_{i}^{\rm{t}}\,| \,{{\boldsymbol{\mathsf{Pa}}}}_{{{{\mathsf{V}}}}_{i}}\right),$$&lt;/span&gt;&lt;/p&gt;&lt;p class="c-article-equation__number"&gt;
                    (3)
                &lt;/p&gt;&lt;/div&gt;&lt;p&gt;where &lt;span class="mathjax-tex"&gt;\({{\boldsymbol{\mathsf{Pa}}}}_{{{\boldsymbol{\mathsf{V}}}}_{i}}\)&lt;/span&gt; represents parents of variable &lt;span class="mathjax-tex"&gt;\({{{\mathsf{V}}}}_{i}\)&lt;/span&gt; according to graph &lt;span class="mathjax-tex"&gt;\({G}^{{{\boldsymbol{\mathsf{U}}}}^{{\prime} }}\)&lt;/span&gt; (that is, the mutilated graph upon intervening on variables in &lt;span class="mathjax-tex"&gt;\({{\boldsymbol{\mathsf{U}}}}^{{\prime} }\)&lt;/span&gt;). Here state of a variable &lt;span class="mathjax-tex"&gt;\({{\mathsf{V}}}_{j}\in {{\boldsymbol{\mathsf{Pa}}}}_{{{{\mathsf{V}}}}_{i}}\)&lt;/span&gt; will be equal to an arbitrary value &lt;span class="mathjax-tex"&gt;\({{\mathsf{v}}}_{j}^{{\prime} }\)&lt;/span&gt; if &lt;span class="mathjax-tex"&gt;\({{\mathsf{V}}}_{j}\in {{\boldsymbol{\mathsf{U}}}}^{{\prime} }\)&lt;/span&gt;. Therefore, intervening on the variable set &lt;span class="mathjax-tex"&gt;\({{\boldsymbol{\mathsf{U}}}}^{{\prime} }\)&lt;/span&gt; modifies the graph used to obtain conditional probabilities and determine the state of variables in &lt;span class="mathjax-tex"&gt;\({{\boldsymbol{\mathsf{U}}}}^{{\prime} }\)&lt;/span&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec13"&gt;Problem formulation from a representation learning perspective&lt;/h3&gt;&lt;p&gt;In the previous section, we drew on the SCM framework to introduce a generic formulation for the task of combinatorial prediction of therapeutic targets. Instead of approaching the problem from a purely causal inference perspective, we draw upon representation learning to approximate the queries of interest to address the limiting real-world setting of a noisy and incomplete causal graph. Formulating our problem using the SCM framework allows for explicit modelling of interventions and formulation of interventional queries (see the description of related works in Supplementary Note &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41551-025-01481-x#MOESM1"&gt;4&lt;/a&gt;). Inspired by this principled problem formulation, we next introduce the problem formulation using a representation learning paradigm.&lt;/p&gt;&lt;p&gt;We let &lt;span class="mathjax-tex"&gt;\(G=({\mathcal{V}},{\mathcal{E}})\)&lt;/span&gt; denote a graph with &lt;span class="mathjax-tex"&gt;\(| {\mathcal{V}}| =n\)&lt;/span&gt; nodes and &lt;span class="mathjax-tex"&gt;\(| {\mathcal{E}}|\)&lt;/span&gt; edges, which contains partial information on causal relationships between nodes in &lt;span class="mathjax-tex"&gt;\({\mathcal{V}}\)&lt;/span&gt; and some noisy relationships. We refer to this graph as a proxy causal graph. Let &lt;span class="mathjax-tex"&gt;\({\mathcal{T}}=\{{{\mathtt{T}}}_{1},\ldots ,{{\mathtt{T}}}_{{\mathsf{M}}}\}\)&lt;/span&gt; be a dataset with an individual sample being a triplet &lt;span class="mathjax-tex"&gt;\({\mathtt{T}}= &amp;lt; {{\bf{x}}}^{\rm{h}},{\mathcal{U}},{{\bf{x}}}^{\rm{d}} &amp;gt;\)&lt;/span&gt; with &lt;b&gt;x&lt;/b&gt;&lt;sup&gt;h&lt;/sup&gt; &lt;span class="stix"&gt;∈&lt;/span&gt; [0, 1]&lt;sup&gt;&lt;i&gt;n&lt;/i&gt;&lt;/sup&gt; being the node states (attributes) of a healthy cell sample (before perturbation), &lt;span class="mathjax-tex"&gt;\({\mathcal{U}}\)&lt;/span&gt; being the set of disease-causing perturbed nodes in &lt;span class="mathjax-tex"&gt;\({\mathcal{V}}\)&lt;/span&gt;, and &lt;b&gt;x&lt;/b&gt;&lt;sup&gt;d&lt;/sup&gt; &lt;span class="stix"&gt;∈&lt;/span&gt; [0, 1]&lt;sup&gt;&lt;i&gt;n&lt;/i&gt;&lt;/sup&gt; being the node states (attributes) of a diseased cell sample (after perturbation). We denote by &lt;span class="mathjax-tex"&gt;\({G}^{{\mathcal{U}}}=({\mathcal{V}},{{\mathcal{E}}}^{{\mathcal{U}}})\)&lt;/span&gt; the graph resulting from the mutilation of edges in &lt;i&gt;G&lt;/i&gt; as a result of perturbing nodes in &lt;span class="mathjax-tex"&gt;\({\mathcal{U}}\)&lt;/span&gt; (one graph per perturbagen; we avoid using superindices for simplicity). Here again we refer to the desired variable states as treated (&lt;b&gt;x&lt;/b&gt;&lt;sup&gt;t&lt;/sup&gt;). Our goal is then to learn a function:&lt;/p&gt;&lt;div id="Equ4" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$f:{G}^{{{\mathcal{U}}}^{{\prime} }},\,{{\bf{x}}}^{\rm{d}},{{\bf{x}}}^{\rm{t}}\to {\rm{argmax}}_{{{\mathcal{U}}}^{{\prime} }}{P}^{\;{G}^{{{\mathcal{U}}}^{{\prime} }}}({\bf{x}}={{\bf{x}}}^{\rm{t}}| {{\bf{x}}}^{\rm{d}},{{\mathcal{U}}}^{{\prime} }).$$&lt;/span&gt;&lt;/p&gt;&lt;p class="c-article-equation__number"&gt;
                    (4)
                &lt;/p&gt;&lt;/div&gt;&lt;p&gt;That, given the graph &lt;span class="mathjax-tex"&gt;\({G}^{{{\mathcal{U}}}^{{\prime} }}\)&lt;/span&gt;, the diseased node states &lt;b&gt;x&lt;/b&gt;&lt;sup&gt;d&lt;/sup&gt; and treated node states &lt;b&gt;x&lt;/b&gt;&lt;sup&gt;t&lt;/sup&gt;, predicts the combinatorial set of nodes &lt;span class="mathjax-tex"&gt;\({{\mathcal{U}}}^{{\prime} }\)&lt;/span&gt; that if perturbed have the highest chance of shifting the node states to the treated state &lt;b&gt;x&lt;/b&gt;&lt;sup&gt;t&lt;/sup&gt;. We note here that &lt;span class="mathjax-tex"&gt;\({P}^{{G}^{{{\mathcal{U}}}^{{\prime} }}}\)&lt;/span&gt; represents probabilities over graph &lt;span class="mathjax-tex"&gt;\({G}^{{\mathcal{U}}}\)&lt;/span&gt; mutilated upon perturbations in nodes in &lt;span class="mathjax-tex"&gt;\({{\mathcal{U}}}^{{\prime} }\)&lt;/span&gt;. Under causal Markov condition, we can factorize &lt;span class="mathjax-tex"&gt;\({P}^{{G}^{{{\mathcal{U}}}^{{\prime} }}}\)&lt;/span&gt; over graph &lt;span class="mathjax-tex"&gt;\({G}^{{{\mathcal{U}}}^{{\prime} }}\)&lt;/span&gt;:&lt;/p&gt;&lt;div id="Equ5" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$f:{G}^{{{\mathcal{U}}}^{{\prime} }},\,{{\bf{x}}}^{\rm{d}},{{\bf{x}}}^{\rm{t}}\to {\rm{argmax}}_{{{\mathcal{U}}}^{{\prime} }}\prod _{i}P({{\bf{x}}}_{i}={{\bf{x}}}_{i}^{\rm{t}}| {{\bf{x}}}_{{{\mathcal{PA}}}_{i}}),$$&lt;/span&gt;&lt;/p&gt;&lt;p class="c-article-equation__number"&gt;
                    (5)
                &lt;/p&gt;&lt;/div&gt;&lt;p&gt;that is, the probability of each node &lt;i&gt;i&lt;/i&gt; depending only on its parents &lt;span class="mathjax-tex"&gt;\({{\mathcal{PA}}}_{i}\)&lt;/span&gt; in graph &lt;span class="mathjax-tex"&gt;\({G}^{{{\mathcal{U}}}^{{\prime} }}\)&lt;/span&gt;.&lt;/p&gt;&lt;p&gt;We assume (1) real-valued node states, (2) &lt;i&gt;G&lt;/i&gt; is fixed and given, and (3) atomic and non-atomic perturbagens (intervening on individual nodes or sets of nodes). Given that the value of each node should depend only on its parents in the graph &lt;span class="mathjax-tex"&gt;\({G}^{{{\mathcal{U}}}^{{\prime} }}\)&lt;/span&gt;, a message-passing framework appears especially suited to compute the factorized probabilities &lt;i&gt;P&lt;/i&gt;.&lt;/p&gt;&lt;p&gt;In the SCM framework, the conditional probabilities in equation (&lt;a data-track="click" data-track-label="link" data-track-action="equation anchor" href="/articles/s41551-025-01481-x#Equ3"&gt;3&lt;/a&gt;) are computed recursively on the graph, each being an expectation over exogenous variables &lt;span class="mathjax-tex"&gt;\(\boldsymbol{\mathsf{E}}\)&lt;/span&gt;. Therefore, node states of the previous time point are not necessary. To translate this query into the representation learning realm, we discard the existence of noise variables and directly try to learn a function encoding the transition from an initial state to a desired state. An exhaustive approach to solving equation (&lt;a data-track="click" data-track-label="link" data-track-action="equation anchor" href="/articles/s41551-025-01481-x#Equ5"&gt;5&lt;/a&gt;) would be to search the space of all potential sets of therapeutic targets &lt;span class="mathjax-tex"&gt;\({{\mathcal{U}}}^{{\prime} }\)&lt;/span&gt; and score how effective each is in achieving the desired treated state. This is, how many cell response prediction approaches can be used for perturbagen discovery&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Lotfollahi, M., Wolf, F. A. &amp;amp; Theis, F. J. scGen predicts single-cell perturbation responses. Nat. Methods 16, 715–721 (2019)." href="/articles/s41551-025-01481-x#ref-CR22" id="ref-link-section-d254919041e5802"&gt;22&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Hetzel, L. et al. Predicting cellular responses to novel drug perturbations at a single-cell resolution. Adv. Neural Inf. Process. Syst. 35, 26711–26722 (2022)." href="/articles/s41551-025-01481-x#ref-CR23" id="ref-link-section-d254919041e5805"&gt;23&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 68" title="Lotfollahi, M. et al. Predicting cellular responses to complex perturbations in high-throughput screens. Mol. Syst. Biol. 19, e11517 (2023)." href="/articles/s41551-025-01481-x#ref-CR68" id="ref-link-section-d254919041e5808"&gt;68&lt;/a&gt;&lt;/sup&gt;. However, with moderately sized graphs, this is highly computationally expensive, if not intractable. Instead, we propose to search for potential perturbagens efficiently with a perturbagen discovery module (&lt;i&gt;ƒ&lt;/i&gt;&lt;sub&gt;p&lt;/sub&gt;) and a way to score each potential perturbagen with a response prediction module (&lt;i&gt;ƒ&lt;/i&gt;&lt;sub&gt;r&lt;/sub&gt;).&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec14"&gt;Relationship to conventional graph prediction tasks&lt;/h3&gt;&lt;p&gt;Given that the prediction for each variable is dependent only on its parents in a graph, GNNs appear especially suited for this problem. We can formulate the query of interest under a graph representation learning paradigm as follows: given a graph &lt;span class="mathjax-tex"&gt;\(G=({\mathcal{V}},{\mathcal{E}})\)&lt;/span&gt;, paired sets of node attributes &lt;span class="mathjax-tex"&gt;\({\mathcal{X}}=\{{{\bf{X}}}_{1},{{\bf{X}}}_{2},\ldots ,{{\bf{X}}}_{m}\}\)&lt;/span&gt; and node labels &lt;span class="mathjax-tex"&gt;\({\mathcal{Y}}=\{{{\bf{Y}}}_{1},{{\bf{Y}}}_{2},\ldots ,{{\bf{Y}}}_{m}\}\)&lt;/span&gt;, where each &lt;b&gt;Y&lt;/b&gt; = {&lt;b&gt;y&lt;/b&gt;&lt;sub&gt;1&lt;/sub&gt;, …, &lt;b&gt;y&lt;/b&gt;&lt;sub&gt;&lt;i&gt;n&lt;/i&gt;&lt;/sub&gt;}, with &lt;b&gt;y&lt;/b&gt;&lt;sub&gt;&lt;i&gt;i&lt;/i&gt;&lt;/sub&gt; &lt;span class="stix"&gt;∈&lt;/span&gt; [0, 1], we aim at training a neural message-passing architecture that given node attributes &lt;b&gt;X&lt;/b&gt;&lt;sub&gt;&lt;i&gt;i&lt;/i&gt;&lt;/sub&gt; predicts the corresponding node labels &lt;b&gt;Y&lt;/b&gt;&lt;sub&gt;&lt;i&gt;i&lt;/i&gt;&lt;/sub&gt;. There are, however, differences between our problem formulation and the conventional graph prediction tasks, namely, graph and node classification (summarized in Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41551-025-01481-x#MOESM1"&gt;13&lt;/a&gt;).&lt;/p&gt;&lt;p&gt;In node classification, a single graph &lt;i&gt;G&lt;/i&gt; is paired with node attributes &lt;b&gt;X&lt;/b&gt;, and the task is to predict the node labels &lt;b&gt;Y&lt;/b&gt;. Our formulation differs in that we have &lt;i&gt;m&lt;/i&gt; paired sets of node attributes &lt;span class="mathjax-tex"&gt;\({\mathcal{X}}\)&lt;/span&gt; and labels &lt;span class="mathjax-tex"&gt;\({\mathcal{Y}}\)&lt;/span&gt; instead of a single set, yet they are similar in that there is a single graph in which GNNs operate. In graph classification, a set of graphs &lt;span class="mathjax-tex"&gt;\({\mathcal{G}}=\{{G}_{1},\ldots ,{G}_{m}\}\)&lt;/span&gt; is paired with a set of node attributes &lt;span class="mathjax-tex"&gt;\({\mathcal{X}}=\{{{\bf{X}}}_{1},{{\bf{X}}}_{2},\ldots ,{{\bf{X}}}_{m}\}\)&lt;/span&gt; and the task is to predict a label for each graph &lt;b&gt;Y&lt;/b&gt; = {&lt;b&gt;y&lt;/b&gt;&lt;sub&gt;1&lt;/sub&gt;, …, &lt;b&gt;y&lt;/b&gt;&lt;sub&gt;&lt;i&gt;m&lt;/i&gt;&lt;/sub&gt;}. Here graphs have a varying structure, and both the topological information and node attributes predict graph labels. In our formulation, a single graph is combined with each node attribute &lt;b&gt;X&lt;/b&gt;&lt;sub&gt;&lt;i&gt;i&lt;/i&gt;&lt;/sub&gt;, and the goal is to predict a label for each node, not for the whole graph.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec15"&gt;PDGrapher model&lt;/h3&gt;&lt;p&gt;PDGrapher is an approach for combinatorial prediction of therapeutic targets composed of two modules. First, a perturbagen discovery module &lt;i&gt;ƒ&lt;/i&gt;&lt;sub&gt;p&lt;/sub&gt; searches the space of potential gene sets to predict a suitable candidate &lt;span class="mathjax-tex"&gt;\({{\mathcal{U}}}^{{\prime} }\)&lt;/span&gt;. Next, a response prediction module &lt;i&gt;ƒ&lt;/i&gt;&lt;sub&gt;r&lt;/sub&gt; checks the goodness of the predicted set &lt;span class="mathjax-tex"&gt;\({{\mathcal{U}}}^{{\prime} }\)&lt;/span&gt;, that is, how effective intervening on variables in &lt;span class="mathjax-tex"&gt;\({{\mathcal{U}}}^{{\prime} }\)&lt;/span&gt; is to shift node states to the desired treated state &lt;b&gt;x&lt;/b&gt;&lt;sup&gt;t&lt;/sup&gt;.&lt;/p&gt;&lt;div id="Equa" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$(1)\,\,{{\bf{x}}}^{\rm{d}},{{\bf{x}}}^{\rm{t}}\mathop{\rightarrow}\limits^{ {f}_{\rm{p}}}\hat{{{\mathcal{U}}}^{{\prime} }}$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div id="Equb" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$(2)\,\,{{\bf{x}}}^{\rm{d}},\hat{{{\mathcal{U}}}^{{\prime} }}\mathop{\rightarrow}\limits^{ {f}_{\rm{r}}}\hat{{{\bf{x}}}^{\rm{t}}}.$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;h3 class="c-article__sub-heading" id="Sec16"&gt;Model optimization&lt;/h3&gt;&lt;p&gt;We optimize our response prediction module &lt;i&gt;ƒ&lt;/i&gt;&lt;sub&gt;r&lt;/sub&gt; using cross-entropy (CE) loss on known triplets of disease intervention &lt;span class="mathjax-tex"&gt;\(&amp;lt; {{\bf{x}}}^{\rm{h}},{\mathcal{U}},{{\bf{x}}}^{\rm{d}} &amp;gt;\)&lt;/span&gt; and treatment intervention &lt;span class="mathjax-tex"&gt;\(&amp;lt; {{\bf{x}}}^{\rm{d}},{{\mathcal{U}}}^{{\prime} },{{\bf{x}}}^{\rm{t}} &amp;gt;\)&lt;/span&gt;:&lt;/p&gt;&lt;div id="Equ6" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${{\mathcal{L}}}_{{f}_{\rm{r}}}={\rm{CE}}\left({{\bf{x}}}^{\rm{d}},\,{f}_{\rm{r}}({{\bf{x}}}^{\rm{h}},\,{\mathcal{U}})\right)+{\rm{CE}}\left({{\bf{x}}}^{\rm{t}},\,{f}_{\rm{r}}({{\bf{x}}}^{\rm{d}},\,{{\mathcal{U}}}^{{\prime} })\right).$$&lt;/span&gt;&lt;/p&gt;&lt;p class="c-article-equation__number"&gt;
                    (6)
                &lt;/p&gt;&lt;/div&gt;&lt;p&gt;We optimize our intervention discovery module &lt;i&gt;ƒ&lt;/i&gt;&lt;sub&gt;p&lt;/sub&gt; using a cycle loss, ensuring that the response to the predicted intervention set &lt;span class="mathjax-tex"&gt;\({{\mathcal{U}}}^{{\prime} }\)&lt;/span&gt; closely matches the desired treated state (the first part of equation (&lt;a data-track="click" data-track-label="link" data-track-action="equation anchor" href="/articles/s41551-025-01481-x#Equ7"&gt;7&lt;/a&gt;)). In addition, we provide a supervisory signal for predicting &lt;span class="mathjax-tex"&gt;\({{\mathcal{U}}}^{{\prime} }\)&lt;/span&gt; in the form of cross-entropy loss (the second part of equation (&lt;a data-track="click" data-track-label="link" data-track-action="equation anchor" href="/articles/s41551-025-01481-x#Equ7"&gt;7&lt;/a&gt;)). So, the total loss is defined as:&lt;/p&gt;&lt;div id="Equ7" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${{\mathcal{L}}}_{{f}_{\rm{p}}}={\rm{CE}}\left({{\bf{x}}}^{\rm{t}},\,{f}_{\rm{r}}({{\bf{x}}}^{\rm{d}},\,{f}_{\rm{p}}({{\bf{x}}}^{\rm{d}},\,{{\bf{x}}}^{\rm{t}}))\right)+{\rm{CE}}\left({{\mathcal{U}}}^{{\prime} },{f}_{\rm{p}}({{\bf{x}}}^{\rm{d}},\,{{\bf{x}}}^{\rm{t}})\right)\,\,({\rm{with}}\,{f}_{\rm{r}}\,{\rm{frozen}}).$$&lt;/span&gt;&lt;/p&gt;&lt;p class="c-article-equation__number"&gt;
                    (7)
                &lt;/p&gt;&lt;/div&gt;&lt;p&gt;We train &lt;i&gt;ƒ&lt;/i&gt;&lt;sub&gt;p&lt;/sub&gt; and &lt;i&gt;ƒ&lt;/i&gt;&lt;sub&gt;r&lt;/sub&gt; in parallel and implement early stopping separately (see ‘Experimental set-up’ for more details). Trained module &lt;i&gt;ƒ&lt;/i&gt;&lt;sub&gt;p&lt;/sub&gt; is then used to predict, for each diseased cell sample, which nodes should be perturbed (&lt;span class="mathjax-tex"&gt;\({{\mathcal{U}}}^{{\prime} }\)&lt;/span&gt;) to achieve a desired treated state (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41551-025-01481-x#Fig1"&gt;1a&lt;/a&gt;).&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec17"&gt;Response prediction module&lt;/h3&gt;&lt;p&gt;Our response prediction module &lt;i&gt;ƒ&lt;/i&gt;&lt;sub&gt;r&lt;/sub&gt; should learn to map pre-perturbagen node values to post-perturbagen node values through learning relationships between connected nodes (equivalent to learning structural equations in SCMs) and propagating the effects of perturbations downstream in the graph (analogous to the recursive nature of query computations in SCMs).&lt;/p&gt;&lt;p&gt;Given a disease intervention triplet &lt;span class="mathjax-tex"&gt;\(&amp;lt; {{\bf{x}}}^{\rm{h}},{\mathcal{U}},{{\bf{x}}}^{\rm{d}} &amp;gt;\)&lt;/span&gt;, we propose a neural model operating on a mutilated graph, &lt;span class="mathjax-tex"&gt;\({G}^{{\mathcal{U}}}\)&lt;/span&gt;, where the node attributes are the concatenation of &lt;b&gt;x&lt;/b&gt;&lt;sup&gt;h&lt;/sup&gt; and &lt;span class="mathjax-tex"&gt;\({{\bf{x}}}_{{\mathcal{U}}}^{{\prime} }\)&lt;/span&gt;, predicting diseased node values &lt;b&gt;x&lt;/b&gt;&lt;sup&gt;d&lt;/sup&gt;. The first element is its gene expression value &lt;span class="mathjax-tex"&gt;\({{\bf{x}}}_{i}^{\rm{h}}\)&lt;/span&gt; and the second is a perturbation flag, a binary label indicating whether a perturbation occurs at node &lt;i&gt;i&lt;/i&gt;. So, each node &lt;i&gt;i&lt;/i&gt; has a two-dimensional attribute vector &lt;span class="mathjax-tex"&gt;\({{\bf{d}}}_{i}=[{{\bf{x}}}_{i}^{\rm{h}}\,| | \,{{\bf{x}}}_{{\mathcal{U}}}^{{\prime} }]\)&lt;/span&gt;. In practice, we embed each node feature into a high-dimensional continuous space by assigning learnable embeddings to each node based on the value of each input feature dimension. Specifically, for each node, we use the binary perturbation flag to assign a &lt;i&gt;d&lt;/i&gt;-dimensional learnable embedding, which is different between nodes but shared across samples for each node. To embed the gene expression value &lt;span class="mathjax-tex"&gt;\({{\bf{x}}}_{i}^{\rm{h}}\in [0,1]\)&lt;/span&gt;, we first calculate thresholds using quantiles to assign the gene expression value into one of the &lt;i&gt;B&lt;/i&gt; bins. We use the bin index to assign a &lt;i&gt;d&lt;/i&gt;-dimensional learnable embedding, which is different between nodes but shared across samples for each node. To increase our model’s representation power, we concatenate a &lt;i&gt;d&lt;/i&gt;-dimensional positional embedding (a &lt;i&gt;d&lt;/i&gt;-dimensional vector initialized randomly following a normal distribution). Concatenating these three embeddings results in an input node representation of dimensionality 3&lt;i&gt;d&lt;/i&gt;. For each node &lt;span class="mathjax-tex"&gt;\(i\in {\mathcal{V}}\)&lt;/span&gt;, an embedding &lt;b&gt;z&lt;/b&gt;&lt;sub&gt;&lt;i&gt;i&lt;/i&gt;&lt;/sub&gt; is computed using a GNN operating on the node’s neighbours’ attributes. The most general formulation of a GNN layer is:&lt;/p&gt;&lt;div id="Equ8" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${{\bf{h}}}_{i}^{{\prime} }=\phi \left({{\bf{h}}}_{i},\mathop{\bigoplus }\limits_{j\in {{\mathcal{N}}}^{i}}\psi ({{\bf{h}}}_{i},{{\bf{h}}}_{j})\right),$$&lt;/span&gt;&lt;/p&gt;&lt;p class="c-article-equation__number"&gt;
                    (8)
                &lt;/p&gt;&lt;/div&gt;&lt;p&gt;where &lt;span class="mathjax-tex"&gt;\({{\bf{h}}}_{i}^{{\prime} }\)&lt;/span&gt; represents the updated information of node &lt;i&gt;i&lt;/i&gt;, and &lt;b&gt;h&lt;/b&gt;&lt;sub&gt;&lt;i&gt;i&lt;/i&gt;&lt;/sub&gt; represents the information of node &lt;i&gt;i&lt;/i&gt; in the previous layer, with embedded &lt;b&gt;d&lt;/b&gt;&lt;sub&gt;&lt;i&gt;i&lt;/i&gt;&lt;/sub&gt; being the input to the first layer. &lt;i&gt;ψ&lt;/i&gt; is a message function, &lt;span class="stix"&gt;⨁&lt;/span&gt; a permutation-invariant aggregate function, and &lt;i&gt;ϕ&lt;/i&gt; is an update function. We obtain an embedding &lt;b&gt;z&lt;/b&gt;&lt;sub&gt;&lt;i&gt;i&lt;/i&gt;&lt;/sub&gt; for node &lt;i&gt;i&lt;/i&gt; by stacking &lt;i&gt;K&lt;/i&gt; GNN layers. The node embedding &lt;span class="mathjax-tex"&gt;\({{\bf{z}}}_{i}\in {\mathbb{R}}\)&lt;/span&gt; is then passed to a multilayer feedforward neural network to obtain an estimate of the values of the post-perturbation nodes &lt;b&gt;x&lt;/b&gt;&lt;sup&gt;d&lt;/sup&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec18"&gt;Perturbation discovery module&lt;/h3&gt;&lt;p&gt;Our perturbagen prediction module &lt;i&gt;ƒ&lt;/i&gt;&lt;sub&gt;p&lt;/sub&gt; should learn the nodes in the graph that should be perturbed to shift the node states (attributes) from diseased &lt;b&gt;x&lt;/b&gt;&lt;sup&gt;d&lt;/sup&gt; to the desired treated state &lt;b&gt;x&lt;/b&gt;&lt;sup&gt;t&lt;/sup&gt;. Given a triplet &lt;span class="mathjax-tex"&gt;\(&amp;lt; {{\bf{x}}}^{\rm{d}},{{\mathcal{U}}}^{{\prime} },{{\bf{x}}}^{\rm{t}} &amp;gt;\)&lt;/span&gt;, we propose a neural model operating on graph &lt;span class="mathjax-tex"&gt;\({G}^{{{\mathcal{U}}}^{{\prime} }}\)&lt;/span&gt; with node features &lt;b&gt;x&lt;/b&gt;&lt;sup&gt;d&lt;/sup&gt; and &lt;b&gt;x&lt;/b&gt;&lt;sup&gt;t&lt;/sup&gt; that predicts a ranking for each node, where the top &lt;i&gt;P&lt;/i&gt; ranked nodes should be predicted as the nodes in &lt;span class="mathjax-tex"&gt;\({{\mathcal{U}}}^{{\prime} }\)&lt;/span&gt;. Each node &lt;i&gt;i&lt;/i&gt; has a two-dimensional attribute vector: &lt;span class="mathjax-tex"&gt;\({{\bf{d}}}_{i}=[{{\bf{x}}}_{i}^{\rm{d}}\,| | \,{{\bf{x}}}_{i}^{\rm{t}}]\)&lt;/span&gt;. In practice, we represent these binary features in a continuous space using the same approach as described for our response prediction module &lt;i&gt;ƒ&lt;/i&gt;&lt;sub&gt;r&lt;/sub&gt;.&lt;/p&gt;&lt;p&gt;For each node &lt;span class="mathjax-tex"&gt;\(i\in {\mathcal{V}}\)&lt;/span&gt;, an embedding &lt;b&gt;z&lt;/b&gt;&lt;sub&gt;&lt;i&gt;i&lt;/i&gt;&lt;/sub&gt; is computed using a GNN operating on the node’s neighbours’ attributes. We obtain an embedding &lt;b&gt;z&lt;/b&gt;&lt;sub&gt;&lt;i&gt;i&lt;/i&gt;&lt;/sub&gt; for node &lt;i&gt;i&lt;/i&gt; by stacking &lt;i&gt;K&lt;/i&gt; GNN layers. The node embedding &lt;span class="mathjax-tex"&gt;\({{\bf{z}}}_{i}\in {\mathbb{R}}\)&lt;/span&gt; is then passed to a multilayer feedforward neural network to predict a real-valued number for node &lt;i&gt;i&lt;/i&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec19"&gt;Model implementation and training&lt;/h3&gt;&lt;p&gt;We implement PDGrapher using PyTorch 1.10.1 (ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 69" title="Paszke, A. et al. Automatic differentiation in PyTorch. In Proc. NIPS Workshop on Autodiff (2017)." href="/articles/s41551-025-01481-x#ref-CR69" id="ref-link-section-d254919041e8426"&gt;69&lt;/a&gt;&lt;/sup&gt;) and the Torch Geometric 2.0.4 Library&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 70" title="Fey, M. &amp;amp; Lenssen, J. E. Fast graph representation learning with PyTorch Geometric. Preprint at 
                https://arxiv.org/abs/1903.02428
                
               (2019)." href="/articles/s41551-025-01481-x#ref-CR70" id="ref-link-section-d254919041e8430"&gt;70&lt;/a&gt;&lt;/sup&gt;. The implemented architecture yields a neural network with the following hyperparameters: number of GNN layers and number of prediction layers. We set the number of prediction layers to two and performed a grid search over the number of GNN layers (one to three layers). We train our model using a 5-fold cross-validation strategy and report PDGrapher’s performance resulting from the best-performing hyperparameter setting.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec20"&gt;Further details on statistical analysis&lt;/h3&gt;&lt;p&gt;We next outline the evaluation set-up, baseline models and statistical tests used to evaluate PDGrapher. We evaluate the performance of PDGrapher against the following existing methods:&lt;/p&gt;&lt;ul class="u-list-style-bullet"&gt;
                &lt;li&gt;
                  &lt;p&gt;Random reference: Given a sample &lt;span class="mathjax-tex"&gt;\({\mathtt{T}}= &amp;lt; {{\bf{x}}}^{\rm{d}},{{\mathcal{U}}}^{{\prime} },{{\bf{x}}}^{\rm{t}} &amp;gt;\)&lt;/span&gt;, the random reference baseline returns &lt;i&gt;N&lt;/i&gt; random genes as the prediction of target genes in &lt;span class="mathjax-tex"&gt;\({{\mathcal{U}}}^{{\prime} }\)&lt;/span&gt;, where &lt;i&gt;N&lt;/i&gt; is the number of genes in &lt;span class="mathjax-tex"&gt;\({{\mathcal{U}}}^{{\prime} }\)&lt;/span&gt;.&lt;/p&gt;
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;p&gt;Cancer genes: Given a sample &lt;span class="mathjax-tex"&gt;\({\mathtt{T}}= &amp;lt; {{\bf{x}}}^{\rm{d}},{{\mathcal{U}}}^{{\prime} },{{\bf{x}}}^{\rm{t}} &amp;gt;\)&lt;/span&gt;, the cancer genes baseline returns the top &lt;i&gt;N&lt;/i&gt; genes from an ordered list where the first &lt;i&gt;M&lt;/i&gt; genes are disease associated (cancer-driver genes). The remaining genes are ranked randomly, and &lt;i&gt;N&lt;/i&gt; is the number of genes in &lt;span class="mathjax-tex"&gt;\({{\mathcal{U}}}^{{\prime} }\)&lt;/span&gt;. The processing of cancer genes is described in ‘Disease-genes information’ in Supplementary Note &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41551-025-01481-x#MOESM1"&gt;3&lt;/a&gt;.&lt;/p&gt;
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;p&gt;Cancer drug targets: Given a sample &lt;span class="mathjax-tex"&gt;\({\mathtt{T}}= &amp;lt; {{\bf{x}}}^{\rm{d}},{{\mathcal{U}}}^{{\prime} },{{\bf{x}}}^{\rm{t}} &amp;gt;\)&lt;/span&gt;, the cancer targets baseline returns the top &lt;i&gt;N&lt;/i&gt; genes from an ordered list where the first &lt;i&gt;M&lt;/i&gt; genes are cancer drug targets and the remaining genes are ranked randomly, and &lt;i&gt;N&lt;/i&gt; is the number of genes in &lt;span class="mathjax-tex"&gt;\({{\mathcal{U}}}^{{\prime} }\)&lt;/span&gt;. The processing of drug target information is described in ‘Drug-targets information’ and ‘Cancer drug and target information’ in Supplementary Note &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41551-025-01481-x#MOESM1"&gt;3&lt;/a&gt;.&lt;/p&gt;
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;p&gt;Perturbed genes: Given a sample &lt;span class="mathjax-tex"&gt;\({\mathtt{T}}= &amp;lt; {{\bf{x}}}^{\rm{d}},{{\mathcal{U}}}^{{\prime} },{{\bf{x}}}^{\rm{t}} &amp;gt;\)&lt;/span&gt;, the perturbed genes baseline returns the top &lt;i&gt;N&lt;/i&gt; genes from an ordered list where the first &lt;i&gt;M&lt;/i&gt; genes are all perturbed genes in the training set and the remaining genes are ranked randomly, and &lt;i&gt;N&lt;/i&gt; is the number of genes in &lt;span class="mathjax-tex"&gt;\({{\mathcal{U}}}^{{\prime} }\)&lt;/span&gt;.&lt;/p&gt;
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;p&gt;scGen&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Lotfollahi, M., Wolf, F. A. &amp;amp; Theis, F. J. scGen predicts single-cell perturbation responses. Nat. Methods 16, 715–721 (2019)." href="/articles/s41551-025-01481-x#ref-CR22" id="ref-link-section-d254919041e8962"&gt;22&lt;/a&gt;&lt;/sup&gt;: scGen is a widely used gold-standard latent variable model for response prediction&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Heumos, L. et al. Best practices for single-cell analysis across modalities. Nat. Rev. Genet. 24, 550–572 (2023)." href="#ref-CR71" id="ref-link-section-d254919041e8966"&gt;71&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Gayoso, A. et al. A Python library for probabilistic analysis of single-cell omics data. Nat. Biotechnol. 40, 163–166 (2022)." href="#ref-CR72" id="ref-link-section-d254919041e8966_1"&gt;72&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Jovic, D. et al. Single-cell RNA sequencing technologies and applications: a brief overview. Clin. Transl. Med. 12, e694 (2022)." href="#ref-CR73" id="ref-link-section-d254919041e8966_2"&gt;73&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 74" title="Luecken, M. D. et al. Benchmarking atlas-level data integration in single-cell genomics. Nat. Methods 19, 41–50 (2021)." href="/articles/s41551-025-01481-x#ref-CR74" id="ref-link-section-d254919041e8969"&gt;74&lt;/a&gt;&lt;/sup&gt;. Given a set of observed cell types in control and perturbed states, scGen predicts the response of a new cell type to the perturbagen seen in training. To use scGen as a baseline, we first fit it to our LINCS gene expression data for each dataset type to predict response to perturbagens, training one model per perturbagen (chemical or genetic). Then, given a sample of paired diseased-treated cell line states, &lt;span class="mathjax-tex"&gt;\({\mathtt{T}}= &amp;lt; {{\bf{x}}}^{\rm{d}},{{\mathcal{U}}}^{{\prime} },{{\bf{x}}}^{\rm{t}} &amp;gt;\)&lt;/span&gt;, we compute the response of the cell line with gene expression &lt;span class="mathjax-tex"&gt;\({{\bf{x}}}^{{\rm{d}}^{{\prime} }}\)&lt;/span&gt; to all perturbagens. The predicted perturbagen is that whose predicted response is closest to &lt;b&gt;x&lt;/b&gt;&lt;sup&gt;t&lt;/sup&gt; in &lt;i&gt;R&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt; score, which quantifies the proportion of variance in treated state explained by the prediction. As scGen trains one model per perturbagen, it needs an exhaustively long training time for datasets with a large number of perturbagens, especially in the leave-cell-out setting. Therefore, we set the maximum training epochs to 100 and only conducted leave-cell-out tests for one split of data for scGen.&lt;/p&gt;
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;p&gt;Biolord&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 33" title="Piran, Z., Cohen, N., Hoshen, Y. &amp;amp; Nitzan, M. Disentanglement of single-cell data with biolord. Nat. Biotechnol. 42, 1678–1683 (2024)." href="/articles/s41551-025-01481-x#ref-CR33" id="ref-link-section-d254919041e9106"&gt;33&lt;/a&gt;&lt;/sup&gt;: Biolord can predict perturbagen response for both chemical and genetic datasets. We followed the official tutorial from the Biolord GitHub repository (&lt;a href="https://github.com/nitzanlab/biolord"&gt;https://github.com/nitzanlab/biolord&lt;/a&gt;), using the recommended parameters. To prevent memory and quota errors, we implemented two filtering steps: (1) instead of storing the entire response gene expression (rGEX) matrix of all input (control) cells for each perturbagen, we only store a vector of the averaged rGEX of the input cells per perturbagen, which is necessary for calculating &lt;i&gt;R&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt; for evaluation; and (2) during prediction, if the number of control cells exceeds 10,000, we randomly downsample the control cells to 10,000. Similar to scGen, we predict the responses gene expression &lt;span class="mathjax-tex"&gt;\({{\bf{x}}}^{{\rm{d}}^{{\prime} }}\)&lt;/span&gt; for all perturbagens and use them to calculate &lt;i&gt;R&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt; to get the rank of predicted perturbagens.&lt;/p&gt;
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;p&gt;ChemCPA&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Hetzel, L. et al. Predicting cellular responses to novel drug perturbations at a single-cell resolution. Adv. Neural Inf. Process. Syst. 35, 26711–26722 (2022)." href="/articles/s41551-025-01481-x#ref-CR23" id="ref-link-section-d254919041e9173"&gt;23&lt;/a&gt;&lt;/sup&gt;: ChemCPA is specifically designed for chemical perturbation. We followed the official tutorials on GitHub for running this model (&lt;a href="https://github.com/theislab/chemCPA"&gt;https://github.com/theislab/chemCPA&lt;/a&gt;), with all parameters set following the authors’ recommendations. Data processing was also conducted using the provided scripts. We constructed drug embedding using RDKit with canonical SMILES sequences, as this is the default setting in the model and the tutorial. As the original ChemCPA model lacks functionality to obtain the predicted rGEX for each drug (averaging over the dosages), we developed a custom script to perform this task. These predictions, &lt;span class="mathjax-tex"&gt;\({{\bf{x}}}^{{\rm{d}}^{{\prime} }}\)&lt;/span&gt;, were subsequently used for calculating &lt;i&gt;R&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt; to get the rank of predicted perturbagens.&lt;/p&gt;
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;p&gt;GEARS&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 34" title="Roohani, Y., Huang, K. &amp;amp; Leskovec, J. Predicting transcriptional outcomes of novel multigene perturbations with gears. Nat. Biotechnol. 42, 927–935 (2024)." href="/articles/s41551-025-01481-x#ref-CR34" id="ref-link-section-d254919041e9235"&gt;34&lt;/a&gt;&lt;/sup&gt;: GEARS is capable of predicting perturbagen responses for genetic perturbation datasets, specifically for predicting the rGEX to unseen perturbagens. However, it is limited to predicting only those genes that are present in the gene network used as prior knowledge for model training. In addition, GEARS cannot process perturbagens with only one sample, so we filtered the data accordingly. We followed the official tutorial from the GEARS GitHub repository (&lt;a href="https://github.com/snap-stanford/GEARS"&gt;https://github.com/snap-stanford/GEARS&lt;/a&gt;), using the recommended parameters. After confirming with the authors, we established that GEARS is suitable only for within-cell-line prediction. Consequently, our experiments with GEARS were conducted exclusively within this scenario.&lt;/p&gt;
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;p&gt;CellOT&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Bunne, C. et al. Learning single-cell perturbation responses using neural optimal transport. Nat. Methods 20, 1759–1768 (2023)." href="/articles/s41551-025-01481-x#ref-CR27" id="ref-link-section-d254919041e9252"&gt;27&lt;/a&gt;&lt;/sup&gt;: CellOT is capable of working with both chemical and genetic datasets. We ran this model by following the official tutorial from GitHub (&lt;a href="https://github.com/bunnech/cellot"&gt;https://github.com/bunnech/cellot&lt;/a&gt;), ensuring that all parameters were set according to the provided guidelines. Due to CellOT’s limitation in processing perturbagens with small sample sizes, we filtered the data to retain only those perturbagens with more than five samples or cells. We then used the predicted rGEX &lt;span class="mathjax-tex"&gt;\({{\bf{x}}}^{{\rm{d}}^{{\prime} }}\)&lt;/span&gt; to calculate &lt;i&gt;R&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt; and the predicted perturbagen ranks. Similar to scGen, CellOT trains one model per perturbagen, which results in an exhaustively long training time for datasets with a large number of perturbagens. This issue becomes even more pronounced when doing leave-cell-out evaluations. Therefore, for this method, we set the maximum training epochs to 100 and only conduct one split in leave-cell-out tests.&lt;/p&gt;
                &lt;/li&gt;
              &lt;/ul&gt;&lt;h3 class="c-article__sub-heading" id="Sec21"&gt;Dataset splits and evaluation settings&lt;/h3&gt;&lt;p&gt;We evaluate PDGrapher and competing methods on two different settings.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec22"&gt;Systematic random dataset splits&lt;/h4&gt;&lt;p&gt;For each cell line, the dataset is split randomly into train and test sets to measure our model performance in an independent and identically distributed setting.&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec23"&gt;Leave-cell-out dataset splits&lt;/h4&gt;&lt;p&gt;To measure model performance on unseen cell lines, we train our model with random splits on one cell line and test on a new cell line. Specifically, for chemical perturbation data, we train a model for each random split per cell line and test it on the entire dataset of the remaining eight cell lines. For genetic data, we train a model for each random split per cell line and test it on the entire dataset of the remaining nine cell lines. For example, with nine cell lines with chemical perturbation (A549, MDAMB231, BT20, VCAP, MCF7, PC3, A375, HT29 and HELA), we conducted an experiment where each split of cell line A549 was used as the training set, and the trained model was tested on the remaining eight cell lines (MDAMB231, BT20, VCAP, MCF7, PC3, A375, HT29 and HELA). Similarly, for cell line MDAMB231, we trained the model on each split of it and tested the model on the other eight cell lines (A549, BT20, VCAP, MCF7, PC3, A375, HT29 and HELA). This process was repeated for all cell lines, providing a comprehensive evaluation of PDGrapher and all competing methods.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec24"&gt;Evaluation set-up&lt;/h3&gt;&lt;p&gt;For all dataset split settings, our model is trained using 5-fold cross-validation, and metrics are reported as the average on the test set. Within each fold, we further split the training set into training and validation sets (8:2) to perform early stopping. We train the model on the training set until the validation loss has not decreased at least 10&lt;sup&gt;−&lt;/sup&gt;&lt;sup&gt;5&lt;/sup&gt; for 15 continuous epochs.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec25"&gt;Evaluation metrics&lt;/h3&gt;&lt;p&gt;We report average sample-wise &lt;i&gt;R&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt; score and average perturbagen-wise &lt;i&gt;R&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt; score to measure performance in the prediction of &lt;b&gt;x&lt;/b&gt;&lt;sup&gt;t&lt;/sup&gt;. The sample-wise &lt;i&gt;R&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt; score is computed as the square of the Pearson correlation between the predicted sample &lt;span class="mathjax-tex"&gt;\({\hat{{\bf{x}}}}^{\rm{t}}\in {{\mathbb{R}}}^{N}\)&lt;/span&gt; and real sample &lt;span class="mathjax-tex"&gt;\({{\bf{x}}}^{\rm{t}}\in {{\mathbb{R}}}^{N}\)&lt;/span&gt;. The perturbagen-wise &lt;i&gt;R&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt; score is adopted from scGen. It is computed as the square of the Pearson correlation of a linear least-squares regression between a set of predicted treated samples &lt;span class="mathjax-tex"&gt;\({\hat{{\bf{X}}}}^{\rm{t}}\in {{\mathbb{R}}}^{N\times S}\)&lt;/span&gt; and a set of real treated samples &lt;span class="mathjax-tex"&gt;\({{\bf{X}}}^{\rm{t}}\in {{\mathbb{R}}}^{N\times S}\)&lt;/span&gt; for the same perturbagen. Here, &lt;i&gt;S&lt;/i&gt; indicates the size of the sets. Higher values indicate better performance in predicting the treated sample &lt;b&gt;x&lt;/b&gt;&lt;sup&gt;t&lt;/sup&gt; given the diseased sample &lt;b&gt;x&lt;/b&gt;&lt;sup&gt;d&lt;/sup&gt; and predicted perturbagen. This is used for evaluating the performance of response prediction. For evaluating perturbagen discovery, when the competing methods cannot predict perturbagen ranks for chemical perturbation data, we first calculate the rank of drugs based on the &lt;i&gt;R&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt; score. We then build a target gene rank from the drug rank by substituting the drugs with their target genes acquired from DrugBank&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 75" title="Wishart, D. S. et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074–D1082 (2018)." href="/articles/s41551-025-01481-x#ref-CR75" id="ref-link-section-d254919041e9618"&gt;75&lt;/a&gt;&lt;/sup&gt; (accessed in November 2022; see details in Supplementary Note &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41551-025-01481-x#MOESM1"&gt;3&lt;/a&gt;). A single drug can have multiple target genes, which we place in the rank in random order. As some methods cannot predict unseen drugs, their predicted target gene lists are often short, introducing bias in evaluation. To address this, we shuffle the missing target genes and attach them to the predicted ranks to create a complete rank. For genetic perturbation data, we directly obtain the target gene rank from the results and then attach the shuffled missing genes to the rank.&lt;/p&gt;&lt;p&gt;To evaluate the performance of our model in ranking predicted therapeutic targets, we use the nDCG, a widely used metric in information retrieval adapted for our setting. The raw DCG score is computed by summing the relevance of each correct target based on its rank in the predicted list, with relevance weighted by a logarithmic discount factor to prioritize higher-ranked interventions. The gain function is defined as 1 − ranking/&lt;i&gt;N&lt;/i&gt;, ensuring that the score reflects the quality of the ranking relative to the total number of nodes in the system. To ensure comparability across datasets or experiments with different numbers of correct interventions, DCG is normalized by the ideal DCG, which represents the maximum possible score for a perfect ranking. This results in nDCG values in the range [0, 1], where higher values indicate better ranking performance and alignment with the ground truth. This metric is particularly suited for our task as it emphasizes the accuracy of top-ranked interventions while accounting for the diminishing importance of lower-ranked predictions.&lt;/p&gt;&lt;p&gt;In addition, we report the proportion of test samples for which the predicted therapeutic targets set has at least one overlapping gene with the ground-truth therapeutic targets set (denoted as the percentage of accurately predicted samples). We also calculated the ratio of correct therapeutic targets that appeared in the top 1, top 10 and top 100 predicted therapeutic targets in the predicted rank, denoted as recall@1, recall@10 and recall@100, respectively.&lt;/p&gt;&lt;p&gt;To assess the overall performance across all experiments and metrics, we calculated an aggregated metric, averaging all metric values for each method.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec26"&gt;Statistical tests&lt;/h3&gt;&lt;p&gt;In the benchmarking experiments, we performed a one-tailed pairwise &lt;i&gt;t&lt;/i&gt;-test to evaluate whether PDGrapher significantly outperforms the competing methods. For other experiments, such as ablation studies, we used a two-tailed &lt;i&gt;t&lt;/i&gt;-test to determine whether there is a significant difference in performance between the two models. A significance threshold of 0.05 was used for all tests. &lt;i&gt;P&lt;/i&gt; values of perturbagen discovery and response prediction tests are presented in the &lt;a data-track="click" data-track-label="link" data-track-action="section anchor" href="/articles/s41551-025-01481-x#Sec34"&gt;Source data&lt;/a&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec27"&gt;Ablation studies&lt;/h3&gt;&lt;p&gt;In the ablation study, we evaluated PDGrapher by optimizing it with only the supervision loss (PDGrapher-Super) and with only the cycle loss (PDGrapher-Cycle) across all chemical datasets. We then compared the perturbagen prediction performance of these submodels with that of PDGrapher (PDGrapher-SuperCycle). To train PDGrapher-Super and PDGrapher-Cycle, for each cell line, we set the number of layers to that which was found optimal for the validation set in the random splitting setting for PDGrapher-SuperCycle.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec28"&gt;Sensitivity studies&lt;/h3&gt;&lt;p&gt;To test the sensitivity of PDGrapher on PPI networks, we used data from STRING (&lt;a href="https://string-db.org/"&gt;string-db.org&lt;/a&gt;), which provides a confidence score for each edge. The method for acquiring and preprocessing the PPI networks from STRING is detailed in Supplementary Note &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41551-025-01481-x#MOESM1"&gt;3&lt;/a&gt;. For the sensitivity tests, we selected two cell lines: the chemical dataset MDAMB231 and the genetic dataset MCF7. For each cell line, we processed the data using the five PPI networks described in Supplementary Note &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41551-025-01481-x#MOESM1"&gt;3&lt;/a&gt;. We optimized PDGrapher using 5-fold cross-validation as described in ‘Evaluation set-up’ and optimized the number of GNN layers using the validation set in each split.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec29"&gt;Synthetic datasets&lt;/h3&gt;&lt;p&gt;We generated three synthetic datasets:&lt;/p&gt;&lt;ol class="u-list-style-none"&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;1.&lt;/span&gt;
                  
                    &lt;p&gt;Dataset with missing components removing bridge edges: this dataset is generated by progressively removing bridge edges from the existing PPI network. Bridge edges are those whose removal disconnects parts of the network. We vary the fraction of bridge edges removed in increments (from zero to one) and, for each fraction, we create a new edge list representing the modified network (Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41551-025-01481-x#MOESM1"&gt;5&lt;/a&gt;). This process ensures that different levels of network sparsity are introduced, affecting the overall structure and connectivity. We pair these networks with gene expression data from chemical-PPI-breast-MDAMB231.&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;2.&lt;/span&gt;
                  
                    &lt;p&gt;Dataset with missing components removing random edges: this dataset is generated by progressively removing random edges from the existing PPI network. We vary the fraction of bridge edges removed in increments ([0, 0.1, … 0.6]) and, for each fraction, we create a new edge list representing the modified network. The number of remaining directed edges in the network upon random edge removal are 273,319, 242,912, 212,525, 182,177, 151,811 and 121,472.&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;3.&lt;/span&gt;
                  
                    &lt;p&gt;Dataset with latent confounder noise: our starting point is the chemical-PPI-breast-MDAMB231 dataset. The synthetic datasets were constructed with varying levels of confounding bias introduced into the gene expression data. To simulate latent confounder effects, Gaussian noise with distinct means and variances was progressively added to random subsets of genes. Genes were grouped into 50 predefined subsets, each representing a latent confounder group. For each group, a Gaussian distribution was defined, with the mean drawn randomly from a uniform distribution in the range [0.5, 0.5] and the standard deviation [0.1, 0.5]. A fraction ([0.2, 0.4, 0.6, 0.8, 1]) of these subsets was randomly selected for perturbation and, for each gene in these subsets, its expression value was incremented by a value sampled from the respective Gaussian distribution. The perturbed gene expression values were then clamped between zero and one to ensure validity. This strategy ensures that different latent biases are introduced globally to gene expression patterns while maintaining controlled variability. We pair the noisy version of the gene expression data with the global unperturbed PPI network.&lt;/p&gt;
                  
                &lt;/li&gt;
              &lt;/ol&gt;&lt;h3 class="c-article__sub-heading" id="Sec30"&gt;Network proximity between predicted and true perturbagens&lt;/h3&gt;&lt;p&gt;Let &lt;span class="mathjax-tex"&gt;\({\mathcal{P}}\)&lt;/span&gt; be the set of predicted therapeutic targets, &lt;span class="mathjax-tex"&gt;\({\mathcal{R}}\)&lt;/span&gt; be the set of ground-truth therapeutic targets, and spd(&lt;i&gt;p&lt;/i&gt;, &lt;i&gt;r&lt;/i&gt;) be the shortest-path distance between nodes in &lt;span class="mathjax-tex"&gt;\({\mathcal{P}}\)&lt;/span&gt; and &lt;span class="mathjax-tex"&gt;\({\mathcal{R}}\)&lt;/span&gt;. We measure the closest distance between &lt;span class="mathjax-tex"&gt;\({\mathcal{P}}\)&lt;/span&gt; and &lt;span class="mathjax-tex"&gt;\({\mathcal{R}}\)&lt;/span&gt; as:&lt;/p&gt;&lt;div id="Equ9" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$d({\mathcal{P}},{\mathcal{R}})=\frac{1}{| {\mathcal{R}}| | {\mathcal{P}}| }\sum _{r\in {\mathcal{R}}}\sum _{p\in {\mathcal{P}}}{\rm{spd}}(p,r).$$&lt;/span&gt;&lt;/p&gt;&lt;p class="c-article-equation__number"&gt;
                    (9)
                &lt;/p&gt;&lt;/div&gt;&lt;p&gt;As part of our performance analyses, we measure the network proximity of PDGrapher and competing methods. We compared the distributions of network proximity values using a Mann–Whitney &lt;i&gt;U&lt;/i&gt;-test, along with a rank-biserial correlation to measure effect size. To assess the uncertainty of effect sizes, we performed bootstrapping with 1,000 resamples to estimate 95% CIs.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec31"&gt;Reporting summary&lt;/h3&gt;&lt;p&gt;Further information on research design is available in the &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41551-025-01481-x#MOESM2"&gt;Nature Portfolio Reporting Summary&lt;/a&gt; linked to this article.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Tue, 09 Sep 2025 09:39:47 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTFBwaHlsM3k0cmYyYlFXeTFjc3NsbmtmUXU0VGlFWUttMGhmQ1Z4UGFDVFQ5RzZqNENGaXdxM0dhd1k5bTFyMDg4MHoxMjhobktyV0Q5cDNZcnlfLUFRODUw</guid></item><item><title>瞄准NAD的新兴战略、应用和挑战-自然</title><link>https://www.nature.com/articles/s43587-025-00947-6</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;ol class="c-article-references" data-track-component="outbound reference" data-track-context="references section"&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="1."&gt;&lt;p class="c-article-references__text" id="ref-CR1"&gt;Navas, L. E. &amp;amp; Carnero, A. NAD&lt;sup&gt;+&lt;/sup&gt; metabolism, stemness, the immune response, and cancer. &lt;i&gt;Signal Transduct. Target. Ther.&lt;/i&gt; &lt;b&gt;6&lt;/b&gt;, 2 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41392-020-00354-w" data-track-item_id="10.1038/s41392-020-00354-w" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41392-020-00354-w" aria-label="Article reference 1" data-doi="10.1038/s41392-020-00354-w"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXis1KjsLk%3D" aria-label="CAS reference 1"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33384409" aria-label="PubMed reference 1"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775471" aria-label="PubMed Central reference 1"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 1" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20metabolism%2C%20stemness%2C%20the%20immune%20response%2C%20and%20cancer&amp;amp;journal=Signal%20Transduct.%20Target.%20Ther.&amp;amp;doi=10.1038%2Fs41392-020-00354-w&amp;amp;volume=6&amp;amp;publication_year=2021&amp;amp;author=Navas%2CLE&amp;amp;author=Carnero%2CA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="2."&gt;&lt;p class="c-article-references__text" id="ref-CR2"&gt;Xiao, W., Wang, R. S., Handy, D. E. &amp;amp; Loscalzo, J. NAD(H) and NADP(H) redox couples and cellular energy metabolism. &lt;i&gt;Antioxid. Redox Signal.&lt;/i&gt; &lt;b&gt;28&lt;/b&gt;, 251–272 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1089/ars.2017.7216" data-track-item_id="10.1089/ars.2017.7216" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1089%2Fars.2017.7216" aria-label="Article reference 2" data-doi="10.1089/ars.2017.7216"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXitVWgtbbK" aria-label="CAS reference 2"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=28648096" aria-label="PubMed reference 2"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737637" aria-label="PubMed Central reference 2"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%28H%29%20and%20NADP%28H%29%20redox%20couples%20and%20cellular%20energy%20metabolism&amp;amp;journal=Antioxid.%20Redox%20Signal.&amp;amp;doi=10.1089%2Fars.2017.7216&amp;amp;volume=28&amp;amp;pages=251-272&amp;amp;publication_year=2018&amp;amp;author=Xiao%2CW&amp;amp;author=Wang%2CRS&amp;amp;author=Handy%2CDE&amp;amp;author=Loscalzo%2CJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="3."&gt;&lt;p class="c-article-references__text" id="ref-CR3"&gt;Braidy, N. et al. Role of nicotinamide adenine dinucleotide and related precursors as therapeutic targets for age-related degenerative diseases: rationale, biochemistry, pharmacokinetics, and outcomes. &lt;i&gt;Antioxid. Redox Signal.&lt;/i&gt; &lt;b&gt;30&lt;/b&gt;, 251–294 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1089/ars.2017.7269" data-track-item_id="10.1089/ars.2017.7269" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1089%2Fars.2017.7269" aria-label="Article reference 3" data-doi="10.1089/ars.2017.7269"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXitlyit77O" aria-label="CAS reference 3"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29634344" aria-label="PubMed reference 3"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 3" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Role%20of%20nicotinamide%20adenine%20dinucleotide%20and%20related%20precursors%20as%20therapeutic%20targets%20for%20age-related%20degenerative%20diseases%3A%20rationale%2C%20biochemistry%2C%20pharmacokinetics%2C%20and%20outcomes&amp;amp;journal=Antioxid.%20Redox%20Signal.&amp;amp;doi=10.1089%2Fars.2017.7269&amp;amp;volume=30&amp;amp;pages=251-294&amp;amp;publication_year=2019&amp;amp;author=Braidy%2CN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="4."&gt;&lt;p class="c-article-references__text" id="ref-CR4"&gt;Verdin, E. NAD&lt;sup&gt;+&lt;/sup&gt; in aging, metabolism, and neurodegeneration. &lt;i&gt;Science&lt;/i&gt; &lt;b&gt;350&lt;/b&gt;, 1208–1213 (2015).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.aac4854" data-track-item_id="10.1126/science.aac4854" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.aac4854" aria-label="Article reference 4" data-doi="10.1126/science.aac4854"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXhvFamtb%2FK" aria-label="CAS reference 4"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26785480" aria-label="PubMed reference 4"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20in%20aging%2C%20metabolism%2C%20and%20neurodegeneration&amp;amp;journal=Science&amp;amp;doi=10.1126%2Fscience.aac4854&amp;amp;volume=350&amp;amp;pages=1208-1213&amp;amp;publication_year=2015&amp;amp;author=Verdin%2CE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="5."&gt;&lt;p class="c-article-references__text" id="ref-CR5"&gt;Covarrubias, A. J., Perrone, R., Grozio, A. &amp;amp; Verdin, E. NAD&lt;sup&gt;+&lt;/sup&gt; metabolism and its roles in cellular processes during ageing. &lt;i&gt;Nat. Rev. Mol. Cell Biol.&lt;/i&gt; &lt;b&gt;22&lt;/b&gt;, 119–141 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41580-020-00313-x" data-track-item_id="10.1038/s41580-020-00313-x" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41580-020-00313-x" aria-label="Article reference 5" data-doi="10.1038/s41580-020-00313-x"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXis1yhu7vO" aria-label="CAS reference 5"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33353981" aria-label="PubMed reference 5"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20metabolism%20and%20its%20roles%20in%20cellular%20processes%20during%20ageing&amp;amp;journal=Nat.%20Rev.%20Mol.%20Cell%20Biol.&amp;amp;doi=10.1038%2Fs41580-020-00313-x&amp;amp;volume=22&amp;amp;pages=119-141&amp;amp;publication_year=2021&amp;amp;author=Covarrubias%2CAJ&amp;amp;author=Perrone%2CR&amp;amp;author=Grozio%2CA&amp;amp;author=Verdin%2CE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="6."&gt;&lt;p class="c-article-references__text" id="ref-CR6"&gt;Lautrup, S., Sinclair, D. A., Mattson, M. P. &amp;amp; Fang, E. F. NAD&lt;sup&gt;+&lt;/sup&gt; in brain aging and neurodegenerative disorders. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;b&gt;30&lt;/b&gt;, 630–655 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2019.09.001" data-track-item_id="10.1016/j.cmet.2019.09.001" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2019.09.001" aria-label="Article reference 6" data-doi="10.1016/j.cmet.2019.09.001"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXhvFSqtrvI" aria-label="CAS reference 6"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31577933" aria-label="PubMed reference 6"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787556" aria-label="PubMed Central reference 6"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20in%20brain%20aging%20and%20neurodegenerative%20disorders&amp;amp;journal=Cell%20Metab.&amp;amp;doi=10.1016%2Fj.cmet.2019.09.001&amp;amp;volume=30&amp;amp;pages=630-655&amp;amp;publication_year=2019&amp;amp;author=Lautrup%2CS&amp;amp;author=Sinclair%2CDA&amp;amp;author=Mattson%2CMP&amp;amp;author=Fang%2CEF"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="7."&gt;&lt;p class="c-article-references__text" id="ref-CR7"&gt;Zhu, Y., Liu, J., Park, J., Rai, P. &amp;amp; Zhai, R. G. Subcellular compartmentalization of NAD&lt;sup&gt;+&lt;/sup&gt; and its role in cancer: a sereNADe of metabolic melodies. &lt;i&gt;Pharmacol. Ther.&lt;/i&gt; &lt;b&gt;200&lt;/b&gt;, 27–41 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.pharmthera.2019.04.002" data-track-item_id="10.1016/j.pharmthera.2019.04.002" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.pharmthera.2019.04.002" aria-label="Article reference 7" data-doi="10.1016/j.pharmthera.2019.04.002"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXnsFGnsbk%3D" aria-label="CAS reference 7"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30974124" aria-label="PubMed reference 7"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010080" aria-label="PubMed Central reference 7"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Subcellular%20compartmentalization%20of%20NAD%2B%20and%20its%20role%20in%20cancer%3A%20a%20sereNADe%20of%20metabolic%20melodies&amp;amp;journal=Pharmacol.%20Ther.&amp;amp;doi=10.1016%2Fj.pharmthera.2019.04.002&amp;amp;volume=200&amp;amp;pages=27-41&amp;amp;publication_year=2019&amp;amp;author=Zhu%2CY&amp;amp;author=Liu%2CJ&amp;amp;author=Park%2CJ&amp;amp;author=Rai%2CP&amp;amp;author=Zhai%2CRG"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="8."&gt;&lt;p class="c-article-references__text" id="ref-CR8"&gt;Canto, C., Menzies, K. J. &amp;amp; Auwerx, J. NAD&lt;sup&gt;+&lt;/sup&gt; metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;b&gt;22&lt;/b&gt;, 31–53 (2015).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2015.05.023" data-track-item_id="10.1016/j.cmet.2015.05.023" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2015.05.023" aria-label="Article reference 8" data-doi="10.1016/j.cmet.2015.05.023"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXhtV2lsL3N" aria-label="CAS reference 8"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26118927" aria-label="PubMed reference 8"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487780" aria-label="PubMed Central reference 8"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20metabolism%20and%20the%20control%20of%20energy%20homeostasis%3A%20a%20balancing%20act%20between%20mitochondria%20and%20the%20nucleus&amp;amp;journal=Cell%20Metab.&amp;amp;doi=10.1016%2Fj.cmet.2015.05.023&amp;amp;volume=22&amp;amp;pages=31-53&amp;amp;publication_year=2015&amp;amp;author=Canto%2CC&amp;amp;author=Menzies%2CKJ&amp;amp;author=Auwerx%2CJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="9."&gt;&lt;p class="c-article-references__text" id="ref-CR9"&gt;Stein, L. R. &amp;amp; Imai, S. The dynamic regulation of NAD metabolism in mitochondria. &lt;i&gt;Trends Endocrinol. Metab.&lt;/i&gt; &lt;b&gt;23&lt;/b&gt;, 420–428 (2012).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.tem.2012.06.005" data-track-item_id="10.1016/j.tem.2012.06.005" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.tem.2012.06.005" aria-label="Article reference 9" data-doi="10.1016/j.tem.2012.06.005"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC38XhtVOqtb%2FN" aria-label="CAS reference 9"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=22819213" aria-label="PubMed reference 9"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683958" aria-label="PubMed Central reference 9"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 9" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20dynamic%20regulation%20of%20NAD%20metabolism%20in%20mitochondria&amp;amp;journal=Trends%20Endocrinol.%20Metab.&amp;amp;doi=10.1016%2Fj.tem.2012.06.005&amp;amp;volume=23&amp;amp;pages=420-428&amp;amp;publication_year=2012&amp;amp;author=Stein%2CLR&amp;amp;author=Imai%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="10."&gt;&lt;p class="c-article-references__text" id="ref-CR10"&gt;Lautrup, S. et al. Decreased mitochondrial NAD&lt;sup&gt;+&lt;/sup&gt; in WRN deficient cells links to dysfunctional proliferation. &lt;i&gt;Aging&lt;/i&gt; &lt;b&gt;17&lt;/b&gt;, 937–959 (2025).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2MXht1yktr3K" aria-label="CAS reference 10"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=40179319" aria-label="PubMed reference 10"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12074813" aria-label="PubMed Central reference 10"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 10" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Decreased%20mitochondrial%20NAD%2B%20in%20WRN%20deficient%20cells%20links%20to%20dysfunctional%20proliferation&amp;amp;journal=Aging&amp;amp;volume=17&amp;amp;pages=937-959&amp;amp;publication_year=2025&amp;amp;author=Lautrup%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="11."&gt;&lt;p class="c-article-references__text" id="ref-CR11"&gt;Amjad, S. et al. Role of NAD&lt;sup&gt;+&lt;/sup&gt; in regulating cellular and metabolic signaling pathways. &lt;i&gt;Mol. Metab.&lt;/i&gt; &lt;b&gt;49&lt;/b&gt;, 101195 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.molmet.2021.101195" data-track-item_id="10.1016/j.molmet.2021.101195" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.molmet.2021.101195" aria-label="Article reference 11" data-doi="10.1016/j.molmet.2021.101195"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXmtFWnsr8%3D" aria-label="CAS reference 11"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33609766" aria-label="PubMed reference 11"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973386" aria-label="PubMed Central reference 11"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Role%20of%20NAD%2B%20in%20regulating%20cellular%20and%20metabolic%20signaling%20pathways&amp;amp;journal=Mol.%20Metab.&amp;amp;doi=10.1016%2Fj.molmet.2021.101195&amp;amp;volume=49&amp;amp;publication_year=2021&amp;amp;author=Amjad%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="12."&gt;&lt;p class="c-article-references__text" id="ref-CR12"&gt;Xie, N. et al. NAD&lt;sup&gt;+&lt;/sup&gt; metabolism: pathophysiologic mechanisms and therapeutic potential. &lt;i&gt;Signal Transduct. Target. Ther.&lt;/i&gt; &lt;b&gt;5&lt;/b&gt;, 227 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41392-020-00311-7" data-track-item_id="10.1038/s41392-020-00311-7" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41392-020-00311-7" aria-label="Article reference 12" data-doi="10.1038/s41392-020-00311-7"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXitVCmtLbI" aria-label="CAS reference 12"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33028824" aria-label="PubMed reference 12"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539288" aria-label="PubMed Central reference 12"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20metabolism%3A%20pathophysiologic%20mechanisms%20and%20therapeutic%20potential&amp;amp;journal=Signal%20Transduct.%20Target.%20Ther.&amp;amp;doi=10.1038%2Fs41392-020-00311-7&amp;amp;volume=5&amp;amp;publication_year=2020&amp;amp;author=Xie%2CN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="13."&gt;&lt;p class="c-article-references__text" id="ref-CR13"&gt;Janssens, G. E. et al. Healthy aging and muscle function are positively associated with NAD&lt;sup&gt;+&lt;/sup&gt; abundance in humans. &lt;i&gt;Nat. Aging&lt;/i&gt; &lt;b&gt;2&lt;/b&gt;, 254–263 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s43587-022-00174-3" data-track-item_id="10.1038/s43587-022-00174-3" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs43587-022-00174-3" aria-label="Article reference 13" data-doi="10.1038/s43587-022-00174-3"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXmtFSltr8%3D" aria-label="CAS reference 13"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37118369" aria-label="PubMed reference 13"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Healthy%20aging%20and%20muscle%20function%20are%20positively%20associated%20with%20NAD%2B%20abundance%20in%20humans&amp;amp;journal=Nat.%20Aging&amp;amp;doi=10.1038%2Fs43587-022-00174-3&amp;amp;volume=2&amp;amp;pages=254-263&amp;amp;publication_year=2022&amp;amp;author=Janssens%2CGE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="14."&gt;&lt;p class="c-article-references__text" id="ref-CR14"&gt;Basse, A. L. et al. NAMPT-dependent NAD&lt;sup&gt;+&lt;/sup&gt; biosynthesis controls circadian metabolism in a tissue-specific manner. &lt;i&gt;Proc. Natl Acad. Sci. USA&lt;/i&gt; &lt;b&gt;120&lt;/b&gt;, e2220102120 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1073/pnas.2220102120" data-track-item_id="10.1073/pnas.2220102120" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1073%2Fpnas.2220102120" aria-label="Article reference 14" data-doi="10.1073/pnas.2220102120"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXot1KgtbY%3D" aria-label="CAS reference 14"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36996103" aria-label="PubMed reference 14"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083581" aria-label="PubMed Central reference 14"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAMPT-dependent%20NAD%2B%20biosynthesis%20controls%20circadian%20metabolism%20in%20a%20tissue-specific%20manner&amp;amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;amp;doi=10.1073%2Fpnas.2220102120&amp;amp;volume=120&amp;amp;publication_year=2023&amp;amp;author=Basse%2CAL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="15."&gt;&lt;p class="c-article-references__text" id="ref-CR15"&gt;Bonkowski, M. S. &amp;amp; Sinclair, D. A. Slowing ageing by design: the rise of NAD&lt;sup&gt;+&lt;/sup&gt; and sirtuin-activating compounds. &lt;i&gt;Nat. Rev. Mol. Cell Biol.&lt;/i&gt; &lt;b&gt;17&lt;/b&gt;, 679–690 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nrm.2016.93" data-track-item_id="10.1038/nrm.2016.93" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnrm.2016.93" aria-label="Article reference 15" data-doi="10.1038/nrm.2016.93"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28Xhtl2lsrrK" aria-label="CAS reference 15"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27552971" aria-label="PubMed reference 15"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107309" aria-label="PubMed Central reference 15"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 15" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Slowing%20ageing%20by%20design%3A%20the%20rise%20of%20NAD%2B%20and%20sirtuin-activating%20compounds&amp;amp;journal=Nat.%20Rev.%20Mol.%20Cell%20Biol.&amp;amp;doi=10.1038%2Fnrm.2016.93&amp;amp;volume=17&amp;amp;pages=679-690&amp;amp;publication_year=2016&amp;amp;author=Bonkowski%2CMS&amp;amp;author=Sinclair%2CDA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="16."&gt;&lt;p class="c-article-references__text" id="ref-CR16"&gt;Yaku, K., Okabe, K. &amp;amp; Nakagawa, T. NAD metabolism: implications in aging and longevity. &lt;i&gt;Ageing Res. Rev.&lt;/i&gt; &lt;b&gt;47&lt;/b&gt;, 1–17 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.arr.2018.05.006" data-track-item_id="10.1016/j.arr.2018.05.006" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.arr.2018.05.006" aria-label="Article reference 16" data-doi="10.1016/j.arr.2018.05.006"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXhtFSqsLvJ" aria-label="CAS reference 16"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29883761" aria-label="PubMed reference 16"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 16" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%20metabolism%3A%20implications%20in%20aging%20and%20longevity&amp;amp;journal=Ageing%20Res.%20Rev.&amp;amp;doi=10.1016%2Fj.arr.2018.05.006&amp;amp;volume=47&amp;amp;pages=1-17&amp;amp;publication_year=2018&amp;amp;author=Yaku%2CK&amp;amp;author=Okabe%2CK&amp;amp;author=Nakagawa%2CT"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="17."&gt;&lt;p class="c-article-references__text" id="ref-CR17"&gt;McReynolds, M. R., Chellappa, K. &amp;amp; Baur, J. A. Age-related NAD&lt;sup&gt;+&lt;/sup&gt; decline. &lt;i&gt;Exp. Gerontol.&lt;/i&gt; &lt;b&gt;134&lt;/b&gt;, 110888 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.exger.2020.110888" data-track-item_id="10.1016/j.exger.2020.110888" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.exger.2020.110888" aria-label="Article reference 17" data-doi="10.1016/j.exger.2020.110888"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXks1Gmt78%3D" aria-label="CAS reference 17"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32097708" aria-label="PubMed reference 17"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442590" aria-label="PubMed Central reference 17"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Age-related%20NAD%2B%20decline&amp;amp;journal=Exp.%20Gerontol.&amp;amp;doi=10.1016%2Fj.exger.2020.110888&amp;amp;volume=134&amp;amp;publication_year=2020&amp;amp;author=McReynolds%2CMR&amp;amp;author=Chellappa%2CK&amp;amp;author=Baur%2CJA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="18."&gt;&lt;p class="c-article-references__text" id="ref-CR18"&gt;Peluso, A., Damgaard, M. V., Mori, M. A. S. &amp;amp; Treebak, J. T. Age-dependent decline of NAD&lt;sup&gt;+&lt;/sup&gt;-universal truth or confounded consensus? &lt;i&gt;Nutrients&lt;/i&gt; &lt;a href="https://doi.org/10.3390/nu14010101" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3390/nu14010101"&gt;https://doi.org/10.3390/nu14010101&lt;/a&gt; (2021).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="19."&gt;&lt;p class="c-article-references__text" id="ref-CR19"&gt;Wang, H. L. et al. Meeting Summary of The NYO3 5th NO-Age/AD Meeting and the 1st Norway-UK Joint Meeting on Aging and Dementia: recent progress on the mechanisms and interventional strategies. &lt;i&gt;J. Gerontol. A Biol. Sci. Med. Sci.&lt;/i&gt; &lt;a href="https://doi.org/10.1093/gerona/glae029" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1093/gerona/glae029"&gt;https://doi.org/10.1093/gerona/glae029&lt;/a&gt; (2024).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="20."&gt;&lt;p class="c-article-references__text" id="ref-CR20"&gt;Zhang, J., Wang, H. L. &amp;amp; Fang, E. F. in &lt;i&gt;Molecular, Cellular, and Metabolic Fundamentals of Human Aging&lt;/i&gt;. (eds. E. F. Fang et al.) Ch. 5, 107–119 (Elsevier/Academic Press, 2022).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="21."&gt;&lt;p class="c-article-references__text" id="ref-CR21"&gt;Guo, C., Sun, L., Chen, X. &amp;amp; Zhang, D. Oxidative stress, mitochondrial damage and neurodegenerative diseases. &lt;i&gt;Neural Regen. Res&lt;/i&gt; &lt;b&gt;8&lt;/b&gt;, 2003–2014 (2013).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXhvFamt7nE" aria-label="CAS reference 21"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=25206509" aria-label="PubMed reference 21"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145906" aria-label="PubMed Central reference 21"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Oxidative%20stress%2C%20mitochondrial%20damage%20and%20neurodegenerative%20diseases&amp;amp;journal=Neural%20Regen.%20Res&amp;amp;volume=8&amp;amp;pages=2003-2014&amp;amp;publication_year=2013&amp;amp;author=Guo%2CC&amp;amp;author=Sun%2CL&amp;amp;author=Chen%2CX&amp;amp;author=Zhang%2CD"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="22."&gt;&lt;p class="c-article-references__text" id="ref-CR22"&gt;Fang, E. F. Mitophagy and NAD&lt;sup&gt;+&lt;/sup&gt; inhibit Alzheimer disease. &lt;i&gt;Autophagy&lt;/i&gt; &lt;b&gt;15&lt;/b&gt;, 1112–1114 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1080/15548627.2019.1596497" data-track-item_id="10.1080/15548627.2019.1596497" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1080%2F15548627.2019.1596497" aria-label="Article reference 22" data-doi="10.1080/15548627.2019.1596497"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXmsFentbo%3D" aria-label="CAS reference 22"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30922179" aria-label="PubMed reference 22"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526831" aria-label="PubMed Central reference 22"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 22" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Mitophagy%20and%20NAD%2B%20inhibit%20Alzheimer%20disease&amp;amp;journal=Autophagy&amp;amp;doi=10.1080%2F15548627.2019.1596497&amp;amp;volume=15&amp;amp;pages=1112-1114&amp;amp;publication_year=2019&amp;amp;author=Fang%2CEF"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="23."&gt;&lt;p class="c-article-references__text" id="ref-CR23"&gt;Fang, E. F. et al. NAD&lt;sup&gt;+&lt;/sup&gt; in aging: molecular mechanisms and translational implications. &lt;i&gt;Trends Mol. Med.&lt;/i&gt; &lt;b&gt;23&lt;/b&gt;, 899–916 (2017).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.molmed.2017.08.001" data-track-item_id="10.1016/j.molmed.2017.08.001" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.molmed.2017.08.001" aria-label="Article reference 23" data-doi="10.1016/j.molmed.2017.08.001"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXhtl2gtLnO" aria-label="CAS reference 23"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=28899755" aria-label="PubMed reference 23"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494058" aria-label="PubMed Central reference 23"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20in%20aging%3A%20molecular%20mechanisms%20and%20translational%20implications&amp;amp;journal=Trends%20Mol.%20Med.&amp;amp;doi=10.1016%2Fj.molmed.2017.08.001&amp;amp;volume=23&amp;amp;pages=899-916&amp;amp;publication_year=2017&amp;amp;author=Fang%2CEF"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="24."&gt;&lt;p class="c-article-references__text" id="ref-CR24"&gt;Flones, I. H. et al. Mitochondrial complex I deficiency stratifies idiopathic Parkinson’s disease. &lt;i&gt;Nat. Commun.&lt;/i&gt; &lt;b&gt;15&lt;/b&gt;, 3631 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-024-47867-4" data-track-item_id="10.1038/s41467-024-47867-4" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-024-47867-4" aria-label="Article reference 24" data-doi="10.1038/s41467-024-47867-4"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38684731" aria-label="PubMed reference 24"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11059185" aria-label="PubMed Central reference 24"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 24" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Mitochondrial%20complex%20I%20deficiency%20stratifies%20idiopathic%20Parkinson%E2%80%99s%20disease&amp;amp;journal=Nat.%20Commun.&amp;amp;doi=10.1038%2Fs41467-024-47867-4&amp;amp;volume=15&amp;amp;publication_year=2024&amp;amp;author=Flones%2CIH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="25."&gt;&lt;p class="c-article-references__text" id="ref-CR25"&gt;Toker, L. et al. Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson’s disease brain. &lt;i&gt;Mol. Neurodegener.&lt;/i&gt; &lt;b&gt;16&lt;/b&gt;, 31 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1186/s13024-021-00450-7" data-track-item_id="10.1186/s13024-021-00450-7" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s13024-021-00450-7" aria-label="Article reference 25" data-doi="10.1186/s13024-021-00450-7"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXhtlKnur%2FJ" aria-label="CAS reference 25"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33947435" aria-label="PubMed reference 25"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097820" aria-label="PubMed Central reference 25"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 25" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Genome-wide%20histone%20acetylation%20analysis%20reveals%20altered%20transcriptional%20regulation%20in%20the%20Parkinson%E2%80%99s%20disease%20brain&amp;amp;journal=Mol.%20Neurodegener.&amp;amp;doi=10.1186%2Fs13024-021-00450-7&amp;amp;volume=16&amp;amp;publication_year=2021&amp;amp;author=Toker%2CL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="26."&gt;&lt;p class="c-article-references__text" id="ref-CR26"&gt;Dolle, C. et al. Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease. &lt;i&gt;Nat. Commun.&lt;/i&gt; &lt;b&gt;7&lt;/b&gt;, 13548 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/ncomms13548" data-track-item_id="10.1038/ncomms13548" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fncomms13548" aria-label="Article reference 26" data-doi="10.1038/ncomms13548"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XitFSnsrbM" aria-label="CAS reference 26"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27874000" aria-label="PubMed reference 26"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121427" aria-label="PubMed Central reference 26"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 26" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Defective%20mitochondrial%20DNA%20homeostasis%20in%20the%20substantia%20nigra%20in%20Parkinson%20disease&amp;amp;journal=Nat.%20Commun.&amp;amp;doi=10.1038%2Fncomms13548&amp;amp;volume=7&amp;amp;publication_year=2016&amp;amp;author=Dolle%2CC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="27."&gt;&lt;p class="c-article-references__text" id="ref-CR27"&gt;Hoyland, L. E. et al. Subcellular NAD&lt;sup&gt;+&lt;/sup&gt; pools are interconnected and buffered by mitochondrial NAD. &lt;i&gt;Nat. Metab.&lt;/i&gt; &lt;b&gt;6&lt;/b&gt;, 2319–2337 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s42255-024-01174-w" data-track-item_id="10.1038/s42255-024-01174-w" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs42255-024-01174-w" aria-label="Article reference 27" data-doi="10.1038/s42255-024-01174-w"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=39702414" aria-label="PubMed reference 27"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 27" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Subcellular%20NAD%2B%20pools%20are%20interconnected%20and%20buffered%20by%20mitochondrial%20NAD&amp;amp;journal=Nat.%20Metab.&amp;amp;doi=10.1038%2Fs42255-024-01174-w&amp;amp;volume=6&amp;amp;pages=2319-2337&amp;amp;publication_year=2024&amp;amp;author=Hoyland%2CLE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="28."&gt;&lt;p class="c-article-references__text" id="ref-CR28"&gt;Yoshino, J., Baur, J. A. &amp;amp; Imai, S. I. NAD&lt;sup&gt;+&lt;/sup&gt; intermediates: the biology and therapeutic potential of NMN and NR. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;b&gt;27&lt;/b&gt;, 513–528 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2017.11.002" data-track-item_id="10.1016/j.cmet.2017.11.002" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2017.11.002" aria-label="Article reference 28" data-doi="10.1016/j.cmet.2017.11.002"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXhvF2js7%2FP" aria-label="CAS reference 28"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29249689" aria-label="PubMed reference 28"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 28" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20intermediates%3A%20the%20biology%20and%20therapeutic%20potential%20of%20NMN%20and%20NR&amp;amp;journal=Cell%20Metab.&amp;amp;doi=10.1016%2Fj.cmet.2017.11.002&amp;amp;volume=27&amp;amp;pages=513-528&amp;amp;publication_year=2018&amp;amp;author=Yoshino%2CJ&amp;amp;author=Baur%2CJA&amp;amp;author=Imai%2CSI"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="29."&gt;&lt;p class="c-article-references__text" id="ref-CR29"&gt;Mills, K. F. et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;b&gt;24&lt;/b&gt;, 795–806 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2016.09.013" data-track-item_id="10.1016/j.cmet.2016.09.013" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2016.09.013" aria-label="Article reference 29" data-doi="10.1016/j.cmet.2016.09.013"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XhslKmsLvF" aria-label="CAS reference 29"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=28068222" aria-label="PubMed reference 29"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668137" aria-label="PubMed Central reference 29"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 29" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Long-term%20administration%20of%20nicotinamide%20mononucleotide%20mitigates%20age-associated%20physiological%20decline%20in%20mice&amp;amp;journal=Cell%20Metab.&amp;amp;doi=10.1016%2Fj.cmet.2016.09.013&amp;amp;volume=24&amp;amp;pages=795-806&amp;amp;publication_year=2016&amp;amp;author=Mills%2CKF"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="30."&gt;&lt;p class="c-article-references__text" id="ref-CR30"&gt;Camacho-Pereira, J. et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;b&gt;23&lt;/b&gt;, 1127–1139 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2016.05.006" data-track-item_id="10.1016/j.cmet.2016.05.006" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2016.05.006" aria-label="Article reference 30" data-doi="10.1016/j.cmet.2016.05.006"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XptVCktLY%3D" aria-label="CAS reference 30"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27304511" aria-label="PubMed reference 30"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911708" aria-label="PubMed Central reference 30"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=CD38%20dictates%20age-related%20NAD%20decline%20and%20mitochondrial%20dysfunction%20through%20an%20SIRT3-dependent%20mechanism&amp;amp;journal=Cell%20Metab.&amp;amp;doi=10.1016%2Fj.cmet.2016.05.006&amp;amp;volume=23&amp;amp;pages=1127-1139&amp;amp;publication_year=2016&amp;amp;author=Camacho-Pereira%2CJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="31."&gt;&lt;p class="c-article-references__text" id="ref-CR31"&gt;Bai, P. et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;b&gt;13&lt;/b&gt;, 461–468 (2011).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2011.03.004" data-track-item_id="10.1016/j.cmet.2011.03.004" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2011.03.004" aria-label="Article reference 31" data-doi="10.1016/j.cmet.2011.03.004"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXktF2nsLc%3D" aria-label="CAS reference 31"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=21459330" aria-label="PubMed reference 31"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086520" aria-label="PubMed Central reference 31"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 31" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=PARP-1%20inhibition%20increases%20mitochondrial%20metabolism%20through%20SIRT1%20activation&amp;amp;journal=Cell%20Metab.&amp;amp;doi=10.1016%2Fj.cmet.2011.03.004&amp;amp;volume=13&amp;amp;pages=461-468&amp;amp;publication_year=2011&amp;amp;author=Bai%2CP"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="32."&gt;&lt;p class="c-article-references__text" id="ref-CR32"&gt;Migaud, M. E., Ziegler, M. &amp;amp; Baur, J. A. Regulation of and challenges in targeting NAD&lt;sup&gt;+&lt;/sup&gt; metabolism. &lt;i&gt;Nat. Rev. Mol. Cell Biol.&lt;/i&gt; &lt;b&gt;25&lt;/b&gt;, 822–840 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41580-024-00752-w" data-track-item_id="10.1038/s41580-024-00752-w" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41580-024-00752-w" aria-label="Article reference 32" data-doi="10.1038/s41580-024-00752-w"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXhsF2jtrrP" aria-label="CAS reference 32"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=39026037" aria-label="PubMed reference 32"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 32" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Regulation%20of%20and%20challenges%20in%20targeting%20NAD%2B%20metabolism&amp;amp;journal=Nat.%20Rev.%20Mol.%20Cell%20Biol.&amp;amp;doi=10.1038%2Fs41580-024-00752-w&amp;amp;volume=25&amp;amp;pages=822-840&amp;amp;publication_year=2024&amp;amp;author=Migaud%2CME&amp;amp;author=Ziegler%2CM&amp;amp;author=Baur%2CJA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="33."&gt;&lt;p class="c-article-references__text" id="ref-CR33"&gt;Bogan, K. L. &amp;amp; Brenner, C. Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD&lt;sup&gt;+&lt;/sup&gt; precursor vitamins in human nutrition. &lt;i&gt;Annu. Rev. Nutr.&lt;/i&gt; &lt;b&gt;28&lt;/b&gt;, 115–130 (2008).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1146/annurev.nutr.28.061807.155443" data-track-item_id="10.1146/annurev.nutr.28.061807.155443" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1146%2Fannurev.nutr.28.061807.155443" aria-label="Article reference 33" data-doi="10.1146/annurev.nutr.28.061807.155443"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXhtV2isL%2FJ" aria-label="CAS reference 33"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=18429699" aria-label="PubMed reference 33"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 33" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinic%20acid%2C%20nicotinamide%2C%20and%20nicotinamide%20riboside%3A%20a%20molecular%20evaluation%20of%20NAD%2B%20precursor%20vitamins%20in%20human%20nutrition&amp;amp;journal=Annu.%20Rev.%20Nutr.&amp;amp;doi=10.1146%2Fannurev.nutr.28.061807.155443&amp;amp;volume=28&amp;amp;pages=115-130&amp;amp;publication_year=2008&amp;amp;author=Bogan%2CKL&amp;amp;author=Brenner%2CC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="34."&gt;&lt;p class="c-article-references__text" id="ref-CR34"&gt;Zapata-Perez, R., Wanders, R. J. A., van Karnebeek, C. D. M. &amp;amp; Houtkooper, R. H. NAD&lt;sup&gt;+&lt;/sup&gt; homeostasis in human health and disease. &lt;i&gt;EMBO Mol. Med.&lt;/i&gt; &lt;b&gt;13&lt;/b&gt;, e13943 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.15252/emmm.202113943" data-track-item_id="10.15252/emmm.202113943" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.15252%2Femmm.202113943" aria-label="Article reference 34" data-doi="10.15252/emmm.202113943"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXhtF2msLrF" aria-label="CAS reference 34"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34041853" aria-label="PubMed reference 34"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261484" aria-label="PubMed Central reference 34"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 34" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20homeostasis%20in%20human%20health%20and%20disease&amp;amp;journal=EMBO%20Mol.%20Med.&amp;amp;doi=10.15252%2Femmm.202113943&amp;amp;volume=13&amp;amp;publication_year=2021&amp;amp;author=Zapata-Perez%2CR&amp;amp;author=Wanders%2CRJA&amp;amp;author=Karnebeek%2CCDM&amp;amp;author=Houtkooper%2CRH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="35."&gt;&lt;p class="c-article-references__text" id="ref-CR35"&gt;Lautrup, S., Hou, Y., Fang, E. F. &amp;amp; Bohr, V. A. Roles of NAD&lt;sup&gt;+&lt;/sup&gt; in health and aging. &lt;i&gt;Cold Spring Harb. Perspect. Med.&lt;/i&gt; &lt;a href="https://doi.org/10.1101/cshperspect.a041193" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/cshperspect.a041193"&gt;https://doi.org/10.1101/cshperspect.a041193&lt;/a&gt; (2024).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="36."&gt;&lt;p class="c-article-references__text" id="ref-CR36"&gt;Kerr, J. S. et al. Mitophagy and Alzheimer’s disease: cellular and molecular mechanisms. &lt;i&gt;Trends Neurosci.&lt;/i&gt; &lt;b&gt;40&lt;/b&gt;, 151–166 (2017).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.tins.2017.01.002" data-track-item_id="10.1016/j.tins.2017.01.002" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.tins.2017.01.002" aria-label="Article reference 36" data-doi="10.1016/j.tins.2017.01.002"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXitFeitb8%3D" aria-label="CAS reference 36"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=28190529" aria-label="PubMed reference 36"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341618" aria-label="PubMed Central reference 36"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 36" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Mitophagy%20and%20Alzheimer%E2%80%99s%20disease%3A%20cellular%20and%20molecular%20mechanisms&amp;amp;journal=Trends%20Neurosci.&amp;amp;doi=10.1016%2Fj.tins.2017.01.002&amp;amp;volume=40&amp;amp;pages=151-166&amp;amp;publication_year=2017&amp;amp;author=Kerr%2CJS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="37."&gt;&lt;p class="c-article-references__text" id="ref-CR37"&gt;Fang, E. F. et al. Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease. &lt;i&gt;Nat. Neurosci.&lt;/i&gt; &lt;b&gt;22&lt;/b&gt;, 401–412 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41593-018-0332-9" data-track-item_id="10.1038/s41593-018-0332-9" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41593-018-0332-9" aria-label="Article reference 37" data-doi="10.1038/s41593-018-0332-9"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXmsVymt7w%3D" aria-label="CAS reference 37"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30742114" aria-label="PubMed reference 37"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693625" aria-label="PubMed Central reference 37"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 37" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Mitophagy%20inhibits%20amyloid-beta%20and%20tau%20pathology%20and%20reverses%20cognitive%20deficits%20in%20models%20of%20Alzheimer%E2%80%99s%20disease&amp;amp;journal=Nat.%20Neurosci.&amp;amp;doi=10.1038%2Fs41593-018-0332-9&amp;amp;volume=22&amp;amp;pages=401-412&amp;amp;publication_year=2019&amp;amp;author=Fang%2CEF"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="38."&gt;&lt;p class="c-article-references__text" id="ref-CR38"&gt;Veverova, K. et al. Alterations of human CSF and serum-based mitophagy biomarkers in the continuum of Alzheimer disease. &lt;i&gt;Autophagy&lt;/i&gt; &lt;a href="https://doi.org/10.1080/15548627.2024.2340408" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1080/15548627.2024.2340408"&gt;https://doi.org/10.1080/15548627.2024.2340408&lt;/a&gt; (2024).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="39."&gt;&lt;p class="c-article-references__text" id="ref-CR39"&gt;Zhang, J., Wang, H. L., Veverova, K., Vyhnalek, M. &amp;amp; Fang, E. F. Identification and potential clinical applications of novel autophagy/mitophagy proteins in the biofluids of Alzheimer’s disease patients. &lt;i&gt;Ageing Res. Rev.&lt;/i&gt; &lt;b&gt;99&lt;/b&gt;, 102378 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.arr.2024.102378" data-track-item_id="10.1016/j.arr.2024.102378" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.arr.2024.102378" aria-label="Article reference 39" data-doi="10.1016/j.arr.2024.102378"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXhtl2ksLnF" aria-label="CAS reference 39"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38876257" aria-label="PubMed reference 39"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 39" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Identification%20and%20potential%20clinical%20applications%20of%20novel%20autophagy%2Fmitophagy%20proteins%20in%20the%20biofluids%20of%20Alzheimer%E2%80%99s%20disease%20patients&amp;amp;journal=Ageing%20Res.%20Rev.&amp;amp;doi=10.1016%2Fj.arr.2024.102378&amp;amp;volume=99&amp;amp;publication_year=2024&amp;amp;author=Zhang%2CJ&amp;amp;author=Wang%2CHL&amp;amp;author=Veverova%2CK&amp;amp;author=Vyhnalek%2CM&amp;amp;author=Fang%2CEF"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="40."&gt;&lt;p class="c-article-references__text" id="ref-CR40"&gt;Mattson, M. P. &amp;amp; Arumugam, T. V. Hallmarks of brain aging: adaptive and pathological modification by metabolic states. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;b&gt;27&lt;/b&gt;, 1176–1199 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2018.05.011" data-track-item_id="10.1016/j.cmet.2018.05.011" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2018.05.011" aria-label="Article reference 40" data-doi="10.1016/j.cmet.2018.05.011"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXhtVyksbnF" aria-label="CAS reference 40"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29874566" aria-label="PubMed reference 40"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039826" aria-label="PubMed Central reference 40"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 40" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Hallmarks%20of%20brain%20aging%3A%20adaptive%20and%20pathological%20modification%20by%20metabolic%20states&amp;amp;journal=Cell%20Metab.&amp;amp;doi=10.1016%2Fj.cmet.2018.05.011&amp;amp;volume=27&amp;amp;pages=1176-1199&amp;amp;publication_year=2018&amp;amp;author=Mattson%2CMP&amp;amp;author=Arumugam%2CTV"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="41."&gt;&lt;p class="c-article-references__text" id="ref-CR41"&gt;Wilson, D. M. III et al. Hallmarks of neurodegenerative diseases. &lt;i&gt;Cell&lt;/i&gt; &lt;b&gt;186&lt;/b&gt;, 693–714 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cell.2022.12.032" data-track-item_id="10.1016/j.cell.2022.12.032" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2022.12.032" aria-label="Article reference 41" data-doi="10.1016/j.cell.2022.12.032"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXjtl2lt7Y%3D" aria-label="CAS reference 41"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36803602" aria-label="PubMed reference 41"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 41" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Hallmarks%20of%20neurodegenerative%20diseases&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2022.12.032&amp;amp;volume=186&amp;amp;pages=693-714&amp;amp;publication_year=2023&amp;amp;author=Wilson%2CDM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="42."&gt;&lt;p class="c-article-references__text" id="ref-CR42"&gt;Hou, Y. et al. Ageing as a risk factor for neurodegenerative disease. &lt;i&gt;Nat. Rev. Neurol.&lt;/i&gt; &lt;b&gt;15&lt;/b&gt;, 565–581 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41582-019-0244-7" data-track-item_id="10.1038/s41582-019-0244-7" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41582-019-0244-7" aria-label="Article reference 42" data-doi="10.1038/s41582-019-0244-7"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31501588" aria-label="PubMed reference 42"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 42" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Ageing%20as%20a%20risk%20factor%20for%20neurodegenerative%20disease&amp;amp;journal=Nat.%20Rev.%20Neurol.&amp;amp;doi=10.1038%2Fs41582-019-0244-7&amp;amp;volume=15&amp;amp;pages=565-581&amp;amp;publication_year=2019&amp;amp;author=Hou%2CY"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="43."&gt;&lt;p class="c-article-references__text" id="ref-CR43"&gt;Hou, Y. et al. NAD&lt;sup&gt;+&lt;/sup&gt; supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency. &lt;i&gt;Proc. Natl Acad. Sci. USA&lt;/i&gt; &lt;b&gt;115&lt;/b&gt;, E1876–E1885 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1073/pnas.1718819115" data-track-item_id="10.1073/pnas.1718819115" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1073%2Fpnas.1718819115" aria-label="Article reference 43" data-doi="10.1073/pnas.1718819115"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXitVaqsbrE" aria-label="CAS reference 43"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29432159" aria-label="PubMed reference 43"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828618" aria-label="PubMed Central reference 43"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 43" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20supplementation%20normalizes%20key%20Alzheimer%E2%80%99s%20features%20and%20DNA%20damage%20responses%20in%20a%20new%20AD%20mouse%20model%20with%20introduced%20DNA%20repair%20deficiency&amp;amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;amp;doi=10.1073%2Fpnas.1718819115&amp;amp;volume=115&amp;amp;pages=E1876-E1885&amp;amp;publication_year=2018&amp;amp;author=Hou%2CY"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="44."&gt;&lt;p class="c-article-references__text" id="ref-CR44"&gt;Xie, C. et al. Amelioration of Alzheimer’s disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow. &lt;i&gt;Nat. Biomed. Eng.&lt;/i&gt; &lt;b&gt;6&lt;/b&gt;, 76–93 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41551-021-00819-5" data-track-item_id="10.1038/s41551-021-00819-5" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41551-021-00819-5" aria-label="Article reference 44" data-doi="10.1038/s41551-021-00819-5"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XksFeitLs%3D" aria-label="CAS reference 44"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34992270" aria-label="PubMed reference 44"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782726" aria-label="PubMed Central reference 44"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 44" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Amelioration%20of%20Alzheimer%E2%80%99s%20disease%20pathology%20by%20mitophagy%20inducers%20identified%20via%20machine%20learning%20and%20a%20cross-species%20workflow&amp;amp;journal=Nat.%20Biomed.%20Eng.&amp;amp;doi=10.1038%2Fs41551-021-00819-5&amp;amp;volume=6&amp;amp;pages=76-93&amp;amp;publication_year=2022&amp;amp;author=Xie%2CC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="45."&gt;&lt;p class="c-article-references__text" id="ref-CR45"&gt;Zhao, N. et al. Effect of alternating nicotinamide phosphoribosyltransferase expression levels on mitophagy in Alzheimer’s disease mouse models. &lt;i&gt;Biochim. Biophys. Acta Mol. Basis Dis.&lt;/i&gt; &lt;b&gt;1870&lt;/b&gt;, 167288 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.bbadis.2024.167288" data-track-item_id="10.1016/j.bbadis.2024.167288" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.bbadis.2024.167288" aria-label="Article reference 45" data-doi="10.1016/j.bbadis.2024.167288"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXht12hu7fP" aria-label="CAS reference 45"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38862096" aria-label="PubMed reference 45"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 45" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Effect%20of%20alternating%20nicotinamide%20phosphoribosyltransferase%20expression%20levels%20on%20mitophagy%20in%20Alzheimer%E2%80%99s%20disease%20mouse%20models&amp;amp;journal=Biochim.%20Biophys.%20Acta%20Mol.%20Basis%20Dis.&amp;amp;doi=10.1016%2Fj.bbadis.2024.167288&amp;amp;volume=1870&amp;amp;publication_year=2024&amp;amp;author=Zhao%2CN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="46."&gt;&lt;p class="c-article-references__text" id="ref-CR46"&gt;Gulaj, E., Pawlak, K., Bien, B. &amp;amp; Pawlak, D. Kynurenine and its metabolites in Alzheimer’s disease patients. &lt;i&gt;Adv. Med Sci.&lt;/i&gt; &lt;b&gt;55&lt;/b&gt;, 204–211 (2010).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.2478/v10039-010-0023-6" data-track-item_id="10.2478/v10039-010-0023-6" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.2478%2Fv10039-010-0023-6" aria-label="Article reference 46" data-doi="10.2478/v10039-010-0023-6"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXjvVWhu7s%3D" aria-label="CAS reference 46"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=20639188" aria-label="PubMed reference 46"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 46" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Kynurenine%20and%20its%20metabolites%20in%20Alzheimer%E2%80%99s%20disease%20patients&amp;amp;journal=Adv.%20Med%20Sci.&amp;amp;doi=10.2478%2Fv10039-010-0023-6&amp;amp;volume=55&amp;amp;pages=204-211&amp;amp;publication_year=2010&amp;amp;author=Gulaj%2CE&amp;amp;author=Pawlak%2CK&amp;amp;author=Bien%2CB&amp;amp;author=Pawlak%2CD"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="47."&gt;&lt;p class="c-article-references__text" id="ref-CR47"&gt;Giil, L. M. et al. Kynurenine pathway metabolites in Alzheimer’s disease. &lt;i&gt;J. Alzheimers Dis.&lt;/i&gt; &lt;b&gt;60&lt;/b&gt;, 495–504 (2017).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.3233/JAD-170485" data-track-item_id="10.3233/JAD-170485" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3233%2FJAD-170485" aria-label="Article reference 47" data-doi="10.3233/JAD-170485"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXhsFClt7vN" aria-label="CAS reference 47"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=28869479" aria-label="PubMed reference 47"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 47" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Kynurenine%20pathway%20metabolites%20in%20Alzheimer%E2%80%99s%20disease&amp;amp;journal=J.%20Alzheimers%20Dis.&amp;amp;doi=10.3233%2FJAD-170485&amp;amp;volume=60&amp;amp;pages=495-504&amp;amp;publication_year=2017&amp;amp;author=Giil%2CLM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="48."&gt;&lt;p class="c-article-references__text" id="ref-CR48"&gt;Fathi, M. et al. Dynamic changes in metabolites of the kynurenine pathway in Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: a systematic review and meta-analysis. &lt;i&gt;Front. Immunol.&lt;/i&gt; &lt;b&gt;13&lt;/b&gt;, 997240 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.3389/fimmu.2022.997240" data-track-item_id="10.3389/fimmu.2022.997240" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3389%2Ffimmu.2022.997240" aria-label="Article reference 48" data-doi="10.3389/fimmu.2022.997240"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XisleiurrI" aria-label="CAS reference 48"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36263032" aria-label="PubMed reference 48"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574226" aria-label="PubMed Central reference 48"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 48" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Dynamic%20changes%20in%20metabolites%20of%20the%20kynurenine%20pathway%20in%20Alzheimer%E2%80%99s%20disease%2C%20Parkinson%E2%80%99s%20disease%2C%20and%20Huntington%E2%80%99s%20disease%3A%20a%20systematic%20review%20and%20meta-analysis&amp;amp;journal=Front.%20Immunol.&amp;amp;doi=10.3389%2Ffimmu.2022.997240&amp;amp;volume=13&amp;amp;publication_year=2022&amp;amp;author=Fathi%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="49."&gt;&lt;p class="c-article-references__text" id="ref-CR49"&gt;Knapskog, A. B. et al. Higher concentrations of kynurenic acid in CSF are associated with the slower clinical progression of Alzheimer’s disease. &lt;i&gt;Alzheimers Dement.&lt;/i&gt; &lt;b&gt;19&lt;/b&gt;, 5573–5582 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/alz.13162" data-track-item_id="10.1002/alz.13162" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Falz.13162" aria-label="Article reference 49" data-doi="10.1002/alz.13162"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXhtF2ntbbL" aria-label="CAS reference 49"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37264981" aria-label="PubMed reference 49"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 49" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Higher%20concentrations%20of%20kynurenic%20acid%20in%20CSF%20are%20associated%20with%20the%20slower%20clinical%20progression%20of%20Alzheimer%E2%80%99s%20disease&amp;amp;journal=Alzheimers%20Dement.&amp;amp;doi=10.1002%2Falz.13162&amp;amp;volume=19&amp;amp;pages=5573-5582&amp;amp;publication_year=2023&amp;amp;author=Knapskog%2CAB"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="50."&gt;&lt;p class="c-article-references__text" id="ref-CR50"&gt;Knapskog, A. B. et al. Sex-specific associations of kynurenic acid with neopterin in Alzheimer’s disease. &lt;i&gt;Alzheimers Res. Ther.&lt;/i&gt; &lt;b&gt;16&lt;/b&gt;, 167 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1186/s13195-024-01531-7" data-track-item_id="10.1186/s13195-024-01531-7" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s13195-024-01531-7" aria-label="Article reference 50" data-doi="10.1186/s13195-024-01531-7"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXhs1Cju73J" aria-label="CAS reference 50"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=39068471" aria-label="PubMed reference 50"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11282793" aria-label="PubMed Central reference 50"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 50" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Sex-specific%20associations%20of%20kynurenic%20acid%20with%20neopterin%20in%20Alzheimer%E2%80%99s%20disease&amp;amp;journal=Alzheimers%20Res.%20Ther.&amp;amp;doi=10.1186%2Fs13195-024-01531-7&amp;amp;volume=16&amp;amp;publication_year=2024&amp;amp;author=Knapskog%2CAB"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="51."&gt;&lt;p class="c-article-references__text" id="ref-CR51"&gt;González-Sánchez, M. et al. Kynurenic acid levels are increased in the CSF of Alzheimer’s disease patients. &lt;i&gt;Biomolecules&lt;/i&gt; &lt;a href="https://doi.org/10.3390/biom10040571" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3390/biom10040571"&gt;https://doi.org/10.3390/biom10040571&lt;/a&gt; (2020).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="52."&gt;&lt;p class="c-article-references__text" id="ref-CR52"&gt;Jacobs, K. R. et al. Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer’s disease and relationship to amyloid-β and tau. &lt;i&gt;Neurobiol. Aging&lt;/i&gt; &lt;b&gt;80&lt;/b&gt;, 11–20 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.neurobiolaging.2019.03.015" data-track-item_id="10.1016/j.neurobiolaging.2019.03.015" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.neurobiolaging.2019.03.015" aria-label="Article reference 52" data-doi="10.1016/j.neurobiolaging.2019.03.015"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXotVKhtbk%3D" aria-label="CAS reference 52"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31055163" aria-label="PubMed reference 52"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 52" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Correlation%20between%20plasma%20and%20CSF%20concentrations%20of%20kynurenine%20pathway%20metabolites%20in%20Alzheimer%E2%80%99s%20disease%20and%20relationship%20to%20amyloid-%CE%B2%20and%20tau&amp;amp;journal=Neurobiol.%20Aging&amp;amp;doi=10.1016%2Fj.neurobiolaging.2019.03.015&amp;amp;volume=80&amp;amp;pages=11-20&amp;amp;publication_year=2019&amp;amp;author=Jacobs%2CKR"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="53."&gt;&lt;p class="c-article-references__text" id="ref-CR53"&gt;Wennström, M. et al. Kynurenic acid levels in cerebrospinal fluid from patients with Alzheimer’s disease or dementia with lewy bodies. &lt;i&gt;Int. J. Tryptophan Res.&lt;/i&gt; &lt;b&gt;7&lt;/b&gt;, 1–7 (2014).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.4137/IJTR.S13958" data-track-item_id="10.4137/IJTR.S13958" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.4137%2FIJTR.S13958" aria-label="Article reference 53" data-doi="10.4137/IJTR.S13958"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=24855376" aria-label="PubMed reference 53"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011721" aria-label="PubMed Central reference 53"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 53" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Kynurenic%20acid%20levels%20in%20cerebrospinal%20fluid%20from%20patients%20with%20Alzheimer%E2%80%99s%20disease%20or%20dementia%20with%20lewy%20bodies&amp;amp;journal=Int.%20J.%20Tryptophan%20Res.&amp;amp;doi=10.4137%2FIJTR.S13958&amp;amp;volume=7&amp;amp;pages=1-7&amp;amp;publication_year=2014&amp;amp;author=Wennstr%C3%B6m%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="54."&gt;&lt;p class="c-article-references__text" id="ref-CR54"&gt;van der Velpen, V. et al. Systemic and central nervous system metabolic alterations in Alzheimer’s disease. &lt;i&gt;Alzheimers Res. Ther.&lt;/i&gt; &lt;b&gt;11&lt;/b&gt;, 93 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1186/s13195-019-0551-7" data-track-item_id="10.1186/s13195-019-0551-7" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s13195-019-0551-7" aria-label="Article reference 54" data-doi="10.1186/s13195-019-0551-7"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31779690" aria-label="PubMed reference 54"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883620" aria-label="PubMed Central reference 54"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 54" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Systemic%20and%20central%20nervous%20system%20metabolic%20alterations%20in%20Alzheimer%E2%80%99s%20disease&amp;amp;journal=Alzheimers%20Res.%20Ther.&amp;amp;doi=10.1186%2Fs13195-019-0551-7&amp;amp;volume=11&amp;amp;publication_year=2019&amp;amp;author=Velpen%2CV"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="55."&gt;&lt;p class="c-article-references__text" id="ref-CR55"&gt;Xue, C. et al. Tryptophan metabolism in health and disease. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;b&gt;35&lt;/b&gt;, 1304–1326 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2023.06.004" data-track-item_id="10.1016/j.cmet.2023.06.004" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2023.06.004" aria-label="Article reference 55" data-doi="10.1016/j.cmet.2023.06.004"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXht12qsLfN" aria-label="CAS reference 55"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37352864" aria-label="PubMed reference 55"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 55" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Tryptophan%20metabolism%20in%20health%20and%20disease&amp;amp;journal=Cell%20Metab.&amp;amp;doi=10.1016%2Fj.cmet.2023.06.004&amp;amp;volume=35&amp;amp;pages=1304-1326&amp;amp;publication_year=2023&amp;amp;author=Xue%2CC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="56."&gt;&lt;p class="c-article-references__text" id="ref-CR56"&gt;Schwarcz, R., Bruno, J. P., Muchowski, P. J. &amp;amp; Wu, H. Q. Kynurenines in the mammalian brain: when physiology meets pathology. &lt;i&gt;Nat. Rev. Neurosci.&lt;/i&gt; &lt;b&gt;13&lt;/b&gt;, 465–477 (2012).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nrn3257" data-track-item_id="10.1038/nrn3257" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnrn3257" aria-label="Article reference 56" data-doi="10.1038/nrn3257"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC38Xot1CmsL4%3D" aria-label="CAS reference 56"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=22678511" aria-label="PubMed reference 56"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681811" aria-label="PubMed Central reference 56"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 56" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Kynurenines%20in%20the%20mammalian%20brain%3A%20when%20physiology%20meets%20pathology&amp;amp;journal=Nat.%20Rev.%20Neurosci.&amp;amp;doi=10.1038%2Fnrn3257&amp;amp;volume=13&amp;amp;pages=465-477&amp;amp;publication_year=2012&amp;amp;author=Schwarcz%2CR&amp;amp;author=Bruno%2CJP&amp;amp;author=Muchowski%2CPJ&amp;amp;author=Wu%2CHQ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="57."&gt;&lt;p class="c-article-references__text" id="ref-CR57"&gt;Yulug, B. et al. Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial. &lt;i&gt;Transl. Neurodegener.&lt;/i&gt; &lt;b&gt;12&lt;/b&gt;, 4 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1186/s40035-023-00336-2" data-track-item_id="10.1186/s40035-023-00336-2" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s40035-023-00336-2" aria-label="Article reference 57" data-doi="10.1186/s40035-023-00336-2"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXitFSrur4%3D" aria-label="CAS reference 57"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36703196" aria-label="PubMed reference 57"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879258" aria-label="PubMed Central reference 57"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 57" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Combined%20metabolic%20activators%20improve%20cognitive%20functions%20in%20Alzheimer%E2%80%99s%20disease%20patients%3A%20a%20randomised%2C%20double-blinded%2C%20placebo-controlled%20phase-II%20trial&amp;amp;journal=Transl.%20Neurodegener.&amp;amp;doi=10.1186%2Fs40035-023-00336-2&amp;amp;volume=12&amp;amp;publication_year=2023&amp;amp;author=Yulug%2CB"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="58."&gt;&lt;p class="c-article-references__text" id="ref-CR58"&gt;Orr, M. E. et al. A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment. &lt;i&gt;Geroscience&lt;/i&gt; &lt;b&gt;46&lt;/b&gt;, 665–682 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1007/s11357-023-00999-9" data-track-item_id="10.1007/s11357-023-00999-9" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s11357-023-00999-9" aria-label="Article reference 58" data-doi="10.1007/s11357-023-00999-9"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXisFSktL7E" aria-label="CAS reference 58"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37994989" aria-label="PubMed reference 58"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 58" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=A%20randomized%20placebo-controlled%20trial%20of%20nicotinamide%20riboside%20in%20older%20adults%20with%20mild%20cognitive%20impairment&amp;amp;journal=Geroscience&amp;amp;doi=10.1007%2Fs11357-023-00999-9&amp;amp;volume=46&amp;amp;pages=665-682&amp;amp;publication_year=2024&amp;amp;author=Orr%2CME"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="59."&gt;&lt;p class="c-article-references__text" id="ref-CR59"&gt;Orr, M. E. et al. Results from a pilot study: the effects of nicotinamide riboside on mild cognitive impairment. &lt;i&gt;Alzheimer’s Dement.&lt;/i&gt; &lt;b&gt;16&lt;/b&gt;, e044746 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/alz.044746" data-track-item_id="10.1002/alz.044746" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Falz.044746" aria-label="Article reference 59" data-doi="10.1002/alz.044746"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 59" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Results%20from%20a%20pilot%20study%3A%20the%20effects%20of%20nicotinamide%20riboside%20on%20mild%20cognitive%20impairment&amp;amp;journal=Alzheimer%E2%80%99s%20Dement.&amp;amp;doi=10.1002%2Falz.044746&amp;amp;volume=16&amp;amp;publication_year=2020&amp;amp;author=Orr%2CME"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="60."&gt;&lt;p class="c-article-references__text" id="ref-CR60"&gt;Grill, J. D. et al. A Phase 2a proof‐of‐concept double‐blind, randomized, placebo‐controlled trial of nicotinamide in early Alzheimer’s disease. In &lt;i&gt;Alzheimer’s Association International Conference&lt;/i&gt;, abstract: 77979 (AAIC, 2023).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="61."&gt;&lt;p class="c-article-references__text" id="ref-CR61"&gt;Bloem, B. R., Okun, M. S. &amp;amp; Klein, C. Parkinson’s disease. &lt;i&gt;Lancet&lt;/i&gt; &lt;b&gt;397&lt;/b&gt;, 2284–2303 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0140-6736(21)00218-X" data-track-item_id="10.1016/S0140-6736(21)00218-X" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0140-6736%2821%2900218-X" aria-label="Article reference 61" data-doi="10.1016/S0140-6736(21)00218-X"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXhsVegsLbF" aria-label="CAS reference 61"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33848468" aria-label="PubMed reference 61"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 61" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Parkinson%E2%80%99s%20disease&amp;amp;journal=Lancet&amp;amp;doi=10.1016%2FS0140-6736%2821%2900218-X&amp;amp;volume=397&amp;amp;pages=2284-2303&amp;amp;publication_year=2021&amp;amp;author=Bloem%2CBR&amp;amp;author=Okun%2CMS&amp;amp;author=Klein%2CC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="62."&gt;&lt;p class="c-article-references__text" id="ref-CR62"&gt;Dickson, D. W. Parkinson’s disease and parkinsonism: neuropathology. &lt;i&gt;Cold Spring Harb. Perspect. Med.&lt;/i&gt; &lt;a href="https://doi.org/10.1101/cshperspect.a009258" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/cshperspect.a009258"&gt;https://doi.org/10.1101/cshperspect.a009258&lt;/a&gt; (2012).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="63."&gt;&lt;p class="c-article-references__text" id="ref-CR63"&gt;Dickson, D. W. Neuropathology of Parkinson disease. &lt;i&gt;Parkinsonism Relat. Disord.&lt;/i&gt; &lt;b&gt;46&lt;/b&gt;, S30–S33 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.parkreldis.2017.07.033" data-track-item_id="10.1016/j.parkreldis.2017.07.033" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.parkreldis.2017.07.033" aria-label="Article reference 63" data-doi="10.1016/j.parkreldis.2017.07.033"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=28780180" aria-label="PubMed reference 63"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 63" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Neuropathology%20of%20Parkinson%20disease&amp;amp;journal=Parkinsonism%20Relat.%20Disord.&amp;amp;doi=10.1016%2Fj.parkreldis.2017.07.033&amp;amp;volume=46&amp;amp;pages=S30-S33&amp;amp;publication_year=2018&amp;amp;author=Dickson%2CDW"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="64."&gt;&lt;p class="c-article-references__text" id="ref-CR64"&gt;Kalia, L. V. &amp;amp; Lang, A. E. Parkinson’s disease. &lt;i&gt;Lancet&lt;/i&gt; &lt;b&gt;386&lt;/b&gt;, 896–912 (2015).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0140-6736(14)61393-3" data-track-item_id="10.1016/S0140-6736(14)61393-3" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0140-6736%2814%2961393-3" aria-label="Article reference 64" data-doi="10.1016/S0140-6736(14)61393-3"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXmsl2rtb4%3D" aria-label="CAS reference 64"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=25904081" aria-label="PubMed reference 64"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 64" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Parkinson%E2%80%99s%20disease&amp;amp;journal=Lancet&amp;amp;doi=10.1016%2FS0140-6736%2814%2961393-3&amp;amp;volume=386&amp;amp;pages=896-912&amp;amp;publication_year=2015&amp;amp;author=Kalia%2CLV&amp;amp;author=Lang%2CAE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="65."&gt;&lt;p class="c-article-references__text" id="ref-CR65"&gt;Wallings, R. L., Humble, S. W., Ward, M. E. &amp;amp; Wade-Martins, R. Lysosomal dysfunction at the centre of Parkinson’s disease and frontotemporal dementia/amyotrophic lateral sclerosis. &lt;i&gt;Trends Neurosci.&lt;/i&gt; &lt;b&gt;42&lt;/b&gt;, 899–912 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.tins.2019.10.002" data-track-item_id="10.1016/j.tins.2019.10.002" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.tins.2019.10.002" aria-label="Article reference 65" data-doi="10.1016/j.tins.2019.10.002"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXitVajurvN" aria-label="CAS reference 65"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31704179" aria-label="PubMed reference 65"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6931156" aria-label="PubMed Central reference 65"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 65" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Lysosomal%20dysfunction%20at%20the%20centre%20of%20Parkinson%E2%80%99s%20disease%20and%20frontotemporal%20dementia%2Famyotrophic%20lateral%20sclerosis&amp;amp;journal=Trends%20Neurosci.&amp;amp;doi=10.1016%2Fj.tins.2019.10.002&amp;amp;volume=42&amp;amp;pages=899-912&amp;amp;publication_year=2019&amp;amp;author=Wallings%2CRL&amp;amp;author=Humble%2CSW&amp;amp;author=Ward%2CME&amp;amp;author=Wade-Martins%2CR"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="66."&gt;&lt;p class="c-article-references__text" id="ref-CR66"&gt;Navarro-Romero, A., Montpeyo, M. &amp;amp; Martinez-Vicente, M. The emerging role of the lysosome in Parkinson’s disease. &lt;i&gt;Cells&lt;/i&gt; &lt;a href="https://doi.org/10.3390/cells9112399" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3390/cells9112399"&gt;https://doi.org/10.3390/cells9112399&lt;/a&gt; (2020).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="67."&gt;&lt;p class="c-article-references__text" id="ref-CR67"&gt;Hirsch, E. C. &amp;amp; Hunot, S. Neuroinflammation in Parkinson’s disease: a target for neuroprotection? &lt;i&gt;Lancet Neurol.&lt;/i&gt; &lt;b&gt;8&lt;/b&gt;, 382–397 (2009).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S1474-4422(09)70062-6" data-track-item_id="10.1016/S1474-4422(09)70062-6" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS1474-4422%2809%2970062-6" aria-label="Article reference 67" data-doi="10.1016/S1474-4422(09)70062-6"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXks1Sis70%3D" aria-label="CAS reference 67"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=19296921" aria-label="PubMed reference 67"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 67" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Neuroinflammation%20in%20Parkinson%E2%80%99s%20disease%3A%20a%20target%20for%20neuroprotection%3F&amp;amp;journal=Lancet%20Neurol.&amp;amp;doi=10.1016%2FS1474-4422%2809%2970062-6&amp;amp;volume=8&amp;amp;pages=382-397&amp;amp;publication_year=2009&amp;amp;author=Hirsch%2CEC&amp;amp;author=Hunot%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="68."&gt;&lt;p class="c-article-references__text" id="ref-CR68"&gt;Turconi, G. et al. Nicotinamide riboside first alleviates symptoms but later downregulates dopamine metabolism in proteasome inhibition mouse model of Parkinson’s disease. &lt;i&gt;Heliyon&lt;/i&gt; &lt;b&gt;10&lt;/b&gt;, e34355 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.heliyon.2024.e34355" data-track-item_id="10.1016/j.heliyon.2024.e34355" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.heliyon.2024.e34355" aria-label="Article reference 68" data-doi="10.1016/j.heliyon.2024.e34355"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXhsFGlsbnL" aria-label="CAS reference 68"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=39108921" aria-label="PubMed reference 68"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11301377" aria-label="PubMed Central reference 68"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 68" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinamide%20riboside%20first%20alleviates%20symptoms%20but%20later%20downregulates%20dopamine%20metabolism%20in%20proteasome%20inhibition%20mouse%20model%20of%20Parkinson%E2%80%99s%20disease&amp;amp;journal=Heliyon&amp;amp;doi=10.1016%2Fj.heliyon.2024.e34355&amp;amp;volume=10&amp;amp;publication_year=2024&amp;amp;author=Turconi%2CG"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="69."&gt;&lt;p class="c-article-references__text" id="ref-CR69"&gt;SenGupta, T. et al. Base excision repair causes age-dependent accumulation of single-stranded DNA breaks that contribute to Parkinson disease pathology. &lt;i&gt;Cell Rep.&lt;/i&gt; &lt;b&gt;36&lt;/b&gt;, 109668 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.celrep.2021.109668" data-track-item_id="10.1016/j.celrep.2021.109668" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.celrep.2021.109668" aria-label="Article reference 69" data-doi="10.1016/j.celrep.2021.109668"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXitVSjt7jP" aria-label="CAS reference 69"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34496255" aria-label="PubMed reference 69"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441048" aria-label="PubMed Central reference 69"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 69" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Base%20excision%20repair%20causes%20age-dependent%20accumulation%20of%20single-stranded%20DNA%20breaks%20that%20contribute%20to%20Parkinson%20disease%20pathology&amp;amp;journal=Cell%20Rep.&amp;amp;doi=10.1016%2Fj.celrep.2021.109668&amp;amp;volume=36&amp;amp;publication_year=2021&amp;amp;author=SenGupta%2CT"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="70."&gt;&lt;p class="c-article-references__text" id="ref-CR70"&gt;Schondorf, D. C. et al. The NAD&lt;sup&gt;+&lt;/sup&gt; precursor nicotinamide riboside rescues mitochondrial defects and neuronal loss in iPSC and fly models of Parkinson’s disease. &lt;i&gt;Cell Rep.&lt;/i&gt; &lt;b&gt;23&lt;/b&gt;, 2976–2988 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.celrep.2018.05.009" data-track-item_id="10.1016/j.celrep.2018.05.009" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.celrep.2018.05.009" aria-label="Article reference 70" data-doi="10.1016/j.celrep.2018.05.009"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29874584" aria-label="PubMed reference 70"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 70" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20NAD%2B%20precursor%20nicotinamide%20riboside%20rescues%20mitochondrial%20defects%20and%20neuronal%20loss%20in%20iPSC%20and%20fly%20models%20of%20Parkinson%E2%80%99s%20disease&amp;amp;journal=Cell%20Rep.&amp;amp;doi=10.1016%2Fj.celrep.2018.05.009&amp;amp;volume=23&amp;amp;pages=2976-2988&amp;amp;publication_year=2018&amp;amp;author=Schondorf%2CDC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="71."&gt;&lt;p class="c-article-references__text" id="ref-CR71"&gt;Chang, K. H. et al. Alternations of metabolic profile and kynurenine metabolism in the plasma of Parkinson’s disease. &lt;i&gt;Mol. Neurobiol.&lt;/i&gt; &lt;b&gt;55&lt;/b&gt;, 6319–6328 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1007/s12035-017-0845-3" data-track-item_id="10.1007/s12035-017-0845-3" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s12035-017-0845-3" aria-label="Article reference 71" data-doi="10.1007/s12035-017-0845-3"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXitlCrtg%3D%3D" aria-label="CAS reference 71"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29294246" aria-label="PubMed reference 71"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 71" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Alternations%20of%20metabolic%20profile%20and%20kynurenine%20metabolism%20in%20the%20plasma%20of%20Parkinson%E2%80%99s%20disease&amp;amp;journal=Mol.%20Neurobiol.&amp;amp;doi=10.1007%2Fs12035-017-0845-3&amp;amp;volume=55&amp;amp;pages=6319-6328&amp;amp;publication_year=2018&amp;amp;author=Chang%2CKH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="72."&gt;&lt;p class="c-article-references__text" id="ref-CR72"&gt;Heilman, P. L. et al. Tryptophan metabolites are associated with symptoms and nigral pathology in Parkinson’s disease. &lt;i&gt;Mov. Disord.&lt;/i&gt; &lt;b&gt;35&lt;/b&gt;, 2028–2037 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/mds.28202" data-track-item_id="10.1002/mds.28202" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fmds.28202" aria-label="Article reference 72" data-doi="10.1002/mds.28202"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXis1WlsLzE" aria-label="CAS reference 72"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32710594" aria-label="PubMed reference 72"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754343" aria-label="PubMed Central reference 72"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 72" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Tryptophan%20metabolites%20are%20associated%20with%20symptoms%20and%20nigral%20pathology%20in%20Parkinson%E2%80%99s%20disease&amp;amp;journal=Mov.%20Disord.&amp;amp;doi=10.1002%2Fmds.28202&amp;amp;volume=35&amp;amp;pages=2028-2037&amp;amp;publication_year=2020&amp;amp;author=Heilman%2CPL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="73."&gt;&lt;p class="c-article-references__text" id="ref-CR73"&gt;Brakedal, B. et al. The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;b&gt;34&lt;/b&gt;, 396–407 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2022.02.001" data-track-item_id="10.1016/j.cmet.2022.02.001" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2022.02.001" aria-label="Article reference 73" data-doi="10.1016/j.cmet.2022.02.001"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38Xls1Ohtbc%3D" aria-label="CAS reference 73"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=35235774" aria-label="PubMed reference 73"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 73" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20NADPARK%20study%3A%20a%20randomized%20phase%20I%20trial%20of%20nicotinamide%20riboside%20supplementation%20in%20Parkinson%E2%80%99s%20disease&amp;amp;journal=Cell%20Metab.&amp;amp;doi=10.1016%2Fj.cmet.2022.02.001&amp;amp;volume=34&amp;amp;pages=396-407&amp;amp;publication_year=2022&amp;amp;author=Brakedal%2CB"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="74."&gt;&lt;p class="c-article-references__text" id="ref-CR74"&gt;Gaare, J. J. et al. Nicotinamide riboside supplementation is not associated with altered methylation homeostasis in Parkinson’s disease. &lt;i&gt;iScience&lt;/i&gt; &lt;b&gt;26&lt;/b&gt;, 106278 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.isci.2023.106278" data-track-item_id="10.1016/j.isci.2023.106278" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.isci.2023.106278" aria-label="Article reference 74" data-doi="10.1016/j.isci.2023.106278"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXlvFSlsLw%3D" aria-label="CAS reference 74"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36936793" aria-label="PubMed reference 74"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014306" aria-label="PubMed Central reference 74"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 74" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinamide%20riboside%20supplementation%20is%20not%20associated%20with%20altered%20methylation%20homeostasis%20in%20Parkinson%E2%80%99s%20disease&amp;amp;journal=iScience&amp;amp;doi=10.1016%2Fj.isci.2023.106278&amp;amp;volume=26&amp;amp;publication_year=2023&amp;amp;author=Gaare%2CJJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="75."&gt;&lt;p class="c-article-references__text" id="ref-CR75"&gt;Berven, H. et al. NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease. &lt;i&gt;Nat. Commun.&lt;/i&gt; &lt;b&gt;14&lt;/b&gt;, 7793 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-023-43514-6" data-track-item_id="10.1038/s41467-023-43514-6" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-023-43514-6" aria-label="Article reference 75" data-doi="10.1038/s41467-023-43514-6"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXisVOrt7jF" aria-label="CAS reference 75"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38016950" aria-label="PubMed reference 75"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684646" aria-label="PubMed Central reference 75"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 75" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NR-SAFE%3A%20a%20randomized%2C%20double-blind%20safety%20trial%20of%20high%20dose%20nicotinamide%20riboside%20in%20Parkinson%E2%80%99s%20disease&amp;amp;journal=Nat.%20Commun.&amp;amp;doi=10.1038%2Fs41467-023-43514-6&amp;amp;volume=14&amp;amp;publication_year=2023&amp;amp;author=Berven%2CH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="76."&gt;&lt;p class="c-article-references__text" id="ref-CR76"&gt;Feldman, E. L. et al. Amyotrophic lateral sclerosis. &lt;i&gt;Lancet&lt;/i&gt; &lt;b&gt;400&lt;/b&gt;, 1363–1380 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0140-6736(22)01272-7" data-track-item_id="10.1016/S0140-6736(22)01272-7" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0140-6736%2822%2901272-7" aria-label="Article reference 76" data-doi="10.1016/S0140-6736(22)01272-7"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XisFyrs7vL" aria-label="CAS reference 76"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36116464" aria-label="PubMed reference 76"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089700" aria-label="PubMed Central reference 76"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 76" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Amyotrophic%20lateral%20sclerosis&amp;amp;journal=Lancet&amp;amp;doi=10.1016%2FS0140-6736%2822%2901272-7&amp;amp;volume=400&amp;amp;pages=1363-1380&amp;amp;publication_year=2022&amp;amp;author=Feldman%2CEL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="77."&gt;&lt;p class="c-article-references__text" id="ref-CR77"&gt;Lombardo, F. L. et al. A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial. &lt;i&gt;Trials&lt;/i&gt; &lt;b&gt;24&lt;/b&gt;, 792 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1186/s13063-023-07638-w" data-track-item_id="10.1186/s13063-023-07638-w" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s13063-023-07638-w" aria-label="Article reference 77" data-doi="10.1186/s13063-023-07638-w"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38053196" aria-label="PubMed reference 77"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696667" aria-label="PubMed Central reference 77"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 77" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=A%20randomized%20double-blind%20clinical%20trial%20on%20safety%20and%20efficacy%20of%20tauroursodeoxycholic%20acid%20%28TUDCA%29%20as%20add-on%20treatment%20in%20patients%20affected%20by%20amyotrophic%20lateral%20sclerosis%20%28ALS%29%3A%20the%20statistical%20analysis%20plan%20of%20TUDCA-ALS%20trial&amp;amp;journal=Trials&amp;amp;doi=10.1186%2Fs13063-023-07638-w&amp;amp;volume=24&amp;amp;publication_year=2023&amp;amp;author=Lombardo%2CFL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="78."&gt;&lt;p class="c-article-references__text" id="ref-CR78"&gt;Wang, X. et al. Deletion of nampt in projection neurons of adult mice leads to motor dysfunction, neurodegeneration, and death. &lt;i&gt;Cell Rep.&lt;/i&gt; &lt;b&gt;20&lt;/b&gt;, 2184–2200 (2017).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.celrep.2017.08.022" data-track-item_id="10.1016/j.celrep.2017.08.022" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.celrep.2017.08.022" aria-label="Article reference 78" data-doi="10.1016/j.celrep.2017.08.022"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXhsVSltb7K" aria-label="CAS reference 78"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=28854367" aria-label="PubMed reference 78"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021762" aria-label="PubMed Central reference 78"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 78" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Deletion%20of%20nampt%20in%20projection%20neurons%20of%20adult%20mice%20leads%20to%20motor%20dysfunction%2C%20neurodegeneration%2C%20and%20death&amp;amp;journal=Cell%20Rep.&amp;amp;doi=10.1016%2Fj.celrep.2017.08.022&amp;amp;volume=20&amp;amp;pages=2184-2200&amp;amp;publication_year=2017&amp;amp;author=Wang%2CX"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="79."&gt;&lt;p class="c-article-references__text" id="ref-CR79"&gt;Harlan, B. A. et al. Enhancing NAD&lt;sup&gt;+&lt;/sup&gt; salvage pathway reverts the toxicity of primary astrocytes expressing amyotrophic lateral sclerosis-linked mutant superoxide dismutase 1 (SOD1). &lt;i&gt;J. Biol. Chem.&lt;/i&gt; &lt;b&gt;291&lt;/b&gt;, 10836–10846 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1074/jbc.M115.698779" data-track-item_id="10.1074/jbc.M115.698779" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1074%2Fjbc.M115.698779" aria-label="Article reference 79" data-doi="10.1074/jbc.M115.698779"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XnvVamtro%3D" aria-label="CAS reference 79"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27002158" aria-label="PubMed reference 79"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865928" aria-label="PubMed Central reference 79"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 79" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Enhancing%20NAD%2B%20salvage%20pathway%20reverts%20the%20toxicity%20of%20primary%20astrocytes%20expressing%20amyotrophic%20lateral%20sclerosis-linked%20mutant%20superoxide%20dismutase%201%20%28SOD1%29&amp;amp;journal=J.%20Biol.%20Chem.&amp;amp;doi=10.1074%2Fjbc.M115.698779&amp;amp;volume=291&amp;amp;pages=10836-10846&amp;amp;publication_year=2016&amp;amp;author=Harlan%2CBA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="80."&gt;&lt;p class="c-article-references__text" id="ref-CR80"&gt;Blacher, E. et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. &lt;i&gt;Nature&lt;/i&gt; &lt;b&gt;572&lt;/b&gt;, 474–480 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41586-019-1443-5" data-track-item_id="10.1038/s41586-019-1443-5" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41586-019-1443-5" aria-label="Article reference 80" data-doi="10.1038/s41586-019-1443-5"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXhsFyhurbM" aria-label="CAS reference 80"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31330533" aria-label="PubMed reference 80"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 80" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Potential%20roles%20of%20gut%20microbiome%20and%20metabolites%20in%20modulating%20ALS%20in%20mice&amp;amp;journal=Nature&amp;amp;doi=10.1038%2Fs41586-019-1443-5&amp;amp;volume=572&amp;amp;pages=474-480&amp;amp;publication_year=2019&amp;amp;author=Blacher%2CE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="81."&gt;&lt;p class="c-article-references__text" id="ref-CR81"&gt;Li, J. Y. et al. Alterations in metabolic biomarkers and their potential role in amyotrophic lateral sclerosis. &lt;i&gt;Ann. Clin. Transl. Neurol.&lt;/i&gt; &lt;b&gt;9&lt;/b&gt;, 1027–1038 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/acn3.51580" data-track-item_id="10.1002/acn3.51580" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Facn3.51580" aria-label="Article reference 81" data-doi="10.1002/acn3.51580"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XhsVaiurbN" aria-label="CAS reference 81"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=35584112" aria-label="PubMed reference 81"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268864" aria-label="PubMed Central reference 81"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 81" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Alterations%20in%20metabolic%20biomarkers%20and%20their%20potential%20role%20in%20amyotrophic%20lateral%20sclerosis&amp;amp;journal=Ann.%20Clin.%20Transl.%20Neurol.&amp;amp;doi=10.1002%2Facn3.51580&amp;amp;volume=9&amp;amp;pages=1027-1038&amp;amp;publication_year=2022&amp;amp;author=Li%2CJY"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="82."&gt;&lt;p class="c-article-references__text" id="ref-CR82"&gt;de la Rubia, J. E. et al. Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study. &lt;i&gt;Amyotroph. Lateral Scler. Frontotemporal Degener.&lt;/i&gt; &lt;b&gt;20&lt;/b&gt;, 115–122 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1080/21678421.2018.1536152" data-track-item_id="10.1080/21678421.2018.1536152" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1080%2F21678421.2018.1536152" aria-label="Article reference 82" data-doi="10.1080/21678421.2018.1536152"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30668199" aria-label="PubMed reference 82"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 82" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Efficacy%20and%20tolerability%20of%20EH301%20for%20amyotrophic%20lateral%20sclerosis%3A%20a%20randomized%2C%20double-blind%2C%20placebo-controlled%20human%20pilot%20study&amp;amp;journal=Amyotroph.%20Lateral%20Scler.%20Frontotemporal%20Degener.&amp;amp;doi=10.1080%2F21678421.2018.1536152&amp;amp;volume=20&amp;amp;pages=115-122&amp;amp;publication_year=2019&amp;amp;author=Rubia%2CJE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="83."&gt;&lt;p class="c-article-references__text" id="ref-CR83"&gt;Han, S., Choi, J. R., Soon Shin, K. &amp;amp; Kang, S. J. Resveratrol upregulated heat shock proteins and extended the survival of G93A-SOD1 mice. &lt;i&gt;Brain Res.&lt;/i&gt; &lt;b&gt;1483&lt;/b&gt;, 112–117 (2012).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.brainres.2012.09.022" data-track-item_id="10.1016/j.brainres.2012.09.022" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.brainres.2012.09.022" aria-label="Article reference 83" data-doi="10.1016/j.brainres.2012.09.022"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC38XhsVemurzO" aria-label="CAS reference 83"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=23000195" aria-label="PubMed reference 83"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 83" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Resveratrol%20upregulated%20heat%20shock%20proteins%20and%20extended%20the%20survival%20of%20G93A-SOD1%20mice&amp;amp;journal=Brain%20Res.&amp;amp;doi=10.1016%2Fj.brainres.2012.09.022&amp;amp;volume=1483&amp;amp;pages=112-117&amp;amp;publication_year=2012&amp;amp;author=Han%2CS&amp;amp;author=Choi%2CJR&amp;amp;author=Soon%20Shin%2CK&amp;amp;author=Kang%2CSJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="84."&gt;&lt;p class="c-article-references__text" id="ref-CR84"&gt;Korner, S. et al. Differential sirtuin expression patterns in amyotrophic lateral sclerosis (ALS) postmortem tissue: neuroprotective or neurotoxic properties of sirtuins in ALS? &lt;i&gt;Neurodegener. Dis.&lt;/i&gt; &lt;b&gt;11&lt;/b&gt;, 141–152 (2013).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1159/000338048" data-track-item_id="10.1159/000338048" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1159%2F000338048" aria-label="Article reference 84" data-doi="10.1159/000338048"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=22796962" aria-label="PubMed reference 84"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 84" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Differential%20sirtuin%20expression%20patterns%20in%20amyotrophic%20lateral%20sclerosis%20%28ALS%29%20postmortem%20tissue%3A%20neuroprotective%20or%20neurotoxic%20properties%20of%20sirtuins%20in%20ALS%3F&amp;amp;journal=Neurodegener.%20Dis.&amp;amp;doi=10.1159%2F000338048&amp;amp;volume=11&amp;amp;pages=141-152&amp;amp;publication_year=2013&amp;amp;author=Korner%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="85."&gt;&lt;p class="c-article-references__text" id="ref-CR85"&gt;Yoshino, M. et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. &lt;i&gt;Science&lt;/i&gt; &lt;b&gt;372&lt;/b&gt;, 1224–1229 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.abe9985" data-track-item_id="10.1126/science.abe9985" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.abe9985" aria-label="Article reference 85" data-doi="10.1126/science.abe9985"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXhtlamurvE" aria-label="CAS reference 85"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33888596" aria-label="PubMed reference 85"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550608" aria-label="PubMed Central reference 85"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 85" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinamide%20mononucleotide%20increases%20muscle%20insulin%20sensitivity%20in%20prediabetic%20women&amp;amp;journal=Science&amp;amp;doi=10.1126%2Fscience.abe9985&amp;amp;volume=372&amp;amp;pages=1224-1229&amp;amp;publication_year=2021&amp;amp;author=Yoshino%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="86."&gt;&lt;p class="c-article-references__text" id="ref-CR86"&gt;Fan, L., Cacicedo, J. M. &amp;amp; Ido, Y. Impaired nicotinamide adenine dinucleotide (NAD&lt;sup&gt;+&lt;/sup&gt;) metabolism in diabetes and diabetic tissues: Implications for nicotinamide-related compound treatment. &lt;i&gt;J. Diabetes Investig.&lt;/i&gt; &lt;b&gt;11&lt;/b&gt;, 1403–1419 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/jdi.13303" data-track-item_id="10.1111/jdi.13303" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Fjdi.13303" aria-label="Article reference 86" data-doi="10.1111/jdi.13303"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXit1yhs7nL" aria-label="CAS reference 86"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32428995" aria-label="PubMed reference 86"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610120" aria-label="PubMed Central reference 86"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 86" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Impaired%20nicotinamide%20adenine%20dinucleotide%20%28NAD%2B%29%20metabolism%20in%20diabetes%20and%20diabetic%20tissues%3A%20Implications%20for%20nicotinamide-related%20compound%20treatment&amp;amp;journal=J.%20Diabetes%20Investig.&amp;amp;doi=10.1111%2Fjdi.13303&amp;amp;volume=11&amp;amp;pages=1403-1419&amp;amp;publication_year=2020&amp;amp;author=Fan%2CL&amp;amp;author=Cacicedo%2CJM&amp;amp;author=Ido%2CY"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="87."&gt;&lt;p class="c-article-references__text" id="ref-CR87"&gt;Galderisi, A. et al. Metabolomics reveals new metabolic perturbations in children with type 1 diabetes. &lt;i&gt;Pediatr. Diabetes&lt;/i&gt; &lt;b&gt;19&lt;/b&gt;, 59–67 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/pedi.12524" data-track-item_id="10.1111/pedi.12524" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Fpedi.12524" aria-label="Article reference 87" data-doi="10.1111/pedi.12524"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXhvFWksLo%3D" aria-label="CAS reference 87"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=28401628" aria-label="PubMed reference 87"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 87" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Metabolomics%20reveals%20new%20metabolic%20perturbations%20in%20children%20with%20type%201%20diabetes&amp;amp;journal=Pediatr.%20Diabetes&amp;amp;doi=10.1111%2Fpedi.12524&amp;amp;volume=19&amp;amp;pages=59-67&amp;amp;publication_year=2018&amp;amp;author=Galderisi%2CA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="88."&gt;&lt;p class="c-article-references__text" id="ref-CR88"&gt;Gürcü, S. et al. Neopterin and biopterin levels and tryptophan degradation in patients with diabetes. &lt;i&gt;Sci. Rep.&lt;/i&gt; &lt;b&gt;10&lt;/b&gt;, 17025 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41598-020-74183-w" data-track-item_id="10.1038/s41598-020-74183-w" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41598-020-74183-w" aria-label="Article reference 88" data-doi="10.1038/s41598-020-74183-w"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33046801" aria-label="PubMed reference 88"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552423" aria-label="PubMed Central reference 88"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 88" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Neopterin%20and%20biopterin%20levels%20and%20tryptophan%20degradation%20in%20patients%20with%20diabetes&amp;amp;journal=Sci.%20Rep.&amp;amp;doi=10.1038%2Fs41598-020-74183-w&amp;amp;volume=10&amp;amp;publication_year=2020&amp;amp;author=G%C3%BCrc%C3%BC%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="89."&gt;&lt;p class="c-article-references__text" id="ref-CR89"&gt;Oxenkrug, G., van der Hart, M. &amp;amp; Summergrad, P. Elevated anthranilic acid plasma concentrations in type 1 but not type 2 diabetes mellitus. &lt;i&gt;Integr. Mol. Med.&lt;/i&gt; &lt;b&gt;2&lt;/b&gt;, 365–368 (2015).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.15761/IMM.1000169" data-track-item_id="10.15761/IMM.1000169" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.15761%2FIMM.1000169" aria-label="Article reference 89" data-doi="10.15761/IMM.1000169"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26523229" aria-label="PubMed reference 89"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624227" aria-label="PubMed Central reference 89"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 89" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Elevated%20anthranilic%20acid%20plasma%20concentrations%20in%20type%201%20but%20not%20type%202%20diabetes%20mellitus&amp;amp;journal=Integr.%20Mol.%20Med.&amp;amp;doi=10.15761%2FIMM.1000169&amp;amp;volume=2&amp;amp;pages=365-368&amp;amp;publication_year=2015&amp;amp;author=Oxenkrug%2CG&amp;amp;author=Hart%2CM&amp;amp;author=Summergrad%2CP"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="90."&gt;&lt;p class="c-article-references__text" id="ref-CR90"&gt;Orabona, C. et al. Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes. &lt;i&gt;JCI Insight&lt;/i&gt; &lt;a href="https://doi.org/10.1172/jci.insight.96244" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1172/jci.insight.96244"&gt;https://doi.org/10.1172/jci.insight.96244&lt;/a&gt; (2018).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="91."&gt;&lt;p class="c-article-references__text" id="ref-CR91"&gt;Oxenkrug, G. F. Increased plasma levels of xanthurenic and kynurenic acids in type 2 diabetes. &lt;i&gt;Mol. Neurobiol.&lt;/i&gt; &lt;b&gt;52&lt;/b&gt;, 805–810 (2015).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1007/s12035-015-9232-0" data-track-item_id="10.1007/s12035-015-9232-0" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s12035-015-9232-0" aria-label="Article reference 91" data-doi="10.1007/s12035-015-9232-0"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXhtVSqtb3L" aria-label="CAS reference 91"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26055228" aria-label="PubMed reference 91"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558247" aria-label="PubMed Central reference 91"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 91" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Increased%20plasma%20levels%20of%20xanthurenic%20and%20kynurenic%20acids%20in%20type%202%20diabetes&amp;amp;journal=Mol.%20Neurobiol.&amp;amp;doi=10.1007%2Fs12035-015-9232-0&amp;amp;volume=52&amp;amp;pages=805-810&amp;amp;publication_year=2015&amp;amp;author=Oxenkrug%2CGF"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="92."&gt;&lt;p class="c-article-references__text" id="ref-CR92"&gt;Vangipurapu, J., Fernandes Silva, L., Kuulasmaa, T., Smith, U. &amp;amp; Laakso, M. Microbiota-related metabolites and the risk of type 2 diabetes. &lt;i&gt;Diabetes Care&lt;/i&gt; &lt;b&gt;43&lt;/b&gt;, 1319–1325 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.2337/dc19-2533" data-track-item_id="10.2337/dc19-2533" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.2337%2Fdc19-2533" aria-label="Article reference 92" data-doi="10.2337/dc19-2533"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXhvFGjtLzE" aria-label="CAS reference 92"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32295805" aria-label="PubMed reference 92"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 92" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Microbiota-related%20metabolites%20and%20the%20risk%20of%20type%202%20diabetes&amp;amp;journal=Diabetes%20Care&amp;amp;doi=10.2337%2Fdc19-2533&amp;amp;volume=43&amp;amp;pages=1319-1325&amp;amp;publication_year=2020&amp;amp;author=Vangipurapu%2CJ&amp;amp;author=Fernandes%20Silva%2CL&amp;amp;author=Kuulasmaa%2CT&amp;amp;author=Smith%2CU&amp;amp;author=Laakso%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="93."&gt;&lt;p class="c-article-references__text" id="ref-CR93"&gt;Qi, Q. et al. Host and gut microbial tryptophan metabolism and type 2 diabetes: an integrative analysis of host genetics, diet, gut microbiome and circulating metabolites in cohort studies. &lt;i&gt;Gut&lt;/i&gt; &lt;b&gt;71&lt;/b&gt;, 1095–1105 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1136/gutjnl-2021-324053" data-track-item_id="10.1136/gutjnl-2021-324053" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1136%2Fgutjnl-2021-324053" aria-label="Article reference 93" data-doi="10.1136/gutjnl-2021-324053"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XitFejsrbJ" aria-label="CAS reference 93"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34127525" aria-label="PubMed reference 93"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 93" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Host%20and%20gut%20microbial%20tryptophan%20metabolism%20and%20type%202%20diabetes%3A%20an%20integrative%20analysis%20of%20host%20genetics%2C%20diet%2C%20gut%20microbiome%20and%20circulating%20metabolites%20in%20cohort%20studies&amp;amp;journal=Gut&amp;amp;doi=10.1136%2Fgutjnl-2021-324053&amp;amp;volume=71&amp;amp;pages=1095-1105&amp;amp;publication_year=2022&amp;amp;author=Qi%2CQ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="94."&gt;&lt;p class="c-article-references__text" id="ref-CR94"&gt;Abedi, S., Vessal, M., Asadian, F. &amp;amp; Takhshid, M. A. Association of serum kynurenine/tryptophan ratio with poor glycemic control in patients with type2 diabetes. &lt;i&gt;J. Diabetes Metab. Disord.&lt;/i&gt; &lt;b&gt;20&lt;/b&gt;, 1521–1527 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1007/s40200-021-00895-z" data-track-item_id="10.1007/s40200-021-00895-z" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s40200-021-00895-z" aria-label="Article reference 94" data-doi="10.1007/s40200-021-00895-z"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XivFWnsb4%3D" aria-label="CAS reference 94"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34900804" aria-label="PubMed reference 94"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630152" aria-label="PubMed Central reference 94"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 94" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Association%20of%20serum%20kynurenine%2Ftryptophan%20ratio%20with%20poor%20glycemic%20control%20in%20patients%20with%20type2%20diabetes&amp;amp;journal=J.%20Diabetes%20Metab.%20Disord.&amp;amp;doi=10.1007%2Fs40200-021-00895-z&amp;amp;volume=20&amp;amp;pages=1521-1527&amp;amp;publication_year=2021&amp;amp;author=Abedi%2CS&amp;amp;author=Vessal%2CM&amp;amp;author=Asadian%2CF&amp;amp;author=Takhshid%2CMA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="95."&gt;&lt;p class="c-article-references__text" id="ref-CR95"&gt;Moon, J. Y. et al. Gut microbiota and plasma metabolites associated with diabetes in women with, or at high risk for, HIV infection. &lt;i&gt;EBioMedicine&lt;/i&gt; &lt;b&gt;37&lt;/b&gt;, 392–400 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.ebiom.2018.10.037" data-track-item_id="10.1016/j.ebiom.2018.10.037" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.ebiom.2018.10.037" aria-label="Article reference 95" data-doi="10.1016/j.ebiom.2018.10.037"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30366816" aria-label="PubMed reference 95"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286648" aria-label="PubMed Central reference 95"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 95" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Gut%20microbiota%20and%20plasma%20metabolites%20associated%20with%20diabetes%20in%20women%20with%2C%20or%20at%20high%20risk%20for%2C%20HIV%20infection&amp;amp;journal=EBioMedicine&amp;amp;doi=10.1016%2Fj.ebiom.2018.10.037&amp;amp;volume=37&amp;amp;pages=392-400&amp;amp;publication_year=2018&amp;amp;author=Moon%2CJY"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="96."&gt;&lt;p class="c-article-references__text" id="ref-CR96"&gt;Dollerup, O. L. et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. &lt;i&gt;Am. J. Clin. Nutr.&lt;/i&gt; &lt;b&gt;108&lt;/b&gt;, 343–353 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/ajcn/nqy132" data-track-item_id="10.1093/ajcn/nqy132" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Fajcn%2Fnqy132" aria-label="Article reference 96" data-doi="10.1093/ajcn/nqy132"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29992272" aria-label="PubMed reference 96"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 96" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=A%20randomized%20placebo-controlled%20clinical%20trial%20of%20nicotinamide%20riboside%20in%20obese%20men%3A%20safety%2C%20insulin-sensitivity%2C%20and%20lipid-mobilizing%20effects&amp;amp;journal=Am.%20J.%20Clin.%20Nutr.&amp;amp;doi=10.1093%2Fajcn%2Fnqy132&amp;amp;volume=108&amp;amp;pages=343-353&amp;amp;publication_year=2018&amp;amp;author=Dollerup%2COL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="97."&gt;&lt;p class="c-article-references__text" id="ref-CR97"&gt;Dollerup, O. L. et al. Effects of nicotinamide riboside on endocrine pancreatic function and incretin hormones in nondiabetic men with obesity. &lt;i&gt;J. Clin. Endocrinol. Metab.&lt;/i&gt; &lt;b&gt;104&lt;/b&gt;, 5703–5714 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1210/jc.2019-01081" data-track-item_id="10.1210/jc.2019-01081" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1210%2Fjc.2019-01081" aria-label="Article reference 97" data-doi="10.1210/jc.2019-01081"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31390002" aria-label="PubMed reference 97"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 97" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Effects%20of%20nicotinamide%20riboside%20on%20endocrine%20pancreatic%20function%20and%20incretin%20hormones%20in%20nondiabetic%20men%20with%20obesity&amp;amp;journal=J.%20Clin.%20Endocrinol.%20Metab.&amp;amp;doi=10.1210%2Fjc.2019-01081&amp;amp;volume=104&amp;amp;pages=5703-5714&amp;amp;publication_year=2019&amp;amp;author=Dollerup%2COL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="98."&gt;&lt;p class="c-article-references__text" id="ref-CR98"&gt;Dollerup, O. L. et al. Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin-resistant men. &lt;i&gt;J. Physiol.&lt;/i&gt; &lt;b&gt;598&lt;/b&gt;, 731–754 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1113/JP278752" data-track-item_id="10.1113/JP278752" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1113%2FJP278752" aria-label="Article reference 98" data-doi="10.1113/JP278752"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXisVyhurvM" aria-label="CAS reference 98"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31710095" aria-label="PubMed reference 98"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 98" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinamide%20riboside%20does%20not%20alter%20mitochondrial%20respiration%2C%20content%20or%20morphology%20in%20skeletal%20muscle%20from%20obese%20and%20insulin-resistant%20men&amp;amp;journal=J.%20Physiol.&amp;amp;doi=10.1113%2FJP278752&amp;amp;volume=598&amp;amp;pages=731-754&amp;amp;publication_year=2020&amp;amp;author=Dollerup%2COL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="99."&gt;&lt;p class="c-article-references__text" id="ref-CR99"&gt;Remie, C. M. E. et al. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. &lt;i&gt;Am. J. Clin. Nutr.&lt;/i&gt; &lt;b&gt;112&lt;/b&gt;, 413–426 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/ajcn/nqaa072" data-track-item_id="10.1093/ajcn/nqaa072" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Fajcn%2Fnqaa072" aria-label="Article reference 99" data-doi="10.1093/ajcn/nqaa072"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32320006" aria-label="PubMed reference 99"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398770" aria-label="PubMed Central reference 99"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 99" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinamide%20riboside%20supplementation%20alters%20body%20composition%20and%20skeletal%20muscle%20acetylcarnitine%20concentrations%20in%20healthy%20obese%20humans&amp;amp;journal=Am.%20J.%20Clin.%20Nutr.&amp;amp;doi=10.1093%2Fajcn%2Fnqaa072&amp;amp;volume=112&amp;amp;pages=413-426&amp;amp;publication_year=2020&amp;amp;author=Remie%2CCME"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="100."&gt;&lt;p class="c-article-references__text" id="ref-CR100"&gt;Dunaif, A. et al. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. &lt;i&gt;Diabetes&lt;/i&gt; &lt;b&gt;41&lt;/b&gt;, 1257–1266 (1992).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.2337/diab.41.10.1257" data-track-item_id="10.2337/diab.41.10.1257" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.2337%2Fdiab.41.10.1257" aria-label="Article reference 100" data-doi="10.2337/diab.41.10.1257"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:STN:280:DyaK3s%2Fht1CqsQ%3D%3D" aria-label="CAS reference 100"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=1397698" aria-label="PubMed reference 100"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 100" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Evidence%20for%20distinctive%20and%20intrinsic%20defects%20in%20insulin%20action%20in%20polycystic%20ovary%20syndrome&amp;amp;journal=Diabetes&amp;amp;doi=10.2337%2Fdiab.41.10.1257&amp;amp;volume=41&amp;amp;pages=1257-1266&amp;amp;publication_year=1992&amp;amp;author=Dunaif%2CA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="101."&gt;&lt;p class="c-article-references__text" id="ref-CR101"&gt;Polderman, K. H., Gooren, L. J., Asscheman, H., Bakker, A. &amp;amp; Heine, R. J. Induction of insulin resistance by androgens and estrogens. &lt;i&gt;J. Clin. Endocrinol. Metab.&lt;/i&gt; &lt;b&gt;79&lt;/b&gt;, 265–271 (1994).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK2cXltVSgs78%3D" aria-label="CAS reference 101"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=8027240" aria-label="PubMed reference 101"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 101" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Induction%20of%20insulin%20resistance%20by%20androgens%20and%20estrogens&amp;amp;journal=J.%20Clin.%20Endocrinol.%20Metab.&amp;amp;volume=79&amp;amp;pages=265-271&amp;amp;publication_year=1994&amp;amp;author=Polderman%2CKH&amp;amp;author=Gooren%2CLJ&amp;amp;author=Asscheman%2CH&amp;amp;author=Bakker%2CA&amp;amp;author=Heine%2CRJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="102."&gt;&lt;p class="c-article-references__text" id="ref-CR102"&gt;Kane, A. E. et al. Long-term NMN treatment increases lifespan and healthspan in mice in a sex dependent manner. Preprint at &lt;i&gt;bioRxiv&lt;/i&gt; &lt;a href="https://doi.org/10.1101/2024.06.21.599604" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2024.06.21.599604"&gt;https://doi.org/10.1101/2024.06.21.599604&lt;/a&gt; (2024).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="103."&gt;&lt;p class="c-article-references__text" id="ref-CR103"&gt;Lapatto, H. A. K. et al. Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study. &lt;i&gt;Sci. Adv.&lt;/i&gt; &lt;b&gt;9&lt;/b&gt;, eadd5163 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/sciadv.add5163" data-track-item_id="10.1126/sciadv.add5163" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fsciadv.add5163" aria-label="Article reference 103" data-doi="10.1126/sciadv.add5163"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36638183" aria-label="PubMed reference 103"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839336" aria-label="PubMed Central reference 103"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 103" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinamide%20riboside%20improves%20muscle%20mitochondrial%20biogenesis%2C%20satellite%20cell%20differentiation%2C%20and%20gut%20microbiota%20in%20a%20twin%20study&amp;amp;journal=Sci.%20Adv.&amp;amp;doi=10.1126%2Fsciadv.add5163&amp;amp;volume=9&amp;amp;publication_year=2023&amp;amp;author=Lapatto%2CHAK"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="104."&gt;&lt;p class="c-article-references__text" id="ref-CR104"&gt;Qiu, Y. et al. NAD&lt;sup&gt;+&lt;/sup&gt; exhaustion by CD38 upregulation contributes to blood pressure elevation and vascular damage in hypertension. &lt;i&gt;Signal Transduct. Target. Ther.&lt;/i&gt; &lt;b&gt;8&lt;/b&gt;, 353 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41392-023-01577-3" data-track-item_id="10.1038/s41392-023-01577-3" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41392-023-01577-3" aria-label="Article reference 104" data-doi="10.1038/s41392-023-01577-3"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXhvFehu7rO" aria-label="CAS reference 104"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37718359" aria-label="PubMed reference 104"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505611" aria-label="PubMed Central reference 104"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 104" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20exhaustion%20by%20CD38%20upregulation%20contributes%20to%20blood%20pressure%20elevation%20and%20vascular%20damage%20in%20hypertension&amp;amp;journal=Signal%20Transduct.%20Target.%20Ther.&amp;amp;doi=10.1038%2Fs41392-023-01577-3&amp;amp;volume=8&amp;amp;publication_year=2023&amp;amp;author=Qiu%2CY"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="105."&gt;&lt;p class="c-article-references__text" id="ref-CR105"&gt;Lund, A. et al. Plasma kynurenines and prognosis in patients with heart failure. &lt;i&gt;PLoS ONE&lt;/i&gt; &lt;b&gt;15&lt;/b&gt;, e0227365 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1371/journal.pone.0227365" data-track-item_id="10.1371/journal.pone.0227365" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1371%2Fjournal.pone.0227365" aria-label="Article reference 105" data-doi="10.1371/journal.pone.0227365"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXisVemtbw%3D" aria-label="CAS reference 105"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31923223" aria-label="PubMed reference 105"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953806" aria-label="PubMed Central reference 105"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 105" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Plasma%20kynurenines%20and%20prognosis%20in%20patients%20with%20heart%20failure&amp;amp;journal=PLoS%20ONE&amp;amp;doi=10.1371%2Fjournal.pone.0227365&amp;amp;volume=15&amp;amp;publication_year=2020&amp;amp;author=Lund%2CA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="106."&gt;&lt;p class="c-article-references__text" id="ref-CR106"&gt;Pedersen, E. R. et al. Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris. &lt;i&gt;Arterioscler. Thromb. Vasc. Biol.&lt;/i&gt; &lt;b&gt;35&lt;/b&gt;, 455–462 (2015).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1161/ATVBAHA.114.304674" data-track-item_id="10.1161/ATVBAHA.114.304674" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1161%2FATVBAHA.114.304674" aria-label="Article reference 106" data-doi="10.1161/ATVBAHA.114.304674"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXhtFyqs7s%3D" aria-label="CAS reference 106"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=25524770" aria-label="PubMed reference 106"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 106" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Associations%20of%20plasma%20kynurenines%20with%20risk%20of%20acute%20myocardial%20infarction%20in%20patients%20with%20stable%20angina%20pectoris&amp;amp;journal=Arterioscler.%20Thromb.%20Vasc.%20Biol.&amp;amp;doi=10.1161%2FATVBAHA.114.304674&amp;amp;volume=35&amp;amp;pages=455-462&amp;amp;publication_year=2015&amp;amp;author=Pedersen%2CER"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="107."&gt;&lt;p class="c-article-references__text" id="ref-CR107"&gt;Shi, B. et al. Targeting gut microbiota-derived kynurenine to predict and protect the remodeling of the pressure-overloaded young heart. &lt;i&gt;Sci. Adv.&lt;/i&gt; &lt;b&gt;9&lt;/b&gt;, eadg7417 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/sciadv.adg7417" data-track-item_id="10.1126/sciadv.adg7417" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fsciadv.adg7417" aria-label="Article reference 107" data-doi="10.1126/sciadv.adg7417"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXhsV2lsbbJ" aria-label="CAS reference 107"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37450589" aria-label="PubMed reference 107"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348671" aria-label="PubMed Central reference 107"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 107" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Targeting%20gut%20microbiota-derived%20kynurenine%20to%20predict%20and%20protect%20the%20remodeling%20of%20the%20pressure-overloaded%20young%20heart&amp;amp;journal=Sci.%20Adv.&amp;amp;doi=10.1126%2Fsciadv.adg7417&amp;amp;volume=9&amp;amp;publication_year=2023&amp;amp;author=Shi%2CB"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="108."&gt;&lt;p class="c-article-references__text" id="ref-CR108"&gt;Konishi, M. et al. Impact of plasma kynurenine level on functional capacity and outcome in heart failure - results from Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). &lt;i&gt;Circ. J.&lt;/i&gt; &lt;b&gt;81&lt;/b&gt;, 52–61 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1253/circj.CJ-16-0791" data-track-item_id="10.1253/circj.CJ-16-0791" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1253%2Fcircj.CJ-16-0791" aria-label="Article reference 108" data-doi="10.1253/circj.CJ-16-0791"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27904018" aria-label="PubMed reference 108"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 108" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Impact%20of%20plasma%20kynurenine%20level%20on%20functional%20capacity%20and%20outcome%20in%20heart%20failure%20-%20results%20from%20Studies%20Investigating%20Co-morbidities%20Aggravating%20Heart%20Failure%20%28SICA-HF%29&amp;amp;journal=Circ.%20J.&amp;amp;doi=10.1253%2Fcircj.CJ-16-0791&amp;amp;volume=81&amp;amp;pages=52-61&amp;amp;publication_year=2016&amp;amp;author=Konishi%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="109."&gt;&lt;p class="c-article-references__text" id="ref-CR109"&gt;de Picciotto, N. E. et al. Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice. &lt;i&gt;Aging Cell&lt;/i&gt; &lt;b&gt;15&lt;/b&gt;, 522–530 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/acel.12461" data-track-item_id="10.1111/acel.12461" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Facel.12461" aria-label="Article reference 109" data-doi="10.1111/acel.12461"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26970090" aria-label="PubMed reference 109"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854911" aria-label="PubMed Central reference 109"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 109" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinamide%20mononucleotide%20supplementation%20reverses%20vascular%20dysfunction%20and%20oxidative%20stress%20with%20aging%20in%20mice&amp;amp;journal=Aging%20Cell&amp;amp;doi=10.1111%2Facel.12461&amp;amp;volume=15&amp;amp;pages=522-530&amp;amp;publication_year=2016&amp;amp;author=Picciotto%2CNE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="110."&gt;&lt;p class="c-article-references__text" id="ref-CR110"&gt;Abdellatif, M., Bugger, H., Kroemer, G. &amp;amp; Sedej, S. NAD&lt;sup&gt;+&lt;/sup&gt; and vascular dysfunction: from mechanisms to therapeutic opportunities. &lt;i&gt;J. Lipid Atheroscler.&lt;/i&gt; &lt;b&gt;11&lt;/b&gt;, 111–132 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.12997/jla.2022.11.2.111" data-track-item_id="10.12997/jla.2022.11.2.111" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.12997%2Fjla.2022.11.2.111" aria-label="Article reference 110" data-doi="10.12997/jla.2022.11.2.111"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38Xis1KgsbjE" aria-label="CAS reference 110"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=35656147" aria-label="PubMed reference 110"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133775" aria-label="PubMed Central reference 110"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 110" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20and%20vascular%20dysfunction%3A%20from%20mechanisms%20to%20therapeutic%20opportunities&amp;amp;journal=J.%20Lipid%20Atheroscler.&amp;amp;doi=10.12997%2Fjla.2022.11.2.111&amp;amp;volume=11&amp;amp;pages=111-132&amp;amp;publication_year=2022&amp;amp;author=Abdellatif%2CM&amp;amp;author=Bugger%2CH&amp;amp;author=Kroemer%2CG&amp;amp;author=Sedej%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="111."&gt;&lt;p class="c-article-references__text" id="ref-CR111"&gt;Abdellatif, M., Sedej, S. &amp;amp; Kroemer, G. NAD&lt;sup&gt;+&lt;/sup&gt; metabolism in cardiac health, aging, and disease. &lt;i&gt;Circulation&lt;/i&gt; &lt;b&gt;144&lt;/b&gt;, 1795–1817 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1161/CIRCULATIONAHA.121.056589" data-track-item_id="10.1161/CIRCULATIONAHA.121.056589" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1161%2FCIRCULATIONAHA.121.056589" aria-label="Article reference 111" data-doi="10.1161/CIRCULATIONAHA.121.056589"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXisFyitb7L" aria-label="CAS reference 111"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34843394" aria-label="PubMed reference 111"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 111" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20metabolism%20in%20cardiac%20health%2C%20aging%2C%20and%20disease&amp;amp;journal=Circulation&amp;amp;doi=10.1161%2FCIRCULATIONAHA.121.056589&amp;amp;volume=144&amp;amp;pages=1795-1817&amp;amp;publication_year=2021&amp;amp;author=Abdellatif%2CM&amp;amp;author=Sedej%2CS&amp;amp;author=Kroemer%2CG"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="112."&gt;&lt;p class="c-article-references__text" id="ref-CR112"&gt;Wang, D. D. et al. Safety and tolerability of nicotinamide riboside in heart failure with reduced ejection fraction. &lt;i&gt;JACC Basic Transl. Sci.&lt;/i&gt; &lt;b&gt;7&lt;/b&gt;, 1183–1196 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.jacbts.2022.06.012" data-track-item_id="10.1016/j.jacbts.2022.06.012" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.jacbts.2022.06.012" aria-label="Article reference 112" data-doi="10.1016/j.jacbts.2022.06.012"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36644285" aria-label="PubMed reference 112"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831861" aria-label="PubMed Central reference 112"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 112" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Safety%20and%20tolerability%20of%20nicotinamide%20riboside%20in%20heart%20failure%20with%20reduced%20ejection%20fraction&amp;amp;journal=JACC%20Basic%20Transl.%20Sci.&amp;amp;doi=10.1016%2Fj.jacbts.2022.06.012&amp;amp;volume=7&amp;amp;pages=1183-1196&amp;amp;publication_year=2022&amp;amp;author=Wang%2CDD"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="113."&gt;&lt;p class="c-article-references__text" id="ref-CR113"&gt;Fang, E. F. &amp;amp; Tao, J. Targeting on the NAD&lt;sup&gt;+&lt;/sup&gt;-mitophagy axis to treat cardiovascular disease. &lt;i&gt;Aging Med.&lt;/i&gt; &lt;b&gt;3&lt;/b&gt;, 151–152 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/agm2.12123" data-track-item_id="10.1002/agm2.12123" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fagm2.12123" aria-label="Article reference 113" data-doi="10.1002/agm2.12123"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 113" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Targeting%20on%20the%20NAD%2B-mitophagy%20axis%20to%20treat%20cardiovascular%20disease&amp;amp;journal=Aging%20Med.&amp;amp;doi=10.1002%2Fagm2.12123&amp;amp;volume=3&amp;amp;pages=151-152&amp;amp;publication_year=2020&amp;amp;author=Fang%2CEF&amp;amp;author=Tao%2CJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="114."&gt;&lt;p class="c-article-references__text" id="ref-CR114"&gt;Canner, P. L. et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. &lt;i&gt;J. Am. Coll. Cardiol.&lt;/i&gt; &lt;b&gt;8&lt;/b&gt;, 1245–1255 (1986).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0735-1097(86)80293-5" data-track-item_id="10.1016/S0735-1097(86)80293-5" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0735-1097%2886%2980293-5" aria-label="Article reference 114" data-doi="10.1016/S0735-1097(86)80293-5"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:STN:280:DyaL2s%2FlvVCqtQ%3D%3D" aria-label="CAS reference 114"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=3782631" aria-label="PubMed reference 114"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 114" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Fifteen%20year%20mortality%20in%20Coronary%20Drug%20Project%20patients%3A%20long-term%20benefit%20with%20niacin&amp;amp;journal=J.%20Am.%20Coll.%20Cardiol.&amp;amp;doi=10.1016%2FS0735-1097%2886%2980293-5&amp;amp;volume=8&amp;amp;pages=1245-1255&amp;amp;publication_year=1986&amp;amp;author=Canner%2CPL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="115."&gt;&lt;p class="c-article-references__text" id="ref-CR115"&gt;Maher, V. M. et al. Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a). &lt;i&gt;JAMA&lt;/i&gt; &lt;b&gt;274&lt;/b&gt;, 1771–1774 (1995).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1001/jama.1995.03530220037029" data-track-item_id="10.1001/jama.1995.03530220037029" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1001%2Fjama.1995.03530220037029" aria-label="Article reference 115" data-doi="10.1001/jama.1995.03530220037029"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:STN:280:DyaK28%2FpslSgtg%3D%3D" aria-label="CAS reference 115"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=7500507" aria-label="PubMed reference 115"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 115" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Effects%20of%20lowering%20elevated%20LDL%20cholesterol%20on%20the%20cardiovascular%20risk%20of%20lipoprotein%28a%29&amp;amp;journal=JAMA&amp;amp;doi=10.1001%2Fjama.1995.03530220037029&amp;amp;volume=274&amp;amp;pages=1771-1774&amp;amp;publication_year=1995&amp;amp;author=Maher%2CVM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="116."&gt;&lt;p class="c-article-references__text" id="ref-CR116"&gt;Matthan, N. R., Giovanni, A., Schaefer, E. J., Brown, B. G. &amp;amp; Lichtenstein, A. H. Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL. &lt;i&gt;J. Lipid Res.&lt;/i&gt; &lt;b&gt;44&lt;/b&gt;, 800–806 (2003).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1194/jlr.M200439-JLR200" data-track-item_id="10.1194/jlr.M200439-JLR200" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1194%2Fjlr.M200439-JLR200" aria-label="Article reference 116" data-doi="10.1194/jlr.M200439-JLR200"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXjtFCrtrc%3D" aria-label="CAS reference 116"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=12562840" aria-label="PubMed reference 116"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 116" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Impact%20of%20simvastatin%2C%20niacin%2C%20and%2For%20antioxidants%20on%20cholesterol%20metabolism%20in%20CAD%20patients%20with%20low%20HDL&amp;amp;journal=J.%20Lipid%20Res.&amp;amp;doi=10.1194%2Fjlr.M200439-JLR200&amp;amp;volume=44&amp;amp;pages=800-806&amp;amp;publication_year=2003&amp;amp;author=Matthan%2CNR&amp;amp;author=Giovanni%2CA&amp;amp;author=Schaefer%2CEJ&amp;amp;author=Brown%2CBG&amp;amp;author=Lichtenstein%2CAH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="117."&gt;&lt;p class="c-article-references__text" id="ref-CR117"&gt;Phan, B. A. et al. Effects of niacin on glucose levels, coronary stenosis progression, and clinical events in subjects with normal baseline glucose levels (&amp;lt;100 mg/dl): a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), HDL-Atherosclerosis Treatment Study (HATS), Armed Forces Regression Study (AFREGS), and Carotid Plaque Composition by MRI during lipid-lowering (CPC) study. &lt;i&gt;Am. J. Cardiol.&lt;/i&gt; &lt;b&gt;111&lt;/b&gt;, 352–355 (2013).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.amjcard.2012.09.034" data-track-item_id="10.1016/j.amjcard.2012.09.034" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.amjcard.2012.09.034" aria-label="Article reference 117" data-doi="10.1016/j.amjcard.2012.09.034"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC38XhslSmtLfJ" aria-label="CAS reference 117"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=23168285" aria-label="PubMed reference 117"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 117" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Effects%20of%20niacin%20on%20glucose%20levels%2C%20coronary%20stenosis%20progression%2C%20and%20clinical%20events%20in%20subjects%20with%20normal%20baseline%20glucose%20levels%20%28%3C100%E2%80%89mg%2Fdl%29%3A%20a%20combined%20analysis%20of%20the%20Familial%20Atherosclerosis%20Treatment%20Study%20%28FATS%29%2C%20HDL-Atherosclerosis%20Treatment%20Study%20%28HATS%29%2C%20Armed%20Forces%20Regression%20Study%20%28AFREGS%29%2C%20and%20Carotid%20Plaque%20Composition%20by%20MRI%20during%20lipid-lowering%20%28CPC%29%20study&amp;amp;journal=Am.%20J.%20Cardiol.&amp;amp;doi=10.1016%2Fj.amjcard.2012.09.034&amp;amp;volume=111&amp;amp;pages=352-355&amp;amp;publication_year=2013&amp;amp;author=Phan%2CBA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="118."&gt;&lt;p class="c-article-references__text" id="ref-CR118"&gt;Haynes, R. et al. Serious adverse effects of extended-release niacin/laropiprant: results from the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial. &lt;i&gt;Clin. Ther.&lt;/i&gt; &lt;b&gt;41&lt;/b&gt;, 1767–1777 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.clinthera.2019.06.012" data-track-item_id="10.1016/j.clinthera.2019.06.012" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.clinthera.2019.06.012" aria-label="Article reference 118" data-doi="10.1016/j.clinthera.2019.06.012"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXhsFKhtr3I" aria-label="CAS reference 118"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31447131" aria-label="PubMed reference 118"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 118" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Serious%20adverse%20effects%20of%20extended-release%20niacin%2Flaropiprant%3A%20results%20from%20the%20Heart%20Protection%20Study%202-Treatment%20of%20HDL%20to%20Reduce%20the%20Incidence%20of%20Vascular%20Events%20%28HPS2-THRIVE%29%20Trial&amp;amp;journal=Clin.%20Ther.&amp;amp;doi=10.1016%2Fj.clinthera.2019.06.012&amp;amp;volume=41&amp;amp;pages=1767-1777&amp;amp;publication_year=2019&amp;amp;author=Haynes%2CR"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="119."&gt;&lt;p class="c-article-references__text" id="ref-CR119"&gt;Group, H. T. C. HPS2-THRIVE randomized placebo-controlled trial in 25,673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment. &lt;i&gt;Eur. Heart J.&lt;/i&gt; &lt;b&gt;34&lt;/b&gt;, 1279–1291 (2013).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/eurheartj/eht055" data-track-item_id="10.1093/eurheartj/eht055" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Feurheartj%2Feht055" aria-label="Article reference 119" data-doi="10.1093/eurheartj/eht055"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 119" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=HPS2-THRIVE%20randomized%20placebo-controlled%20trial%20in%2025%2C673%20high-risk%20patients%20of%20ER%20niacin%2Flaropiprant%3A%20trial%20design%2C%20pre-specified%20muscle%20and%20liver%20outcomes%2C%20and%20reasons%20for%20stopping%20study%20treatment&amp;amp;journal=Eur.%20Heart%20J.&amp;amp;doi=10.1093%2Feurheartj%2Feht055&amp;amp;volume=34&amp;amp;pages=1279-1291&amp;amp;publication_year=2013&amp;amp;author=Group%2CHTC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="120."&gt;&lt;p class="c-article-references__text" id="ref-CR120"&gt;Teo, K. K. et al. Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) trial. &lt;i&gt;Stroke&lt;/i&gt; &lt;b&gt;44&lt;/b&gt;, 2688–2693 (2013).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1161/STROKEAHA.113.001529" data-track-item_id="10.1161/STROKEAHA.113.001529" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1161%2FSTROKEAHA.113.001529" aria-label="Article reference 120" data-doi="10.1161/STROKEAHA.113.001529"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXhsFyktrzM" aria-label="CAS reference 120"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=23881958" aria-label="PubMed reference 120"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886540" aria-label="PubMed Central reference 120"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 120" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Extended-release%20niacin%20therapy%20and%20risk%20of%20ischemic%20stroke%20in%20patients%20with%20cardiovascular%20disease%3A%20the%20Atherothrombosis%20Intervention%20in%20Metabolic%20Syndrome%20with%20low%20HDL%2FHigh%20Triglycerides%3A%20Impact%20on%20Global%20Health%20Outcome%20%28AIM-HIGH%29%20trial&amp;amp;journal=Stroke&amp;amp;doi=10.1161%2FSTROKEAHA.113.001529&amp;amp;volume=44&amp;amp;pages=2688-2693&amp;amp;publication_year=2013&amp;amp;author=Teo%2CKK"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="121."&gt;&lt;p class="c-article-references__text" id="ref-CR121"&gt;Cheung, M. C., Zhao, X. Q., Chait, A., Albers, J. J. &amp;amp; Brown, B. G. Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. &lt;i&gt;Arterioscler. Thromb. Vasc. Biol.&lt;/i&gt; &lt;b&gt;21&lt;/b&gt;, 1320–1326 (2001).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1161/hq0801.095151" data-track-item_id="10.1161/hq0801.095151" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1161%2Fhq0801.095151" aria-label="Article reference 121" data-doi="10.1161/hq0801.095151"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD3MXmtVartrw%3D" aria-label="CAS reference 121"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=11498460" aria-label="PubMed reference 121"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 121" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Antioxidant%20supplements%20block%20the%20response%20of%20HDL%20to%20simvastatin-niacin%20therapy%20in%20patients%20with%20coronary%20artery%20disease%20and%20low%20HDL&amp;amp;journal=Arterioscler.%20Thromb.%20Vasc.%20Biol.&amp;amp;doi=10.1161%2Fhq0801.095151&amp;amp;volume=21&amp;amp;pages=1320-1326&amp;amp;publication_year=2001&amp;amp;author=Cheung%2CMC&amp;amp;author=Zhao%2CXQ&amp;amp;author=Chait%2CA&amp;amp;author=Albers%2CJJ&amp;amp;author=Brown%2CBG"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="122."&gt;&lt;p class="c-article-references__text" id="ref-CR122"&gt;McDermott, M. M. et al. Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial. &lt;i&gt;Nat. Commun.&lt;/i&gt; &lt;b&gt;15&lt;/b&gt;, 5046 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-024-49092-5" data-track-item_id="10.1038/s41467-024-49092-5" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-024-49092-5" aria-label="Article reference 122" data-doi="10.1038/s41467-024-49092-5"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXhtl2mt7jF" aria-label="CAS reference 122"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38871717" aria-label="PubMed reference 122"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11176364" aria-label="PubMed Central reference 122"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 122" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinamide%20riboside%20for%20peripheral%20artery%20disease%3A%20the%20NICE%20randomized%20clinical%20trial&amp;amp;journal=Nat.%20Commun.&amp;amp;doi=10.1038%2Fs41467-024-49092-5&amp;amp;volume=15&amp;amp;publication_year=2024&amp;amp;author=McDermott%2CMM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="123."&gt;&lt;p class="c-article-references__text" id="ref-CR123"&gt;Abdellatif, M. et al. Nicotinamide for the treatment of heart failure with preserved ejection fraction. &lt;i&gt;Sci. Transl. Med.&lt;/i&gt; &lt;a href="https://doi.org/10.1126/scitranslmed.abd7064" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1126/scitranslmed.abd7064"&gt;https://doi.org/10.1126/scitranslmed.abd7064&lt;/a&gt; (2021).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="124."&gt;&lt;p class="c-article-references__text" id="ref-CR124"&gt;Gariani, K. et al. Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease. &lt;i&gt;J. Hepatol.&lt;/i&gt; &lt;b&gt;66&lt;/b&gt;, 132–141 (2017).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.jhep.2016.08.024" data-track-item_id="10.1016/j.jhep.2016.08.024" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.jhep.2016.08.024" aria-label="Article reference 124" data-doi="10.1016/j.jhep.2016.08.024"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28Xhs1SitrjO" aria-label="CAS reference 124"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27663419" aria-label="PubMed reference 124"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 124" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Inhibiting%20poly%20ADP-ribosylation%20increases%20fatty%20acid%20oxidation%20and%20protects%20against%20fatty%20liver%20disease&amp;amp;journal=J.%20Hepatol.&amp;amp;doi=10.1016%2Fj.jhep.2016.08.024&amp;amp;volume=66&amp;amp;pages=132-141&amp;amp;publication_year=2017&amp;amp;author=Gariani%2CK"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="125."&gt;&lt;p class="c-article-references__text" id="ref-CR125"&gt;Dellinger, R. W. et al. Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: a double-blind, placebo-controlled clinical trial. &lt;i&gt;Hepatology&lt;/i&gt; &lt;b&gt;78&lt;/b&gt;, 863–877 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/hep.32778" data-track-item_id="10.1002/hep.32778" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fhep.32778" aria-label="Article reference 125" data-doi="10.1002/hep.32778"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36082508" aria-label="PubMed reference 125"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 125" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinamide%20riboside%20and%20pterostilbene%20reduces%20markers%20of%20hepatic%20inflammation%20in%20NAFLD%3A%20a%20double-blind%2C%20placebo-controlled%20clinical%20trial&amp;amp;journal=Hepatology&amp;amp;doi=10.1002%2Fhep.32778&amp;amp;volume=78&amp;amp;pages=863-877&amp;amp;publication_year=2023&amp;amp;author=Dellinger%2CRW"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="126."&gt;&lt;p class="c-article-references__text" id="ref-CR126"&gt;Pirinen, E. et al. Niacin cures systemic NAD&lt;sup&gt;+&lt;/sup&gt; deficiency and improves muscle performance in adult-onset mitochondrial myopathy. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;b&gt;31&lt;/b&gt;, 1078–1090 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2020.04.008" data-track-item_id="10.1016/j.cmet.2020.04.008" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2020.04.008" aria-label="Article reference 126" data-doi="10.1016/j.cmet.2020.04.008"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXovVGgsr4%3D" aria-label="CAS reference 126"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32386566" aria-label="PubMed reference 126"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 126" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Niacin%20cures%20systemic%20NAD%2B%20deficiency%20and%20improves%20muscle%20performance%20in%20adult-onset%20mitochondrial%20myopathy&amp;amp;journal=Cell%20Metab.&amp;amp;doi=10.1016%2Fj.cmet.2020.04.008&amp;amp;volume=31&amp;amp;pages=1078-1090&amp;amp;publication_year=2020&amp;amp;author=Pirinen%2CE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="127."&gt;&lt;p class="c-article-references__text" id="ref-CR127"&gt;Mukherjee, S. et al. Nicotinamide adenine dinucleotide biosynthesis promotes liver regeneration. &lt;i&gt;Hepatology&lt;/i&gt; &lt;b&gt;65&lt;/b&gt;, 616–630 (2017).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/hep.28912" data-track-item_id="10.1002/hep.28912" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fhep.28912" aria-label="Article reference 127" data-doi="10.1002/hep.28912"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXhtlCnsrg%3D" aria-label="CAS reference 127"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27809334" aria-label="PubMed reference 127"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 127" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinamide%20adenine%20dinucleotide%20biosynthesis%20promotes%20liver%20regeneration&amp;amp;journal=Hepatology&amp;amp;doi=10.1002%2Fhep.28912&amp;amp;volume=65&amp;amp;pages=616-630&amp;amp;publication_year=2017&amp;amp;author=Mukherjee%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="128."&gt;&lt;p class="c-article-references__text" id="ref-CR128"&gt;Dall, M. et al. Hepatocyte-specific perturbation of NAD&lt;sup&gt;+&lt;/sup&gt; biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis-like phenotypes. &lt;i&gt;J. Biol. Chem.&lt;/i&gt; &lt;b&gt;297&lt;/b&gt;, 101388 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.jbc.2021.101388" data-track-item_id="10.1016/j.jbc.2021.101388" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.jbc.2021.101388" aria-label="Article reference 128" data-doi="10.1016/j.jbc.2021.101388"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXis1Kmtb7N" aria-label="CAS reference 128"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34762911" aria-label="PubMed reference 128"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648833" aria-label="PubMed Central reference 128"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 128" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Hepatocyte-specific%20perturbation%20of%20NAD%2B%20biosynthetic%20pathways%20in%20mice%20induces%20reversible%20nonalcoholic%20steatohepatitis-like%20phenotypes&amp;amp;journal=J.%20Biol.%20Chem.&amp;amp;doi=10.1016%2Fj.jbc.2021.101388&amp;amp;volume=297&amp;amp;publication_year=2021&amp;amp;author=Dall%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="129."&gt;&lt;p class="c-article-references__text" id="ref-CR129"&gt;Li, D. J. et al. NAD&lt;sup&gt;+&lt;/sup&gt;-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5/irisin. &lt;i&gt;Theranostics&lt;/i&gt; &lt;b&gt;11&lt;/b&gt;, 4381–4402 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.7150/thno.53652" data-track-item_id="10.7150/thno.53652" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.7150%2Fthno.53652" aria-label="Article reference 129" data-doi="10.7150/thno.53652"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33754067" aria-label="PubMed reference 129"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977447" aria-label="PubMed Central reference 129"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 129" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B-boosting%20therapy%20alleviates%20nonalcoholic%20fatty%20liver%20disease%20via%20stimulating%20a%20novel%20exerkine%20Fndc5%2Firisin&amp;amp;journal=Theranostics&amp;amp;doi=10.7150%2Fthno.53652&amp;amp;volume=11&amp;amp;pages=4381-4402&amp;amp;publication_year=2021&amp;amp;author=Li%2CDJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="130."&gt;&lt;p class="c-article-references__text" id="ref-CR130"&gt;Zhang, C. et al. The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non-alcoholic fatty liver disease. &lt;i&gt;Mol. Syst. Biol.&lt;/i&gt; &lt;b&gt;16&lt;/b&gt;, e9495 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.15252/msb.209495" data-track-item_id="10.15252/msb.209495" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.15252%2Fmsb.209495" aria-label="Article reference 130" data-doi="10.15252/msb.209495"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXnvFKnurc%3D" aria-label="CAS reference 130"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32337855" aria-label="PubMed reference 130"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184219" aria-label="PubMed Central reference 130"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 130" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20acute%20effect%20of%20metabolic%20cofactor%20supplementation%3A%20a%20potential%20therapeutic%20strategy%20against%20non-alcoholic%20fatty%20liver%20disease&amp;amp;journal=Mol.%20Syst.%20Biol.&amp;amp;doi=10.15252%2Fmsb.209495&amp;amp;volume=16&amp;amp;publication_year=2020&amp;amp;author=Zhang%2CC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="131."&gt;&lt;p class="c-article-references__text" id="ref-CR131"&gt;Basse, A. L. et al. Nampt controls skeletal muscle development by maintaining Ca&lt;sup&gt;2+&lt;/sup&gt; homeostasis and mitochondrial integrity. &lt;i&gt;Mol. Metab.&lt;/i&gt; &lt;b&gt;53&lt;/b&gt;, 101271 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.molmet.2021.101271" data-track-item_id="10.1016/j.molmet.2021.101271" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.molmet.2021.101271" aria-label="Article reference 131" data-doi="10.1016/j.molmet.2021.101271"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXhsVansr%2FK" aria-label="CAS reference 131"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34119711" aria-label="PubMed reference 131"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259345" aria-label="PubMed Central reference 131"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 131" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nampt%20controls%20skeletal%20muscle%20development%20by%20maintaining%20Ca2%2B%20homeostasis%20and%20mitochondrial%20integrity&amp;amp;journal=Mol.%20Metab.&amp;amp;doi=10.1016%2Fj.molmet.2021.101271&amp;amp;volume=53&amp;amp;publication_year=2021&amp;amp;author=Basse%2CAL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="132."&gt;&lt;p class="c-article-references__text" id="ref-CR132"&gt;Frederick, D. W. et al. Loss of NAD homeostasis leads to progressive and reversible degeneration of skeletal muscle. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;b&gt;24&lt;/b&gt;, 269–282 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2016.07.005" data-track-item_id="10.1016/j.cmet.2016.07.005" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2016.07.005" aria-label="Article reference 132" data-doi="10.1016/j.cmet.2016.07.005"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28Xht1GhurvO" aria-label="CAS reference 132"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27508874" aria-label="PubMed reference 132"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985182" aria-label="PubMed Central reference 132"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 132" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Loss%20of%20NAD%20homeostasis%20leads%20to%20progressive%20and%20reversible%20degeneration%20of%20skeletal%20muscle&amp;amp;journal=Cell%20Metab.&amp;amp;doi=10.1016%2Fj.cmet.2016.07.005&amp;amp;volume=24&amp;amp;pages=269-282&amp;amp;publication_year=2016&amp;amp;author=Frederick%2CDW"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="133."&gt;&lt;p class="c-article-references__text" id="ref-CR133"&gt;Chubanava, S. et al. NAD depletion in skeletal muscle does not compromise muscle function or accelerate aging. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;a href="https://doi.org/10.1016/j.cmet.2025.04.002" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/j.cmet.2025.04.002"&gt;https://doi.org/10.1016/j.cmet.2025.04.002&lt;/a&gt; (2025).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="134."&gt;&lt;p class="c-article-references__text" id="ref-CR134"&gt;Ryu, D. et al. NAD&lt;sup&gt;+&lt;/sup&gt; repletion improves muscle function in muscular dystrophy and counters global PARylation. &lt;i&gt;Sci. Transl. Med.&lt;/i&gt; &lt;b&gt;8&lt;/b&gt;, 361ra139 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/scitranslmed.aaf5504" data-track-item_id="10.1126/scitranslmed.aaf5504" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscitranslmed.aaf5504" aria-label="Article reference 134" data-doi="10.1126/scitranslmed.aaf5504"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27798264" aria-label="PubMed reference 134"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535761" aria-label="PubMed Central reference 134"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 134" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20repletion%20improves%20muscle%20function%20in%20muscular%20dystrophy%20and%20counters%20global%20PARylation&amp;amp;journal=Sci.%20Transl.%20Med.&amp;amp;doi=10.1126%2Fscitranslmed.aaf5504&amp;amp;volume=8&amp;amp;publication_year=2016&amp;amp;author=Ryu%2CD"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="135."&gt;&lt;p class="c-article-references__text" id="ref-CR135"&gt;de Zelicourt, A. et al. CD38-NADase is a new major contributor to Duchenne muscular dystrophic phenotype. &lt;i&gt;EMBO Mol. Med.&lt;/i&gt; &lt;b&gt;14&lt;/b&gt;, e12860 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.15252/emmm.202012860" data-track-item_id="10.15252/emmm.202012860" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.15252%2Femmm.202012860" aria-label="Article reference 135" data-doi="10.15252/emmm.202012860"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=35298089" aria-label="PubMed reference 135"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081905" aria-label="PubMed Central reference 135"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 135" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=CD38-NADase%20is%20a%20new%20major%20contributor%20to%20Duchenne%20muscular%20dystrophic%20phenotype&amp;amp;journal=EMBO%20Mol.%20Med.&amp;amp;doi=10.15252%2Femmm.202012860&amp;amp;volume=14&amp;amp;publication_year=2022&amp;amp;author=Zelicourt%2CA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="136."&gt;&lt;p class="c-article-references__text" id="ref-CR136"&gt;Elhassan, Y. S. et al. Nicotinamide riboside augments the aged human skeletal muscle NAD&lt;sup&gt;+&lt;/sup&gt; metabolome and induces transcriptomic and anti-inflammatory signatures. &lt;i&gt;Cell Rep.&lt;/i&gt; &lt;b&gt;28&lt;/b&gt;, 1717–1728 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.celrep.2019.07.043" data-track-item_id="10.1016/j.celrep.2019.07.043" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.celrep.2019.07.043" aria-label="Article reference 136" data-doi="10.1016/j.celrep.2019.07.043"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXhsF2ms7zN" aria-label="CAS reference 136"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31412242" aria-label="PubMed reference 136"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702140" aria-label="PubMed Central reference 136"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 136" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinamide%20riboside%20augments%20the%20aged%20human%20skeletal%20muscle%20NAD%2B%20metabolome%20and%20induces%20transcriptomic%20and%20anti-inflammatory%20signatures&amp;amp;journal=Cell%20Rep.&amp;amp;doi=10.1016%2Fj.celrep.2019.07.043&amp;amp;volume=28&amp;amp;pages=1717-1728&amp;amp;publication_year=2019&amp;amp;author=Elhassan%2CYS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="137."&gt;&lt;p class="c-article-references__text" id="ref-CR137"&gt;Ito, K. &amp;amp; Barnes, P. J. COPD as a disease of accelerated lung aging. &lt;i&gt;Chest&lt;/i&gt; &lt;b&gt;135&lt;/b&gt;, 173–180 (2009).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1378/chest.08-1419" data-track-item_id="10.1378/chest.08-1419" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1378%2Fchest.08-1419" aria-label="Article reference 137" data-doi="10.1378/chest.08-1419"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=19136405" aria-label="PubMed reference 137"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 137" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=COPD%20as%20a%20disease%20of%20accelerated%20lung%20aging&amp;amp;journal=Chest&amp;amp;doi=10.1378%2Fchest.08-1419&amp;amp;volume=135&amp;amp;pages=173-180&amp;amp;publication_year=2009&amp;amp;author=Ito%2CK&amp;amp;author=Barnes%2CPJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="138."&gt;&lt;p class="c-article-references__text" id="ref-CR138"&gt;Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. &amp;amp; Kroemer, G. Hallmarks of aging: an expanding universe. &lt;i&gt;Cell&lt;/i&gt; &lt;b&gt;186&lt;/b&gt;, 243–278 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cell.2022.11.001" data-track-item_id="10.1016/j.cell.2022.11.001" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2022.11.001" aria-label="Article reference 138" data-doi="10.1016/j.cell.2022.11.001"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXivVyitQ%3D%3D" aria-label="CAS reference 138"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36599349" aria-label="PubMed reference 138"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 138" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Hallmarks%20of%20aging%3A%20an%20expanding%20universe&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2022.11.001&amp;amp;volume=186&amp;amp;pages=243-278&amp;amp;publication_year=2023&amp;amp;author=Lopez-Otin%2CC&amp;amp;author=Blasco%2CMA&amp;amp;author=Partridge%2CL&amp;amp;author=Serrano%2CM&amp;amp;author=Kroemer%2CG"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="139."&gt;&lt;p class="c-article-references__text" id="ref-CR139"&gt;Norheim, K. L. et al. Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial. &lt;i&gt;Nat. Aging&lt;/i&gt; &lt;a href="https://doi.org/10.1038/s43587-024-00758-1" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1038/s43587-024-00758-1"&gt;https://doi.org/10.1038/s43587-024-00758-1&lt;/a&gt; (2024).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="140."&gt;&lt;p class="c-article-references__text" id="ref-CR140"&gt;Ghosh, T. S., Shanahan, F. &amp;amp; O’Toole, P. W. The gut microbiome as a modulator of healthy ageing. &lt;i&gt;Nat. Rev. Gastroenterol. Hepatol.&lt;/i&gt; &lt;b&gt;19&lt;/b&gt;, 565–584 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41575-022-00605-x" data-track-item_id="10.1038/s41575-022-00605-x" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41575-022-00605-x" aria-label="Article reference 140" data-doi="10.1038/s41575-022-00605-x"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=35468952" aria-label="PubMed reference 140"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035980" aria-label="PubMed Central reference 140"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 140" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20gut%20microbiome%20as%20a%20modulator%20of%20healthy%20ageing&amp;amp;journal=Nat.%20Rev.%20Gastroenterol.%20Hepatol.&amp;amp;doi=10.1038%2Fs41575-022-00605-x&amp;amp;volume=19&amp;amp;pages=565-584&amp;amp;publication_year=2022&amp;amp;author=Ghosh%2CTS&amp;amp;author=Shanahan%2CF&amp;amp;author=O%E2%80%99Toole%2CPW"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="141."&gt;&lt;p class="c-article-references__text" id="ref-CR141"&gt;Shats, I. et al. Bacteria boost mammalian host NAD metabolism by engaging the deamidated biosynthesis pathway. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;b&gt;31&lt;/b&gt;, 564–579 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2020.02.001" data-track-item_id="10.1016/j.cmet.2020.02.001" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2020.02.001" aria-label="Article reference 141" data-doi="10.1016/j.cmet.2020.02.001"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXlt1egtbw%3D" aria-label="CAS reference 141"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32130883" aria-label="PubMed reference 141"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194078" aria-label="PubMed Central reference 141"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 141" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Bacteria%20boost%20mammalian%20host%20NAD%20metabolism%20by%20engaging%20the%20deamidated%20biosynthesis%20pathway&amp;amp;journal=Cell%20Metab.&amp;amp;doi=10.1016%2Fj.cmet.2020.02.001&amp;amp;volume=31&amp;amp;pages=564-579&amp;amp;publication_year=2020&amp;amp;author=Shats%2CI"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="142."&gt;&lt;p class="c-article-references__text" id="ref-CR142"&gt;Chellappa, K. et al. NAD precursors cycle between host tissues and the gut microbiome. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;b&gt;34&lt;/b&gt;, 1947–1959 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2022.11.004" data-track-item_id="10.1016/j.cmet.2022.11.004" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2022.11.004" aria-label="Article reference 142" data-doi="10.1016/j.cmet.2022.11.004"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XjtVKksLnK" aria-label="CAS reference 142"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36476934" aria-label="PubMed reference 142"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825113" aria-label="PubMed Central reference 142"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 142" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%20precursors%20cycle%20between%20host%20tissues%20and%20the%20gut%20microbiome&amp;amp;journal=Cell%20Metab.&amp;amp;doi=10.1016%2Fj.cmet.2022.11.004&amp;amp;volume=34&amp;amp;pages=1947-1959&amp;amp;publication_year=2022&amp;amp;author=Chellappa%2CK"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="143."&gt;&lt;p class="c-article-references__text" id="ref-CR143"&gt;Kim, L. J. et al. Host-microbiome interactions in nicotinamide mononucleotide (NMN) deamidation. &lt;i&gt;FEBS Lett.&lt;/i&gt; &lt;b&gt;597&lt;/b&gt;, 2196–2220 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/1873-3468.14698" data-track-item_id="10.1002/1873-3468.14698" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2F1873-3468.14698" aria-label="Article reference 143" data-doi="10.1002/1873-3468.14698"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXhs1OgsrzE" aria-label="CAS reference 143"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37463842" aria-label="PubMed reference 143"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 143" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Host-microbiome%20interactions%20in%20nicotinamide%20mononucleotide%20%28NMN%29%20deamidation&amp;amp;journal=FEBS%20Lett.&amp;amp;doi=10.1002%2F1873-3468.14698&amp;amp;volume=597&amp;amp;pages=2196-2220&amp;amp;publication_year=2023&amp;amp;author=Kim%2CLJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="144."&gt;&lt;p class="c-article-references__text" id="ref-CR144"&gt;Peluso, A. A. et al. Oral supplementation of nicotinamide riboside alters intestinal microbial composition in rats and mice, but not humans. &lt;i&gt;NPJ Aging&lt;/i&gt; &lt;b&gt;9&lt;/b&gt;, 7 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41514-023-00106-4" data-track-item_id="10.1038/s41514-023-00106-4" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41514-023-00106-4" aria-label="Article reference 144" data-doi="10.1038/s41514-023-00106-4"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXntlGlu74%3D" aria-label="CAS reference 144"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37012386" aria-label="PubMed reference 144"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070358" aria-label="PubMed Central reference 144"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 144" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Oral%20supplementation%20of%20nicotinamide%20riboside%20alters%20intestinal%20microbial%20composition%20in%20rats%20and%20mice%2C%20but%20not%20humans&amp;amp;journal=NPJ%20Aging&amp;amp;doi=10.1038%2Fs41514-023-00106-4&amp;amp;volume=9&amp;amp;publication_year=2023&amp;amp;author=Peluso%2CAA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="145."&gt;&lt;p class="c-article-references__text" id="ref-CR145"&gt;Rodionov, D. A. et al. Transcriptional regulation of NAD metabolism in bacteria: genomic reconstruction of NiaR (YrxA) regulon. &lt;i&gt;Nucleic Acids Res.&lt;/i&gt; &lt;b&gt;36&lt;/b&gt;, 2032–2046 (2008).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/nar/gkn046" data-track-item_id="10.1093/nar/gkn046" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Fnar%2Fgkn046" aria-label="Article reference 145" data-doi="10.1093/nar/gkn046"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXktl2lu7s%3D" aria-label="CAS reference 145"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=18276644" aria-label="PubMed reference 145"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2330245" aria-label="PubMed Central reference 145"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 145" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Transcriptional%20regulation%20of%20NAD%20metabolism%20in%20bacteria%3A%20genomic%20reconstruction%20of%20NiaR%20%28YrxA%29%20regulon&amp;amp;journal=Nucleic%20Acids%20Res.&amp;amp;doi=10.1093%2Fnar%2Fgkn046&amp;amp;volume=36&amp;amp;pages=2032-2046&amp;amp;publication_year=2008&amp;amp;author=Rodionov%2CDA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="146."&gt;&lt;p class="c-article-references__text" id="ref-CR146"&gt;Biagi, E. et al. Gut microbiota and extreme longevity. &lt;i&gt;Curr. Biol.&lt;/i&gt; &lt;b&gt;26&lt;/b&gt;, 1480–1485 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cub.2016.04.016" data-track-item_id="10.1016/j.cub.2016.04.016" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cub.2016.04.016" aria-label="Article reference 146" data-doi="10.1016/j.cub.2016.04.016"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XnvV2ktLs%3D" aria-label="CAS reference 146"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27185560" aria-label="PubMed reference 146"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 146" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Gut%20microbiota%20and%20extreme%20longevity&amp;amp;journal=Curr.%20Biol.&amp;amp;doi=10.1016%2Fj.cub.2016.04.016&amp;amp;volume=26&amp;amp;pages=1480-1485&amp;amp;publication_year=2016&amp;amp;author=Biagi%2CE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="147."&gt;&lt;p class="c-article-references__text" id="ref-CR147"&gt;Chu, X. et al. Nicotinamide adenine dinucleotide supplementation drives gut microbiota variation in Alzheimer’s mouse model. &lt;i&gt;Front. Aging Neurosci.&lt;/i&gt; &lt;b&gt;14&lt;/b&gt;, 993615 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.3389/fnagi.2022.993615" data-track-item_id="10.3389/fnagi.2022.993615" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3389%2Ffnagi.2022.993615" aria-label="Article reference 147" data-doi="10.3389/fnagi.2022.993615"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXkvVWnsb8%3D" aria-label="CAS reference 147"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36185477" aria-label="PubMed reference 147"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520302" aria-label="PubMed Central reference 147"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 147" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinamide%20adenine%20dinucleotide%20supplementation%20drives%20gut%20microbiota%20variation%20in%20Alzheimer%E2%80%99s%20mouse%20model&amp;amp;journal=Front.%20Aging%20Neurosci.&amp;amp;doi=10.3389%2Ffnagi.2022.993615&amp;amp;volume=14&amp;amp;publication_year=2022&amp;amp;author=Chu%2CX"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="148."&gt;&lt;p class="c-article-references__text" id="ref-CR148"&gt;Fang, E. F. et al. Nuclear DNA damage signalling to mitochondria in ageing. &lt;i&gt;Nat. Rev. Mol. Cell Biol.&lt;/i&gt; &lt;b&gt;17&lt;/b&gt;, 308–321 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nrm.2016.14" data-track-item_id="10.1038/nrm.2016.14" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnrm.2016.14" aria-label="Article reference 148" data-doi="10.1038/nrm.2016.14"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XjvVGrtr0%3D" aria-label="CAS reference 148"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26956196" aria-label="PubMed reference 148"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161407" aria-label="PubMed Central reference 148"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 148" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nuclear%20DNA%20damage%20signalling%20to%20mitochondria%20in%20ageing&amp;amp;journal=Nat.%20Rev.%20Mol.%20Cell%20Biol.&amp;amp;doi=10.1038%2Fnrm.2016.14&amp;amp;volume=17&amp;amp;pages=308-321&amp;amp;publication_year=2016&amp;amp;author=Fang%2CEF"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="149."&gt;&lt;p class="c-article-references__text" id="ref-CR149"&gt;Fang, E. F. et al. Defective mitophagy in XPA via PARP-1 hyperactivation and NAD&lt;sup&gt;+&lt;/sup&gt;/SIRT1 reduction. &lt;i&gt;Cell&lt;/i&gt; &lt;b&gt;157&lt;/b&gt;, 882–896 (2014).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cell.2014.03.026" data-track-item_id="10.1016/j.cell.2014.03.026" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2014.03.026" aria-label="Article reference 149" data-doi="10.1016/j.cell.2014.03.026"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXotFGqsr8%3D" aria-label="CAS reference 149"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=24813611" aria-label="PubMed reference 149"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625837" aria-label="PubMed Central reference 149"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 149" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Defective%20mitophagy%20in%20XPA%20via%20PARP-1%20hyperactivation%20and%20NAD%2B%2FSIRT1%20reduction&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2014.03.026&amp;amp;volume=157&amp;amp;pages=882-896&amp;amp;publication_year=2014&amp;amp;author=Fang%2CEF"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="150."&gt;&lt;p class="c-article-references__text" id="ref-CR150"&gt;Fang, E. F. et al. NAD&lt;sup&gt;+&lt;/sup&gt; replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;b&gt;24&lt;/b&gt;, 566–581 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2016.09.004" data-track-item_id="10.1016/j.cmet.2016.09.004" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2016.09.004" aria-label="Article reference 150" data-doi="10.1016/j.cmet.2016.09.004"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XhsFKmurjE" aria-label="CAS reference 150"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27732836" aria-label="PubMed reference 150"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777858" aria-label="PubMed Central reference 150"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 150" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20replenishment%20improves%20lifespan%20and%20healthspan%20in%20ataxia%20telangiectasia%20models%20via%20mitophagy%20and%20DNA%20repair&amp;amp;journal=Cell%20Metab.&amp;amp;doi=10.1016%2Fj.cmet.2016.09.004&amp;amp;volume=24&amp;amp;pages=566-581&amp;amp;publication_year=2016&amp;amp;author=Fang%2CEF"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="151."&gt;&lt;p class="c-article-references__text" id="ref-CR151"&gt;Scheibye-Knudsen, M. et al. Cockayne syndrome group A and B proteins converge on transcription-linked resolution of non-B DNA. &lt;i&gt;Proc. Natl Acad. Sci. USA&lt;/i&gt; &lt;b&gt;113&lt;/b&gt;, 12502–12507 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1073/pnas.1610198113" data-track-item_id="10.1073/pnas.1610198113" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1073%2Fpnas.1610198113" aria-label="Article reference 151" data-doi="10.1073/pnas.1610198113"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28Xhs1ykurbO" aria-label="CAS reference 151"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27791127" aria-label="PubMed reference 151"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098674" aria-label="PubMed Central reference 151"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 151" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Cockayne%20syndrome%20group%20A%20and%20B%20proteins%20converge%20on%20transcription-linked%20resolution%20of%20non-B%20DNA&amp;amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;amp;doi=10.1073%2Fpnas.1610198113&amp;amp;volume=113&amp;amp;pages=12502-12507&amp;amp;publication_year=2016&amp;amp;author=Scheibye-Knudsen%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="152."&gt;&lt;p class="c-article-references__text" id="ref-CR152"&gt;Fang, E. F. et al. NAD&lt;sup&gt;+&lt;/sup&gt; augmentation restores mitophagy and limits accelerated aging in Werner syndrome. &lt;i&gt;Nat. Commun.&lt;/i&gt; &lt;b&gt;10&lt;/b&gt;, 5284 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-019-13172-8" data-track-item_id="10.1038/s41467-019-13172-8" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-019-13172-8" aria-label="Article reference 152" data-doi="10.1038/s41467-019-13172-8"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31754102" aria-label="PubMed reference 152"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872719" aria-label="PubMed Central reference 152"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 152" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20augmentation%20restores%20mitophagy%20and%20limits%20accelerated%20aging%20in%20Werner%20syndrome&amp;amp;journal=Nat.%20Commun.&amp;amp;doi=10.1038%2Fs41467-019-13172-8&amp;amp;volume=10&amp;amp;publication_year=2019&amp;amp;author=Fang%2CEF"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="153."&gt;&lt;p class="c-article-references__text" id="ref-CR153"&gt;Maynard, S. et al. Lamin A/C impairments cause mitochondrial dysfunction by attenuating PGC1α and the NAMPT-NAD&lt;sup&gt;+&lt;/sup&gt; pathway. &lt;i&gt;Nucleic Acids Res.&lt;/i&gt; &lt;b&gt;50&lt;/b&gt;, 9948–9965 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/nar/gkac741" data-track-item_id="10.1093/nar/gkac741" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Fnar%2Fgkac741" aria-label="Article reference 153" data-doi="10.1093/nar/gkac741"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXkslejs70%3D" aria-label="CAS reference 153"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36099415" aria-label="PubMed reference 153"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508839" aria-label="PubMed Central reference 153"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 153" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Lamin%20A%2FC%20impairments%20cause%20mitochondrial%20dysfunction%20by%20attenuating%20PGC1%CE%B1%20and%20the%20NAMPT-NAD%2B%20pathway&amp;amp;journal=Nucleic%20Acids%20Res.&amp;amp;doi=10.1093%2Fnar%2Fgkac741&amp;amp;volume=50&amp;amp;pages=9948-9965&amp;amp;publication_year=2022&amp;amp;author=Maynard%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="154."&gt;&lt;p class="c-article-references__text" id="ref-CR154"&gt;Rothblum-Oviatt, C. et al. Ataxia telangiectasia: a review. &lt;i&gt;Orphanet J. Rare Dis.&lt;/i&gt; &lt;b&gt;11&lt;/b&gt;, 159 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1186/s13023-016-0543-7" data-track-item_id="10.1186/s13023-016-0543-7" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s13023-016-0543-7" aria-label="Article reference 154" data-doi="10.1186/s13023-016-0543-7"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27884168" aria-label="PubMed reference 154"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123280" aria-label="PubMed Central reference 154"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 154" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Ataxia%20telangiectasia%3A%20a%20review&amp;amp;journal=Orphanet%20J.%20Rare%20Dis.&amp;amp;doi=10.1186%2Fs13023-016-0543-7&amp;amp;volume=11&amp;amp;publication_year=2016&amp;amp;author=Rothblum-Oviatt%2CC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="155."&gt;&lt;p class="c-article-references__text" id="ref-CR155"&gt;Khanna, K. K., Lavin, M. F., Jackson, S. P. &amp;amp; Mulhern, T. D. ATM, a central controller of cellular responses to DNA damage. &lt;i&gt;Cell Death Differ.&lt;/i&gt; &lt;b&gt;8&lt;/b&gt;, 1052–1065 (2001).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/sj.cdd.4400874" data-track-item_id="10.1038/sj.cdd.4400874" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fsj.cdd.4400874" aria-label="Article reference 155" data-doi="10.1038/sj.cdd.4400874"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD3MXoslWjsb8%3D" aria-label="CAS reference 155"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=11687884" aria-label="PubMed reference 155"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 155" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=ATM%2C%20a%20central%20controller%20of%20cellular%20responses%20to%20DNA%20damage&amp;amp;journal=Cell%20Death%20Differ.&amp;amp;doi=10.1038%2Fsj.cdd.4400874&amp;amp;volume=8&amp;amp;pages=1052-1065&amp;amp;publication_year=2001&amp;amp;author=Khanna%2CKK&amp;amp;author=Lavin%2CMF&amp;amp;author=Jackson%2CSP&amp;amp;author=Mulhern%2CTD"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="156."&gt;&lt;p class="c-article-references__text" id="ref-CR156"&gt;Presterud, R. et al. Long-term nicotinamide riboside use improves coordination and eye movements in ataxia telangiectasia. &lt;i&gt;Mov. Disord.&lt;/i&gt; &lt;b&gt;39&lt;/b&gt;, 360–369 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/mds.29645" data-track-item_id="10.1002/mds.29645" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fmds.29645" aria-label="Article reference 156" data-doi="10.1002/mds.29645"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXit1yktL%2FN" aria-label="CAS reference 156"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37899683" aria-label="PubMed reference 156"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 156" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Long-term%20nicotinamide%20riboside%20use%20improves%20coordination%20and%20eye%20movements%20in%20ataxia%20telangiectasia&amp;amp;journal=Mov.%20Disord.&amp;amp;doi=10.1002%2Fmds.29645&amp;amp;volume=39&amp;amp;pages=360-369&amp;amp;publication_year=2024&amp;amp;author=Presterud%2CR"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="157."&gt;&lt;p class="c-article-references__text" id="ref-CR157"&gt;Veenhuis, S. J. G. et al. Nicotinamide riboside improves ataxia scores and immunoglobulin levels in ataxia telangiectasia. &lt;i&gt;Mov. Disord.&lt;/i&gt; &lt;b&gt;36&lt;/b&gt;, 2951–2957 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/mds.28788" data-track-item_id="10.1002/mds.28788" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fmds.28788" aria-label="Article reference 157" data-doi="10.1002/mds.28788"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XislyhtLc%3D" aria-label="CAS reference 157"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34515380" aria-label="PubMed reference 157"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291897" aria-label="PubMed Central reference 157"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 157" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinamide%20riboside%20improves%20ataxia%20scores%20and%20immunoglobulin%20levels%20in%20ataxia%20telangiectasia&amp;amp;journal=Mov.%20Disord.&amp;amp;doi=10.1002%2Fmds.28788&amp;amp;volume=36&amp;amp;pages=2951-2957&amp;amp;publication_year=2021&amp;amp;author=Veenhuis%2CSJG"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="158."&gt;&lt;p class="c-article-references__text" id="ref-CR158"&gt;Steinbrucker, K., Tiefenthaler, E., Schernthaner, E. M., Jungwirth, J. &amp;amp; Wortmann, S. B. Nicotinamide riboside for ataxia telangiectasia: a report of an early treated individual. &lt;i&gt;Neuropediatrics&lt;/i&gt; &lt;b&gt;54&lt;/b&gt;, 78–81 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1055/a-1959-9404" data-track-item_id="10.1055/a-1959-9404" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1055%2Fa-1959-9404" aria-label="Article reference 158" data-doi="10.1055/a-1959-9404"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36223879" aria-label="PubMed reference 158"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 158" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinamide%20riboside%20for%20ataxia%20telangiectasia%3A%20a%20report%20of%20an%20early%20treated%20individual&amp;amp;journal=Neuropediatrics&amp;amp;doi=10.1055%2Fa-1959-9404&amp;amp;volume=54&amp;amp;pages=78-81&amp;amp;publication_year=2023&amp;amp;author=Steinbrucker%2CK&amp;amp;author=Tiefenthaler%2CE&amp;amp;author=Schernthaner%2CEM&amp;amp;author=Jungwirth%2CJ&amp;amp;author=Wortmann%2CSB"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="159."&gt;&lt;p class="c-article-references__text" id="ref-CR159"&gt;Chen, L. &amp;amp; Oshima, J. Werner syndrome. &lt;i&gt;J. Biomed. Biotechnol.&lt;/i&gt; &lt;b&gt;2&lt;/b&gt;, 46–54 (2002).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD38XovFWru7k%3D" aria-label="CAS reference 159"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=12488583" aria-label="PubMed reference 159"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC153784" aria-label="PubMed Central reference 159"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 159" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Werner%20syndrome&amp;amp;journal=J.%20Biomed.%20Biotechnol.&amp;amp;volume=2&amp;amp;pages=46-54&amp;amp;publication_year=2002&amp;amp;author=Chen%2CL&amp;amp;author=Oshima%2CJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="160."&gt;&lt;p class="c-article-references__text" id="ref-CR160"&gt;Shamanna, R. A., Croteau, D. L., Lee, J. H. &amp;amp; Bohr, V. A. Recent advances in understanding Werner syndrome. &lt;i&gt;F1000Res&lt;/i&gt; &lt;b&gt;6&lt;/b&gt;, 1779 (2017).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.12688/f1000research.12110.1" data-track-item_id="10.12688/f1000research.12110.1" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.12688%2Ff1000research.12110.1" aria-label="Article reference 160" data-doi="10.12688/f1000research.12110.1"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29043077" aria-label="PubMed reference 160"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621106" aria-label="PubMed Central reference 160"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 160" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Recent%20advances%20in%20understanding%20Werner%20syndrome&amp;amp;journal=F1000Res&amp;amp;doi=10.12688%2Ff1000research.12110.1&amp;amp;volume=6&amp;amp;publication_year=2017&amp;amp;author=Shamanna%2CRA&amp;amp;author=Croteau%2CDL&amp;amp;author=Lee%2CJH&amp;amp;author=Bohr%2CVA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="161."&gt;&lt;p class="c-article-references__text" id="ref-CR161"&gt;Tian, Y. et al. WRN loss accelerates abnormal adipocyte metabolism in Werner syndrome. &lt;i&gt;Cell Biosci.&lt;/i&gt; &lt;b&gt;14&lt;/b&gt;, 7 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1186/s13578-023-01183-4" data-track-item_id="10.1186/s13578-023-01183-4" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s13578-023-01183-4" aria-label="Article reference 161" data-doi="10.1186/s13578-023-01183-4"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXhtFOgurg%3D" aria-label="CAS reference 161"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38184705" aria-label="PubMed reference 161"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10770995" aria-label="PubMed Central reference 161"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 161" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=WRN%20loss%20accelerates%20abnormal%20adipocyte%20metabolism%20in%20Werner%20syndrome&amp;amp;journal=Cell%20Biosci.&amp;amp;doi=10.1186%2Fs13578-023-01183-4&amp;amp;volume=14&amp;amp;publication_year=2024&amp;amp;author=Tian%2CY"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="162."&gt;&lt;p class="c-article-references__text" id="ref-CR162"&gt;Shoji, M. et al. Nicotinamide riboside supplementation benefits in patients with Werner syndrome: a double-blind randomized crossover placebo-controlled trial. &lt;i&gt;Aging Cell&lt;/i&gt; &lt;a href="https://doi.org/10.1111/acel.70093" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1111/acel.70093"&gt;https://doi.org/10.1111/acel.70093&lt;/a&gt; (2025).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="163."&gt;&lt;p class="c-article-references__text" id="ref-CR163"&gt;Huang, A. R., Jiang, K., Lin, F. R., Deal, J. A. &amp;amp; Reed, N. S. Hearing loss and dementia prevalence in older adults in the US. &lt;i&gt;JAMA&lt;/i&gt; &lt;b&gt;329&lt;/b&gt;, 171–173 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1001/jama.2022.20954" data-track-item_id="10.1001/jama.2022.20954" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1001%2Fjama.2022.20954" aria-label="Article reference 163" data-doi="10.1001/jama.2022.20954"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36625819" aria-label="PubMed reference 163"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856835" aria-label="PubMed Central reference 163"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 163" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Hearing%20loss%20and%20dementia%20prevalence%20in%20older%20adults%20in%20the%20US&amp;amp;journal=JAMA&amp;amp;doi=10.1001%2Fjama.2022.20954&amp;amp;volume=329&amp;amp;pages=171-173&amp;amp;publication_year=2023&amp;amp;author=Huang%2CAR&amp;amp;author=Jiang%2CK&amp;amp;author=Lin%2CFR&amp;amp;author=Deal%2CJA&amp;amp;author=Reed%2CNS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="164."&gt;&lt;p class="c-article-references__text" id="ref-CR164"&gt;Okur, M. N. et al. Long-term NAD&lt;sup&gt;+&lt;/sup&gt; supplementation prevents the progression of age-related hearing loss in mice. &lt;i&gt;Aging Cell&lt;/i&gt; &lt;b&gt;22&lt;/b&gt;, e13909 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/acel.13909" data-track-item_id="10.1111/acel.13909" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Facel.13909" aria-label="Article reference 164" data-doi="10.1111/acel.13909"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXhtlKlsr%2FN" aria-label="CAS reference 164"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37395319" aria-label="PubMed reference 164"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497810" aria-label="PubMed Central reference 164"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 164" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Long-term%20NAD%2B%20supplementation%20prevents%20the%20progression%20of%20age-related%20hearing%20loss%20in%20mice&amp;amp;journal=Aging%20Cell&amp;amp;doi=10.1111%2Facel.13909&amp;amp;volume=22&amp;amp;publication_year=2023&amp;amp;author=Okur%2CMN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="165."&gt;&lt;p class="c-article-references__text" id="ref-CR165"&gt;Okur, M. N. et al. Short-term NAD&lt;sup&gt;+&lt;/sup&gt; supplementation prevents hearing loss in mouse models of Cockayne syndrome. &lt;i&gt;NPJ Aging Mech. Dis.&lt;/i&gt; &lt;b&gt;6&lt;/b&gt;, 1 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41514-019-0040-z" data-track-item_id="10.1038/s41514-019-0040-z" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41514-019-0040-z" aria-label="Article reference 165" data-doi="10.1038/s41514-019-0040-z"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXhtl2htLo%3D" aria-label="CAS reference 165"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31934345" aria-label="PubMed reference 165"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946667" aria-label="PubMed Central reference 165"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 165" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Short-term%20NAD%2B%20supplementation%20prevents%20hearing%20loss%20in%20mouse%20models%20of%20Cockayne%20syndrome&amp;amp;journal=NPJ%20Aging%20Mech.%20Dis.&amp;amp;doi=10.1038%2Fs41514-019-0040-z&amp;amp;volume=6&amp;amp;publication_year=2020&amp;amp;author=Okur%2CMN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="166."&gt;&lt;p class="c-article-references__text" id="ref-CR166"&gt;Williams, P. A. et al. Vitamin B&lt;sub&gt;3&lt;/sub&gt; modulates mitochondrial vulnerability and prevents glaucoma in aged mice. &lt;i&gt;Science&lt;/i&gt; &lt;b&gt;355&lt;/b&gt;, 756–760 (2017).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.aal0092" data-track-item_id="10.1126/science.aal0092" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.aal0092" aria-label="Article reference 166" data-doi="10.1126/science.aal0092"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXis1yjur0%3D" aria-label="CAS reference 166"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=28209901" aria-label="PubMed reference 166"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408298" aria-label="PubMed Central reference 166"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 166" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Vitamin%20B3%20modulates%20mitochondrial%20vulnerability%20and%20prevents%20glaucoma%20in%20aged%20mice&amp;amp;journal=Science&amp;amp;doi=10.1126%2Fscience.aal0092&amp;amp;volume=355&amp;amp;pages=756-760&amp;amp;publication_year=2017&amp;amp;author=Williams%2CPA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="167."&gt;&lt;p class="c-article-references__text" id="ref-CR167"&gt;Pang, H. et al. Aberrant NAD&lt;sup&gt;+&lt;/sup&gt; metabolism underlies Zika virus-induced microcephaly. &lt;i&gt;Nat. Metab.&lt;/i&gt; &lt;b&gt;3&lt;/b&gt;, 1109–1124 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s42255-021-00437-0" data-track-item_id="10.1038/s42255-021-00437-0" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs42255-021-00437-0" aria-label="Article reference 167" data-doi="10.1038/s42255-021-00437-0"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXitVOht77I" aria-label="CAS reference 167"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34385701" aria-label="PubMed reference 167"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 167" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Aberrant%20NAD%2B%20metabolism%20underlies%20Zika%20virus-induced%20microcephaly&amp;amp;journal=Nat.%20Metab.&amp;amp;doi=10.1038%2Fs42255-021-00437-0&amp;amp;volume=3&amp;amp;pages=1109-1124&amp;amp;publication_year=2021&amp;amp;author=Pang%2CH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="168."&gt;&lt;p class="c-article-references__text" id="ref-CR168"&gt;Jiang, Y. et al. Treatment of SARS-CoV-2-induced pneumonia with NAD&lt;sup&gt;+&lt;/sup&gt; and NMN in two mouse models. &lt;i&gt;Cell Discov.&lt;/i&gt; &lt;b&gt;8&lt;/b&gt;, 38 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41421-022-00409-y" data-track-item_id="10.1038/s41421-022-00409-y" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41421-022-00409-y" aria-label="Article reference 168" data-doi="10.1038/s41421-022-00409-y"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XhtFyjtbzE" aria-label="CAS reference 168"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=35487885" aria-label="PubMed reference 168"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053567" aria-label="PubMed Central reference 168"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 168" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Treatment%20of%20SARS-CoV-2-induced%20pneumonia%20with%20NAD%2B%20and%20NMN%20in%20two%20mouse%20models&amp;amp;journal=Cell%20Discov.&amp;amp;doi=10.1038%2Fs41421-022-00409-y&amp;amp;volume=8&amp;amp;publication_year=2022&amp;amp;author=Jiang%2CY"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="169."&gt;&lt;p class="c-article-references__text" id="ref-CR169"&gt;Chen, P. M. et al. CD38 reduces mitochondrial fitness and cytotoxic T cell response against viral infection in lupus patients by suppressing mitophagy. &lt;i&gt;Sci. Adv.&lt;/i&gt; &lt;b&gt;8&lt;/b&gt;, eabo4271 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/sciadv.abo4271" data-track-item_id="10.1126/sciadv.abo4271" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fsciadv.abo4271" aria-label="Article reference 169" data-doi="10.1126/sciadv.abo4271"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XhvVSrurnO" aria-label="CAS reference 169"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=35704572" aria-label="PubMed reference 169"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200274" aria-label="PubMed Central reference 169"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 169" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=CD38%20reduces%20mitochondrial%20fitness%20and%20cytotoxic%20T%20cell%20response%20against%20viral%20infection%20in%20lupus%20patients%20by%20suppressing%20mitophagy&amp;amp;journal=Sci.%20Adv.&amp;amp;doi=10.1126%2Fsciadv.abo4271&amp;amp;volume=8&amp;amp;publication_year=2022&amp;amp;author=Chen%2CPM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="170."&gt;&lt;p class="c-article-references__text" id="ref-CR170"&gt;Kontani, K., Nishina, H., Ohoka, Y., Takahashi, K. &amp;amp; Katada, T. NAD glycohydrolase specifically induced by retinoic acid in human leukemic HL-60 cells. Identification of the NAD glycohydrolase as leukocyte cell surface antigen CD38. &lt;i&gt;J. Biol. Chem.&lt;/i&gt; &lt;b&gt;268&lt;/b&gt;, 16895–16898 (1993).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0021-9258(19)85279-1" data-track-item_id="10.1016/S0021-9258(19)85279-1" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0021-9258%2819%2985279-1" aria-label="Article reference 170" data-doi="10.1016/S0021-9258(19)85279-1"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK3sXltlOjtrg%3D" aria-label="CAS reference 170"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=8394323" aria-label="PubMed reference 170"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 170" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%20glycohydrolase%20specifically%20induced%20by%20retinoic%20acid%20in%20human%20leukemic%20HL-60%20cells.%20Identification%20of%20the%20NAD%20glycohydrolase%20as%20leukocyte%20cell%20surface%20antigen%20CD38&amp;amp;journal=J.%20Biol.%20Chem.&amp;amp;doi=10.1016%2FS0021-9258%2819%2985279-1&amp;amp;volume=268&amp;amp;pages=16895-16898&amp;amp;publication_year=1993&amp;amp;author=Kontani%2CK&amp;amp;author=Nishina%2CH&amp;amp;author=Ohoka%2CY&amp;amp;author=Takahashi%2CK&amp;amp;author=Katada%2CT"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="171."&gt;&lt;p class="c-article-references__text" id="ref-CR171"&gt;Aksoy, P., White, T. A., Thompson, M. &amp;amp; Chini, E. N. Regulation of intracellular levels of NAD: a novel role for CD38. &lt;i&gt;Biochem. Biophys. Res. Commun.&lt;/i&gt; &lt;b&gt;345&lt;/b&gt;, 1386–1392 (2006).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.bbrc.2006.05.042" data-track-item_id="10.1016/j.bbrc.2006.05.042" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.bbrc.2006.05.042" aria-label="Article reference 171" data-doi="10.1016/j.bbrc.2006.05.042"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD28Xltl2gs74%3D" aria-label="CAS reference 171"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=16730329" aria-label="PubMed reference 171"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 171" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Regulation%20of%20intracellular%20levels%20of%20NAD%3A%20a%20novel%20role%20for%20CD38&amp;amp;journal=Biochem.%20Biophys.%20Res.%20Commun.&amp;amp;doi=10.1016%2Fj.bbrc.2006.05.042&amp;amp;volume=345&amp;amp;pages=1386-1392&amp;amp;publication_year=2006&amp;amp;author=Aksoy%2CP&amp;amp;author=White%2CTA&amp;amp;author=Thompson%2CM&amp;amp;author=Chini%2CEN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="172."&gt;&lt;p class="c-article-references__text" id="ref-CR172"&gt;Young, G. S., Choleris, E., Lund, F. E. &amp;amp; Kirkland, J. B. Decreased cADPR and increased NAD&lt;sup&gt;+&lt;/sup&gt; in the Cd38-/- mouse. &lt;i&gt;Biochem. Biophys. Res. Commun.&lt;/i&gt; &lt;b&gt;346&lt;/b&gt;, 188–192 (2006).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.bbrc.2006.05.100" data-track-item_id="10.1016/j.bbrc.2006.05.100" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.bbrc.2006.05.100" aria-label="Article reference 172" data-doi="10.1016/j.bbrc.2006.05.100"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD28Xls1Gmtr4%3D" aria-label="CAS reference 172"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=16750163" aria-label="PubMed reference 172"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 172" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Decreased%20cADPR%20and%20increased%20NAD%2B%20in%20the%20Cd38-%2F-%20mouse&amp;amp;journal=Biochem.%20Biophys.%20Res.%20Commun.&amp;amp;doi=10.1016%2Fj.bbrc.2006.05.100&amp;amp;volume=346&amp;amp;pages=188-192&amp;amp;publication_year=2006&amp;amp;author=Young%2CGS&amp;amp;author=Choleris%2CE&amp;amp;author=Lund%2CFE&amp;amp;author=Kirkland%2CJB"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="173."&gt;&lt;p class="c-article-references__text" id="ref-CR173"&gt;Chini, C. et al. The NADase CD38 is induced by factors secreted from senescent cells providing a potential link between senescence and age-related cellular NAD&lt;sup&gt;+&lt;/sup&gt; decline. &lt;i&gt;Biochem. Biophys. Res. Commun.&lt;/i&gt; &lt;b&gt;513&lt;/b&gt;, 486–493 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.bbrc.2019.03.199" data-track-item_id="10.1016/j.bbrc.2019.03.199" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.bbrc.2019.03.199" aria-label="Article reference 173" data-doi="10.1016/j.bbrc.2019.03.199"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXmvFCitrs%3D" aria-label="CAS reference 173"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30975470" aria-label="PubMed reference 173"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486859" aria-label="PubMed Central reference 173"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 173" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20NADase%20CD38%20is%20induced%20by%20factors%20secreted%20from%20senescent%20cells%20providing%20a%20potential%20link%20between%20senescence%20and%20age-related%20cellular%20NAD%2B%20decline&amp;amp;journal=Biochem.%20Biophys.%20Res.%20Commun.&amp;amp;doi=10.1016%2Fj.bbrc.2019.03.199&amp;amp;volume=513&amp;amp;pages=486-493&amp;amp;publication_year=2019&amp;amp;author=Chini%2CC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="174."&gt;&lt;p class="c-article-references__text" id="ref-CR174"&gt;Chini, C. C. S. et al. CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD&lt;sup&gt;+&lt;/sup&gt; and NMN levels. &lt;i&gt;Nat. Metab.&lt;/i&gt; &lt;b&gt;2&lt;/b&gt;, 1284–1304 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s42255-020-00298-z" data-track-item_id="10.1038/s42255-020-00298-z" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs42255-020-00298-z" aria-label="Article reference 174" data-doi="10.1038/s42255-020-00298-z"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXis1Shs7fK" aria-label="CAS reference 174"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33199925" aria-label="PubMed reference 174"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752031" aria-label="PubMed Central reference 174"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 174" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=CD38%20ecto-enzyme%20in%20immune%20cells%20is%20induced%20during%20aging%20and%20regulates%20NAD%2B%20and%20NMN%20levels&amp;amp;journal=Nat.%20Metab.&amp;amp;doi=10.1038%2Fs42255-020-00298-z&amp;amp;volume=2&amp;amp;pages=1284-1304&amp;amp;publication_year=2020&amp;amp;author=Chini%2CCCS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="175."&gt;&lt;p class="c-article-references__text" id="ref-CR175"&gt;Covarrubias, A. J. et al. Senescent cells promote tissue NAD&lt;sup&gt;+&lt;/sup&gt; decline during ageing via the activation of CD38&lt;sup&gt;+&lt;/sup&gt; macrophages. &lt;i&gt;Nat. Metab.&lt;/i&gt; &lt;b&gt;2&lt;/b&gt;, 1265–1283 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s42255-020-00305-3" data-track-item_id="10.1038/s42255-020-00305-3" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs42255-020-00305-3" aria-label="Article reference 175" data-doi="10.1038/s42255-020-00305-3"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXis1Shs7fL" aria-label="CAS reference 175"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33199924" aria-label="PubMed reference 175"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908681" aria-label="PubMed Central reference 175"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 175" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Senescent%20cells%20promote%20tissue%20NAD%2B%20decline%20during%20ageing%20via%20the%20activation%20of%20CD38%2B%20macrophages&amp;amp;journal=Nat.%20Metab.&amp;amp;doi=10.1038%2Fs42255-020-00305-3&amp;amp;volume=2&amp;amp;pages=1265-1283&amp;amp;publication_year=2020&amp;amp;author=Covarrubias%2CAJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="176."&gt;&lt;p class="c-article-references__text" id="ref-CR176"&gt;Jin, D. et al. CD38 is critical for social behaviour by regulating oxytocin secretion. &lt;i&gt;Nature&lt;/i&gt; &lt;b&gt;446&lt;/b&gt;, 41–45 (2007).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nature05526" data-track-item_id="10.1038/nature05526" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnature05526" aria-label="Article reference 176" data-doi="10.1038/nature05526"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2sXit1arsLw%3D" aria-label="CAS reference 176"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=17287729" aria-label="PubMed reference 176"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 176" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=CD38%20is%20critical%20for%20social%20behaviour%20by%20regulating%20oxytocin%20secretion&amp;amp;journal=Nature&amp;amp;doi=10.1038%2Fnature05526&amp;amp;volume=446&amp;amp;pages=41-45&amp;amp;publication_year=2007&amp;amp;author=Jin%2CD"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="177."&gt;&lt;p class="c-article-references__text" id="ref-CR177"&gt;Migaud, M. E. et al. Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof. Patent PCT WO2018089830A1 (2021).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="178."&gt;&lt;p class="c-article-references__text" id="ref-CR178"&gt;Brenner, C., Belenky, P. &amp;amp; Bogan, K. L. Yeast strain and method for using the same to produce nicotinamide riboside. Patent US8114626B2 (2012).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="179."&gt;&lt;p class="c-article-references__text" id="ref-CR179"&gt;Zhang, N. &amp;amp; Sauve, A. A. Synthesis of beta-nicotinamide riboside using an efficient two-step methodology. &lt;i&gt;Curr. Protoc. Nucleic Acid Chem.&lt;/i&gt; &lt;b&gt;71&lt;/b&gt;, 14.14.1–14.14.9 (2017).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/cpnc.43" data-track-item_id="10.1002/cpnc.43" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fcpnc.43" aria-label="Article reference 179" data-doi="10.1002/cpnc.43"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29275540" aria-label="PubMed reference 179"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 179" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Synthesis%20of%20beta-nicotinamide%20riboside%20using%20an%20efficient%20two-step%20methodology&amp;amp;journal=Curr.%20Protoc.%20Nucleic%20Acid%20Chem.&amp;amp;doi=10.1002%2Fcpnc.43&amp;amp;volume=71&amp;amp;pages=14.14.1-14.14.9&amp;amp;publication_year=2017&amp;amp;author=Zhang%2CN&amp;amp;author=Sauve%2CAA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="180."&gt;&lt;p class="c-article-references__text" id="ref-CR180"&gt;Zhang, M., Jiang, Y., Su, Z., Sun, W. &amp;amp; Zhan, L. Novel synthesis method of nicotinamide ribose. Patent CN111892635A (2020).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="181."&gt;&lt;p class="c-article-references__text" id="ref-CR181"&gt;Sinclair, D. A. &amp;amp; Ear, P. H. Biological production of NAD precursors and analogs. WO Patent 2015/069860 (2015).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="182."&gt;&lt;p class="c-article-references__text" id="ref-CR182"&gt;Jin, C. &amp;amp; Wang, J. Carriers for enzyme or cell immobilization and immobilization method using the carriers. Patent US8486676B2 (2013).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="183."&gt;&lt;p class="c-article-references__text" id="ref-CR183"&gt;Kameda, A. et al. A novel ATP regeneration system using polyphosphate-AMP phosphotransferase and polyphosphate kinase. &lt;i&gt;J. Biosci. Bioeng.&lt;/i&gt; &lt;b&gt;91&lt;/b&gt;, 557–563 (2001).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S1389-1723(01)80173-0" data-track-item_id="10.1016/S1389-1723(01)80173-0" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS1389-1723%2801%2980173-0" aria-label="Article reference 183" data-doi="10.1016/S1389-1723(01)80173-0"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD3MXmt1Wgs70%3D" aria-label="CAS reference 183"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=16233039" aria-label="PubMed reference 183"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 183" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=A%20novel%20ATP%20regeneration%20system%20using%20polyphosphate-AMP%20phosphotransferase%20and%20polyphosphate%20kinase&amp;amp;journal=J.%20Biosci.%20Bioeng.&amp;amp;doi=10.1016%2FS1389-1723%2801%2980173-0&amp;amp;volume=91&amp;amp;pages=557-563&amp;amp;publication_year=2001&amp;amp;author=Kameda%2CA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="184."&gt;&lt;p class="c-article-references__text" id="ref-CR184"&gt;Zheng, C., Li, Y., Wu, X., Gao, L. &amp;amp; Chen, X. Advances in the synthesis and physiological metabolic regulation of nicotinamide mononucleotide. &lt;i&gt;Nutrients&lt;/i&gt; &lt;a href="https://doi.org/10.3390/nu16142354" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3390/nu16142354"&gt;https://doi.org/10.3390/nu16142354&lt;/a&gt; (2024).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="185."&gt;&lt;p class="c-article-references__text" id="ref-CR185"&gt;Yang, Y., Zhang, N., Zhang, G. &amp;amp; Sauve, A. A. NRH salvage and conversion to NAD&lt;sup&gt;+&lt;/sup&gt; requires NRH kinase activity by adenosine kinase. &lt;i&gt;Nat. Metab.&lt;/i&gt; &lt;b&gt;2&lt;/b&gt;, 364–379 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s42255-020-0194-9" data-track-item_id="10.1038/s42255-020-0194-9" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs42255-020-0194-9" aria-label="Article reference 185" data-doi="10.1038/s42255-020-0194-9"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXnslGlsL4%3D" aria-label="CAS reference 185"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32694608" aria-label="PubMed reference 185"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384296" aria-label="PubMed Central reference 185"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 185" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NRH%20salvage%20and%20conversion%20to%20NAD%2B%20requires%20NRH%20kinase%20activity%20by%20adenosine%20kinase&amp;amp;journal=Nat.%20Metab.&amp;amp;doi=10.1038%2Fs42255-020-0194-9&amp;amp;volume=2&amp;amp;pages=364-379&amp;amp;publication_year=2020&amp;amp;author=Yang%2CY&amp;amp;author=Zhang%2CN&amp;amp;author=Zhang%2CG&amp;amp;author=Sauve%2CAA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="186."&gt;&lt;p class="c-article-references__text" id="ref-CR186"&gt;Yang, Y., Mohammed, F. S., Zhang, N. &amp;amp; Sauve, A. A. Dihydronicotinamide riboside is a potent NAD&lt;sup&gt;+&lt;/sup&gt; concentration enhancer in vitro and in vivo. &lt;i&gt;J. Biol. Chem.&lt;/i&gt; &lt;b&gt;294&lt;/b&gt;, 9295–9307 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1074/jbc.RA118.005772" data-track-item_id="10.1074/jbc.RA118.005772" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1074%2Fjbc.RA118.005772" aria-label="Article reference 186" data-doi="10.1074/jbc.RA118.005772"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXht1CjsrzL" aria-label="CAS reference 186"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30948509" aria-label="PubMed reference 186"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556581" aria-label="PubMed Central reference 186"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 186" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Dihydronicotinamide%20riboside%20is%20a%20potent%20NAD%2B%20concentration%20enhancer%20in%20vitro%20and%20in%20vivo&amp;amp;journal=J.%20Biol.%20Chem.&amp;amp;doi=10.1074%2Fjbc.RA118.005772&amp;amp;volume=294&amp;amp;pages=9295-9307&amp;amp;publication_year=2019&amp;amp;author=Yang%2CY&amp;amp;author=Mohammed%2CFS&amp;amp;author=Zhang%2CN&amp;amp;author=Sauve%2CAA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="187."&gt;&lt;p class="c-article-references__text" id="ref-CR187"&gt;Zapata-Perez, R. et al. Reduced nicotinamide mononucleotide is a new and potent NAD&lt;sup&gt;+&lt;/sup&gt; precursor in mammalian cells and mice. &lt;i&gt;FASEB J.&lt;/i&gt; &lt;b&gt;35&lt;/b&gt;, e21456 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1096/fj.202001826R" data-track-item_id="10.1096/fj.202001826R" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1096%2Ffj.202001826R" aria-label="Article reference 187" data-doi="10.1096/fj.202001826R"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXnt1OqsL4%3D" aria-label="CAS reference 187"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33724555" aria-label="PubMed reference 187"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 187" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Reduced%20nicotinamide%20mononucleotide%20is%20a%20new%20and%20potent%20NAD%2B%20precursor%20in%20mammalian%20cells%20and%20mice&amp;amp;journal=FASEB%20J.&amp;amp;doi=10.1096%2Ffj.202001826R&amp;amp;volume=35&amp;amp;publication_year=2021&amp;amp;author=Zapata-Perez%2CR"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="188."&gt;&lt;p class="c-article-references__text" id="ref-CR188"&gt;Giroud-Gerbetant, J. et al. A reduced form of nicotinamide riboside defines a new path for NAD&lt;sup&gt;+&lt;/sup&gt; biosynthesis and acts as an orally bioavailable NAD&lt;sup&gt;+&lt;/sup&gt; precursor. &lt;i&gt;Mol. Metab.&lt;/i&gt; &lt;b&gt;30&lt;/b&gt;, 192–202 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.molmet.2019.09.013" data-track-item_id="10.1016/j.molmet.2019.09.013" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.molmet.2019.09.013" aria-label="Article reference 188" data-doi="10.1016/j.molmet.2019.09.013"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXhvFOktL3N" aria-label="CAS reference 188"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31767171" aria-label="PubMed reference 188"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807296" aria-label="PubMed Central reference 188"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 188" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=A%20reduced%20form%20of%20nicotinamide%20riboside%20defines%20a%20new%20path%20for%20NAD%2B%20biosynthesis%20and%20acts%20as%20an%20orally%20bioavailable%20NAD%2B%20precursor&amp;amp;journal=Mol.%20Metab.&amp;amp;doi=10.1016%2Fj.molmet.2019.09.013&amp;amp;volume=30&amp;amp;pages=192-202&amp;amp;publication_year=2019&amp;amp;author=Giroud-Gerbetant%2CJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="189."&gt;&lt;p class="c-article-references__text" id="ref-CR189"&gt;Liu, Y. et al. Reduced nicotinamide mononucleotide (NMNH) potently enhances NAD&lt;sup&gt;+&lt;/sup&gt; and suppresses glycolysis, the TCA cycle, and cell growth. &lt;i&gt;J. Proteome Res.&lt;/i&gt; &lt;b&gt;20&lt;/b&gt;, 2596–2606 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1021/acs.jproteome.0c01037" data-track-item_id="10.1021/acs.jproteome.0c01037" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1021%2Facs.jproteome.0c01037" aria-label="Article reference 189" data-doi="10.1021/acs.jproteome.0c01037"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXnslCmsLo%3D" aria-label="CAS reference 189"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33793246" aria-label="PubMed reference 189"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 189" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Reduced%20nicotinamide%20mononucleotide%20%28NMNH%29%20potently%20enhances%20NAD%2B%20and%20suppresses%20glycolysis%2C%20the%20TCA%20cycle%2C%20and%20cell%20growth&amp;amp;journal=J.%20Proteome%20Res.&amp;amp;doi=10.1021%2Facs.jproteome.0c01037&amp;amp;volume=20&amp;amp;pages=2596-2606&amp;amp;publication_year=2021&amp;amp;author=Liu%2CY"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="190."&gt;&lt;p class="c-article-references__text" id="ref-CR190"&gt;Membrez, M. et al. Trigonelline is an NAD&lt;sup&gt;+&lt;/sup&gt; precursor that improves muscle function during ageing and is reduced in human sarcopenia. &lt;i&gt;Nat. Metab.&lt;/i&gt; &lt;b&gt;6&lt;/b&gt;, 433–447 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s42255-024-00997-x" data-track-item_id="10.1038/s42255-024-00997-x" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs42255-024-00997-x" aria-label="Article reference 190" data-doi="10.1038/s42255-024-00997-x"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXmsVWjur8%3D" aria-label="CAS reference 190"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38504132" aria-label="PubMed reference 190"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10963276" aria-label="PubMed Central reference 190"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 190" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Trigonelline%20is%20an%20NAD%2B%20precursor%20that%20improves%20muscle%20function%20during%20ageing%20and%20is%20reduced%20in%20human%20sarcopenia&amp;amp;journal=Nat.%20Metab.&amp;amp;doi=10.1038%2Fs42255-024-00997-x&amp;amp;volume=6&amp;amp;pages=433-447&amp;amp;publication_year=2024&amp;amp;author=Membrez%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="191."&gt;&lt;p class="c-article-references__text" id="ref-CR191"&gt;Ren, J. et al. Evidence of brain target engagement in Parkinson’s disease and multiple sclerosis by the investigational nanomedicine, CNM-Au8, in the REPAIR phase 2 clinical trials. &lt;i&gt;J. Nanobiotechnology&lt;/i&gt; &lt;b&gt;21&lt;/b&gt;, 478 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1186/s12951-023-02236-z" data-track-item_id="10.1186/s12951-023-02236-z" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s12951-023-02236-z" aria-label="Article reference 191" data-doi="10.1186/s12951-023-02236-z"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXis1SgsLzP" aria-label="CAS reference 191"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38087362" aria-label="PubMed reference 191"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10717868" aria-label="PubMed Central reference 191"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 191" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Evidence%20of%20brain%20target%20engagement%20in%20Parkinson%E2%80%99s%20disease%20and%20multiple%20sclerosis%20by%20the%20investigational%20nanomedicine%2C%20CNM-Au8%2C%20in%20the%20REPAIR%20phase%202%20clinical%20trials&amp;amp;journal=J.%20Nanobiotechnology&amp;amp;doi=10.1186%2Fs12951-023-02236-z&amp;amp;volume=21&amp;amp;publication_year=2023&amp;amp;author=Ren%2CJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="192."&gt;&lt;p class="c-article-references__text" id="ref-CR192"&gt;Vucic, S. et al. Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension. &lt;i&gt;EClinicalMedicine&lt;/i&gt; &lt;b&gt;60&lt;/b&gt;, 102036 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.eclinm.2023.102036" data-track-item_id="10.1016/j.eclinm.2023.102036" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.eclinm.2023.102036" aria-label="Article reference 192" data-doi="10.1016/j.eclinm.2023.102036"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37396808" aria-label="PubMed reference 192"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314176" aria-label="PubMed Central reference 192"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 192" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Efficacy%20and%20safety%20of%20CNM-Au8%20in%20amyotrophic%20lateral%20sclerosis%20%28RESCUE-ALS%20study%29%3A%20a%20phase%202%2C%20randomised%2C%20double-blind%2C%20placebo-controlled%20trial%20and%20open%20label%20extension&amp;amp;journal=EClinicalMedicine&amp;amp;doi=10.1016%2Fj.eclinm.2023.102036&amp;amp;volume=60&amp;amp;publication_year=2023&amp;amp;author=Vucic%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="193."&gt;&lt;p class="c-article-references__text" id="ref-CR193"&gt;Writing Committee for the HEALEY ALS Platform Trial; Berryet al. CNM-Au8 in amyotrophic lateral sclerosis: the HEALEY ALS Platform Trial. &lt;i&gt;JAMA&lt;/i&gt; &lt;b&gt;333&lt;/b&gt;, 1138–1149 (2025).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1001/jama.2024.27643" data-track-item_id="10.1001/jama.2024.27643" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1001%2Fjama.2024.27643" aria-label="Article reference 193" data-doi="10.1001/jama.2024.27643"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 193" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=CNM-Au8%20in%20amyotrophic%20lateral%20sclerosis%3A%20the%20HEALEY%20ALS%20Platform%20Trial&amp;amp;journal=JAMA&amp;amp;doi=10.1001%2Fjama.2024.27643&amp;amp;volume=333&amp;amp;pages=1138-1149&amp;amp;publication_year=2025"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="194."&gt;&lt;p class="c-article-references__text" id="ref-CR194"&gt;Wang, H. L. et al. A luminescent-based protocol for NAD&lt;sup&gt;+&lt;/sup&gt;/NADH detection in &lt;i&gt;C. elegans&lt;/i&gt;, mice, and human whole blood. &lt;i&gt;STAR Protoc.&lt;/i&gt; &lt;b&gt;5&lt;/b&gt;, 103428 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.xpro.2024.103428" data-track-item_id="10.1016/j.xpro.2024.103428" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.xpro.2024.103428" aria-label="Article reference 194" data-doi="10.1016/j.xpro.2024.103428"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXisFWhsr%2FN" aria-label="CAS reference 194"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=39487980" aria-label="PubMed reference 194"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567065" aria-label="PubMed Central reference 194"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 194" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=A%20luminescent-based%20protocol%20for%20NAD%2B%2FNADH%20detection%20in%20C.%20elegans%2C%20mice%2C%20and%20human%20whole%20blood&amp;amp;journal=STAR%20Protoc.&amp;amp;doi=10.1016%2Fj.xpro.2024.103428&amp;amp;volume=5&amp;amp;publication_year=2024&amp;amp;author=Wang%2CHL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="195."&gt;&lt;p class="c-article-references__text" id="ref-CR195"&gt;Zhu, X. H., Lu, M., Lee, B. Y., Ugurbil, K. &amp;amp; Chen, W. In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences. &lt;i&gt;Proc. Natl Acad. Sci. USA&lt;/i&gt; &lt;b&gt;112&lt;/b&gt;, 2876–2881 (2015).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1073/pnas.1417921112" data-track-item_id="10.1073/pnas.1417921112" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1073%2Fpnas.1417921112" aria-label="Article reference 195" data-doi="10.1073/pnas.1417921112"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXivFajsbg%3D" aria-label="CAS reference 195"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=25730862" aria-label="PubMed reference 195"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352772" aria-label="PubMed Central reference 195"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 195" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=In%20vivo%20NAD%20assay%20reveals%20the%20intracellular%20NAD%20contents%20and%20redox%20state%20in%20healthy%20human%20brain%20and%20their%20age%20dependences&amp;amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;amp;doi=10.1073%2Fpnas.1417921112&amp;amp;volume=112&amp;amp;pages=2876-2881&amp;amp;publication_year=2015&amp;amp;author=Zhu%2CXH&amp;amp;author=Lu%2CM&amp;amp;author=Lee%2CBY&amp;amp;author=Ugurbil%2CK&amp;amp;author=Chen%2CW"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="196."&gt;&lt;p class="c-article-references__text" id="ref-CR196"&gt;Yu, Q. et al. A biosensor for measuring NAD&lt;sup&gt;+&lt;/sup&gt; levels at the point of care. &lt;i&gt;Nat. Metab.&lt;/i&gt; &lt;b&gt;1&lt;/b&gt;, 1219–1225 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s42255-019-0151-7" data-track-item_id="10.1038/s42255-019-0151-7" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs42255-019-0151-7" aria-label="Article reference 196" data-doi="10.1038/s42255-019-0151-7"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXks1Krtbw%3D" aria-label="CAS reference 196"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32694678" aria-label="PubMed reference 196"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 196" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=A%20biosensor%20for%20measuring%20NAD%2B%20levels%20at%20the%20point%20of%20care&amp;amp;journal=Nat.%20Metab.&amp;amp;doi=10.1038%2Fs42255-019-0151-7&amp;amp;volume=1&amp;amp;pages=1219-1225&amp;amp;publication_year=2019&amp;amp;author=Yu%2CQ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="197."&gt;&lt;p class="c-article-references__text" id="ref-CR197"&gt;Cambronne, X. A. &amp;amp; Kraus, W. L. Location, location, location: compartmentalization of NAD&lt;sup&gt;+&lt;/sup&gt; synthesis and functions in mammalian cells. &lt;i&gt;Trends Biochem. Sci.&lt;/i&gt; &lt;b&gt;45&lt;/b&gt;, 858–873 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.tibs.2020.05.010" data-track-item_id="10.1016/j.tibs.2020.05.010" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.tibs.2020.05.010" aria-label="Article reference 197" data-doi="10.1016/j.tibs.2020.05.010"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXhtFegu7nE" aria-label="CAS reference 197"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32595066" aria-label="PubMed reference 197"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502477" aria-label="PubMed Central reference 197"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 197" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Location%2C%20location%2C%20location%3A%20compartmentalization%20of%20NAD%2B%20synthesis%20and%20functions%20in%20mammalian%20cells&amp;amp;journal=Trends%20Biochem.%20Sci.&amp;amp;doi=10.1016%2Fj.tibs.2020.05.010&amp;amp;volume=45&amp;amp;pages=858-873&amp;amp;publication_year=2020&amp;amp;author=Cambronne%2CXA&amp;amp;author=Kraus%2CWL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="198."&gt;&lt;p class="c-article-references__text" id="ref-CR198"&gt;Dziadosz, M. et al. Quantification of NAD&lt;sup&gt;+&lt;/sup&gt; in human brain with &lt;sup&gt;1&lt;/sup&gt;H MR spectroscopy at 3 T: comparison of three localization techniques with different handling of water magnetization. &lt;i&gt;Magn. Reson. Med.&lt;/i&gt; &lt;b&gt;88&lt;/b&gt;, 1027–1038 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/mrm.29267" data-track-item_id="10.1002/mrm.29267" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fmrm.29267" aria-label="Article reference 198" data-doi="10.1002/mrm.29267"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XhvVCnt7%2FE" aria-label="CAS reference 198"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=35526238" aria-label="PubMed reference 198"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322547" aria-label="PubMed Central reference 198"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 198" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Quantification%20of%20NAD%2B%20in%20human%20brain%20with%201H%20MR%20spectroscopy%20at%203%20T%3A%20comparison%20of%20three%20localization%20techniques%20with%20different%20handling%20of%20water%20magnetization&amp;amp;journal=Magn.%20Reson.%20Med.&amp;amp;doi=10.1002%2Fmrm.29267&amp;amp;volume=88&amp;amp;pages=1027-1038&amp;amp;publication_year=2022&amp;amp;author=Dziadosz%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="199."&gt;&lt;p class="c-article-references__text" id="ref-CR199"&gt;Peng, Y., Zhang, Z., He, L., Li, C. &amp;amp; Liu, M. NMR spectroscopy for metabolomics in the living system: recent progress and future challenges. &lt;i&gt;Anal. Bioanal. Chem.&lt;/i&gt; &lt;b&gt;416&lt;/b&gt;, 2319–2334 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1007/s00216-024-05137-8" data-track-item_id="10.1007/s00216-024-05137-8" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s00216-024-05137-8" aria-label="Article reference 199" data-doi="10.1007/s00216-024-05137-8"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXhvVejt7Y%3D" aria-label="CAS reference 199"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38240793" aria-label="PubMed reference 199"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10950998" aria-label="PubMed Central reference 199"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 199" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NMR%20spectroscopy%20for%20metabolomics%20in%20the%20living%20system%3A%20recent%20progress%20and%20future%20challenges&amp;amp;journal=Anal.%20Bioanal.%20Chem.&amp;amp;doi=10.1007%2Fs00216-024-05137-8&amp;amp;volume=416&amp;amp;pages=2319-2334&amp;amp;publication_year=2024&amp;amp;author=Peng%2CY&amp;amp;author=Zhang%2CZ&amp;amp;author=He%2CL&amp;amp;author=Li%2CC&amp;amp;author=Liu%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="200."&gt;&lt;p class="c-article-references__text" id="ref-CR200"&gt;Mevenkamp, J. et al. Development of a &lt;sup&gt;31&lt;/sup&gt;P magnetic resonance spectroscopy technique to quantify NADH and NAD&lt;sup&gt;+&lt;/sup&gt; at 3 T. &lt;i&gt;Nat. Commun.&lt;/i&gt; &lt;b&gt;15&lt;/b&gt;, 9159 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-024-53292-4" data-track-item_id="10.1038/s41467-024-53292-4" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-024-53292-4" aria-label="Article reference 200" data-doi="10.1038/s41467-024-53292-4"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXitleqtbfO" aria-label="CAS reference 200"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=39443469" aria-label="PubMed reference 200"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11499639" aria-label="PubMed Central reference 200"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 200" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Development%20of%20a%2031P%20magnetic%20resonance%20spectroscopy%20technique%20to%20quantify%20NADH%20and%20NAD%2B%20at%203%20T&amp;amp;journal=Nat.%20Commun.&amp;amp;doi=10.1038%2Fs41467-024-53292-4&amp;amp;volume=15&amp;amp;publication_year=2024&amp;amp;author=Mevenkamp%2CJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="201."&gt;&lt;p class="c-article-references__text" id="ref-CR201"&gt;Matsuyama, R. et al. Stabilization and quantitative measurement of nicotinamide adenine dinucleotide in human whole blood using dried blood spot sampling. &lt;i&gt;Anal. Bioanal. Chem.&lt;/i&gt; &lt;b&gt;415&lt;/b&gt;, 775–785 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1007/s00216-022-04469-7" data-track-item_id="10.1007/s00216-022-04469-7" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s00216-022-04469-7" aria-label="Article reference 201" data-doi="10.1007/s00216-022-04469-7"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XjtFWgur%2FJ" aria-label="CAS reference 201"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36504284" aria-label="PubMed reference 201"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 201" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Stabilization%20and%20quantitative%20measurement%20of%20nicotinamide%20adenine%20dinucleotide%20in%20human%20whole%20blood%20using%20dried%20blood%20spot%20sampling&amp;amp;journal=Anal.%20Bioanal.%20Chem.&amp;amp;doi=10.1007%2Fs00216-022-04469-7&amp;amp;volume=415&amp;amp;pages=775-785&amp;amp;publication_year=2023&amp;amp;author=Matsuyama%2CR"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="202."&gt;&lt;p class="c-article-references__text" id="ref-CR202"&gt;Song, Q. et al. The safety and antiaging effects of nicotinamide mononucleotide in human clinical trials: an update. &lt;i&gt;Adv. Nutr.&lt;/i&gt; &lt;b&gt;14&lt;/b&gt;, 1416–1435 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.advnut.2023.08.008" data-track-item_id="10.1016/j.advnut.2023.08.008" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.advnut.2023.08.008" aria-label="Article reference 202" data-doi="10.1016/j.advnut.2023.08.008"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXht1Khtg%3D%3D" aria-label="CAS reference 202"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37619764" aria-label="PubMed reference 202"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10721522" aria-label="PubMed Central reference 202"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 202" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20safety%20and%20antiaging%20effects%20of%20nicotinamide%20mononucleotide%20in%20human%20clinical%20trials%3A%20an%20update&amp;amp;journal=Adv.%20Nutr.&amp;amp;doi=10.1016%2Fj.advnut.2023.08.008&amp;amp;volume=14&amp;amp;pages=1416-1435&amp;amp;publication_year=2023&amp;amp;author=Song%2CQ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="203."&gt;&lt;p class="c-article-references__text" id="ref-CR203"&gt;Damgaard, M. V. &amp;amp; Treebak, J. T. What is really known about the effects of nicotinamide riboside supplementation in humans. &lt;i&gt;Sci. Adv.&lt;/i&gt; &lt;b&gt;9&lt;/b&gt;, eadi4862 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/sciadv.adi4862" data-track-item_id="10.1126/sciadv.adi4862" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fsciadv.adi4862" aria-label="Article reference 203" data-doi="10.1126/sciadv.adi4862"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXhsF2ktLfJ" aria-label="CAS reference 203"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37478182" aria-label="PubMed reference 203"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361580" aria-label="PubMed Central reference 203"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 203" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=What%20is%20really%20known%20about%20the%20effects%20of%20nicotinamide%20riboside%20supplementation%20in%20humans&amp;amp;journal=Sci.%20Adv.&amp;amp;doi=10.1126%2Fsciadv.adi4862&amp;amp;volume=9&amp;amp;publication_year=2023&amp;amp;author=Damgaard%2CMV&amp;amp;author=Treebak%2CJT"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="204."&gt;&lt;p class="c-article-references__text" id="ref-CR204"&gt;Airhart, S. E. et al. An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD&lt;sup&gt;+&lt;/sup&gt; levels in healthy volunteers. &lt;i&gt;PLoS ONE&lt;/i&gt; &lt;b&gt;12&lt;/b&gt;, e0186459 (2017).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1371/journal.pone.0186459" data-track-item_id="10.1371/journal.pone.0186459" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1371%2Fjournal.pone.0186459" aria-label="Article reference 204" data-doi="10.1371/journal.pone.0186459"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29211728" aria-label="PubMed reference 204"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718430" aria-label="PubMed Central reference 204"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 204" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=An%20open-label%2C%20non-randomized%20study%20of%20the%20pharmacokinetics%20of%20the%20nutritional%20supplement%20nicotinamide%20riboside%20%28NR%29%20and%20its%20effects%20on%20blood%20NAD%2B%20levels%20in%20healthy%20volunteers&amp;amp;journal=PLoS%20ONE&amp;amp;doi=10.1371%2Fjournal.pone.0186459&amp;amp;volume=12&amp;amp;publication_year=2017&amp;amp;author=Airhart%2CSE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="205."&gt;&lt;p class="c-article-references__text" id="ref-CR205"&gt;Belenky, P., Christensen, K. C., Gazzaniga, F., Pletnev, A. A. &amp;amp; Brenner, C. Nicotinamide riboside and nicotinic acid riboside salvage in fungi and mammals. Quantitative basis for Urh1 and purine nucleoside phosphorylase function in NAD&lt;sup&gt;+&lt;/sup&gt; metabolism. &lt;i&gt;J. Biol. Chem.&lt;/i&gt; &lt;b&gt;284&lt;/b&gt;, 158–164 (2009).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1074/jbc.M807976200" data-track-item_id="10.1074/jbc.M807976200" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1074%2Fjbc.M807976200" aria-label="Article reference 205" data-doi="10.1074/jbc.M807976200"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXhsFCjtL%2FM" aria-label="CAS reference 205"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=19001417" aria-label="PubMed reference 205"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2610512" aria-label="PubMed Central reference 205"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 205" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinamide%20riboside%20and%20nicotinic%20acid%20riboside%20salvage%20in%20fungi%20and%20mammals.%20Quantitative%20basis%20for%20Urh1%20and%20purine%20nucleoside%20phosphorylase%20function%20in%20NAD%2B%20metabolism&amp;amp;journal=J.%20Biol.%20Chem.&amp;amp;doi=10.1074%2Fjbc.M807976200&amp;amp;volume=284&amp;amp;pages=158-164&amp;amp;publication_year=2009&amp;amp;author=Belenky%2CP&amp;amp;author=Christensen%2CKC&amp;amp;author=Gazzaniga%2CF&amp;amp;author=Pletnev%2CAA&amp;amp;author=Brenner%2CC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="206."&gt;&lt;p class="c-article-references__text" id="ref-CR206"&gt;Yaku, K. et al. BST1 regulates nicotinamide riboside metabolism via its glycohydrolase and base-exchange activities. &lt;i&gt;Nat. Commun.&lt;/i&gt; &lt;b&gt;12&lt;/b&gt;, 6767 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-021-27080-3" data-track-item_id="10.1038/s41467-021-27080-3" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-021-27080-3" aria-label="Article reference 206" data-doi="10.1038/s41467-021-27080-3"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXisFCmu7fL" aria-label="CAS reference 206"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34799586" aria-label="PubMed reference 206"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604996" aria-label="PubMed Central reference 206"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 206" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=BST1%20regulates%20nicotinamide%20riboside%20metabolism%20via%20its%20glycohydrolase%20and%20base-exchange%20activities&amp;amp;journal=Nat.%20Commun.&amp;amp;doi=10.1038%2Fs41467-021-27080-3&amp;amp;volume=12&amp;amp;publication_year=2021&amp;amp;author=Yaku%2CK"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="207."&gt;&lt;p class="c-article-references__text" id="ref-CR207"&gt;Liu, L. et al. Quantitative analysis of NAD synthesis-breakdown fluxes. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;b&gt;27&lt;/b&gt;, 1067–1080 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2018.03.018" data-track-item_id="10.1016/j.cmet.2018.03.018" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2018.03.018" aria-label="Article reference 207" data-doi="10.1016/j.cmet.2018.03.018"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXotFegtLc%3D" aria-label="CAS reference 207"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29685734" aria-label="PubMed reference 207"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932087" aria-label="PubMed Central reference 207"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 207" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Quantitative%20analysis%20of%20NAD%20synthesis-breakdown%20fluxes&amp;amp;journal=Cell%20Metab.&amp;amp;doi=10.1016%2Fj.cmet.2018.03.018&amp;amp;volume=27&amp;amp;pages=1067-1080&amp;amp;publication_year=2018&amp;amp;author=Liu%2CL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="208."&gt;&lt;p class="c-article-references__text" id="ref-CR208"&gt;Ratajczak, J. et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. &lt;i&gt;Nat. Commun.&lt;/i&gt; &lt;b&gt;7&lt;/b&gt;, 13103 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/ncomms13103" data-track-item_id="10.1038/ncomms13103" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fncomms13103" aria-label="Article reference 208" data-doi="10.1038/ncomms13103"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28Xhs1GnurnN" aria-label="CAS reference 208"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27725675" aria-label="PubMed reference 208"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476803" aria-label="PubMed Central reference 208"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 208" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NRK1%20controls%20nicotinamide%20mononucleotide%20and%20nicotinamide%20riboside%20metabolism%20in%20mammalian%20cells&amp;amp;journal=Nat.%20Commun.&amp;amp;doi=10.1038%2Fncomms13103&amp;amp;volume=7&amp;amp;publication_year=2016&amp;amp;author=Ratajczak%2CJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="209."&gt;&lt;p class="c-article-references__text" id="ref-CR209"&gt;Mateuszuk, Ł. et al. Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside. &lt;i&gt;Biochem. Pharmacol.&lt;/i&gt; &lt;b&gt;178&lt;/b&gt;, 114019 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.bcp.2020.114019" data-track-item_id="10.1016/j.bcp.2020.114019" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.bcp.2020.114019" aria-label="Article reference 209" data-doi="10.1016/j.bcp.2020.114019"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXhtF2lsL3M" aria-label="CAS reference 209"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32389638" aria-label="PubMed reference 209"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 209" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Reversal%20of%20endothelial%20dysfunction%20by%20nicotinamide%20mononucleotide%20via%20extracellular%20conversion%20to%20nicotinamide%20riboside&amp;amp;journal=Biochem.%20Pharmacol.&amp;amp;doi=10.1016%2Fj.bcp.2020.114019&amp;amp;volume=178&amp;amp;publication_year=2020&amp;amp;author=Mateuszuk%2C%C5%81"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="210."&gt;&lt;p class="c-article-references__text" id="ref-CR210"&gt;Fletcher, R. S. et al. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells. &lt;i&gt;Mol. Metab.&lt;/i&gt; &lt;b&gt;6&lt;/b&gt;, 819–832 (2017).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.molmet.2017.05.011" data-track-item_id="10.1016/j.molmet.2017.05.011" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.molmet.2017.05.011" aria-label="Article reference 210" data-doi="10.1016/j.molmet.2017.05.011"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXptlShsLk%3D" aria-label="CAS reference 210"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=28752046" aria-label="PubMed reference 210"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518663" aria-label="PubMed Central reference 210"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 210" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinamide%20riboside%20kinases%20display%20redundancy%20in%20mediating%20nicotinamide%20mononucleotide%20and%20nicotinamide%20riboside%20metabolism%20in%20skeletal%20muscle%20cells&amp;amp;journal=Mol.%20Metab.&amp;amp;doi=10.1016%2Fj.molmet.2017.05.011&amp;amp;volume=6&amp;amp;pages=819-832&amp;amp;publication_year=2017&amp;amp;author=Fletcher%2CRS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="211."&gt;&lt;p class="c-article-references__text" id="ref-CR211"&gt;Sociali, G. et al. Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model. &lt;i&gt;Oncotarget&lt;/i&gt; &lt;b&gt;7&lt;/b&gt;, 2968–2984 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.18632/oncotarget.6502" data-track-item_id="10.18632/oncotarget.6502" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.18632%2Foncotarget.6502" aria-label="Article reference 211" data-doi="10.18632/oncotarget.6502"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26658104" aria-label="PubMed reference 211"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 211" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Antitumor%20effect%20of%20combined%20NAMPT%20and%20CD73%20inhibition%20in%20an%20ovarian%20cancer%20model&amp;amp;journal=Oncotarget&amp;amp;doi=10.18632%2Foncotarget.6502&amp;amp;volume=7&amp;amp;pages=2968-2984&amp;amp;publication_year=2016&amp;amp;author=Sociali%2CG"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="212."&gt;&lt;p class="c-article-references__text" id="ref-CR212"&gt;Grozio, A. et al. Slc12a8 is a nicotinamide mononucleotide transporter. &lt;i&gt;Nat. Metab.&lt;/i&gt; &lt;b&gt;1&lt;/b&gt;, 47–57 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s42255-018-0009-4" data-track-item_id="10.1038/s42255-018-0009-4" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs42255-018-0009-4" aria-label="Article reference 212" data-doi="10.1038/s42255-018-0009-4"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXltlOnsL0%3D" aria-label="CAS reference 212"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31131364" aria-label="PubMed reference 212"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530925" aria-label="PubMed Central reference 212"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 212" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Slc12a8%20is%20a%20nicotinamide%20mononucleotide%20transporter&amp;amp;journal=Nat.%20Metab.&amp;amp;doi=10.1038%2Fs42255-018-0009-4&amp;amp;volume=1&amp;amp;pages=47-57&amp;amp;publication_year=2019&amp;amp;author=Grozio%2CA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="213."&gt;&lt;p class="c-article-references__text" id="ref-CR213"&gt;Damgaard, M. V. et al. Intravenous nicotinamide riboside elevates mouse skeletal muscle NAD&lt;sup&gt;+&lt;/sup&gt; without impacting respiratory capacity or insulin sensitivity. &lt;i&gt;iScience&lt;/i&gt; &lt;b&gt;25&lt;/b&gt;, 103863 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.isci.2022.103863" data-track-item_id="10.1016/j.isci.2022.103863" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.isci.2022.103863" aria-label="Article reference 213" data-doi="10.1016/j.isci.2022.103863"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38Xht1Wjt7vP" aria-label="CAS reference 213"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=35198907" aria-label="PubMed reference 213"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844641" aria-label="PubMed Central reference 213"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 213" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Intravenous%20nicotinamide%20riboside%20elevates%20mouse%20skeletal%20muscle%20NAD%2B%20without%20impacting%20respiratory%20capacity%20or%20insulin%20sensitivity&amp;amp;journal=iScience&amp;amp;doi=10.1016%2Fj.isci.2022.103863&amp;amp;volume=25&amp;amp;publication_year=2022&amp;amp;author=Damgaard%2CMV"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="214."&gt;&lt;p class="c-article-references__text" id="ref-CR214"&gt;Hawkins, J. et al. Randomized, placebo-controlled, pilot clinical study evaluating acute Niagen®+ IV and NAD+ IV in healthy adults. Preprint at &lt;i&gt;medRxiv&lt;/i&gt; &lt;a href="https://doi.org/10.1101/2024.06.06.24308565" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2024.06.06.24308565"&gt;https://doi.org/10.1101/2024.06.06.24308565&lt;/a&gt; (2024).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="215."&gt;&lt;p class="c-article-references__text" id="ref-CR215"&gt;Conlon, N. J. The Role of NAD&lt;sup&gt;+&lt;/sup&gt; in regenerative medicine. &lt;i&gt;Plast. Reconstr. Surg.&lt;/i&gt; &lt;b&gt;150&lt;/b&gt;, 41s–48s (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1097/PRS.0000000000009673" data-track-item_id="10.1097/PRS.0000000000009673" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1097%2FPRS.0000000000009673" aria-label="Article reference 215" data-doi="10.1097/PRS.0000000000009673"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XisFartrfI" aria-label="CAS reference 215"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36170435" aria-label="PubMed reference 215"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 215" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20Role%20of%20NAD%2B%20in%20regenerative%20medicine&amp;amp;journal=Plast.%20Reconstr.%20Surg.&amp;amp;doi=10.1097%2FPRS.0000000000009673&amp;amp;volume=150&amp;amp;pages=41s-48s&amp;amp;publication_year=2022&amp;amp;author=Conlon%2CNJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="216."&gt;&lt;p class="c-article-references__text" id="ref-CR216"&gt;Lee, S. H. et al. Augmentation of NAD&lt;sup&gt;+&lt;/sup&gt; by dunnione ameliorates imiquimod-induced psoriasis-like dermatitis in mice. &lt;i&gt;J. Inflamm. Res.&lt;/i&gt; &lt;b&gt;15&lt;/b&gt;, 4623–4636 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.2147/JIR.S372543" data-track-item_id="10.2147/JIR.S372543" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.2147%2FJIR.S372543" aria-label="Article reference 216" data-doi="10.2147/JIR.S372543"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XhvVaisLvK" aria-label="CAS reference 216"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=35991005" aria-label="PubMed reference 216"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386739" aria-label="PubMed Central reference 216"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 216" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Augmentation%20of%20NAD%2B%20by%20dunnione%20ameliorates%20imiquimod-induced%20psoriasis-like%20dermatitis%20in%20mice&amp;amp;journal=J.%20Inflamm.%20Res.&amp;amp;doi=10.2147%2FJIR.S372543&amp;amp;volume=15&amp;amp;pages=4623-4636&amp;amp;publication_year=2022&amp;amp;author=Lee%2CSH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="217."&gt;&lt;p class="c-article-references__text" id="ref-CR217"&gt;Han, K. et al. Boosting NAD preferentially blunts Th17 inflammation via arginine biosynthesis and redox control in healthy and psoriasis subjects. &lt;i&gt;Cell Rep. Med.&lt;/i&gt; &lt;a href="https://doi.org/10.1016/j.xcrm.2023.101157" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/j.xcrm.2023.101157"&gt;https://doi.org/10.1016/j.xcrm.2023.101157&lt;/a&gt; (2023).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="218."&gt;&lt;p class="c-article-references__text" id="ref-CR218"&gt;Zhang, Z., Lu, Y., Qi, J. &amp;amp; Wu, W. An update on oral drug delivery via intestinal lymphatic transport. &lt;i&gt;Acta Pharm. Sin. B&lt;/i&gt; &lt;b&gt;11&lt;/b&gt;, 2449–2468 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.apsb.2020.12.022" data-track-item_id="10.1016/j.apsb.2020.12.022" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.apsb.2020.12.022" aria-label="Article reference 218" data-doi="10.1016/j.apsb.2020.12.022"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXitFKis73J" aria-label="CAS reference 218"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34522594" aria-label="PubMed reference 218"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424224" aria-label="PubMed Central reference 218"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 218" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=An%20update%20on%20oral%20drug%20delivery%20via%20intestinal%20lymphatic%20transport&amp;amp;journal=Acta%20Pharm.%20Sin.%20B&amp;amp;doi=10.1016%2Fj.apsb.2020.12.022&amp;amp;volume=11&amp;amp;pages=2449-2468&amp;amp;publication_year=2021&amp;amp;author=Zhang%2CZ&amp;amp;author=Lu%2CY&amp;amp;author=Qi%2CJ&amp;amp;author=Wu%2CW"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="219."&gt;&lt;p class="c-article-references__text" id="ref-CR219"&gt;Sun, S. et al. Design and preparation of NMN nanoparticles based on protein-marine polysaccharide with increased NAD&lt;sup&gt;+&lt;/sup&gt; level in &lt;span class="u-small-caps"&gt;d&lt;/span&gt;-galactose induced aging mice model. &lt;i&gt;Colloids Surf. B Biointerfaces&lt;/i&gt; &lt;b&gt;239&lt;/b&gt;, 113903 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.colsurfb.2024.113903" data-track-item_id="10.1016/j.colsurfb.2024.113903" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.colsurfb.2024.113903" aria-label="Article reference 219" data-doi="10.1016/j.colsurfb.2024.113903"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXotlKgu7k%3D" aria-label="CAS reference 219"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38599036" aria-label="PubMed reference 219"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 219" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Design%20and%20preparation%20of%20NMN%20nanoparticles%20based%20on%20protein-marine%20polysaccharide%20with%20increased%20NAD%2B%20level%20in%20d-galactose%20induced%20aging%20mice%20model&amp;amp;journal=Colloids%20Surf.%20B%20Biointerfaces&amp;amp;doi=10.1016%2Fj.colsurfb.2024.113903&amp;amp;volume=239&amp;amp;publication_year=2024&amp;amp;author=Sun%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="220."&gt;&lt;p class="c-article-references__text" id="ref-CR220"&gt;Zhang, D. et al. Hydroxyapatite-based nano-drug delivery system for nicotinamide mononucleotide (NMN): significantly enhancing NMN bioavailability and replenishing in vivo nicotinamide adenine dinucleotide (NAD&lt;sup&gt;+&lt;/sup&gt;) levels. &lt;i&gt;J. Pharm. Pharmacol.&lt;/i&gt; &lt;b&gt;75&lt;/b&gt;, 1569–1580 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/jpp/rgad090" data-track-item_id="10.1093/jpp/rgad090" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Fjpp%2Frgad090" aria-label="Article reference 220" data-doi="10.1093/jpp/rgad090"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2MXhtVGgsLbE" aria-label="CAS reference 220"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37862582" aria-label="PubMed reference 220"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 220" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Hydroxyapatite-based%20nano-drug%20delivery%20system%20for%20nicotinamide%20mononucleotide%20%28NMN%29%3A%20significantly%20enhancing%20NMN%20bioavailability%20and%20replenishing%20in%20vivo%20nicotinamide%20adenine%20dinucleotide%20%28NAD%2B%29%20levels&amp;amp;journal=J.%20Pharm.%20Pharmacol.&amp;amp;doi=10.1093%2Fjpp%2Frgad090&amp;amp;volume=75&amp;amp;pages=1569-1580&amp;amp;publication_year=2023&amp;amp;author=Zhang%2CD"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="221."&gt;&lt;p class="c-article-references__text" id="ref-CR221"&gt;Trammell, S. A. et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. &lt;i&gt;Nat. Commun.&lt;/i&gt; &lt;b&gt;7&lt;/b&gt;, 12948 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/ncomms12948" data-track-item_id="10.1038/ncomms12948" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fncomms12948" aria-label="Article reference 221" data-doi="10.1038/ncomms12948"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28Xhs1GnsbfF" aria-label="CAS reference 221"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27721479" aria-label="PubMed reference 221"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062546" aria-label="PubMed Central reference 221"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 221" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinamide%20riboside%20is%20uniquely%20and%20orally%20bioavailable%20in%20mice%20and%20humans&amp;amp;journal=Nat.%20Commun.&amp;amp;doi=10.1038%2Fncomms12948&amp;amp;volume=7&amp;amp;publication_year=2016&amp;amp;author=Trammell%2CSA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="222."&gt;&lt;p class="c-article-references__text" id="ref-CR222"&gt;Martens, C. R. et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD&lt;sup&gt;+&lt;/sup&gt; in healthy middle-aged and older adults. &lt;i&gt;Nat. Commun.&lt;/i&gt; &lt;b&gt;9&lt;/b&gt;, 1286 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-018-03421-7" data-track-item_id="10.1038/s41467-018-03421-7" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-018-03421-7" aria-label="Article reference 222" data-doi="10.1038/s41467-018-03421-7"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29599478" aria-label="PubMed reference 222"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876407" aria-label="PubMed Central reference 222"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 222" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Chronic%20nicotinamide%20riboside%20supplementation%20is%20well-tolerated%20and%20elevates%20NAD%2B%20in%20healthy%20middle-aged%20and%20older%20adults&amp;amp;journal=Nat.%20Commun.&amp;amp;doi=10.1038%2Fs41467-018-03421-7&amp;amp;volume=9&amp;amp;publication_year=2018&amp;amp;author=Martens%2CCR"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="223."&gt;&lt;p class="c-article-references__text" id="ref-CR223"&gt;Guyton, J. R. &amp;amp; Bays, H. E. Safety considerations with niacin therapy. &lt;i&gt;Am. J. Cardiol.&lt;/i&gt; &lt;b&gt;99&lt;/b&gt;, 22c–31c (2007).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.amjcard.2006.11.018" data-track-item_id="10.1016/j.amjcard.2006.11.018" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.amjcard.2006.11.018" aria-label="Article reference 223" data-doi="10.1016/j.amjcard.2006.11.018"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2sXjtFGlt7c%3D" aria-label="CAS reference 223"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=17368274" aria-label="PubMed reference 223"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 223" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Safety%20considerations%20with%20niacin%20therapy&amp;amp;journal=Am.%20J.%20Cardiol.&amp;amp;doi=10.1016%2Fj.amjcard.2006.11.018&amp;amp;volume=99&amp;amp;pages=22c-31c&amp;amp;publication_year=2007&amp;amp;author=Guyton%2CJR&amp;amp;author=Bays%2CHE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="224."&gt;&lt;p class="c-article-references__text" id="ref-CR224"&gt;Winter, S. L. &amp;amp; Boyer, J. L. Hepatic toxicity from large doses of vitamin B3 (nicotinamide). &lt;i&gt;N. Engl. J. Med.&lt;/i&gt; &lt;b&gt;289&lt;/b&gt;, 1180–1182 (1973).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1056/NEJM197311292892208" data-track-item_id="10.1056/NEJM197311292892208" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1056%2FNEJM197311292892208" aria-label="Article reference 224" data-doi="10.1056/NEJM197311292892208"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:STN:280:DyaE2c%2FjsFSksQ%3D%3D" aria-label="CAS reference 224"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=4271091" aria-label="PubMed reference 224"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 224" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Hepatic%20toxicity%20from%20large%20doses%20of%20vitamin%20B3%20%28nicotinamide%29&amp;amp;journal=N.%20Engl.%20J.%20Med.&amp;amp;doi=10.1056%2FNEJM197311292892208&amp;amp;volume=289&amp;amp;pages=1180-1182&amp;amp;publication_year=1973&amp;amp;author=Winter%2CSL&amp;amp;author=Boyer%2CJL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="225."&gt;&lt;p class="c-article-references__text" id="ref-CR225"&gt;Rader, J. I., Calvert, R. J. &amp;amp; Hathcock, J. N. Hepatic toxicity of unmodified and time-release preparations of niacin. &lt;i&gt;Am. J. Med&lt;/i&gt; &lt;b&gt;92&lt;/b&gt;, 77–81 (1992).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/0002-9343(92)90018-7" data-track-item_id="10.1016/0002-9343(92)90018-7" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2F0002-9343%2892%2990018-7" aria-label="Article reference 225" data-doi="10.1016/0002-9343(92)90018-7"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:STN:280:DyaK387hslSlsQ%3D%3D" aria-label="CAS reference 225"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=1731514" aria-label="PubMed reference 225"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 225" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Hepatic%20toxicity%20of%20unmodified%20and%20time-release%20preparations%20of%20niacin&amp;amp;journal=Am.%20J.%20Med&amp;amp;doi=10.1016%2F0002-9343%2892%2990018-7&amp;amp;volume=92&amp;amp;pages=77-81&amp;amp;publication_year=1992&amp;amp;author=Rader%2CJI&amp;amp;author=Calvert%2CRJ&amp;amp;author=Hathcock%2CJN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="226."&gt;&lt;p class="c-article-references__text" id="ref-CR226"&gt;Knip, M. et al. Safety of high-dose nicotinamide: a review. &lt;i&gt;Diabetologia&lt;/i&gt; &lt;b&gt;43&lt;/b&gt;, 1337–1345 (2000).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1007/s001250051536" data-track-item_id="10.1007/s001250051536" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s001250051536" aria-label="Article reference 226" data-doi="10.1007/s001250051536"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD3cXnsFWiu70%3D" aria-label="CAS reference 226"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=11126400" aria-label="PubMed reference 226"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 226" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Safety%20of%20high-dose%20nicotinamide%3A%20a%20review&amp;amp;journal=Diabetologia&amp;amp;doi=10.1007%2Fs001250051536&amp;amp;volume=43&amp;amp;pages=1337-1345&amp;amp;publication_year=2000&amp;amp;author=Knip%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="227."&gt;&lt;p class="c-article-references__text" id="ref-CR227"&gt;Jenkins, D. J. A. et al. Supplemental vitamins and minerals for CVD prevention and treatment. &lt;i&gt;J. Am. Coll. Cardiol.&lt;/i&gt; &lt;b&gt;71&lt;/b&gt;, 2570–2584 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.jacc.2018.04.020" data-track-item_id="10.1016/j.jacc.2018.04.020" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.jacc.2018.04.020" aria-label="Article reference 227" data-doi="10.1016/j.jacc.2018.04.020"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXhtVelsLvF" aria-label="CAS reference 227"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29852980" aria-label="PubMed reference 227"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 227" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Supplemental%20vitamins%20and%20minerals%20for%20CVD%20prevention%20and%20treatment&amp;amp;journal=J.%20Am.%20Coll.%20Cardiol.&amp;amp;doi=10.1016%2Fj.jacc.2018.04.020&amp;amp;volume=71&amp;amp;pages=2570-2584&amp;amp;publication_year=2018&amp;amp;author=Jenkins%2CDJA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="228."&gt;&lt;p class="c-article-references__text" id="ref-CR228"&gt;Ferrell, M. et al. A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk. &lt;i&gt;Nat. Med.&lt;/i&gt; &lt;b&gt;30&lt;/b&gt;, 424–434 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41591-023-02793-8" data-track-item_id="10.1038/s41591-023-02793-8" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41591-023-02793-8" aria-label="Article reference 228" data-doi="10.1038/s41591-023-02793-8"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXjvFOlsrg%3D" aria-label="CAS reference 228"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38374343" aria-label="PubMed reference 228"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11841810" aria-label="PubMed Central reference 228"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 228" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=A%20terminal%20metabolite%20of%20niacin%20promotes%20vascular%20inflammation%20and%20contributes%20to%20cardiovascular%20disease%20risk&amp;amp;journal=Nat.%20Med.&amp;amp;doi=10.1038%2Fs41591-023-02793-8&amp;amp;volume=30&amp;amp;pages=424-434&amp;amp;publication_year=2024&amp;amp;author=Ferrell%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="229."&gt;&lt;p class="c-article-references__text" id="ref-CR229"&gt;Ferrell, M. et al. Publisher correction: a terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk. &lt;i&gt;Nat. Med.&lt;/i&gt; &lt;b&gt;30&lt;/b&gt;, 1791 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41591-024-02899-7" data-track-item_id="10.1038/s41591-024-02899-7" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41591-024-02899-7" aria-label="Article reference 229" data-doi="10.1038/s41591-024-02899-7"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXlsV2ms70%3D" aria-label="CAS reference 229"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38448791" aria-label="PubMed reference 229"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 229" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Publisher%20correction%3A%20a%20terminal%20metabolite%20of%20niacin%20promotes%20vascular%20inflammation%20and%20contributes%20to%20cardiovascular%20disease%20risk&amp;amp;journal=Nat.%20Med.&amp;amp;doi=10.1038%2Fs41591-024-02899-7&amp;amp;volume=30&amp;amp;publication_year=2024&amp;amp;author=Ferrell%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="230."&gt;&lt;p class="c-article-references__text" id="ref-CR230"&gt;Diguet, N. et al. Nicotinamide riboside preserves cardiac function in a mouse model of dilated cardiomyopathy. &lt;i&gt;Circulation&lt;/i&gt; &lt;b&gt;137&lt;/b&gt;, 2256–2273 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1161/CIRCULATIONAHA.116.026099" data-track-item_id="10.1161/CIRCULATIONAHA.116.026099" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1161%2FCIRCULATIONAHA.116.026099" aria-label="Article reference 230" data-doi="10.1161/CIRCULATIONAHA.116.026099"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXpsl2gur0%3D" aria-label="CAS reference 230"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29217642" aria-label="PubMed reference 230"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 230" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinamide%20riboside%20preserves%20cardiac%20function%20in%20a%20mouse%20model%20of%20dilated%20cardiomyopathy&amp;amp;journal=Circulation&amp;amp;doi=10.1161%2FCIRCULATIONAHA.116.026099&amp;amp;volume=137&amp;amp;pages=2256-2273&amp;amp;publication_year=2018&amp;amp;author=Diguet%2CN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="231."&gt;&lt;p class="c-article-references__text" id="ref-CR231"&gt;Lv, H. et al. NAD&lt;sup&gt;+&lt;/sup&gt; metabolism maintains inducible PD-L1 expression to drive tumor immune evasion. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;b&gt;33&lt;/b&gt;, 110–127 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2020.10.021" data-track-item_id="10.1016/j.cmet.2020.10.021" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2020.10.021" aria-label="Article reference 231" data-doi="10.1016/j.cmet.2020.10.021"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXitlemsbzP" aria-label="CAS reference 231"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33171124" aria-label="PubMed reference 231"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 231" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20metabolism%20maintains%20inducible%20PD-L1%20expression%20to%20drive%20tumor%20immune%20evasion&amp;amp;journal=Cell%20Metab.&amp;amp;doi=10.1016%2Fj.cmet.2020.10.021&amp;amp;volume=33&amp;amp;pages=110-127&amp;amp;publication_year=2021&amp;amp;author=Lv%2CH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="232."&gt;&lt;p class="c-article-references__text" id="ref-CR232"&gt;Bi, T. Q. &amp;amp; Che, X. M. Nampt/PBEF/visfatin and cancer. &lt;i&gt;Cancer Biol. Ther.&lt;/i&gt; &lt;b&gt;10&lt;/b&gt;, 119–125 (2010).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.4161/cbt.10.2.12581" data-track-item_id="10.4161/cbt.10.2.12581" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.4161%2Fcbt.10.2.12581" aria-label="Article reference 232" data-doi="10.4161/cbt.10.2.12581"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXhsFKntLfL" aria-label="CAS reference 232"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=20647743" aria-label="PubMed reference 232"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 232" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nampt%2FPBEF%2Fvisfatin%20and%20cancer&amp;amp;journal=Cancer%20Biol.%20Ther.&amp;amp;doi=10.4161%2Fcbt.10.2.12581&amp;amp;volume=10&amp;amp;pages=119-125&amp;amp;publication_year=2010&amp;amp;author=Bi%2CTQ&amp;amp;author=Che%2CXM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="233."&gt;&lt;p class="c-article-references__text" id="ref-CR233"&gt;Santidrian, A. F. et al. Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. &lt;i&gt;J. Clin. Invest.&lt;/i&gt; &lt;b&gt;123&lt;/b&gt;, 1068–1081 (2013).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1172/JCI64264" data-track-item_id="10.1172/JCI64264" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1172%2FJCI64264" aria-label="Article reference 233" data-doi="10.1172/JCI64264"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXjvVyhsbY%3D" aria-label="CAS reference 233"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=23426180" aria-label="PubMed reference 233"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582128" aria-label="PubMed Central reference 233"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 233" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Mitochondrial%20complex%20I%20activity%20and%20NAD%2B%2FNADH%20balance%20regulate%20breast%20cancer%20progression&amp;amp;journal=J.%20Clin.%20Invest.&amp;amp;doi=10.1172%2FJCI64264&amp;amp;volume=123&amp;amp;pages=1068-1081&amp;amp;publication_year=2013&amp;amp;author=Santidrian%2CAF"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="234."&gt;&lt;p class="c-article-references__text" id="ref-CR234"&gt;Chen, A. C. et al. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. &lt;i&gt;N. Engl. J. Med.&lt;/i&gt; &lt;b&gt;373&lt;/b&gt;, 1618–1626 (2015).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1056/NEJMoa1506197" data-track-item_id="10.1056/NEJMoa1506197" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1056%2FNEJMoa1506197" aria-label="Article reference 234" data-doi="10.1056/NEJMoa1506197"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XnvFCkt78%3D" aria-label="CAS reference 234"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26488693" aria-label="PubMed reference 234"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 234" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=A%20phase%203%20randomized%20trial%20of%20nicotinamide%20for%20skin-cancer%20chemoprevention&amp;amp;journal=N.%20Engl.%20J.%20Med.&amp;amp;doi=10.1056%2FNEJMoa1506197&amp;amp;volume=373&amp;amp;pages=1618-1626&amp;amp;publication_year=2015&amp;amp;author=Chen%2CAC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="235."&gt;&lt;p class="c-article-references__text" id="ref-CR235"&gt;Surjana, D., Halliday, G. M., Martin, A. J., Moloney, F. J. &amp;amp; Damian, D. L. Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials. &lt;i&gt;J. Invest. Dermatol.&lt;/i&gt; &lt;b&gt;132&lt;/b&gt;, 1497–1500 (2012).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/jid.2011.459" data-track-item_id="10.1038/jid.2011.459" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fjid.2011.459" aria-label="Article reference 235" data-doi="10.1038/jid.2011.459"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC38XhtlOksrY%3D" aria-label="CAS reference 235"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=22297641" aria-label="PubMed reference 235"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 235" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Oral%20nicotinamide%20reduces%20actinic%20keratoses%20in%20phase%20II%20double-blinded%20randomized%20controlled%20trials&amp;amp;journal=J.%20Invest.%20Dermatol.&amp;amp;doi=10.1038%2Fjid.2011.459&amp;amp;volume=132&amp;amp;pages=1497-1500&amp;amp;publication_year=2012&amp;amp;author=Surjana%2CD&amp;amp;author=Halliday%2CGM&amp;amp;author=Martin%2CAJ&amp;amp;author=Moloney%2CFJ&amp;amp;author=Damian%2CDL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="236."&gt;&lt;p class="c-article-references__text" id="ref-CR236"&gt;Yiasemides, E., Sivapirabu, G., Halliday, G. M., Park, J. &amp;amp; Damian, D. L. Oral nicotinamide protects against ultraviolet radiation-induced immunosuppression in humans. &lt;i&gt;Carcinogenesis&lt;/i&gt; &lt;b&gt;30&lt;/b&gt;, 101–105 (2009).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/carcin/bgn248" data-track-item_id="10.1093/carcin/bgn248" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Fcarcin%2Fbgn248" aria-label="Article reference 236" data-doi="10.1093/carcin/bgn248"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXhtVaqtb8%3D" aria-label="CAS reference 236"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=19028705" aria-label="PubMed reference 236"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 236" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Oral%20nicotinamide%20protects%20against%20ultraviolet%20radiation-induced%20immunosuppression%20in%20humans&amp;amp;journal=Carcinogenesis&amp;amp;doi=10.1093%2Fcarcin%2Fbgn248&amp;amp;volume=30&amp;amp;pages=101-105&amp;amp;publication_year=2009&amp;amp;author=Yiasemides%2CE&amp;amp;author=Sivapirabu%2CG&amp;amp;author=Halliday%2CGM&amp;amp;author=Park%2CJ&amp;amp;author=Damian%2CDL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="237."&gt;&lt;p class="c-article-references__text" id="ref-CR237"&gt;Nacarelli, T. et al. NAD&lt;sup&gt;+&lt;/sup&gt; metabolism governs the proinflammatory senescence-associated secretome. &lt;i&gt;Nat. Cell Biol.&lt;/i&gt; &lt;b&gt;21&lt;/b&gt;, 397–407 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41556-019-0287-4" data-track-item_id="10.1038/s41556-019-0287-4" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41556-019-0287-4" aria-label="Article reference 237" data-doi="10.1038/s41556-019-0287-4"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXmsVyltbs%3D" aria-label="CAS reference 237"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30778219" aria-label="PubMed reference 237"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448588" aria-label="PubMed Central reference 237"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 237" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20metabolism%20governs%20the%20proinflammatory%20senescence-associated%20secretome&amp;amp;journal=Nat.%20Cell%20Biol.&amp;amp;doi=10.1038%2Fs41556-019-0287-4&amp;amp;volume=21&amp;amp;pages=397-407&amp;amp;publication_year=2019&amp;amp;author=Nacarelli%2CT"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="238."&gt;&lt;p class="c-article-references__text" id="ref-CR238"&gt;Fang, J. et al. NAD&lt;sup&gt;+&lt;/sup&gt; metabolism-based immunoregulation and therapeutic potential. &lt;i&gt;Cell Biosci.&lt;/i&gt; &lt;b&gt;13&lt;/b&gt;, 81 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1186/s13578-023-01031-5" data-track-item_id="10.1186/s13578-023-01031-5" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s13578-023-01031-5" aria-label="Article reference 238" data-doi="10.1186/s13578-023-01031-5"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXpvVagtrg%3D" aria-label="CAS reference 238"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37165408" aria-label="PubMed reference 238"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171153" aria-label="PubMed Central reference 238"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 238" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20metabolism-based%20immunoregulation%20and%20therapeutic%20potential&amp;amp;journal=Cell%20Biosci.&amp;amp;doi=10.1186%2Fs13578-023-01031-5&amp;amp;volume=13&amp;amp;publication_year=2023&amp;amp;author=Fang%2CJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="239."&gt;&lt;p class="c-article-references__text" id="ref-CR239"&gt;Morandi, F., Horenstein, A. L. &amp;amp; Malavasi, F. The key role of NAD&lt;sup&gt;+&lt;/sup&gt; in anti-tumor immune response: an update. &lt;i&gt;Front. Immunol.&lt;/i&gt; &lt;b&gt;12&lt;/b&gt;, 658263 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.3389/fimmu.2021.658263" data-track-item_id="10.3389/fimmu.2021.658263" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3389%2Ffimmu.2021.658263" aria-label="Article reference 239" data-doi="10.3389/fimmu.2021.658263"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXhs1Wqs7zP" aria-label="CAS reference 239"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33936090" aria-label="PubMed reference 239"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082456" aria-label="PubMed Central reference 239"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 239" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20key%20role%20of%20NAD%2B%20in%20anti-tumor%20immune%20response%3A%20an%20update&amp;amp;journal=Front.%20Immunol.&amp;amp;doi=10.3389%2Ffimmu.2021.658263&amp;amp;volume=12&amp;amp;publication_year=2021&amp;amp;author=Morandi%2CF&amp;amp;author=Horenstein%2CAL&amp;amp;author=Malavasi%2CF"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="240."&gt;&lt;p class="c-article-references__text" id="ref-CR240"&gt;Sun, C. et al. Re-equilibration of imbalanced NAD metabolism ameliorates the impact of telomere dysfunction. &lt;i&gt;EMBO J.&lt;/i&gt; &lt;b&gt;39&lt;/b&gt;, e103420 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.15252/embj.2019103420" data-track-item_id="10.15252/embj.2019103420" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.15252%2Fembj.2019103420" aria-label="Article reference 240" data-doi="10.15252/embj.2019103420"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXhvVWls77M" aria-label="CAS reference 240"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32935380" aria-label="PubMed reference 240"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604620" aria-label="PubMed Central reference 240"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 240" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Re-equilibration%20of%20imbalanced%20NAD%20metabolism%20ameliorates%20the%20impact%20of%20telomere%20dysfunction&amp;amp;journal=EMBO%20J.&amp;amp;doi=10.15252%2Fembj.2019103420&amp;amp;volume=39&amp;amp;publication_year=2020&amp;amp;author=Sun%2CC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="241."&gt;&lt;p class="c-article-references__text" id="ref-CR241"&gt;Wang, H., Lautrup, S., Caponio, D., Zhang, J. &amp;amp; Fang, E. F. DNA damage-induced neurodegeneration in accelerated ageing and Alzheimer’s disease. &lt;i&gt;Int. J. Mol. Sci.&lt;/i&gt; &lt;a href="https://doi.org/10.3390/ijms22136748" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3390/ijms22136748"&gt;https://doi.org/10.3390/ijms22136748&lt;/a&gt; (2021).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="242."&gt;&lt;p class="c-article-references__text" id="ref-CR242"&gt;Ummarino, S. et al. NAD Modulates DNA methylation and cell differentiation. &lt;i&gt;Cells&lt;/i&gt; &lt;a href="https://doi.org/10.3390/cells10112986" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3390/cells10112986"&gt;https://doi.org/10.3390/cells10112986&lt;/a&gt; (2021).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="243."&gt;&lt;p class="c-article-references__text" id="ref-CR243"&gt;Tomita, T. et al. Sirt1-deficiency causes defective protein quality control. &lt;i&gt;Sci. Rep.&lt;/i&gt; &lt;b&gt;5&lt;/b&gt;, 12613 (2015).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/srep12613" data-track-item_id="10.1038/srep12613" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fsrep12613" aria-label="Article reference 243" data-doi="10.1038/srep12613"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXhtlCjsLfK" aria-label="CAS reference 243"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26219988" aria-label="PubMed reference 243"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518232" aria-label="PubMed Central reference 243"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 243" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Sirt1-deficiency%20causes%20defective%20protein%20quality%20control&amp;amp;journal=Sci.%20Rep.&amp;amp;doi=10.1038%2Fsrep12613&amp;amp;volume=5&amp;amp;publication_year=2015&amp;amp;author=Tomita%2CT"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="244."&gt;&lt;p class="c-article-references__text" id="ref-CR244"&gt;Levine, D. C. et al. NAD&lt;sup&gt;+&lt;/sup&gt; controls circadian reprogramming through PER2 nuclear translocation to counter aging. &lt;i&gt;Mol. Cell&lt;/i&gt; &lt;b&gt;78&lt;/b&gt;, 835–849 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.molcel.2020.04.010" data-track-item_id="10.1016/j.molcel.2020.04.010" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.molcel.2020.04.010" aria-label="Article reference 244" data-doi="10.1016/j.molcel.2020.04.010"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXovVCguro%3D" aria-label="CAS reference 244"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32369735" aria-label="PubMed reference 244"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275919" aria-label="PubMed Central reference 244"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 244" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20controls%20circadian%20reprogramming%20through%20PER2%20nuclear%20translocation%20to%20counter%20aging&amp;amp;journal=Mol.%20Cell&amp;amp;doi=10.1016%2Fj.molcel.2020.04.010&amp;amp;volume=78&amp;amp;pages=835-849&amp;amp;publication_year=2020&amp;amp;author=Levine%2CDC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="245."&gt;&lt;p class="c-article-references__text" id="ref-CR245"&gt;Aman, Y. et al. Autophagy in healthy aging and disease. &lt;i&gt;Nat. Aging&lt;/i&gt; &lt;b&gt;1&lt;/b&gt;, 634–650 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s43587-021-00098-4" data-track-item_id="10.1038/s43587-021-00098-4" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs43587-021-00098-4" aria-label="Article reference 245" data-doi="10.1038/s43587-021-00098-4"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34901876" aria-label="PubMed reference 245"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659158" aria-label="PubMed Central reference 245"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 245" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Autophagy%20in%20healthy%20aging%20and%20disease&amp;amp;journal=Nat.%20Aging&amp;amp;doi=10.1038%2Fs43587-021-00098-4&amp;amp;volume=1&amp;amp;pages=634-650&amp;amp;publication_year=2021&amp;amp;author=Aman%2CY"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="246."&gt;&lt;p class="c-article-references__text" id="ref-CR246"&gt;Ludewig, A. H. et al. Pheromone sensing regulates &lt;i&gt;Caenorhabditis elegans&lt;/i&gt; lifespan and stress resistance via the deacetylase SIR-2.1. &lt;i&gt;Proc. Natl Acad. Sci. USA&lt;/i&gt; &lt;b&gt;110&lt;/b&gt;, 5522–5527 (2013).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1073/pnas.1214467110" data-track-item_id="10.1073/pnas.1214467110" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1073%2Fpnas.1214467110" aria-label="Article reference 246" data-doi="10.1073/pnas.1214467110"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXntVegsr0%3D" aria-label="CAS reference 246"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=23509272" aria-label="PubMed reference 246"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619363" aria-label="PubMed Central reference 246"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 246" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Pheromone%20sensing%20regulates%20Caenorhabditis%20elegans%20lifespan%20and%20stress%20resistance%20via%20the%20deacetylase%20SIR-2.1&amp;amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;amp;doi=10.1073%2Fpnas.1214467110&amp;amp;volume=110&amp;amp;pages=5522-5527&amp;amp;publication_year=2013&amp;amp;author=Ludewig%2CAH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="247."&gt;&lt;p class="c-article-references__text" id="ref-CR247"&gt;Lin, J., Handschin, C. &amp;amp; Spiegelman, B. M. Metabolic control through the PGC-1 family of transcription coactivators. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;b&gt;1&lt;/b&gt;, 361–370 (2005).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2005.05.004" data-track-item_id="10.1016/j.cmet.2005.05.004" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2005.05.004" aria-label="Article reference 247" data-doi="10.1016/j.cmet.2005.05.004"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=16054085" aria-label="PubMed reference 247"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 247" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Metabolic%20control%20through%20the%20PGC-1%20family%20of%20transcription%20coactivators&amp;amp;journal=Cell%20Metab.&amp;amp;doi=10.1016%2Fj.cmet.2005.05.004&amp;amp;volume=1&amp;amp;pages=361-370&amp;amp;publication_year=2005&amp;amp;author=Lin%2CJ&amp;amp;author=Handschin%2CC&amp;amp;author=Spiegelman%2CBM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="248."&gt;&lt;p class="c-article-references__text" id="ref-CR248"&gt;Miwa, S., Kashyap, S., Chini, E. &amp;amp; von Zglinicki, T. Mitochondrial dysfunction in cell senescence and aging. &lt;i&gt;J. Clin. Invest.&lt;/i&gt; &lt;a href="https://doi.org/10.1172/JCI158447" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1172/JCI158447"&gt;https://doi.org/10.1172/JCI158447&lt;/a&gt; (2022).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="249."&gt;&lt;p class="c-article-references__text" id="ref-CR249"&gt;Allen, A. R., Jones, A., LoBianco, F. V., Krager, K. J. &amp;amp; Aykin-Burns, N. Effect of Sirt3 on hippocampal MnSOD activity, mitochondrial function, physiology, and cognition in an aged murine model. &lt;i&gt;Behav. Brain Res.&lt;/i&gt; &lt;b&gt;444&lt;/b&gt;, 114335 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.bbr.2023.114335" data-track-item_id="10.1016/j.bbr.2023.114335" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.bbr.2023.114335" aria-label="Article reference 249" data-doi="10.1016/j.bbr.2023.114335"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXktV2itL8%3D" aria-label="CAS reference 249"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36804441" aria-label="PubMed reference 249"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081808" aria-label="PubMed Central reference 249"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 249" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Effect%20of%20Sirt3%20on%20hippocampal%20MnSOD%20activity%2C%20mitochondrial%20function%2C%20physiology%2C%20and%20cognition%20in%20an%20aged%20murine%20model&amp;amp;journal=Behav.%20Brain%20Res.&amp;amp;doi=10.1016%2Fj.bbr.2023.114335&amp;amp;volume=444&amp;amp;publication_year=2023&amp;amp;author=Allen%2CAR&amp;amp;author=Jones%2CA&amp;amp;author=LoBianco%2CFV&amp;amp;author=Krager%2CKJ&amp;amp;author=Aykin-Burns%2CN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="250."&gt;&lt;p class="c-article-references__text" id="ref-CR250"&gt;Chini, C. C. S., Cordeiro, H. S., Tran, N. L. K. &amp;amp; Chini, E. N. NAD metabolism: role in senescence regulation and aging. &lt;i&gt;Aging Cell&lt;/i&gt; &lt;b&gt;23&lt;/b&gt;, e13920 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/acel.13920" data-track-item_id="10.1111/acel.13920" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Facel.13920" aria-label="Article reference 250" data-doi="10.1111/acel.13920"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXhsVOmsrbI" aria-label="CAS reference 250"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37424179" aria-label="PubMed reference 250"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 250" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%20metabolism%3A%20role%20in%20senescence%20regulation%20and%20aging&amp;amp;journal=Aging%20Cell&amp;amp;doi=10.1111%2Facel.13920&amp;amp;volume=23&amp;amp;publication_year=2024&amp;amp;author=Chini%2CCCS&amp;amp;author=Cordeiro%2CHS&amp;amp;author=Tran%2CNLK&amp;amp;author=Chini%2CEN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="251."&gt;&lt;p class="c-article-references__text" id="ref-CR251"&gt;Pareja-Galeano, H., Sanchis-Gomar, F. &amp;amp; Lucia, A. p16INK4a, NAD&lt;sup&gt;+&lt;/sup&gt;, and sestrins: new targets for combating aging-related chronic illness? &lt;i&gt;J. Cell. Physiol.&lt;/i&gt; &lt;b&gt;229&lt;/b&gt;, 1575–1576 (2014).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/jcp.24627" data-track-item_id="10.1002/jcp.24627" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fjcp.24627" aria-label="Article reference 251" data-doi="10.1002/jcp.24627"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXht1alu7jI" aria-label="CAS reference 251"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=24664908" aria-label="PubMed reference 251"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 251" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=p16INK4a%2C%20NAD%2B%2C%20and%20sestrins%3A%20new%20targets%20for%20combating%20aging-related%20chronic%20illness%3F&amp;amp;journal=J.%20Cell.%20Physiol.&amp;amp;doi=10.1002%2Fjcp.24627&amp;amp;volume=229&amp;amp;pages=1575-1576&amp;amp;publication_year=2014&amp;amp;author=Pareja-Galeano%2CH&amp;amp;author=Sanchis-Gomar%2CF&amp;amp;author=Lucia%2CA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="252."&gt;&lt;p class="c-article-references__text" id="ref-CR252"&gt;Zhang, H. et al. NAD&lt;sup&gt;+&lt;/sup&gt; repletion improves mitochondrial and stem cell function and enhances life span in mice. &lt;i&gt;Science&lt;/i&gt; &lt;b&gt;352&lt;/b&gt;, 1436–1443 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.aaf2693" data-track-item_id="10.1126/science.aaf2693" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.aaf2693" aria-label="Article reference 252" data-doi="10.1126/science.aaf2693"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XpslOqsb8%3D" aria-label="CAS reference 252"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27127236" aria-label="PubMed reference 252"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 252" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=NAD%2B%20repletion%20improves%20mitochondrial%20and%20stem%20cell%20function%20and%20enhances%20life%20span%20in%20mice&amp;amp;journal=Science&amp;amp;doi=10.1126%2Fscience.aaf2693&amp;amp;volume=352&amp;amp;pages=1436-1443&amp;amp;publication_year=2016&amp;amp;author=Zhang%2CH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="253."&gt;&lt;p class="c-article-references__text" id="ref-CR253"&gt;Gomes, A. P. et al. Declining NAD&lt;sup&gt;+&lt;/sup&gt; induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. &lt;i&gt;Cell&lt;/i&gt; &lt;b&gt;155&lt;/b&gt;, 1624–1638 (2013).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cell.2013.11.037" data-track-item_id="10.1016/j.cell.2013.11.037" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2013.11.037" aria-label="Article reference 253" data-doi="10.1016/j.cell.2013.11.037"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXhvFylurrJ" aria-label="CAS reference 253"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=24360282" aria-label="PubMed reference 253"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076149" aria-label="PubMed Central reference 253"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 253" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Declining%20NAD%2B%20induces%20a%20pseudohypoxic%20state%20disrupting%20nuclear-mitochondrial%20communication%20during%20aging&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2013.11.037&amp;amp;volume=155&amp;amp;pages=1624-1638&amp;amp;publication_year=2013&amp;amp;author=Gomes%2CAP"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="254."&gt;&lt;p class="c-article-references__text" id="ref-CR254"&gt;Ying, X., Zheng, X., Zhang, X., Yin, Y. &amp;amp; Wang, X. Kynurenine in IDO1&lt;sup&gt;high&lt;/sup&gt; cancer cell-derived extracellular vesicles promotes angiogenesis by inducing endothelial mitophagy in ovarian cancer. &lt;i&gt;J. Transl. Med.&lt;/i&gt; &lt;b&gt;22&lt;/b&gt;, 267 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1186/s12967-024-05054-5" data-track-item_id="10.1186/s12967-024-05054-5" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s12967-024-05054-5" aria-label="Article reference 254" data-doi="10.1186/s12967-024-05054-5"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXmtVClu70%3D" aria-label="CAS reference 254"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38468343" aria-label="PubMed reference 254"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10929174" aria-label="PubMed Central reference 254"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 254" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Kynurenine%20in%20IDO1high%20cancer%20cell-derived%20extracellular%20vesicles%20promotes%20angiogenesis%20by%20inducing%20endothelial%20mitophagy%20in%20ovarian%20cancer&amp;amp;journal=J.%20Transl.%20Med.&amp;amp;doi=10.1186%2Fs12967-024-05054-5&amp;amp;volume=22&amp;amp;publication_year=2024&amp;amp;author=Ying%2CX&amp;amp;author=Zheng%2CX&amp;amp;author=Zhang%2CX&amp;amp;author=Yin%2CY&amp;amp;author=Wang%2CX"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="255."&gt;&lt;p class="c-article-references__text" id="ref-CR255"&gt;Hou, Y. et al. NAD&lt;sup&gt;+&lt;/sup&gt; supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer’s disease via cGAS-STING. &lt;i&gt;Proc. Natl Acad. Sci. USA&lt;/i&gt; &lt;a href="https://doi.org/10.1073/pnas.2011226118" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1073/pnas.2011226118"&gt;https://doi.org/10.1073/pnas.2011226118&lt;/a&gt; (2021).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="256."&gt;&lt;p class="c-article-references__text" id="ref-CR256"&gt;Schmidlin, C. J., Dodson, M. B., Madhavan, L. &amp;amp; Zhang, D. D. Redox regulation by NRF2 in aging and disease. &lt;i&gt;Free Radic. Biol. Med.&lt;/i&gt; &lt;b&gt;134&lt;/b&gt;, 702–707 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.freeradbiomed.2019.01.016" data-track-item_id="10.1016/j.freeradbiomed.2019.01.016" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.freeradbiomed.2019.01.016" aria-label="Article reference 256" data-doi="10.1016/j.freeradbiomed.2019.01.016"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXhs1aku78%3D" aria-label="CAS reference 256"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30654017" aria-label="PubMed reference 256"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588470" aria-label="PubMed Central reference 256"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 256" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Redox%20regulation%20by%20NRF2%20in%20aging%20and%20disease&amp;amp;journal=Free%20Radic.%20Biol.%20Med.&amp;amp;doi=10.1016%2Fj.freeradbiomed.2019.01.016&amp;amp;volume=134&amp;amp;pages=702-707&amp;amp;publication_year=2019&amp;amp;author=Schmidlin%2CCJ&amp;amp;author=Dodson%2CMB&amp;amp;author=Madhavan%2CL&amp;amp;author=Zhang%2CDD"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="257."&gt;&lt;p class="c-article-references__text" id="ref-CR257"&gt;Devereaux, J. et al. Alterations in tryptophan metabolism and de novo NAD&lt;sup&gt;+&lt;/sup&gt; biosynthesis within the microbiota-gut-brain axis in chronic intestinal inflammation. &lt;i&gt;Front. Med.&lt;/i&gt; &lt;b&gt;11&lt;/b&gt;, 1379335 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.3389/fmed.2024.1379335" data-track-item_id="10.3389/fmed.2024.1379335" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3389%2Ffmed.2024.1379335" aria-label="Article reference 257" data-doi="10.3389/fmed.2024.1379335"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 257" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Alterations%20in%20tryptophan%20metabolism%20and%20de%20novo%20NAD%2B%20biosynthesis%20within%20the%20microbiota-gut-brain%20axis%20in%20chronic%20intestinal%20inflammation&amp;amp;journal=Front.%20Med.&amp;amp;doi=10.3389%2Ffmed.2024.1379335&amp;amp;volume=11&amp;amp;publication_year=2024&amp;amp;author=Devereaux%2CJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="258."&gt;&lt;p class="c-article-references__text" id="ref-CR258"&gt;Dehhaghi, M., Kazemi Shariat Panahi, H. &amp;amp; Guillemin, G. J. Microorganisms, tryptophan metabolism, and kynurenine pathway: a complex interconnected loop influencing human health status. &lt;i&gt;Int. J. Tryptophan Res.&lt;/i&gt; &lt;b&gt;12&lt;/b&gt;, 1178646919852996 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1177/1178646919852996" data-track-item_id="10.1177/1178646919852996" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1177%2F1178646919852996" aria-label="Article reference 258" data-doi="10.1177/1178646919852996"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31258331" aria-label="PubMed reference 258"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585246" aria-label="PubMed Central reference 258"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 258" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Microorganisms%2C%20tryptophan%20metabolism%2C%20and%20kynurenine%20pathway%3A%20a%20complex%20interconnected%20loop%20influencing%20human%20health%20status&amp;amp;journal=Int.%20J.%20Tryptophan%20Res.&amp;amp;doi=10.1177%2F1178646919852996&amp;amp;volume=12&amp;amp;publication_year=2019&amp;amp;author=Dehhaghi%2CM&amp;amp;author=Kazemi%20Shariat%20Panahi%2CH&amp;amp;author=Guillemin%2CGJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="259."&gt;&lt;p class="c-article-references__text" id="ref-CR259"&gt;Wellman, A. S. et al. Intestinal epithelial sirtuin 1 regulates intestinal inflammation during aging in mice by altering the intestinal microbiota. &lt;i&gt;Gastroenterology&lt;/i&gt; &lt;b&gt;153&lt;/b&gt;, 772–786 (2017).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1053/j.gastro.2017.05.022" data-track-item_id="10.1053/j.gastro.2017.05.022" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1053%2Fj.gastro.2017.05.022" aria-label="Article reference 259" data-doi="10.1053/j.gastro.2017.05.022"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=28552621" aria-label="PubMed reference 259"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 259" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Intestinal%20epithelial%20sirtuin%201%20regulates%20intestinal%20inflammation%20during%20aging%20in%20mice%20by%20altering%20the%20intestinal%20microbiota&amp;amp;journal=Gastroenterology&amp;amp;doi=10.1053%2Fj.gastro.2017.05.022&amp;amp;volume=153&amp;amp;pages=772-786&amp;amp;publication_year=2017&amp;amp;author=Wellman%2CAS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="260."&gt;&lt;p class="c-article-references__text" id="ref-CR260"&gt;Minhas, P. S. et al. Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologies. &lt;i&gt;Science&lt;/i&gt; &lt;b&gt;385&lt;/b&gt;, eabm6131 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.abm6131" data-track-item_id="10.1126/science.abm6131" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.abm6131" aria-label="Article reference 260" data-doi="10.1126/science.abm6131"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXitVChtLvN" aria-label="CAS reference 260"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=39172838" aria-label="PubMed reference 260"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12313320" aria-label="PubMed Central reference 260"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 260" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Restoring%20hippocampal%20glucose%20metabolism%20rescues%20cognition%20across%20Alzheimer%E2%80%99s%20disease%20pathologies&amp;amp;journal=Science&amp;amp;doi=10.1126%2Fscience.abm6131&amp;amp;volume=385&amp;amp;publication_year=2024&amp;amp;author=Minhas%2CPS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="261."&gt;&lt;p class="c-article-references__text" id="ref-CR261"&gt;Dan, X. et al. Loss of smelling is an early marker of aging and is associated with inflammation and DNA damage in C57BL/6J mice. &lt;i&gt;Aging Cell&lt;/i&gt; &lt;b&gt;22&lt;/b&gt;, e13793 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/acel.13793" data-track-item_id="10.1111/acel.13793" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Facel.13793" aria-label="Article reference 261" data-doi="10.1111/acel.13793"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXktVamu7c%3D" aria-label="CAS reference 261"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36846960" aria-label="PubMed reference 261"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086518" aria-label="PubMed Central reference 261"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 261" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Loss%20of%20smelling%20is%20an%20early%20marker%20of%20aging%20and%20is%20associated%20with%20inflammation%20and%20DNA%20damage%20in%20C57BL%2F6J%20mice&amp;amp;journal=Aging%20Cell&amp;amp;doi=10.1111%2Facel.13793&amp;amp;volume=22&amp;amp;publication_year=2023&amp;amp;author=Dan%2CX"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="262."&gt;&lt;p class="c-article-references__text" id="ref-CR262"&gt;Hamilton, H. L. et al. Nicotinamide adenine dinucleotide precursor supplementation modulates neurite complexity and survival in motor neurons from amyotrophic lateral sclerosis models. &lt;i&gt;Antioxid. Redox Signal.&lt;/i&gt; &lt;b&gt;41&lt;/b&gt;, 573–589 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1089/ars.2023.0360" data-track-item_id="10.1089/ars.2023.0360" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1089%2Fars.2023.0360" aria-label="Article reference 262" data-doi="10.1089/ars.2023.0360"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXitVOmtbfP" aria-label="CAS reference 262"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38504592" aria-label="PubMed reference 262"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 262" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinamide%20adenine%20dinucleotide%20precursor%20supplementation%20modulates%20neurite%20complexity%20and%20survival%20in%20motor%20neurons%20from%20amyotrophic%20lateral%20sclerosis%20models&amp;amp;journal=Antioxid.%20Redox%20Signal.&amp;amp;doi=10.1089%2Fars.2023.0360&amp;amp;volume=41&amp;amp;pages=573-589&amp;amp;publication_year=2024&amp;amp;author=Hamilton%2CHL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="263."&gt;&lt;p class="c-article-references__text" id="ref-CR263"&gt;Szot, J. O. et al. A metabolic signature for NADSYN1-dependent congenital NAD deficiency disorder. &lt;i&gt;J. Clin. Invest.&lt;/i&gt; &lt;a href="https://doi.org/10.1172/JCI174824" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1172/JCI174824"&gt;https://doi.org/10.1172/JCI174824&lt;/a&gt; (2024).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="264."&gt;&lt;p class="c-article-references__text" id="ref-CR264"&gt;Gille, A., Bodor, E. T., Ahmed, K. &amp;amp; Offermanns, S. Nicotinic acid: pharmacological effects and mechanisms of action. &lt;i&gt;Annu. Rev. Pharmacol. Toxicol.&lt;/i&gt; &lt;b&gt;48&lt;/b&gt;, 79–106 (2008).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1146/annurev.pharmtox.48.113006.094746" data-track-item_id="10.1146/annurev.pharmtox.48.113006.094746" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1146%2Fannurev.pharmtox.48.113006.094746" aria-label="Article reference 264" data-doi="10.1146/annurev.pharmtox.48.113006.094746"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXisFynurY%3D" aria-label="CAS reference 264"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=17705685" aria-label="PubMed reference 264"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 264" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinic%20acid%3A%20pharmacological%20effects%20and%20mechanisms%20of%20action&amp;amp;journal=Annu.%20Rev.%20Pharmacol.%20Toxicol.&amp;amp;doi=10.1146%2Fannurev.pharmtox.48.113006.094746&amp;amp;volume=48&amp;amp;pages=79-106&amp;amp;publication_year=2008&amp;amp;author=Gille%2CA&amp;amp;author=Bodor%2CET&amp;amp;author=Ahmed%2CK&amp;amp;author=Offermanns%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="265."&gt;&lt;p class="c-article-references__text" id="ref-CR265"&gt;Gindri, I. M. et al. Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. &lt;i&gt;Am. J. Physiol. Endocrinol. Metab.&lt;/i&gt; &lt;b&gt;326&lt;/b&gt;, E417–E427 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1152/ajpendo.00242.2023" data-track-item_id="10.1152/ajpendo.00242.2023" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1152%2Fajpendo.00242.2023" aria-label="Article reference 265" data-doi="10.1152/ajpendo.00242.2023"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37971292" aria-label="PubMed reference 265"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 265" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Evaluation%20of%20safety%20and%20effectiveness%20of%20NAD%20in%20different%20clinical%20conditions%3A%20a%20systematic%20review&amp;amp;journal=Am.%20J.%20Physiol.%20Endocrinol.%20Metab.&amp;amp;doi=10.1152%2Fajpendo.00242.2023&amp;amp;volume=326&amp;amp;pages=E417-E427&amp;amp;publication_year=2024&amp;amp;author=Gindri%2CIM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="266."&gt;&lt;p class="c-article-references__text" id="ref-CR266"&gt;Schiuma, G., Lara, D., Clement, J., Narducci, M. &amp;amp; Rizzo, R. Nicotinamide adenine dinucleotide: the redox sensor in aging-related disorders. &lt;i&gt;Antioxid. Redox Signal.&lt;/i&gt; &lt;a href="https://doi.org/10.1089/ars.2023.0375" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1089/ars.2023.0375"&gt;https://doi.org/10.1089/ars.2023.0375&lt;/a&gt; (2024).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="267."&gt;&lt;p class="c-article-references__text" id="ref-CR267"&gt;Avalos, J. L., Bever, K. M. &amp;amp; Wolberger, C. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD&lt;sup&gt;+&lt;/sup&gt; cosubstrate specificity of a Sir2 enzyme. &lt;i&gt;Mol. Cell&lt;/i&gt; &lt;b&gt;17&lt;/b&gt;, 855–868 (2005).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.molcel.2005.02.022" data-track-item_id="10.1016/j.molcel.2005.02.022" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.molcel.2005.02.022" aria-label="Article reference 267" data-doi="10.1016/j.molcel.2005.02.022"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2MXjt1Ghurg%3D" aria-label="CAS reference 267"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=15780941" aria-label="PubMed reference 267"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 267" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Mechanism%20of%20sirtuin%20inhibition%20by%20nicotinamide%3A%20altering%20the%20NAD%2B%20cosubstrate%20specificity%20of%20a%20Sir2%20enzyme&amp;amp;journal=Mol.%20Cell&amp;amp;doi=10.1016%2Fj.molcel.2005.02.022&amp;amp;volume=17&amp;amp;pages=855-868&amp;amp;publication_year=2005&amp;amp;author=Avalos%2CJL&amp;amp;author=Bever%2CKM&amp;amp;author=Wolberger%2CC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="268."&gt;&lt;p class="c-article-references__text" id="ref-CR268"&gt;Roos, J., Zinngrebe, J. &amp;amp; Fischer-Posovszky, P. Nicotinamide mononucleotide: a potential effective natural compound against insulin resistance. &lt;i&gt;Signal Transduct. Target. Ther.&lt;/i&gt; &lt;b&gt;6&lt;/b&gt;, 310 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41392-021-00723-z" data-track-item_id="10.1038/s41392-021-00723-z" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41392-021-00723-z" aria-label="Article reference 268" data-doi="10.1038/s41392-021-00723-z"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXit1elurzK" aria-label="CAS reference 268"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34413285" aria-label="PubMed reference 268"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376945" aria-label="PubMed Central reference 268"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 268" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinamide%20mononucleotide%3A%20a%20potential%20effective%20natural%20compound%20against%20insulin%20resistance&amp;amp;journal=Signal%20Transduct.%20Target.%20Ther.&amp;amp;doi=10.1038%2Fs41392-021-00723-z&amp;amp;volume=6&amp;amp;publication_year=2021&amp;amp;author=Roos%2CJ&amp;amp;author=Zinngrebe%2CJ&amp;amp;author=Fischer-Posovszky%2CP"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="269."&gt;&lt;p class="c-article-references__text" id="ref-CR269"&gt;Zapata-Perez, R. et al. Biotechnological production of reduced and oxidized NAD&lt;sup&gt;+&lt;/sup&gt; precursors. &lt;i&gt;Food Res. Int.&lt;/i&gt; &lt;b&gt;165&lt;/b&gt;, 112560 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.foodres.2023.112560" data-track-item_id="10.1016/j.foodres.2023.112560" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.foodres.2023.112560" aria-label="Article reference 269" data-doi="10.1016/j.foodres.2023.112560"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXjtFOqtbY%3D" aria-label="CAS reference 269"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36869544" aria-label="PubMed reference 269"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 269" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Biotechnological%20production%20of%20reduced%20and%20oxidized%20NAD%2B%20precursors&amp;amp;journal=Food%20Res.%20Int.&amp;amp;doi=10.1016%2Fj.foodres.2023.112560&amp;amp;volume=165&amp;amp;publication_year=2023&amp;amp;author=Zapata-Perez%2CR"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="270."&gt;&lt;p class="c-article-references__text" id="ref-CR270"&gt;Li, F., Wu, C. &amp;amp; Wang, G. Targeting NAD metabolism for the therapy of age-related neurodegenerative diseases. &lt;i&gt;Neurosci. Bull.&lt;/i&gt; &lt;b&gt;40&lt;/b&gt;, 218–240 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1007/s12264-023-01072-3" data-track-item_id="10.1007/s12264-023-01072-3" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s12264-023-01072-3" aria-label="Article reference 270" data-doi="10.1007/s12264-023-01072-3"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2MXitVKrsbg%3D" aria-label="CAS reference 270"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37253984" aria-label="PubMed reference 270"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 270" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Targeting%20NAD%20metabolism%20for%20the%20therapy%20of%20age-related%20neurodegenerative%20diseases&amp;amp;journal=Neurosci.%20Bull.&amp;amp;doi=10.1007%2Fs12264-023-01072-3&amp;amp;volume=40&amp;amp;pages=218-240&amp;amp;publication_year=2024&amp;amp;author=Li%2CF&amp;amp;author=Wu%2CC&amp;amp;author=Wang%2CG"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="271."&gt;&lt;p class="c-article-references__text" id="ref-CR271"&gt;Watne, L. O. et al. Cerebrospinal fluid quinolinic acid is strongly associated with delirium and mortality in hip-fracture patients. &lt;i&gt;J. Clin. Invest.&lt;/i&gt; &lt;a href="https://doi.org/10.1172/JCI163472" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1172/JCI163472"&gt;https://doi.org/10.1172/JCI163472&lt;/a&gt; (2023).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="272."&gt;&lt;p class="c-article-references__text" id="ref-CR272"&gt;Suhs, K. W. et al. Kynurenine is a cerebrospinal fluid biomarker for bacterial and viral central nervous system infections. &lt;i&gt;J. Infect. Dis.&lt;/i&gt; &lt;b&gt;220&lt;/b&gt;, 127–138 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/infdis/jiz048" data-track-item_id="10.1093/infdis/jiz048" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Finfdis%2Fjiz048" aria-label="Article reference 272" data-doi="10.1093/infdis/jiz048"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXnvV2hurk%3D" aria-label="CAS reference 272"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30721966" aria-label="PubMed reference 272"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 272" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Kynurenine%20is%20a%20cerebrospinal%20fluid%20biomarker%20for%20bacterial%20and%20viral%20central%20nervous%20system%20infections&amp;amp;journal=J.%20Infect.%20Dis.&amp;amp;doi=10.1093%2Finfdis%2Fjiz048&amp;amp;volume=220&amp;amp;pages=127-138&amp;amp;publication_year=2019&amp;amp;author=Suhs%2CKW"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="273."&gt;&lt;p class="c-article-references__text" id="ref-CR273"&gt;Quist-Paulsen, E. et al. High neopterin and IP-10 levels in cerebrospinal fluid are associated with neurotoxic tryptophan metabolites in acute central nervous system infections. &lt;i&gt;J. Neuroinflammation&lt;/i&gt; &lt;b&gt;15&lt;/b&gt;, 327 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1186/s12974-018-1366-3" data-track-item_id="10.1186/s12974-018-1366-3" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s12974-018-1366-3" aria-label="Article reference 273" data-doi="10.1186/s12974-018-1366-3"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXhtFaisbrK" aria-label="CAS reference 273"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30470234" aria-label="PubMed reference 273"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260858" aria-label="PubMed Central reference 273"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 273" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=High%20neopterin%20and%20IP-10%20levels%20in%20cerebrospinal%20fluid%20are%20associated%20with%20neurotoxic%20tryptophan%20metabolites%20in%20acute%20central%20nervous%20system%20infections&amp;amp;journal=J.%20Neuroinflammation&amp;amp;doi=10.1186%2Fs12974-018-1366-3&amp;amp;volume=15&amp;amp;publication_year=2018&amp;amp;author=Quist-Paulsen%2CE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="274."&gt;&lt;p class="c-article-references__text" id="ref-CR274"&gt;De Pinto, V. Renaissance of VDAC: new insights on a protein family at the interface between mitochondria and cytosol. &lt;i&gt;Biomolecules&lt;/i&gt; &lt;a href="https://doi.org/10.3390/biom11010107" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3390/biom11010107"&gt;https://doi.org/10.3390/biom11010107&lt;/a&gt; (2021).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="275."&gt;&lt;p class="c-article-references__text" id="ref-CR275"&gt;Magri, A. et al. AAV-mediated upregulation of VDAC1 rescues the mitochondrial respiration and sirtuins expression in a SOD1 mouse model of inherited ALS. &lt;i&gt;Cell Death Discov.&lt;/i&gt; &lt;b&gt;10&lt;/b&gt;, 178 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41420-024-01949-w" data-track-item_id="10.1038/s41420-024-01949-w" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41420-024-01949-w" aria-label="Article reference 275" data-doi="10.1038/s41420-024-01949-w"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXosFOqur4%3D" aria-label="CAS reference 275"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38627359" aria-label="PubMed reference 275"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11021507" aria-label="PubMed Central reference 275"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 275" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=AAV-mediated%20upregulation%20of%20VDAC1%20rescues%20the%20mitochondrial%20respiration%20and%20sirtuins%20expression%20in%20a%20SOD1%20mouse%20model%20of%20inherited%20ALS&amp;amp;journal=Cell%20Death%20Discov.&amp;amp;doi=10.1038%2Fs41420-024-01949-w&amp;amp;volume=10&amp;amp;publication_year=2024&amp;amp;author=Magri%2CA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="276."&gt;&lt;p class="c-article-references__text" id="ref-CR276"&gt;Luongo, T. S. et al. SLC25A51 is a mammalian mitochondrial NAD&lt;sup&gt;+&lt;/sup&gt; transporter. &lt;i&gt;Nature&lt;/i&gt; &lt;b&gt;588&lt;/b&gt;, 174–179 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41586-020-2741-7" data-track-item_id="10.1038/s41586-020-2741-7" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41586-020-2741-7" aria-label="Article reference 276" data-doi="10.1038/s41586-020-2741-7"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXitlGjsLfF" aria-label="CAS reference 276"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32906142" aria-label="PubMed reference 276"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718333" aria-label="PubMed Central reference 276"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 276" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=SLC25A51%20is%20a%20mammalian%20mitochondrial%20NAD%2B%20transporter&amp;amp;journal=Nature&amp;amp;doi=10.1038%2Fs41586-020-2741-7&amp;amp;volume=588&amp;amp;pages=174-179&amp;amp;publication_year=2020&amp;amp;author=Luongo%2CTS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="277."&gt;&lt;p class="c-article-references__text" id="ref-CR277"&gt;Canto, C. NAD&lt;sup&gt;+&lt;/sup&gt; precursors: a questionable redundancy. &lt;i&gt;Metabolites&lt;/i&gt; &lt;a href="https://doi.org/10.3390/metabo12070630" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3390/metabo12070630"&gt;https://doi.org/10.3390/metabo12070630&lt;/a&gt; (2022).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="278."&gt;&lt;p class="c-article-references__text" id="ref-CR278"&gt;Kropotov, A. et al. Equilibrative nucleoside transporters mediate the import of nicotinamide riboside and nicotinic acid riboside into human cells. &lt;i&gt;Int. J. Mol. Sci.&lt;/i&gt; &lt;a href="https://doi.org/10.3390/ijms22031391" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3390/ijms22031391"&gt;https://doi.org/10.3390/ijms22031391&lt;/a&gt; (2021).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="279."&gt;&lt;p class="c-article-references__text" id="ref-CR279"&gt;MacKay, D., Hathcock, J. &amp;amp; Guarneri, E. Niacin: chemical forms, bioavailability, and health effects. &lt;i&gt;Nutr. Rev.&lt;/i&gt; &lt;b&gt;70&lt;/b&gt;, 357–366 (2012).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/j.1753-4887.2012.00479.x" data-track-item_id="10.1111/j.1753-4887.2012.00479.x" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Fj.1753-4887.2012.00479.x" aria-label="Article reference 279" data-doi="10.1111/j.1753-4887.2012.00479.x"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=22646128" aria-label="PubMed reference 279"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 279" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Niacin%3A%20chemical%20forms%2C%20bioavailability%2C%20and%20health%20effects&amp;amp;journal=Nutr.%20Rev.&amp;amp;doi=10.1111%2Fj.1753-4887.2012.00479.x&amp;amp;volume=70&amp;amp;pages=357-366&amp;amp;publication_year=2012&amp;amp;author=MacKay%2CD&amp;amp;author=Hathcock%2CJ&amp;amp;author=Guarneri%2CE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="280."&gt;&lt;p class="c-article-references__text" id="ref-CR280"&gt;Chen, M. et al. SLC29A1 and SLC29A2 are human nicotinamide cell membrane transporters. &lt;i&gt;Nat. Commun.&lt;/i&gt; &lt;b&gt;16&lt;/b&gt;, 1181 (2025).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-025-56402-y" data-track-item_id="10.1038/s41467-025-56402-y" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-025-56402-y" aria-label="Article reference 280" data-doi="10.1038/s41467-025-56402-y"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2MXivV2mt7Y%3D" aria-label="CAS reference 280"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=39885119" aria-label="PubMed reference 280"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11782521" aria-label="PubMed Central reference 280"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 280" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=SLC29A1%20and%20SLC29A2%20are%20human%20nicotinamide%20cell%20membrane%20transporters&amp;amp;journal=Nat.%20Commun.&amp;amp;doi=10.1038%2Fs41467-025-56402-y&amp;amp;volume=16&amp;amp;publication_year=2025&amp;amp;author=Chen%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="281."&gt;&lt;p class="c-article-references__text" id="ref-CR281"&gt;Bahn, A. et al. Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13). &lt;i&gt;J. Biol. Chem.&lt;/i&gt; &lt;b&gt;283&lt;/b&gt;, 16332–16341 (2008).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1074/jbc.M800737200" data-track-item_id="10.1074/jbc.M800737200" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1074%2Fjbc.M800737200" aria-label="Article reference 281" data-doi="10.1074/jbc.M800737200"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXmslOjsb4%3D" aria-label="CAS reference 281"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=18411268" aria-label="PubMed reference 281"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 281" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Identification%20of%20a%20new%20urate%20and%20high%20affinity%20nicotinate%20transporter%2C%20hOAT10%20%28SLC22A13%29&amp;amp;journal=J.%20Biol.%20Chem.&amp;amp;doi=10.1074%2Fjbc.M800737200&amp;amp;volume=283&amp;amp;pages=16332-16341&amp;amp;publication_year=2008&amp;amp;author=Bahn%2CA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="282."&gt;&lt;p class="c-article-references__text" id="ref-CR282"&gt;Mathialagan, S. et al. Nicotinic acid transport into human liver involves organic anion transporter 2 (SLC22A7). &lt;i&gt;Biochem. Pharmacol.&lt;/i&gt; &lt;b&gt;174&lt;/b&gt;, 113829 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.bcp.2020.113829" data-track-item_id="10.1016/j.bcp.2020.113829" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.bcp.2020.113829" aria-label="Article reference 282" data-doi="10.1016/j.bcp.2020.113829"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXis12lsbY%3D" aria-label="CAS reference 282"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32001236" aria-label="PubMed reference 282"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 282" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nicotinic%20acid%20transport%20into%20human%20liver%20involves%20organic%20anion%20transporter%202%20%28SLC22A7%29&amp;amp;journal=Biochem.%20Pharmacol.&amp;amp;doi=10.1016%2Fj.bcp.2020.113829&amp;amp;volume=174&amp;amp;publication_year=2020&amp;amp;author=Mathialagan%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Tue, 09 Sep 2025 09:31:34 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTE9DUlZhb1JIbHlZa3I4S1JCVXNtUFhxSlZLaE9vRUswYmZVMDFxLTMzRkwxR0M2YjhRVTM5NUcxbmpiVVFtMUppNHI4Ny1ZU2xBMjlZNzJERWNma3UtN2pR</guid></item><item><title>如何管理工作日与PCOS相关的疲劳、脑雾和能量下降-印度教徒</title><link>https://www.thehindu.com/sci-tech/health/how-to-manage-pcos-related-fatigue-brain-fog-and-energy-dips-during-the-workday/article70018665.ece</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="schemaDiv" id="schemaDiv" itemprop="articleBody"&gt;&lt;p&gt;If you live with &lt;a href="https://www.thehindu.com/sci-tech/health/all-you-need-to-know-about-polycystic-ovary-syndrome/article69226348.ece" target="_self"&gt;polycystic ovary syndrome (PCOS)&lt;/a&gt;, you already know the problem isn’t just “period issues.” It’s that 3 p.m. crash when emails start to run together, the meeting where the right word just doesn’t emerge, the all-encompassing fatigue that copious amounts of coffee can’t fix. Clinically, PCOS is a complex endocrine condition, a combination of metabolic, hormonal, and inflammatory factors; this combination can disrupt a typical workday with fatigue, foggy brain, headaches, mood swings, and sleep problems. Global experts are now beginning to recognize that PCOS is an important public health issue and not simply a fertility problem, and highlight the need for overall better management of PCOS as a part of daily life. &lt;/p&gt;&lt;p class="referpara"&gt;&lt;strong&gt;&lt;b&gt;Also Read: &lt;a href="https://www.thehindu.com/sci-tech/health/pcos-could-lead-to-decreased-alertness-and-longer-reaction-times-study/article69622775.ece" target="_self"&gt;PCOS could lead to decreased alertness and longer reaction times: study  &lt;/a&gt;&lt;/b&gt;&lt;/strong&gt;&lt;/p&gt;&lt;h4 class="sub_head"&gt;Insulin resistance&lt;/h4&gt;&lt;p&gt;Why does work feel harder with PCOS? One reason is insulin resistance, common in PCOS, which can cause a roller-coaster of energy and foggy thinking after high-carb meals. Chronic low-grade inflammation and androgen excess add to the drag in cognition and mood. Emerging brain-imaging and cognitive studies suggest measurable differences in attention, memory, and network connectivity in some women with PCOS, translating into the very real “I can’t focus” days at your desk. None of this means you can’t perform at a high level; it means your brain and metabolism are working against friction that most colleagues don’t feel. &lt;/p&gt;&lt;p&gt;Sleep is another hidden culprit. There is a significantly higher likelihood that women with PCOS suffer from &lt;a href="https://www.thehindu.com/sci-tech/health/more-than-a-snore-deconstructing-sleep-apnoea/article69328805.ece" target="_self"&gt;obstructive sleep apnoea (OSA)&lt;/a&gt;, which causes sleep to be impaired and daytime energy to suffer. Meta-analyses estimate that about a third of women with PCOS have OSA, without even having any classic risk factors. Untreated OSA worsens insulin resistance, blood pressure, and fatigue, and it is no surprise that mornings feel like waking up in wet sand. If your partner complains that you snore loudly or have pauses in breathing while asleep, or you wake up tired and also have headaches in the morning it is important to go for a sleep study; OSA treatment can improve daytime function. &lt;/p&gt;&lt;h4 class="sub_head"&gt;Mental health&lt;/h4&gt;&lt;p&gt; Depression and anxiety rates are higher in PCOS, and fatigue is often the loudest symptom of a low mood. That is not a character flaw; it’s biology and lived experience: acne, hair changes, weight cycling, fertility worries, and years spent seeking a diagnosis can all contribute to mental health issues. &lt;/p&gt;&lt;p&gt;Compassionate care and evidence-based therapy help; so does acknowledging that bad energy days aren’t laziness, they’re part of the condition. &lt;/p&gt;&lt;p class="referpara"&gt;&lt;strong&gt;&lt;b&gt;Also Read:&lt;/b&gt;&lt;b&gt;&lt;a href="https://www.thehindu.com/sci-tech/health/pcos-hidden-toll-of-academic-pressure-on-our-daughters-health/article67327587.ecehttps:/www.thehindu.com/sci-tech/health/pcos-hidden-toll-of-academic-pressure-on-our-daughters-health/article67327587.ece" target="_self"&gt;PCOS: hidden toll of academic pressure on health among young girls &lt;/a&gt;&lt;/b&gt;&lt;/strong&gt;&lt;/p&gt;&lt;h4 class="sub_head"&gt;Staying functional&lt;/h4&gt;&lt;p&gt;So, how do you stay functional at work when your body’s signals are unpredictable?&lt;/p&gt;&lt;p&gt;First, think: fuel like a marathoner. A lower-glycaemic pattern, with fibre-rich vegetables, proteins, healthy fats, and slow carbs—flattens the post-lunch slump for many people with PCOS. You don’t need perfection; you need steadiness: a breakfast with protein, a lunch that isn’t a sugar spike, and a 4 p.m. snack that isn’t a candy bar. Current evidence and guidelines don’t crown a single “PCOS diet,” but they consistently emphasise calorie quality, weight neutrality or gradual loss where appropriate, and glycaemic control to improve symptoms and metabolic risk. &lt;/p&gt;&lt;p&gt;Second, build micro-movement into your schedule. Insulin resistance improves with muscles contracting regularly, not just at the gym. Two-minute “movement snacks” each hour—walk to fill your bottle, calf raises at the printer, stairs instead of the elevator—can be the difference between fog and focus by late afternoon. It’s physiology, not discipline moving glucose into muscle without demanding more insulin that smooths energy curves through the day. &lt;/p&gt;&lt;p&gt;Third, consider your sleep like the audit of any project. Set bed and wake times, dimmer in the evenings, cooler rooms, and caffeine cutoffs become important when your hormones are already nudging your circadian rhythm. If you’re still getting out of bed fatigued, ask about screening for OSA. Sleep treatment such as CPAP (continuous positive airway pressure) therapy is effective for nights and can rescue workdays. ,&lt;/p&gt;&lt;p&gt;Fourth, consider targeted supplements and medications with your doctor. Myo-inositol continues to grow in traction for metabolic improvement and hyperandrogenism in PCOS, and some people benefit from metformin (along with drugs like combined hormonal contraception), or other targeted therapy. None are quick fixes, but over weeks, they can lift the baseline, so your good days outnumber the bad. &lt;/p&gt;&lt;p&gt;Fifth, plan your “energy economy.” Schedule cognitively heavy tasks earlier in the day when you’re sharper. Batch admin during predictable dips. Have a water bottle at your elbow; mild dehydration increases fatigue and headaches. And if heavy periods are normal for you, request iron studies, as iron deficiency is an under-recognised factor causing fatigue in menstruators and is treatable when diagnosed. &lt;/p&gt;&lt;h4 class="sub_head"&gt;The workplace’s role&lt;/h4&gt;&lt;p&gt;Workplaces have a part to play too. Research has shown that those with PCOS may have lower work ability and increased sickness absence; normalising this allows for practical supports—flexible start times following poor-sleep nights, remote work on flare days, times to attend medical appointments—without stigma. Small accommodations can reduce presenteeism and protect productivity much better than powering through and burning out.  &lt;/p&gt;&lt;p&gt;Finally, remember this: PCOS management isn’t a single heroic act; it’s stacking small, boring wins, consistent meals, micro movements, skilful sleep, the right treatment plan, and a humane work setup. When these habits compound, the afternoon fog lifts more often, your energy lasts longer, and your best work stops feeling like a fight.&lt;/p&gt;&lt;p&gt;&lt;i&gt;(Dr. Sandhya Rani is senior consultant, obstetrics &amp;amp; gynaecology, Aster Women &amp;amp; Children Hospital, Bengaluru. sanju.doc@gmail.com)&lt;/i&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="update-publish-time article-published-time-end"&gt;&lt;p class="publish-time-new"&gt; Published &lt;span&gt;- September 09, 2025 03:00 pm IST&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Hindu</author><pubDate>Tue, 09 Sep 2025 09:30:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">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</guid></item><item><title>常见便秘药物有望阻止肾衰竭- SciTechDaily</title><link>https://scitechdaily.com/common-constipation-drug-shows-promise-in-halting-kidney-decline/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="post-content cf entry-content content-spacious"&gt;

		
				
		&lt;figure id="attachment_493469" aria-describedby="caption-attachment-493469" class="wp-caption aligncenter"&gt;&lt;a href="https://scitechdaily.com/images/Human-Kidney-Diagram.jpg"&gt;&lt;img fetchpriority="high" decoding="async" class="size-large wp-image-493469" src="https://scitechdaily.com/images/Human-Kidney-Diagram-777x518.jpg" alt="Human Kidney Diagram" srcset="https://scitechdaily.com/images/Human-Kidney-Diagram-777x518.jpg 777w, https://scitechdaily.com/images/Human-Kidney-Diagram-400x267.jpg 400w, https://scitechdaily.com/images/Human-Kidney-Diagram-768x512.jpg 768w, https://scitechdaily.com/images/Human-Kidney-Diagram-1536x1024.jpg 1536w, https://scitechdaily.com/images/Human-Kidney-Diagram-150x100.jpg 150w, https://scitechdaily.com/images/Human-Kidney-Diagram-450x300.jpg 450w, https://scitechdaily.com/images/Human-Kidney-Diagram-1200x800.jpg 1200w, https://scitechdaily.com/images/Human-Kidney-Diagram.jpg 2000w" sizes="(max-width: 777px) 100vw, 777px"&gt;&lt;/a&gt;&lt;figcaption id="caption-attachment-493469" class="wp-caption-text"&gt;By targeting the gut with a drug originally for constipation, researchers have found a surprising way to protect kidney function in CKD patients. Credit: Shutterstock&lt;/figcaption&gt;&lt;/figure&gt;
&lt;p&gt;&lt;strong&gt;A constipation drug has shown promise in slowing kidney damage in chronic kidney disease patients by improving gut and mitochondrial health.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Chronic kidney disease (CKD) is a widespread and serious medical condition. For many individuals, the progressive loss of kidney function ultimately requires regular dialysis to prevent kidney failure and sustain life. Although CKD poses a major global health challenge, no drug has yet been approved that can directly enhance kidney performance.&lt;/p&gt;
&lt;p&gt;A team led by Professor Takaaki Abe at Tohoku University Graduate School of Medicine has uncovered a surprising possibility. They tested a medication normally prescribed for constipation and found that it may help protect kidney health. For the first time, this drug (lubiprostone) demonstrated an ability to slow the decline of kidney function in patients with CKD.&lt;/p&gt;
&lt;p&gt;“We noticed that constipation is a symptom that often accompanies CKD, and decided to investigate this link further,” explains Abe. “Essentially, constipation disrupts the intestinal microbiota, which worsens kidney function. Working backwards, we hypothesized that we could improve kidney function by treating constipation.”&lt;/p&gt;
&lt;figure id="attachment_493702" aria-describedby="caption-attachment-493702" class="wp-caption aligncenter"&gt;&lt;a href="https://scitechdaily.com/images/Administering-Lubiprostone-Alters-Gut-Microbiota-Graphic.jpg"&gt;&lt;img decoding="async" class="size-large wp-image-493702" src="https://scitechdaily.com/images/Administering-Lubiprostone-Alters-Gut-Microbiota-Graphic-777x605.jpg" alt="Administering Lubiprostone Alters Gut Microbiota Graphic" srcset="https://scitechdaily.com/images/Administering-Lubiprostone-Alters-Gut-Microbiota-Graphic-777x605.jpg 777w, https://scitechdaily.com/images/Administering-Lubiprostone-Alters-Gut-Microbiota-Graphic-400x311.jpg 400w, https://scitechdaily.com/images/Administering-Lubiprostone-Alters-Gut-Microbiota-Graphic-768x598.jpg 768w, https://scitechdaily.com/images/Administering-Lubiprostone-Alters-Gut-Microbiota-Graphic-150x117.jpg 150w, https://scitechdaily.com/images/Administering-Lubiprostone-Alters-Gut-Microbiota-Graphic-450x350.jpg 450w, https://scitechdaily.com/images/Administering-Lubiprostone-Alters-Gut-Microbiota-Graphic.jpg 1137w" sizes="(max-width: 777px) 100vw, 777px"&gt;&lt;/a&gt;&lt;figcaption id="caption-attachment-493702" class="wp-caption-text"&gt;Administering lubiprostone alters gut microbiota, leading to improved mitochondrial function and suppression of inflammation. This improved renal function by increasing the levels of aguA and polyamines. Credit: Shun Watanabe&lt;/figcaption&gt;&lt;/figure&gt;
&lt;p&gt;To explore this idea, the researchers launched a multicenter Phase II clinical trial (LUBI-CKD TRIAL) at nine medical institutions in Japan. The study involved 150 patients with moderate CKD and carefully assessed how lubiprostone influenced their kidney function.&lt;/p&gt;
&lt;h4 data-start="1505" data-end="1534"&gt;Clinical Trial Results&lt;/h4&gt;
&lt;p&gt;The results showed that, compared to the placebo group, the decline in kidney function (defined as the estimated glomerular filtration rate: eGFR) was suppressed in a dose-dependent manner in patients treated with 8 µg or 16 µg of lubiprostone.&lt;/p&gt;
&lt;p&gt;The researchers also investigated the mechanism underlying how this effect occurred. They found that lubiprostone increases spermidine production, which improves mitochondrial function by promoting bacterial growth in the gut. The improved mitochondrial function was seen to exert a renoprotective effect – suppressing further kidney damage.&lt;/p&gt;
&lt;p&gt;Going forward, the research team has plans to validate the trial results in a larger population (Phase 3 clinical trial) and advance the exploration of biomarkers that predict treatment efficacy. Their goal is to provide each patient with CKD the optimal treatment plan tailored to their needs. This discovery has the potential to significantly transform the conventional approach to CKD treatment, which primarily focuses on reducing uremic toxins.&lt;/p&gt;
&lt;p&gt;These findings suggest a new therapeutic strategy in which laxatives suppress renal function decline. This strategy is expected to contribute to the development of treatments for not only CKD, but also mitochondrial dysfunction disorders.&lt;/p&gt;
&lt;p&gt;Reference: “Lubiprostone in chronic kidney disease: Insights into mitochondrial function and polyamines from a randomized phase 2 clinical trial” by Shun Watanabe, Masaaki Nakayama, Takashi Yokoo, Satoru Sanada, Yoshifumi Ubara, Atsushi Komatsuda, Katsuhiko Asanuma, Yusuke Suzuki, Tsuneo Konta, Junichiro J. Kazama, Takehiro Suzuki, Shinji Fukuda, Tomoyoshi Soga, Takuji Yamada, Sayaka Mizutani, Mitsuharu Matsumoto, Yuji Naito, Kensei Taguchi, Kei Fukami, Hitomi Kashiwagi, Koichi Kikuchi, Chitose Suzuki, Hidetaka Tokuno, Marina Urasato, Ryota Kujirai, Yotaro Matsumoto, Yasutoshi Akiyama, Yoshihisa Tomioka, Shun Itai, Yoshiyasu Tongu, Eikan Mishima, Chiharu Kawabe, Tomoko Kasahara, Yoshiaki Ogata, Takafumi Toyohara, Takeya Sato, Tetsuhiro Tanaka, Takaaki Abe and LUBI-CKD TRIAL Investigators, 29 August 2025, &lt;i&gt;&lt;span class="glossaryLink" aria-describedby="tt" data-cmtooltip="&amp;lt;div class=glossaryItemTitle&amp;gt;Science Advances&amp;lt;/div&amp;gt;&amp;lt;div class=glossaryItemBody&amp;gt;&amp;amp;lt;em&amp;amp;gt;Science Advances&amp;amp;lt;/em&amp;amp;gt; is an open-access, peer-reviewed journal published by the American Association for the Advancement of Science (AAAS). It covers a broad range of disciplines including biology, physics, social sciences, and engineering. The journal emphasizes impactful, interdisciplinary research with wide relevance.&amp;lt;/div&amp;gt;" data-gt-translate-attributes='[{"attribute":"data-cmtooltip", "format":"html"}]' tabindex="0" role="link"&gt;Science Advances&lt;/span&gt;&lt;/i&gt;.&lt;br&gt;
&lt;a href="https://doi.org/10.1126/sciadv.adw3934"&gt;DOI: 10.1126/sciadv.adw3934&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Never miss a breakthrough: &lt;a href="https://scitechdaily.com/newsletter/"&gt;Join the SciTechDaily newsletter.&lt;/a&gt;&lt;/b&gt;&lt;/p&gt;
				
		
		
		
	&lt;/div&gt;
&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>SciTechDaily</author><pubDate>Tue, 09 Sep 2025 09:23:02 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMilAFBVV95cUxOeDhkbFNlX3dGT2JUZXBwb1BfZU5idEljY0JSLWVyNWNUV0ZLLXJUVjF2UmFzbENkWU9CUGFWakt0VDhEQ3F2TnYxY092M1NYb0ozTXQ2cXdxQTRSU1RTelVkbjNodlZJNGJENUlXaXpoUWFpRm5neTdNMmFuTFliOEtobHo5SGU4MURSSzFtTWpOU1k2</guid></item><item><title>另一个美国医生团体违反联邦政策，建议所有成年人接种COVID-19疫苗-路透社</title><link>https://www.reuters.com/business/healthcare-pharmaceuticals/another-us-doctors-group-breaks-with-federal-policy-recommends-covid-19-vaccines-2025-09-09/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;body id="readabilityBody"&gt;&lt;p id="cmsg"&gt;Please enable JS and disable any ad blocker&lt;/p&gt;&lt;/body&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Reuters</author><pubDate>Tue, 09 Sep 2025 09:19:44 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMi5wFBVV95cUxPaThiR012UnJtNE5wSU9OandUMUc5YjNDMGpLd1ZxNUJ5WlZnRnhVWThQZHE4YnRpVGZ3cWtRckRpc3V6eUdoSXhKZi03QzF2UElScXJBZTNPNjdPOWhnTnBSVVp2dHJ5bm1ES0VmX2J3dGdQZHdsSU9LU3JoUExEcGI5Y2lzVHFTT0xUQ2dkQUdFRU1KNktza012U3lBN2o3ZF8xNWh0Yk9xM3hkVkR6X3NUYm1hMzAzYnl4VFI2cXp2T1M0TjBvdWNSN29Yc1lrZWdrb1lPQ0ItcDlqakxrSW9mWTVZU28</guid></item><item><title>考古学家发现了2100年前追踪宇宙的“天才创造” - Earth.com</title><link>https://www.earth.com/news/mysterious-antikythera-shipwreck-cosmos-mechanism-reveals-more-secrets/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="page_content__AwOj6"&gt;&lt;p&gt;A team of underwater archaeologists recently returned to the Antikythera shipwreck off the coast of Greece to do further studies on the remains of an ancient Greek trading or cargo ship dating back to the First Century, BCE.&lt;/p&gt;&lt;p&gt;The researchers added new pieces to a story that has been unfolding since the shipwreck was first discovered in 1900.&lt;/p&gt;&lt;p&gt;&lt;a href="https://www.unige.ch/lettres/antic/unites/archeo/enseignants/baumer"&gt;Lorenz E. Baumer&lt;/a&gt; is a professor at the &lt;a href="https://www.unige.ch/en/"&gt;University of Geneva&lt;/a&gt; who has played a central role in the Antikythera project. &lt;/p&gt;&lt;p&gt;As co-director of the excavation alongside the &lt;a href="https://www.esag.swiss/"&gt;Swiss School of Archaeology in Greece&lt;/a&gt;, he has emphasized that the site is far more than a collection of treasures. &lt;/p&gt;&lt;p&gt;His focus is on understanding the structure, orientation, and construction methods of the ship itself, which offers insights into ancient trade and maritime engineering.&lt;/p&gt;&lt;h2 class="wp-block-heading" id="h-importance-of-the-antikythera-shipwreck"&gt;Importance of the Antikythera shipwreck&lt;/h2&gt;&lt;p&gt;“Without any doubt, a unique &lt;a href="https://www.whoi.edu/ocean-learning-hub/ocean-topics/ocean-human-lives/underwater-archaeology/antikythera-shipwreck/" target="_blank" rel="noreferrer noopener"&gt;shipwreck from antiquity&lt;/a&gt;,” said Baumer. Scholars call this site one-of-a-kind because it keeps changing what we know about ancient trade, engineering, and seafaring. &lt;/p&gt;&lt;p&gt;The wreck lies between roughly 150 and 230 feet below the surface, a depth that helps protect wood and metal from storms and anchors. Work here continues in careful, slow steps.&lt;/p&gt;&lt;p&gt;Divers documented a preserved section of the hull with original fasteners and an external protective coating still intact. That structural find anchors the ship on the seabed and helps define its size and orientation.&lt;/p&gt;&lt;p&gt;The team recorded roughly 300 discoveries spread across two excavation zones located about 650 feet apart. These included 21 marble fragments, various pieces of the ship’s hull, over 200 ceramic shards, and amphorae linked to places such as Chios and Rhodes.&lt;/p&gt;&lt;p&gt;“Until now, the wreck has never been investigated as a &lt;a href="https://www.earth.com/news/discovery-300-year-old-sunken-pirate-shipwreck-left-archaeologists-speechless/"&gt;shipwreck&lt;/a&gt;, but the treasures have simply been extracted,” explained Baumer, who added that researchers confirmed a nearby second vessel from the same period, documented about 650 feet away.&lt;/p&gt;&lt;p&gt;Some amphorae show evidence of mastic, a natural resin used as a sealant in antiquity. That detail speaks to the practical tricks ancient crews used to keep liquid cargo safe at sea.&lt;/p&gt;&lt;h2 class="wp-block-heading" id="h-how-ancient-builders-made-ships"&gt;How ancient builders made ships&lt;/h2&gt;&lt;p&gt;The preserved hull section points to a shell-first-build, a method common in the Mediterranean before the Middle Ages. Builders assembled the outer planking first and then fitted frames inside.&lt;/p&gt;&lt;p&gt;This pattern, supported by nautical archaeology, is clear in a peer reviewed &lt;a href="https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1095-9270.2012.00357.x"&gt;article&lt;/a&gt; that summarizes the transition from shell first to frame first shipbuilding across the first millennium AD. &lt;/p&gt;&lt;p&gt;Mortise and tenon joints, pegs, and pitch created strong, watertight hulls that could handle long routes.&lt;/p&gt;&lt;h2 class="wp-block-heading" id="h-mysterious-antikythera-mechanism"&gt;Mysterious Antikythera mechanism&lt;/h2&gt;&lt;p&gt;But long before this season, the world knew of Antikythera not for the ship but for for the Antikythera mechanism. &lt;/p&gt;&lt;p&gt;When the device was uncovered, it constituted one of the most significant discoveries in the history of shipwrecks. &lt;/p&gt;&lt;p&gt;The unique mechanism is an ancient astronomical calculator with complex bronze gears that modeled cycles of the Sun, Moon, and planets; technology leaps beyond its time.&lt;/p&gt;&lt;p&gt;“The Antikythera Mechanism, an ancient Greek astronomical calculator, has challenged researchers since its discovery in 1901,” wrote &lt;a href="https://www.researchgate.net/profile/Tony-Freeth"&gt;Tony Freeth&lt;/a&gt;, Professor at University College London (&lt;a href="https://www.ucl.ac.uk/"&gt;UCL&lt;/a&gt;). &lt;/p&gt;&lt;p&gt;Modern imaging revealed hidden inscriptions and internal gearing that pushed ancient engineering far beyond what many expected.&lt;/p&gt;&lt;div class="wp-block-image"&gt;&lt;figure class="aligncenter size-full"&gt;&lt;a href="https://cff2.earth.com/uploads/2025/09/08161259/Antikythera-Mechanism-shipwreck_greek-cosmos-tracker_reconstructed-pieces_Nature_1m.jpg"&gt;&lt;img loading="lazy" decoding="async" src="https://cff2.earth.com/uploads/2025/09/08161306/Antikythera-Mechanism-shipwreck_greek-cosmos-tracker_reconstructed-pieces_Nature_1s.webp" alt="Parts of a Model of the Cosmos in the ancient Greek Antikythera Mechanism found on a shipwreck from the First Century, BCE. Credit: Nature" class="wp-image-1985072" srcset="https://cff2.earth.com/uploads/2025/09/08161306/Antikythera-Mechanism-shipwreck_greek-cosmos-tracker_reconstructed-pieces_Nature_1s.webp 300w, https://cff2.earth.com/uploads/2025/09/08161306/Antikythera-Mechanism-shipwreck_greek-cosmos-tracker_reconstructed-pieces_Nature_1s-150x150.webp 150w, https://cff2.earth.com/uploads/2025/09/08161306/Antikythera-Mechanism-shipwreck_greek-cosmos-tracker_reconstructed-pieces_Nature_1s-32x32.webp 32w" sizes="(max-width: 300px) 100vw, 300px"&gt;&lt;/a&gt;&lt;figcaption class="wp-element-caption"&gt;&lt;em&gt;Parts of a Model of the Cosmos in the ancient Greek Antikythera Mechanism found on a shipwreck from the First Century, BCE. Click image to enlarge. Credit: Nature&lt;/em&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;/div&gt;&lt;h2 class="wp-block-heading" id="h-charting-the-stars-in-2-100-years-ago"&gt;Charting the stars in 2,100 years ago&lt;/h2&gt;&lt;p&gt;The device arranged the sky as nested rings that turned together to show nine outputs, including the Moon, the lunar nodes, the Sun, and every visible planet. &lt;/p&gt;&lt;p&gt;Those outputs sat on concentric tubes so each ring could carry its own marker and scale without blocking the others.&lt;/p&gt;&lt;p&gt;“A ring system with nine outputs,” wrote Freeth. That layout let users read multiple cycles at once with simple pointers and engraved scales instead of long, cluttered hands.&lt;/p&gt;&lt;p&gt;The writing on the device worked like an instruction guide, explaining what each ring and marker was for. &lt;/p&gt;&lt;p&gt;The front and back panels described regular planetary events, like when planets line up with the Sun or appear opposite it, and those matched the positions shown on the rings.&lt;/p&gt;&lt;p&gt;Those instructions pair with the calendar so a person can count days between events directly on the dials. &lt;/p&gt;&lt;p&gt;Imaging known as Microfocus X-ray Computed Tomography (&lt;a href="https://www.shimadzu.com/an/products/non-destructive-testing/microfocus-x-ray-ct-system/index.html"&gt;MXCT&lt;/a&gt;) exposed buried lettering that tied each planet’s events to specific index marks on its ring.&lt;/p&gt;&lt;h2 class="wp-block-heading" id="h-the-numbers-behind-the-gears"&gt;The numbers behind the gears&lt;/h2&gt;&lt;p&gt;Scientists worked out time cycles that could be built into the gears, such as Venus completing 289 cycles in 462 years or Saturn completing 427 cycles in 442 years. &lt;/p&gt;&lt;p&gt;These numbers were chosen because they allowed for gears with manageable tooth counts that still produced accurate planetary motions.&lt;/p&gt;&lt;p&gt;They tested different possible cycles without needing highly precise measurements, then picked ones that shared common factors. &lt;/p&gt;&lt;p&gt;This way, the same gears could be used in more than one part of the mechanism, keeping it compact and efficient. &lt;/p&gt;&lt;h2 class="wp-block-heading" id="h-unlocking-planetary-motion"&gt;Unlocking planetary motion&lt;/h2&gt;&lt;p&gt;“Solving this complex 3D puzzle reveals a creation of genius,” wrote Freeth. &lt;/p&gt;&lt;p&gt;The mechanism contained gearing that modeled the movements of the Sun, Moon, and five known planets with impressive accuracy. &lt;/p&gt;&lt;p&gt;Using ratios that could be translated into compact gears, it captured cycles that had been studied for centuries by Babylonian and Greek astronomers.&lt;/p&gt;&lt;p&gt;What made this possible was a design that translated complex theories into practical engineering. &lt;/p&gt;&lt;p&gt;Nested tubes and rings allowed planetary markers to move together in a geocentric order, turning the device into a working model of the heavens.&lt;/p&gt;&lt;h2 class="wp-block-heading" id="h-recreating-the-antikythera-mechanism"&gt;Recreating the Antikythera Mechanism&lt;/h2&gt;&lt;div class="wp-block-image"&gt;&lt;figure class="aligncenter size-full"&gt;&lt;a href="https://cff2.earth.com/uploads/2025/09/08161245/Antikythera-Mechanism_greek-cosmos-tracker_ancient-shipwreck-discovery_Nature_1m.jpg"&gt;&lt;img loading="lazy" decoding="async" src="https://cff2.earth.com/uploads/2025/09/08161251/Antikythera-Mechanism_greek-cosmos-tracker_ancient-shipwreck-discovery_Nature_1s.webp" alt="Computer model of the Greek Antikythera Mechanism found on a shipwreck from the First Century, BCE. Credit: Nature" class="wp-image-1985070" srcset="https://cff2.earth.com/uploads/2025/09/08161251/Antikythera-Mechanism_greek-cosmos-tracker_ancient-shipwreck-discovery_Nature_1s.webp 300w, https://cff2.earth.com/uploads/2025/09/08161251/Antikythera-Mechanism_greek-cosmos-tracker_ancient-shipwreck-discovery_Nature_1s-150x150.webp 150w, https://cff2.earth.com/uploads/2025/09/08161251/Antikythera-Mechanism_greek-cosmos-tracker_ancient-shipwreck-discovery_Nature_1s-32x32.webp 32w" sizes="(max-width: 300px) 100vw, 300px"&gt;&lt;/a&gt;&lt;figcaption class="wp-element-caption"&gt;&lt;em&gt;Computer model of the Greek Antikythera Mechanism found on a shipwreck from the First Century, BCE. Click image to enlarge. Credit: Nature&lt;/em&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;/div&gt;&lt;p&gt;This above image reconstruction of the Antikythera Mechanism displays a layered system of celestial motions. At the center sit the dome of the Earth, the Moon’s phase, and its position in the Zodiac. &lt;/p&gt;&lt;p&gt;Around these are rings representing Mercury, Venus, the true Sun, Mars, Jupiter, Saturn, and the Date, each marked with small spheres to track positions and additional markers for oppositions. &lt;/p&gt;&lt;p&gt;The planetary rings are inscribed with scale marks and index letters that record the synodic cycles of the planets. Encircling everything are the bands of the Zodiac and the Egyptian calendar.&lt;/p&gt;&lt;p&gt;On the Sun’s ring, a golden sphere with a pointer indicates the true Sun’s position, as described in the BCI. &lt;/p&gt;&lt;p&gt;When the Sun and Moon pointers align, the Moon’s sphere turns black to mark the New Moon; when they oppose one another, the sphere turns white to show the Full Moon. &lt;/p&gt;&lt;p&gt;A “Dragon Hand” marks the lunar nodes: the Head for the ascending node, the Tail for the descending node. &lt;/p&gt;&lt;p&gt;Small triangles along the Sun’s ring show the eclipse limits, and eclipses are possible when the Dragon Hand falls within these boundaries. &lt;/p&gt;&lt;p&gt;The Moon’s pointer position relative to the Dragon Hand shows whether it lies north or south of the node. Finally, a Date pointer fixed to a narrow outer ring displays the current date in the Egyptian calendar.&lt;/p&gt;&lt;h2 class="wp-block-heading" id="h-science-of-the-antikythera-mechanism"&gt;Science of the Antikythera Mechanism&lt;/h2&gt;&lt;p&gt;The fragments show not only scientific ambition but also fine craftsmanship. The gears were cut from bronze with precise tooth counts, and the inscriptions offered instructions that linked theory to daily use. &lt;/p&gt;&lt;p&gt;This combination of mathematics and engineering reveals how knowledge was made accessible through tools.&lt;/p&gt;&lt;p&gt;Evidence suggests the builders selected cycles that balanced accuracy with mechanical feasibility. &lt;/p&gt;&lt;p&gt;By sharing gears across gear trains and keeping counts manageable, they created a compact system that could still show planetary phases and eclipses.&lt;/p&gt;&lt;p&gt;Modern reconstructions show that the Antikythera Mechanism was more than a timekeeper. It was a scientific instrument that automated predictions of astronomical events, centuries before such technology was thought possible.&lt;/p&gt;&lt;p&gt;Solving its puzzle highlights a design of genius that combined traditions from Babylon, insights from Plato’s Academy, and Greek theories of planetary motion. It reminds us that innovation is not just a modern story but one deeply rooted in the ancient world.&lt;/p&gt;&lt;p&gt;The study is published in &lt;a href="https://www.nature.com/articles/s41598-021-84310-w" target="_blank" rel="noreferrer noopener"&gt;&lt;em&gt;Scientific Reports&lt;/em&gt;&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;Image credits: Swiss School of Archaeology in Greece (ESAG).&lt;/p&gt;&lt;p&gt;—–&lt;/p&gt;&lt;p&gt;Like what you read?&lt;a href="https://www.earth.com/subscribe/"&gt; Subscribe to our newsletter&lt;/a&gt; for engaging articles, exclusive content, and the latest updates. &lt;/p&gt;&lt;p&gt;Check us out on&lt;a href="https://www.earth.com/earthsnap/"&gt; EarthSnap&lt;/a&gt;, a free app brought to you by&lt;a href="https://www.earth.com/author/eralls/"&gt; Eric Ralls&lt;/a&gt; and Earth.com.&lt;/p&gt;&lt;p&gt;—–&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Earth.com</author><pubDate>Tue, 09 Sep 2025 09:05:47 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMinwFBVV95cUxOallkSUZBUUxhM2R3SEpxbUNGTDlqMlM1OGJxb3o1OS1saEFibFFKTlllUFJObU02aWY0UENQQmxYTWxucEV5SUpyUFIybTg4bXQ3S19yYWJaS2h1MzZRVnJMX0V4WFUxa2h4TTdFbW9pQlJLRHVEcXZUM3NBTy0ySnNzUHpsWHdFZ2h0R1lSd0NDRmNyakVYbWtfYWowbFU</guid></item><item><title>父母正在悄悄地为他们的青少年尝试氯胺酮疗法。这非常有争议。-今日美国</title><link>https://www.usatoday.com/story/life/health-wellness/2025/09/09/ketamine-therapys-controversial-rise-in-youth/85623408007/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="gnt_ar_b"&gt;&lt;figure class="gnt_em gnt_em_img gnt_em_img__inset"&gt;&lt;img class="gnt_em_img_i" src="/gcdn/authoring/authoring-images/2025/09/08/USAT/86041165007-lucy.jpeg?width=300&amp;amp;height=463&amp;amp;fit=crop&amp;amp;format=pjpg&amp;amp;auto=webp" srcset="/gcdn/authoring/authoring-images/2025/09/08/USAT/86041165007-lucy.jpeg?width=600&amp;amp;height=926&amp;amp;fit=crop&amp;amp;format=pjpg&amp;amp;auto=webp 2x" elementtiming="ar-lead-image" fetchpriority="high" decoding="async" alt="Most therapeutic ketamine users are in their 30s or older, but Lucy was just 16 when she started the treatment. Despite the potential dangers, her family says trying the controversial therapy outweighed being stuck in the status quo."&gt;&lt;p class="gnt_em_img_ccw gnt_em_img_ccw__cap gnt_em_img_ccw__crd" data-c-caption="Most therapeutic ketamine users are in their 30s or older, but Lucy was just 16 when she started the treatment. Despite the potential dangers, her family says trying the controversial therapy outweighed being stuck in the status quo." data-c-credit="Courtesy Of Jacintha And Lucy"&gt;&lt;/p&gt;&lt;/figure&gt;&lt;p class="gnt_ar_b_p"&gt;Jacintha was at her wits' end. Her daughter was struggling, and they had tried everything ‒ two types of &lt;a href="/story/life/health-wellness/2025/01/30/rfk-jr-antidepressants-ssri-heroin-school-shooters-mental-health/78048367007/" target="_blank" rel="noreferrer noopener" data-t-l=":b|e|k|⚑u" class="gnt_ar_b_a"&gt;antidepressants&lt;/a&gt;, years of &lt;a href="/story/life/health-wellness/2021/09/24/therapy-how-to-find-the-right-therapist-mental-health/5789365001/" target="_blank" rel="noreferrer noopener" data-t-l=":b|e|k|⚑u" class="gnt_ar_b_a"&gt;talk therapy&lt;/a&gt; and weeks of an intensive outpatient program. &lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;She was frantically &lt;a href="/story/money/2025/09/02/google-antitrust-search-ruling/85946554007/" data-t-l=":b|e|k|⚑u" class="gnt_ar_b_a"&gt;Googl&lt;/a&gt;&lt;a href="/story/money/2025/09/02/google-antitrust-search-ruling/85946554007/" target="_blank" rel="noreferrer noopener" data-t-l=":b|e|k|⚑u" class="gnt_ar_b_a"&gt;i&lt;/a&gt;&lt;a href="/story/money/2025/09/02/google-antitrust-search-ruling/85946554007/" data-t-l=":b|e|k|⚑u" class="gnt_ar_b_a"&gt;ng&lt;/a&gt; one night when she came across an article about &lt;a href="/story/entertainment/celebrities/2023/12/15/matthew-perry-ketamine-effects/71936903007/" target="_blank" rel="noreferrer noopener" data-t-l=":b|e|k|⚑u" class="gnt_ar_b_a"&gt;ketamine&lt;/a&gt; therapy. Jacintha, a horseback rider, was familiar with &lt;a href="/story/life/health-wellness/2025/05/30/elon-musk-ketamine-trump-campaign/83942817007/" target="_blank" rel="noreferrer noopener" data-t-l=":b|e|k|⚑u" class="gnt_ar_b_a"&gt;ketamine&lt;/a&gt; as a horse tranquilizer but had never heard of it as a last-stop mental health treatment for treatment-resistant patients like Lucy, who was diagnosed with depression, obsessive-compulsive disorder and post-traumatic stress disorder.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;There was only one thing: Most ketamine users are in their 30s or older. Lucy was just 16.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;“When people are desperate, you're ready to take desperate measures,” says Jacintha, who asked that we withhold her last name to protect her daughter's medical privacy. “I think any parent who sees their child struggling as hard as Lucy was struggling would want to do that.”&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;&lt;a href="/story/life/health-wellness/2024/02/12/what-is-ketamine/72499723007/" target="_blank" rel="noreferrer noopener" data-t-l=":b|e|k|⚑u" class="gnt_ar_b_a"&gt;Ketamine therapy&lt;/a&gt; has been gaining popularity in recent years and, in select cases, has been used to treat young people. Doctors say it can provide life-saving support in instances where other medications have failed, but there are risks involved, including the potential for dependence when improperly administered. Despite the potential dangers, some young users and their families say trying the controversial therapy is preferable to being stuck in the status quo.Dozens of commenters on Reddit talk about seeking out care for minors, but most USA TODAY spoke with declined to go on the record for fear of stigma.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;“The detrimental effect on the brain of growing up with severe treatment-resistant depression is far worse than the whatever risk that we associate with the very sporadic dosing of these low doses of ketamine,” says Chair of Psychiatry at Yale School of Medicine John Krystal. However, he adds there’s little research about ketamine therapy’s effect on young adults, and as such, it should be a last resort.&lt;/p&gt;&lt;h2 class="gnt_ar_b_h2"&gt;How ketamine therapy works in the brain&lt;/h2&gt;&lt;p class="gnt_ar_b_p"&gt;A few months after that Google search, Jacintha and Lucy walked into the Northwest Ketamine Clinic’s Bellevue, Washington, outpost, where Lucy began the first of 12 ketamine infusion sessions, all administered in April and May of 2023.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;The doctors had explained how the ketamine infusion would work: The chemical would bind to receptors in the brain, interfering with the connection between the brain and the body, leading to a disconnected, out-of-body feeling where Lucy might experience detachment from reality. &lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;That first session, Jacintha held Lucy’s hand, cautiously optimistic. Things got worse before they got better, and Lucy experienced mood swings and random spurts of anger. But after the seventh session, it was like something “just completely shifted.”&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;The therapy helped her manage her self-harm and contamination-triggered OCD. Before ketamine therapy, hearing someone cough or breathe loudly in the classroom would send her into panic mode, ultimately causing her to drop out of school. At home, she didn’t enter the downstairs kitchen at all, feeling too overwhelmed by the fridge, dirty dishes, and smells from cooking.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;After the infusions, “I was feeling way better than ever before,” Lucy says. “It really did shift my mood a lot. I was just generally at a higher level of functioning every day; I wasn't depressed all the time.”&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;A representative for Northwest Ketamine Clinic says their clinics don’t treat anyone under the age of 14, but they've seen a rise in interest from parents looking to treat teenagers.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;Ketamine works by stimulating the brain’s resilience mechanisms, according to Krystal. The chemical targets a different system in the brain than standard antidepressants, triggering the release of glutamate, which stimulates the growth of new synapses between brain cells. &lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;“The plasticity of the brain ‒ the ability to learn, adapt, respond ‒ becomes compromised by depression,” Krystal says. “Even a single dose of ketamine can have a positive effect on this kind of plasticity, which may make psychotherapies and (other) kinds of interventions work.”&lt;/p&gt;&lt;figure class="gnt_em gnt_em_img gnt_em_img__inset"&gt;&lt;img class="gnt_em_img_i" fetchpriority="high" data-g-r="lazy" data-gl-src="/gcdn/authoring/authoring-images/2025/09/08/USAT/86041995007-image-15.jpeg?width=300&amp;amp;height=451&amp;amp;fit=crop&amp;amp;format=pjpg&amp;amp;auto=webp" decoding="async" alt="Laura Pickard sought ketamine therapy for relief from depression and grief. Her psychiatrist warned that she may feel intense emotions, and for her, that manifested into feelings about her family as she cycled through memories of them during the infusion"&gt;&lt;p class="gnt_em_img_ccw gnt_em_img_ccw__cap gnt_em_img_ccw__crd" data-c-caption="Laura Pickard sought ketamine therapy for relief from depression and grief. Her psychiatrist warned that she may feel intense emotions, and for her, that manifested into feelings about her family as she cycled through memories of them during the infusion" data-c-credit="Courtesy Of Laura Pickard"&gt;&lt;/p&gt;&lt;/figure&gt;&lt;p class="gnt_ar_b_p"&gt;Laura Pickard, 23, turned to ketamine therapy in search of relief. She had battled depression and anxiety since age 15, cycling through medications like Prozac and Wellbutrin. In 2022, her father died of an overdose, and just 16 months later, her mother died by suicide. &lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;Following her mother’s death, she paused her education at Baylor University and returned home to Los Angeles, where she began working with a counselor who specialized in loss. She described coming out of her depression as putting on glasses for the first time.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;“Before ketamine, everything took five times the amount of effort for me to do because of my depression,” Pickard says. “Going through my ketamine treatments, I woke up motivated to do things; I had energy.”&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;Pickard has since done three maintenance sessions, which she credited with helping her return to school to finish her degree last year.&lt;/p&gt;&lt;h2 class="gnt_ar_b_h2"&gt;'I still get the sense that I was a little too young for it'&lt;/h2&gt;&lt;p class="gnt_ar_b_p"&gt;When Krystal started studying ketamine in the 1990s, it was still known as a horse tranquilizer or by the street name Special K. In recent years, high-profile figures like &lt;a href="/story/life/health-wellness/2024/03/19/what-is-ketamine-elon-musk/73025449007/" target="_blank" rel="noreferrer noopener" data-t-l=":b|e|k|⚑u" class="gnt_ar_b_a"&gt;Elon Musk&lt;/a&gt;, Chrissy Teigen and &lt;a href="/story/life/health-wellness/2022/07/08/ketamine-therapy-depression-praised-celebs-heres-what-know/7776023001/?gnt-cfr=1&amp;amp;gca-cat=p" target="_blank" rel="noreferrer noopener" data-t-l=":b|e|k|⚑u" class="gnt_ar_b_a"&gt;Sharon Osborne&lt;/a&gt; have talked about using the substance for therapeutic purposes, contributing to its name recognition. Most notably, abuse of the drug was linked to &lt;a href="/story/entertainment/celebrities/2023/12/15/matthew-perry-ketamine-effects/71936903007/" target="_blank" rel="noreferrer noopener" data-t-l=":b|e|k|⚑u" class="gnt_ar_b_a"&gt;Matthew Perry&lt;/a&gt;’s death after he was using ketamine under the care of a physician for the treatment of depression.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;Ketamine therapy’s most common short-term side effects are dizziness and nausea, but in extreme cases, long-term, heavy use of ketamine is associated with memory problems, gastrointestinal issues, and urinary tract infections, according to the &lt;a href="https://nida.nih.gov/research-topics/ketamine#health-risks" target="_blank" rel="noreferrer noopener" data-t-l=":b|z|k|⚑u" class="gnt_ar_b_a"&gt;National Institute on Drug Abuse&lt;/a&gt;.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;A &lt;a href="https://pubmed.ncbi.nlm.nih.gov/37153136/" target="_blank" rel="noreferrer noopener" data-t-l=":b|z|k|⚑u" class="gnt_ar_b_a"&gt;2017 case study&lt;/a&gt; from the Yale Child Study Center found depressive symptoms dramatically reduced for adolescents ages 13 to 17 with treatment-resistant depression within 24 hours of receiving an infusion of the therapy, and the improvements lasted at least two weeks.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;“I really would just proceed with caution on this for kids because it's not really been studied in that age group,” says Dr. Ryan Sultan, a psychiatrist specializing in ketamine treatment at Integrative Psychiatry. “The younger the brain, the more unformed it is, and therefore the greater potential of negative effects.”&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;Lucy doesn’t regret the ketamine therapy, but says it’s a bigger step than she realized at the time.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;“I still get the sense that I was a little too young for it, and I wonder, could I have tried something else?” Lucy says.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;Krystal says that ketamine is most effective in a very narrow dose range: a doubled dose would lead to more side effects, but not more effectiveness, and halving the dose would lose the antidepressant effectiveness. He’s seen instances of misuse where people start using ketamine as many as eight times a day, leading their depression to worsen. &lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;Lucy and Pickard receive treatment through intravenous (IV) ketamine therapy ‒ a legal but off-label use of the drug. The only FDA-approved form of the therapy is an &lt;a href="https://www.mayoclinic.org/drugs-supplements/esketamine-nasal-route/description/drg-20458442" target="_blank" rel="noreferrer noopener" data-t-l=":b|z|k|⚑u" class="gnt_ar_b_a"&gt;esketamine&lt;/a&gt; nasal spray known as Spravato, but the majority of ketamine therapy administered is through IV, according to Sultan. Neither form is FDA-approved for children.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;The result is that the field of ketamine therapy goes unregulated. After the FDA &lt;a href="https://web.archive.org/web/20250202084452/https://www.fda.gov/news-events/press-announcements/fda-approves-new-nasal-spray-medication-treatment-resistant-depression-available-only-certified" target="_blank" rel="noreferrer noopener" data-t-l=":b|z|k|⚑u" class="gnt_ar_b_a"&gt;approved esketamine in 2019,&lt;/a&gt; hundreds of independent, outpatient ketamine clinics sprang up around the country. These clinics might employ a mixture of anesthesiologists, psychiatrists, nurse practitioners and therapists, but quality and safety vary across clinics.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;Insurance rarely covers IV ketamine therapy, and users pay hundreds per session out of pocket.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;Krystal warns that people using ketamine for therapy outside of clinics often improperly administer it. Most of the ketamine distributed in the United States is done so illegally, according to the &lt;a href="https://www.dea.gov/sites/default/files/2020-06/Ketamine-2020.pdf" target="_blank" rel="noreferrer noopener" data-t-l=":b|z|k|⚑u" class="gnt_ar_b_a"&gt;Drug Enforcement Administration.&lt;/a&gt;&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;​”Adolescents are at greater risk for addiction problems, and so the concerns that I raise about people having access to ketamine at home are even heightened for adolescents,” Krystal says.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;Jacintha initially worried about introducing the feeling of ketamine to Lucy, but has spoken with Lucy about the dangers of seeking out that feeling in a non-clinical setting.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;“Am I inadvertently introducing her to a euphoric feeling that she may want to continue pursuing in other ways?” Jacintha says. “If she no longer has access to ketamine, but she still wants to go back to the feeling that ketamine gave her, will that lead her into other types of drug abuse?”&lt;/p&gt;&lt;h2 class="gnt_ar_b_h2"&gt;Why ketamine therapy isn't a cure-all&lt;/h2&gt;&lt;p class="gnt_ar_b_p"&gt;Since April of 2023, Lucy has done four maintenance sessions, one every six months, which she utilizes in combination with talk therapy and antidepressants.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;“It’s still prevalent today, sometimes depending on my stress and my mood. But I think the biggest reason why my OCD got more manageable is because my depression was more manageable,” Lucy says.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;Still, Jacintha says she wishes they saw bigger results and cautioned that it's not a miracle cure.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;"I wish that this had been the cannonball that we were looking for, to blow this whole thing open, and it wasn't," Jacintha says.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;Ultimately, Lucy and Jacintha knew the risks of ketamine therapy. But they agreed any side effects would pale in comparison to the struggles Lucy was experiencing.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;“If people think that I'm a bad parent because I chose to give my child ketamine, I would invite you to come and live my life,” Jacintha says. “When you have a child that is in such acute mental anguish, and you see them drowning every day, you cling to hope, that's all you have.”&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;&lt;em&gt;Rachel Hale’s role covering Youth Mental Health at USA TODAY is supported by a partnership with Pivotal and Journalism Funding Partners. Funders do not provide editorial input.&lt;/em&gt;&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;&lt;em&gt;Reach her at rhale@usatoday.com and &lt;a href="https://x.com/rachelleighhale" target="_blank" rel="noreferrer noopener" data-t-l=":b|z|k|⚑u" class="gnt_ar_b_a"&gt;@rachelleighhale&lt;/a&gt; on X.&lt;/em&gt;&lt;/p&gt;&lt;p class="gnt_ar_s gnt_ar_s0"&gt;&lt;/p&gt;&lt;p class="gnt_ar_s gnt_ar_s25"&gt;&lt;/p&gt;&lt;p class="gnt_ar_s gnt_ar_s50"&gt;&lt;/p&gt;&lt;p class="gnt_ar_s gnt_ar_s75"&gt;&lt;/p&gt;&lt;p class="gnt_ar_s gnt_ar_s100"&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>USA Today</author><pubDate>Tue, 09 Sep 2025 09:05:24 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMivgFBVV95cUxPQVZ3cm9RNENmeWNjdTRkQ3N3T21UN0ZMTnVBR0ExT3VzZm14NHFJd2M2LUFpeDh4blR6cmtEakJMVzFRck1CbXdNS3hrTGpTTGNhc2s4aXd4dTJPUkJtSUhYVFVnMGV0S3I2LW5HQVZZeG1hSXc5N0tmYVFxOHZlX041d3IxdGQzY0daZUZPVlAxdjkxcVJjeHM0c0JHT0V4UXNQRWFjenZXWmlSUEd2ZnFja253SGtoaHVWX0Zn</guid></item><item><title>科学家开始在海豹中测试禽流感疫苗-《纽约时报》</title><link>https://www.nytimes.com/2025/09/09/science/bird-flu-seals-vaccine.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;body id="readabilityBody"&gt;&lt;p id="cmsg"&gt;Please enable JS and disable any ad blocker&lt;/p&gt;&lt;/body&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The New York Times</author><pubDate>Tue, 09 Sep 2025 09:00:31 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiekFVX3lxTFBQeUhZNzhfQ3c2b1RQZ2FkblhMUXdxd0V0eU5UaHo0VFdlWmFaNnlkMUZ1dVdrY3FyNU5tazh1MGlROWtDekhfcGo4STJLYWc3Q2YtZUNtME1RMVY4UFpoRGF1a2loV3hrblY3bHphWFgxVnkzazlIVHF3</guid></item><item><title>科学家找到阻止乳腺癌复发的方法- SciTechDaily</title><link>https://scitechdaily.com/scientists-find-a-way-to-stop-breast-cancer-from-coming-back/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="post-content cf entry-content content-spacious"&gt;

		
				
		&lt;figure id="attachment_486157" aria-describedby="caption-attachment-486157" class="wp-caption aligncenter"&gt;&lt;a href="https://scitechdaily.com/images/Computer-Screen-Breast-Cancer-Mammography-Screening-Procedure.jpg"&gt;&lt;img fetchpriority="high" decoding="async" class="size-large wp-image-486157" src="https://scitechdaily.com/images/Computer-Screen-Breast-Cancer-Mammography-Screening-Procedure-777x518.jpg" alt="Computer Screen Breast Cancer Mammography Screening Procedure" srcset="https://scitechdaily.com/images/Computer-Screen-Breast-Cancer-Mammography-Screening-Procedure-777x518.jpg 777w, https://scitechdaily.com/images/Computer-Screen-Breast-Cancer-Mammography-Screening-Procedure-400x267.jpg 400w, https://scitechdaily.com/images/Computer-Screen-Breast-Cancer-Mammography-Screening-Procedure-768x512.jpg 768w, https://scitechdaily.com/images/Computer-Screen-Breast-Cancer-Mammography-Screening-Procedure-1536x1024.jpg 1536w, https://scitechdaily.com/images/Computer-Screen-Breast-Cancer-Mammography-Screening-Procedure-150x100.jpg 150w, https://scitechdaily.com/images/Computer-Screen-Breast-Cancer-Mammography-Screening-Procedure-450x300.jpg 450w, https://scitechdaily.com/images/Computer-Screen-Breast-Cancer-Mammography-Screening-Procedure-1200x800.jpg 1200w, https://scitechdaily.com/images/Computer-Screen-Breast-Cancer-Mammography-Screening-Procedure.jpg 2000w" sizes="(max-width: 777px) 100vw, 777px"&gt;&lt;/a&gt;&lt;figcaption id="caption-attachment-486157" class="wp-caption-text"&gt;Dormant “sleeper” cancer cells, long untouchable, can now be destroyed with common drugs, stopping breast cancer from returning. Credit: Shutterstock&lt;/figcaption&gt;&lt;/figure&gt;
&lt;p&gt;Researchers have discovered that dormant breast cancer cells can be detected and wiped out with existing drugs, dramatically lowering the risk of relapse. The breakthrough brings new hope to survivors haunted by the fear of recurrence.&lt;/p&gt;
&lt;h4&gt;Breakthrough Trial Targets Dormant Breast Cancer Cells&lt;/h4&gt;
&lt;p&gt;A landmark federally funded clinical trial has provided the first real evidence that doctors can pinpoint breast cancer survivors at higher risk of relapse by detecting dormant cancer cells, and that these hidden cells can be successfully treated using already available drugs. The work, led by researchers at the Abramson Cancer Center of the &lt;span class="glossaryLink" aria-describedby="tt" data-cmtooltip="&amp;lt;div class=glossaryItemTitle&amp;gt;University of Pennsylvania&amp;lt;/div&amp;gt;&amp;lt;div class=glossaryItemBody&amp;gt;The University of Pennsylvania (Penn) is a prestigious private Ivy League research university located in Philadelphia, Pennsylvania. Founded in 1740 by Benjamin Franklin, Penn is one of the oldest universities in the United States. It is renowned for its strong emphasis on interdisciplinary education and its professional schools, including the Wharton School, one of the leading business schools globally. The university offers a wide range of undergraduate, graduate, and professional programs across various fields such as law, medicine, engineering, and arts and sciences. Penn is also known for its significant contributions to research, innovative teaching methods, and active campus life, making it a hub of academic and extracurricular activity.&amp;lt;/div&amp;gt;" data-gt-translate-attributes='[{"attribute":"data-cmtooltip", "format":"html"}]' tabindex="0" role="link"&gt;University of Pennsylvania&lt;/span&gt; and Penn’s Perelman School of Medicine, appears in the journal &lt;em&gt;Nature Medicine&lt;/em&gt;.&lt;/p&gt;
&lt;p&gt;Although survival rates for breast cancer continue to improve thanks to better screening and therapies, the disease remains incurable once it comes back after initial treatment. About 30 percent of women and men experience a relapse, leaving them dependent on ongoing treatment that cannot completely remove the cancer. Some forms, such as triple negative and HER2+, often reappear within a few years, while ER+ cases can resurface even decades later. Until now, doctors had no way to identify which survivors carried dormant cells that fuel recurrence or to step in with a therapy that could prevent it.&lt;/p&gt;
&lt;h4&gt;The Hidden Threat of Cancer Relapse&lt;/h4&gt;
&lt;p&gt;In the randomized phase II trial, 51 breast cancer survivors were tested with existing drugs, which successfully cleared dormant tumor cells in 80 percent of participants. After three years, the survival rate without any return of disease exceeded 90 percent among patients given a single drug and reached 100 percent for those who received both medications.&lt;/p&gt;
&lt;p&gt;“The lingering fear of cancer returning is something that hangs over many breast cancer survivors after they celebrate the end of treatment,” said principal investigator Angela DeMichele, MD, MSCE, FASCO, the Mariann T. and Robert J. MacDonald Professor in Breast Cancer Research. “Right now, we just don’t know when or if someone’s cancer will come back—that’s the problem we set out to solve. Our study shows that preventing recurrence by monitoring and targeting dormant tumor cells is a strategy that holds real promise, and I hope it ignites more research in this area.”&lt;/p&gt;
&lt;h4&gt;Survivors’ Hope: Preventing Recurrence Before It Starts&lt;/h4&gt;
&lt;p&gt;The study builds on &lt;a href="https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-021-01416-9"&gt;previous&lt;/a&gt; &lt;a href="https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-024-01878-7"&gt;research&lt;/a&gt; that showed how dormant tumor cells continue to lay in wait in some patients after breast cancer treatment. These so-called “sleeper cells,” also referred to as minimal residual disease (MRD), can reactivate years or even decades later. Because they are not “active” cancer cells and can be scattered throughout the body, they do not show up on standard imaging tests that are used to watch for breast cancer recurrence.&lt;/p&gt;
&lt;p&gt;Once the sleeper cells begin to expand and circulate in the bloodstream, it can lead to the spread of metastatic breast cancer. Patients who have MRD are more likely to experience breast cancer recurrence and have decreased overall survival.&lt;/p&gt;
&lt;h4&gt;Why Dormant Cells Escape Detection&lt;/h4&gt;
&lt;p&gt;Lewis Chodosh, MD, PhD, chair of Cancer Biology and senior author of the study, &lt;a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4497740/"&gt;previously led research&lt;/a&gt; to identify the pathways that allow dormant tumor cells to survive in patients for decades.&lt;/p&gt;
&lt;p&gt;“Our research shows that this sleeper phase represents an opportunity to intervene and eradicate the dormant tumor cells before they have the chance to come back as aggressive, metastatic disease,” Chodosh said. “Surprisingly, we’ve found that certain drugs that &lt;em&gt;don’t&lt;/em&gt; work against actively growing cancers &lt;em&gt;can&lt;/em&gt; be very effective against these sleeper cells. This tells us that the biology of dormant tumor cells is very different from active cancer cells.”&lt;/p&gt;
&lt;p&gt;In the preclinical part of the latest research publication, Chodosh’s team conducted a series of experiments in mice to better understand the underlying mechanisms. They showed that two different drugs—approved by the FDA to treat other conditions—could effectively clear MRD in mice, resulting in longer survival without cancer recurrence. The drugs target autophagy and mTOR signaling, which the researchers found were key mechanisms to allow the tumor cells to remain dormant.&lt;/p&gt;
&lt;h4&gt;How FDA-Approved Drugs Target Dormant Cells&lt;/h4&gt;
&lt;p&gt;DeMichele’s team first enrolled breast cancer survivors who had completed treatment within the last five years and had clear scans into a screening study that looked for dormant tumor cells in participant’s bone marrow.&lt;/p&gt;
&lt;p&gt;If dormant tumor cells were found, patients were then eligible to enroll in the Phase II CLEVER clinical trial, which randomized patients to receive six cycles of either monotherapy with one of two study drugs, or combination therapy with both drugs. The treatment cleared dormant tumor cells in most patients after six to 12 months. After a median follow-up time of 42 months, only two patients on the study have experienced a cancer recurrence.&lt;/p&gt;
&lt;h4&gt;The CLEVER Trial: Promising Early Results&lt;/h4&gt;
&lt;p&gt;“We want to be able to give patients a better option than ‘wait and see’ after they complete breast cancer treatment,” DeMichele said. “We’re encouraged by these results that we’re on the right track.”&lt;/p&gt;
&lt;p&gt;The team is already enrolling patients in two larger, ongoing studies to confirm and extend the results of the CLEVER study: the &lt;a href="https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2021-12420"&gt;Phase II ABBY clinical trial&lt;/a&gt; and the &lt;a href="https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2021-06208"&gt;Phase II PALAVY clinical trial&lt;/a&gt;, available at several cancer centers across the country. &lt;strong&gt;Patients interested in learning more about these or other breast cancer clinical trials at Penn Medicine should contact &lt;/strong&gt;&lt;a href="/cdn-cgi/l/email-protection#7032021511030433111e131502331c191e1913111c240219111c033000151e1e1d15141913191e155e0500151e1e5e151405"&gt;&lt;span class="__cf_email__" data-cfemail="f8ba8a9d998b8cbb99969b9d8abb949196919b9994ac8a9199948bb8889d9696959d9c919b91969dd68d889d9696d69d9c8d"&gt;[email protected]&lt;/span&gt;&lt;/a&gt;&lt;strong&gt;.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Reference: “Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial” by Angela DeMichele, Amy S. Clark, Emily Shea, Lauren J. Bayne, Christopher J. Sterner, Killian Rohn, Samantha Dwyer, Tien-chi Pan, Isoris Nivar, Yan Chen, Paul Wileyto, Lindsay R. Berry, Shannon Deluca, Jessica Savage, Igor Makhlin, Dhruv K. Pant, Heather Martin, Adetutu Egunsola, Nathan Mears, Brooke L. Goodspeed, Elizabeth M. Chislock, Jewell Graves, Jianping Wang, Natalie Shih, George K. Belka, Don Berry, Anupma Nayak, Michael Feldman and Lewis A. Chodosh, 2 September 2025, &lt;i&gt;Nature Medicine&lt;/i&gt;.&lt;br&gt;
&lt;a href="https://www.nature.com/articles/s41591-025-03877-3"&gt;DOI: 10.1038/s41591-025-03877-3&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;The research was made possible with funding from the National Cancer Institute (R01CA208273) and Department of Defense (BC160784), with additional support from the V Foundation, Breast Cancer Research Foundation, QVC “Shoes on Sale,” Avon Foundation, Raynier Institute &amp;amp; Foundation, and generous philanthropic donations. DeMichele &lt;a href="https://www.pennmedicine.org/news/10-million-grant-for-preventing-breast-cancer-recurrence"&gt;previously reported&lt;/a&gt; interim outcomes data from the study at the European Society for Medical Oncology (ESMO) Congress 2023.&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Never miss a breakthrough: &lt;a href="https://scitechdaily.com/newsletter/"&gt;Join the SciTechDaily newsletter.&lt;/a&gt;&lt;/b&gt;&lt;/p&gt;
				
		
		
		
	&lt;/div&gt;
&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>SciTechDaily</author><pubDate>Tue, 09 Sep 2025 08:58:07 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMijwFBVV95cUxPX0hCTFREOWd1ZHZuZEZBYUhDQnp5MC1WVFo4VThTLXQ0OGZ5MEFRMlUyVlFZODNlM0c1Tm5TU044Q1FoWHVYellWS1pnUWdmZGZWUTkxOXJqQWVEemhMQ1ZiRFhackZIdmwxUC00Z2t4bkhyLWgxSlBMVEM5MHdBNE14NDFzbUFZVlZESDZiUQ</guid></item><item><title>日本蜱传感染病例创历史新高- nhk.or.jp</title><link>https://www3.nhk.or.jp/nhkworld/en/news/20250909_13/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="p-article__body"&gt;

      
                    
                  &lt;p&gt;A research institute in Japan says the number of people infected so far this year with a disease transmitted mainly by ticks has reached a record high.&lt;/p&gt;
        
                    
                  &lt;p&gt;Severe Fever with Thrombocytopenia Syndrome, or SFTS, can cause a reduction in blood platelets, hemorrhaging or unconsciousness. The health ministry says from 10 percent to 30 percent of cases are fatal.&lt;/p&gt;
        
                    
                  &lt;p&gt;Preliminary data announced by the Japan Institute for Health Security show four new cases in the seven days to the end of August. That brought the 2025 total to date to 149, surpassing the previous high set for all of 2023.&lt;/p&gt;
        
                    
                  &lt;p&gt;The institute says cases have been reported in 32 prefectures, mainly in western Japan. It says 14 were in Kochi, 12 in Oita, 9 each in Kumamoto and Nagasaki and 8 each in Kagoshima, Shimane and Hyogo.&lt;/p&gt;
        
                    
                  &lt;p&gt;It says there were also infections in the Kanto region and Hokkaido, where no cases were reported until last year.&lt;/p&gt;
        
                    
                  &lt;p&gt;The health ministry says cases could be reported in areas other than western Japan. It is calling on people to reduce skin exposure and take other precautions when going outdoors.&lt;/p&gt;
                &lt;/div&gt;
            &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>nhk.or.jp</author><pubDate>Tue, 09 Sep 2025 07:54:30 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiYkFVX3lxTFBodUc4aXJkbExzLTI1R096VFNHUnhSWGhQTTNWN0RtajA4THc2THQ4QWtDVWVqZU11N0xiNDJUVXh5NTRIRUZHZUNVeWxiRnQxQWVxSDl1Z3hCN0doSTRHei1B</guid></item><item><title>为什么“星际穿越”有好莱坞历史上最精确的黑洞：短波- NPR</title><link>https://www.npr.org/2025/09/09/nx-s1-5534348/interstellar-wormhole-black-hole-space-time-movie</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div id="storytext" class="storytext storylocation linkLocation"&gt;
      &lt;div id="resnx-s1-img-5707572" class="bucketwrap image large"&gt;
            
&lt;div class="credit-caption"&gt;
    &lt;div class="caption-wrap"&gt;
        &lt;div class="caption" aria-label="Image caption"&gt;
            &lt;p&gt;
                Matthew McConaughey in the 2014 film, Interstellar.
                &lt;b class="credit" aria-label="Image credit"&gt;
                    
                    Warner Bros./Alamy
                    
                &lt;/b&gt;
                &lt;b class="hide-caption"&gt;&lt;b&gt;hide caption&lt;/b&gt;&lt;/b&gt;
            &lt;/p&gt;
        &lt;/div&gt;


            &lt;b class="toggle-caption"&gt;&lt;b&gt;toggle caption&lt;/b&gt;&lt;/b&gt;
    &lt;/div&gt;

    &lt;span class="credit" aria-label="Image credit"&gt;
        
        Warner Bros./Alamy
        
    &lt;/span&gt;
&lt;/div&gt;
   &lt;/div&gt;
   &lt;p&gt;Christopher Nolan's &lt;a href="https://www.imdb.com/title/tt0816692/" target="_blank"&gt;&lt;em&gt;&lt;u&gt;Interstellar&lt;/u&gt;&lt;/em&gt;&lt;/a&gt; was a phenomenon in 2014. Set in the future, Earth has been struck by a global crop blight. Former NASA pilot Cooper (Matthew McConaughey) is pulled into a NASA mission to transport the human race to a new planet, via wormhole. Back on Earth, Cooper's daughter, Murph (Jessica Chastain), attempts to complete an equation that will allow this mass-transport of humanity from Earth.&lt;/p&gt;   &lt;p&gt;Many scientists praised the film, particularly for its depiction of black holes. In this episode co-hosts &lt;a href="https://www.npr.org/people/1082526815/regina-g-barber" target="_blank"&gt;&lt;u&gt;Regina G. Barber&lt;/u&gt;&lt;/a&gt; and &lt;a href="https://www.npr.org/people/767284140/emily-kwong" target="_blank"&gt;&lt;u&gt;Emily Kwong&lt;/u&gt;&lt;/a&gt; talk about &lt;em&gt;Interstellar&lt;/em&gt; with &lt;em&gt;Star Trek&lt;/em&gt; scientific advisor and astrophysicist &lt;a href="https://www.erinpmacdonald.com/" target="_blank"&gt;&lt;u&gt;Erin Macdonald&lt;/u&gt;&lt;/a&gt;. They walk through wormholes, black holes and all the ways space-time stretches in the film.&lt;/p&gt;   
   &lt;p&gt;&lt;em&gt;Interested in more on the science behind science fiction? Email us your question at &lt;/em&gt;&lt;a href="mailto:shortwave@npr.org" target="_blank"&gt;&lt;em&gt;&lt;u&gt;shortwave@npr.org&lt;/u&gt;&lt;/em&gt;&lt;/a&gt;&lt;em&gt; – we may feature it in an upcoming episode!&lt;/em&gt;&lt;/p&gt;   &lt;p&gt;&lt;em&gt;Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at &lt;/em&gt;&lt;a href="http://plus.npr.org/shortwave" target="_blank"&gt;&lt;em&gt;plus.npr.org/shortwave&lt;/em&gt;&lt;/a&gt;&lt;em&gt;.&lt;/em&gt;&lt;/p&gt;   &lt;p&gt;&lt;em&gt;Listen to Short Wave on &lt;/em&gt;&lt;a href="https://n.pr/3HOQKeK" target="_blank"&gt;&lt;em&gt;Spotify&lt;/em&gt;&lt;/a&gt;&lt;em&gt; and &lt;/em&gt;&lt;a href="https://n.pr/3WA9vqh" target="_blank"&gt;&lt;em&gt;Apple Podcasts&lt;/em&gt;&lt;/a&gt;&lt;em&gt;.&lt;/em&gt;&lt;/p&gt;   &lt;p&gt;&lt;em&gt;This episode was produced by Rachel Carlson and edited by our showrunner, Rebecca Ramirez. Tyler Jones checked the facts. Jimmy Keeley was the audio engineer. &lt;/em&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>NPR</author><pubDate>Tue, 09 Sep 2025 07:00:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMimgFBVV95cUxPYXlCdVNOSWZqTF9fNFkzZHl2dFNacGZjY0lKSVRtZERLSFUtQVNrQUVOVVFwMmEyZFc2ZWtSNkt2WFNoQ2dpSnNjM2V0SnBxNHdpOTIzYnFQM3RKYXVxMmtKX3pCMU8wWU5LNVd1RkUySmJwamc3UEx6ak5TZ0labWZRdC15cDZxUWtNcTBENnZqeFpDVTBuVnpR</guid></item><item><title>外周动脉疾病：腿部出现动脉阻塞的6个早期迹象-印度时报</title><link>https://timesofindia.indiatimes.com/life-style/health-fitness/peripheral-artery-disease-6-early-signs-of-blocked-arteries-that-appear-in-the-legs/photostory/123779582.cms</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="COQxt" data-ua-type="1"&gt;&lt;p&gt;Most people think leg pain is a natural sign of aging. It is easy to dismiss that agonizing cramping feeling on a walk if it goes away with rest. But experts warn that these are signs that something more ominous is going on in your arteries.&lt;br&gt;Dr. Sumit Kapadia, one of the finest vascular and endovascular specialists, recently shared a case of a patient who had blamed his leg pain on age. He described, "My legs hurt when I walked, but when I sat down, the pain went away. I figured it was not too bad." After they probed further, they discovered that the cause was blocked arteries in the legs, or Peripheral Artery Disease (PAD).&lt;br&gt; PAD affects blood flow to the lower body and, if not treated, can lead to severe problems like infections, ulcers, or amputation. Early detection is key, and in his patients, Dr. Kapadia regularly sees these six early warning signs:&lt;br&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Times of India</author><pubDate>Tue, 09 Sep 2025 06:30:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMi_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</guid></item><item><title>新的“快速球”测试可以在3分钟内评估阿尔茨海默氏症的风险- ScienceAlert</title><link>https://www.sciencealert.com/new-fastball-test-could-assess-alzheimers-risk-in-just-3-minutes</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="post-content"&gt;
			&lt;p&gt;A new test could help to diagnose memory issues associated with  &lt;a href="https://www.sciencealert.com/go/IaO" class="lar_link lar_link_outgoing" data-linkid="73015" data-postid="173505" rel="nofollow" target="_self"&gt;Alzheimer's&lt;/a&gt; disease in as little as three minutes.&lt;/p&gt;&lt;p&gt;According to &lt;a href="https://doi.org/10.1093/braincomms/fcaf279"&gt;recently published findings&lt;/a&gt;, the test, called the Fastball EEG test, may one day help doctors flag people who need further checks for Alzheimer's disease without the need for unnecessary waits or time-consuming procedures.&lt;/p&gt;&lt;p&gt;&lt;a href="https://www.alz.org/alzheimers-dementia/what-is-alzheimers"&gt;Alzheimer's disease&lt;/a&gt; affects millions of people worldwide. It's a progressive condition, in which brain cells are slowly damaged and die – leading to memory loss, confusion, and difficulties with thinking and daily tasks.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Related: &lt;a href="https://www.sciencealert.com/your-vision-can-predict-dementia-12-years-before-diagnosis-study-discovers"&gt;Your Vision Can Predict Dementia 12 Years Before Diagnosis, Study Discovers&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;The disease process begins long before symptoms manifest. Proteins called amyloid and tau gradually build up in the brain, forming plaques and tangles that interfere with communication between nerve cells. By the time memory problems are significant enough for diagnosis, much of the damage has already been done.&lt;/p&gt;&lt;figure id="attachment_173515" aria-describedby="caption-attachment-173515" class="wp-caption alignnone"&gt;&lt;img decoding="async" src="https://www.sciencealert.com/images/2025/09/AD_tau_tangles_642.jpg" alt="tau tangles" class="wp-image-173515 size-full" srcset="https://www.sciencealert.com/images/2025/09/AD_tau_tangles_642.jpg 642w, https://www.sciencealert.com/images/2025/09/AD_tau_tangles_642-592x415.jpg 592w, https://www.sciencealert.com/images/2025/09/AD_tau_tangles_642-600x421.jpg 600w" sizes="(max-width: 642px) 100vw, 642px" loading="lazy"&gt;&lt;figcaption id="caption-attachment-173515" class="wp-caption-text"&gt;Tangles of tau proteins can trigger the death of neurons, leading to Alzheimer's disease. (&lt;a href="https://www.canva.com/photos/MADerDrK0Vs/"&gt;selvanegra/Getty Images Pro/Canva&lt;/a&gt;)&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;It's important to note that the signs of Alzheimer's disease and symptoms &lt;a href="https://doi.org/10.1038/s41582-022-00642-9"&gt;don't develop similarly&lt;/a&gt; in all patients. This means the amount of amyloid plaques and tau tangles a person has in their brain &lt;a href="https://doi.org/10.1038/s41582-022-00642-9"&gt;doesn't always match&lt;/a&gt; the severity of the disease.&lt;/p&gt;&lt;p&gt;In addition, the amount of plaques and tangles can only be estimated via imaging or blood tests. These factors make Alzheimer's disease difficult to diagnose and predict how it will progress. This is why researchers are keen to develop tests that can spot signs of the disease earlier.&lt;/p&gt;&lt;p&gt;Traditionally, diagnosis has relied on &lt;a href="https://doi.org/10.2147/NDT.S212328"&gt;cognitive screening tests&lt;/a&gt;, where a doctor asks a patient to remember words, copy drawings, or complete problem-solving tasks. These tools are effective, but take time and require trained staff. They may also be stressful for the patients and can be influenced by factors such as a person's education level, their &lt;a href="https://doi.org/10.1177/15333175221117006"&gt;language skills&lt;/a&gt;, or &lt;a href="https://doi.org/10.3390/jintelligence7040022"&gt;test-related performance anxiety&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;More advanced diagnostic options, including brain scans and laboratory analysis of cerebrospinal fluid (a fluid that protects the brain and spinal cord), can indicate the presence of Alzheimer's disease in the brain. But these tests are &lt;a href="https://doi.org/10.1016/j.drudis.2024.103911"&gt;expensive and invasive&lt;/a&gt;.&lt;/p&gt;&lt;figure id="attachment_173511" aria-describedby="caption-attachment-173511" class="wp-caption alignnone"&gt;&lt;img decoding="async" src="https://www.sciencealert.com/images/2025/09/AD_brain_scans_642.jpg" alt="brain scans" class="wp-image-173511 size-full" srcset="https://www.sciencealert.com/images/2025/09/AD_brain_scans_642.jpg 642w, https://www.sciencealert.com/images/2025/09/AD_brain_scans_642-592x415.jpg 592w, https://www.sciencealert.com/images/2025/09/AD_brain_scans_642-600x421.jpg 600w" sizes="(max-width: 642px) 100vw, 642px" loading="lazy"&gt;&lt;figcaption id="caption-attachment-173511" class="wp-caption-text"&gt;Brain scans can indicate risk of Alzheimer's, but are expensive. (&lt;a href="https://www.canva.com/photos/MAEGJABe-88/"&gt;pixelshot/Canva&lt;/a&gt;)&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;But the &lt;a href="https://www.bath.ac.uk/projects/diagnosing-dementia-using-fastball-neurocognitive-assessment/"&gt;Fastball EEG test&lt;/a&gt; uses a different approach.&lt;/p&gt;&lt;p&gt;Instead of asking patients to actively recall or solve problems, it measures how the brain responds to images flashed on a screen. Participants first see a set of eight pictures, which they're asked to name but not memorise.&lt;/p&gt;&lt;p&gt;Then, during the test, hundreds of images are shown in quick succession – around three per second. Every fifth image is one of the eight previously shown. The EEG headset records the brain's electrical activity, picking up tiny signals that reveal whether the brain recognises these familiar images.&lt;/p&gt;&lt;p&gt;In healthy people, the recognition response is clear. But in people with &lt;a href="https://www.alzheimers.org.uk/about-dementia/types-dementia/mild-cognitive-impairment-mci"&gt;mild cognitive impairment&lt;/a&gt; (problems with thinking, memory, or problem-solving, which often precedes Alzheimer's disease) and especially those with memory issues, the response is weaker.&lt;/p&gt;&lt;p&gt;To understand the test's suitability, researchers recruited 106 participants to their study. This included 54 healthy adults and 52 people with mild cognitive impairment (MCI). Among the latter group, some had memory-specific problems (amnestic MCI), while others had difficulties unrelated to memory – such as problems with attention (non-amnestic MCI).&lt;/p&gt;&lt;p&gt;The researchers found that the Fastball test was sensitive enough to distinguish between these groups. Those with amnestic MCI showed significantly reduced brain responses to the familiar images compared to healthy adults and those with non-amnestic MCI. In other words, the test quickly identified the kind of memory impairment most closely linked to early Alzheimer's.&lt;/p&gt;&lt;p&gt;They then repeated the test a year later. Some of the participants who'd only had mild cognitive impairment in the first test had progressed to either Alzheimer's disease dementia or another type of dementia, called &lt;a href="https://www.alzheimers.org.uk/about-dementia/types-dementia/vascular-dementia"&gt;vascular dementia&lt;/a&gt;, which manifests in symptoms similar to Alzheimer's.&lt;/p&gt;&lt;p&gt;The researchers also asked the participants who developed dementia to perform the standard cognitive tests currently used to diagnose Alzheimer's.&lt;/p&gt;&lt;p&gt;These participants showed no or little difference in this test, which means the test wasn't sensitive enough to detect the transition from mild cognitive impairment to dementia. But with the Fastball test, the participants performed marginally worse than they had previously.&lt;/p&gt;&lt;p&gt;However, of the 42 participants with mild cognitive impairment who repeated the Fastball test a year later, only eight had transitioned to dementia. So, although the results are very promising in illustrating the test's accuracy, they should be interpreted with caution as they're based on a small number of people.&lt;/p&gt;&lt;h2&gt;The future of diagnosis&lt;/h2&gt;&lt;p&gt;Crucially, the test is fast – lasting only three minutes. It also doesn't rely on the participant's effort, mood, or test-taking ability, which can influence cognitive test results. It can also be done at home or in a GP's office, which might reduce anxiety for patients and make it easier to reach a larger group of people.&lt;/p&gt;&lt;p&gt;However, the study did not include other conditions where &lt;a href="https://www.alzheimers.org.uk/about-dementia/worried-about-memory-problems/causes-of-memory-problems"&gt;memory impairment is also present&lt;/a&gt; – such as  &lt;a href="https://www.sciencealert.com/depression" class="lar_link lar_link_outgoing" data-linkid="73097" data-postid="173505" rel="nofollow" target="_self"&gt;depression&lt;/a&gt; or thyroid problems – so it cannot be used as a standalone diagnostic tool for Alzheimer's disease. Future studies in more diverse populations, which take these other conditions into account, will be needed to better understand the test's strengths, limitations, and potential.&lt;/p&gt;&lt;p&gt;Other tests, which are currently in development, may be better for diagnosing Alzheimer's disease specifically. For example, &lt;a href="https://www.alz.org/alzheimers-dementia/diagnosis/medical_tests#:%7E:text=Blood%20tests,-Researchers%20are%20investigating&amp;amp;text=These%20markers%20may%20include%20tau,tests%20to%20diagnose%20the%20disease."&gt;blood tests&lt;/a&gt; could transform Alzheimer's diagnosis once they're more widely rolled out.&lt;/p&gt;&lt;p&gt;These measure proteins linked to Alzheimer's and can give a snapshot of disease processes happening in the brain. Some tests currently being studied would only require a &lt;a href="https://aaic.alz.org/releases_2023/finger-prick-blood-test-alzheimers-disease.asp"&gt;finger-prick of blood&lt;/a&gt;. If they prove to be accurate, this could mean patients could do these tests at home and mail them in for analysis.&lt;/p&gt;&lt;p&gt;Tools such as the Fastball test and blood tests could help shift the focus of Alzheimer's care from late diagnosis to early intervention.&lt;/p&gt;&lt;p&gt;By identifying people at risk of the disease years earlier, doctors could recommend lifestyle changes, monitor patients more closely, or provide them with appropriate therapies earlier, while they can still make the most difference.&lt;img decoding="async" src="https://counter.theconversation.com/content/264519/count.gif?distributor=republish-lightbox-basic" alt="The Conversation" referrerpolicy="no-referrer-when-downgrade" loading="lazy"&gt;
&lt;/p&gt;&lt;p&gt;&lt;em&gt;&lt;a href="https://theconversation.com/profiles/eleftheria-kodosaki-1072802"&gt;Eleftheria Kodosaki&lt;/a&gt;, Research Fellow in Neuroimmunology, &lt;a href="https://theconversation.com/institutions/ucl-1885"&gt;UCL&lt;/a&gt;&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;This article is republished from &lt;a href="https://theconversation.com"&gt;The Conversation&lt;/a&gt; under a Creative Commons license. Read the &lt;a href="https://theconversation.com/alzheimers-disease-new-three-minute-test-can-spot-memory-issues-heres-how-it-works-and-what-it-can-tell-you-264519"&gt;original article&lt;/a&gt;.&lt;/strong&gt;&lt;/p&gt;
		&lt;/div&gt;
	&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>ScienceAlert</author><pubDate>Tue, 09 Sep 2025 05:52:11 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMimAFBVV95cUxPWTJpdjEwdG85RTBUZE9tM2Z5SUg1ZHIxUzVTVjBpdTRCNHlRR3p1NDJ0bFhCWFJiZmpGSHBVVmVxemFCX2FCWjNNSHROSW1rbFdTdnlZWVdzQ05PSnVnUjVlSE9vWm5nSmdnUDBzc0dqSEpnOVlHdXY5MHA4WU9JQUV0Tm9fSGpDSEl1cTNoUC1DNjd6UnJyUg</guid></item><item><title>进化如何解释人类的自闭症发病率- Phys.org</title><link>https://phys.org/news/2025-09-evolution-autism-humans.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="mt-4 article-main"&gt;
										
&lt;div class="article-gallery lightGallery"&gt;
    &lt;div data-thumb="https://scx1.b-cdn.net/csz/news/tmb/2025/evolving-brain.jpg" data-src="https://scx2.b-cdn.net/gfx/news/hires/2025/evolving-brain.jpg" data-sub-html="Credit: Unsplash/CC0 Public Domain"&gt;
        &lt;figure class="article-img"&gt;
            &lt;img src="https://scx1.b-cdn.net/csz/news/800a/2025/evolving-brain.jpg" alt="evolving brain" title="Credit: Unsplash/CC0 Public Domain"&gt;
             &lt;figcaption class="text-darken text-low-up text-truncate-js text-truncate mt-3"&gt;
                Credit: Unsplash/CC0 Public Domain
            &lt;/figcaption&gt;        &lt;/figure&gt;
    &lt;/div&gt;
&lt;/div&gt;&lt;p&gt;A paper in &lt;a href="https://academic.oup.com/mbe/article-lookup/doi/10.1093/molbev/msaf189" target="_blank"&gt;&lt;i&gt;Molecular Biology and Evolution&lt;/i&gt;&lt;/a&gt; finds that the relatively high rate of autism-spectrum disorders in humans is likely due to how humans evolved in the past. The paper is titled "A general principle of neuronal evolution reveals a human accelerated neuron type potentially underlying the high prevalence of autism in humans."&lt;/p&gt;


										      
																																	&lt;p&gt;About one in 31 (3.2%) children in the United States has been identified with autism spectrum disorder. Globally, the World Health Organization estimates that around one in 100 children have autism.&lt;/p&gt;
&lt;p&gt;From an &lt;a href="https://phys.org/tags/evolutionary+perspective/" rel="tag" class="textTag"&gt;evolutionary perspective&lt;/a&gt;, many scientists believe that autism and schizophrenia may be unique to humans. It is very rare to find behaviors associated with the disorders in non-human primates. In addition, behaviors associated with those disorders generally involve cognitive traits like speech production and comprehension that are either unique to or much more sophisticated in humans.&lt;/p&gt;
&lt;p&gt;With the development of single cell RNA sequencing, it became possible to define specific cell types across the brain. As investigators published more large-scale datasets, it became clear that the mammalian brain contains a staggering array of neuronal cell types.&lt;/p&gt;
&lt;p&gt;In addition, large-scale sequencing studies have identified extensive genetic changes in the brain unique to Homo sapiens—genomic elements that did not change much in mammalian evolution in general but evolved rapidly in humans.&lt;/p&gt;
&lt;p&gt;While previous investigations found that some cell types have remained more consistent throughout evolution than others, the factors driving these differences in evolutionary rate remain unknown.&lt;/p&gt;
&lt;p&gt;Researchers here investigated recently published cross-species single-nucleus RNA sequencing datasets from three distinct regions of the &lt;a href="https://phys.org/tags/mammalian+brain/" rel="tag" class="textTag"&gt;mammalian brain&lt;/a&gt;. They found that the most abundant type of outer-layer brain neurons, L2/3 IT neurons, evolved exceptionally quickly in the human lineage compared to other apes.&lt;/p&gt;

																																						&lt;p class="w-100 mb-4 ads"&gt;
    
     
&lt;ins class="adsbygoogle" data-ad-layout="in-article" data-ad-format="fluid" data-ad-client="ca-pub-0536483524803400" data-ad-slot="8188791252"&gt;&lt;/ins&gt;

&lt;/p&gt;
																																			&lt;p&gt;Surprisingly, this accelerated evolution was accompanied by dramatic changes in autism-associated genes, which was likely driven by natural selection specific to the human lineage. The researchers explain that although the results strongly suggest natural selection for &lt;a href="https://phys.org/tags/autism+spectrum+disorder/" rel="tag" class="textTag"&gt;autism spectrum disorder&lt;/a&gt;-associated genes, the reason why this conferred fitness benefits to human ancestors is unclear.&lt;/p&gt;
&lt;p&gt;Answering this is difficult because we do not know what human-specific features of cognition, brain anatomy, and neuronal wiring gave human ancestors a fitness advantage, but the investigators here speculate that many of these genes are associated with &lt;a href="https://phys.org/tags/developmental+delay/" rel="tag" class="textTag"&gt;developmental delay&lt;/a&gt;, so their evolution could have contributed to the slower postnatal brain development in humans compared to chimpanzees.&lt;/p&gt;
&lt;p&gt;Furthermore, the capacity for &lt;a href="https://phys.org/tags/speech+production/" rel="tag" class="textTag"&gt;speech production&lt;/a&gt; and comprehension unique to humans is often affected by autism and schizophrenia.&lt;/p&gt;
&lt;p&gt;It's possible that the rapid evolution of autism-linked genes conferred a fitness advantage by slowing postnatal brain development or increasing the capacity for language; the lengthier brain development time in &lt;a href="https://phys.org/tags/early+childhood/" rel="tag" class="textTag"&gt;early childhood&lt;/a&gt; was beneficial to human evolution because it led to more complex thinking.&lt;/p&gt;
&lt;p&gt;"Our results suggest that some of the same genetic changes that make the human brain unique also made humans more neurodiverse," said the paper's lead author, Alexander L. Starr.&lt;/p&gt;

																																	
																														
																				&lt;div class="article-main__more p-4"&gt;
																						&lt;p&gt;&lt;strong&gt;More information:&lt;/strong&gt;
												Alexander L Starr et al, A General Principle of Neuronal Evolution Reveals a Human-Accelerated Neuron Type Potentially Underlying the High Prevalence of Autism in Humans, &lt;i&gt;Molecular Biology and Evolution&lt;/i&gt; (2025). &lt;a data-doi="1" href="https://dx.doi.org/10.1093/molbev/msaf189" target="_blank"&gt;DOI: 10.1093/molbev/msaf189&lt;/a&gt;
																						
																						&lt;/p&gt;
																					&lt;/div&gt;
                               														
																					
                              													                                        
										
										&lt;div class="d-none d-print-block"&gt;
											 &lt;p class="mb-4"&gt;
												&lt;strong&gt;Citation&lt;/strong&gt;:
												How evolution explains autism rates in humans (2025, September 9)
												retrieved 9 September 2025
												from https://phys.org/news/2025-09-evolution-autism-humans.html
											 &lt;/p&gt;
											 &lt;p class="border text-muted p-3"&gt;
											 This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
											 part may be reproduced without the written permission. The content is provided for information purposes only.
											 &lt;/p&gt;
										&lt;/div&gt;
                                        
									&lt;/div&gt;
								&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Phys.org</author><pubDate>Tue, 09 Sep 2025 04:00:01 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiakFVX3lxTE1JX3Q5STFqaG9lTGoxUkxLNjZzTWRHU1p2Z0p1SFByMEZOaklSVnN5UXRXWlFadnBhaExYLXJRY1hOdUJJVzVXVHUteWFkUVVkbnNvSElwdHI1amZRWFl4UUpzVk9OV1FaREE</guid></item><item><title>锻炼肌肉、燃烧脂肪和增强脑力的睡眠开关- ScienceDaily</title><link>https://www.sciencedaily.com/releases/2025/09/250908175446.htm</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;p id="first" class="lead"&gt;As every bodybuilder knows, a deep, restful sleep boosts levels of growth hormone to build strong muscle and bone and burn fat. And as every teenager should know, they won't reach their full height potential without adequate growth hormone from a full night's sleep.&lt;/p&gt;

						&lt;div id="text"&gt;
&lt;p&gt;But why lack of sleep -- in particular the early, deep phase called non-REM sleep -- lowers levels of growth hormone has been a mystery.&lt;/p&gt;
&lt;p&gt;In a study published in the current issue of the journal &lt;em&gt;Cell&lt;/em&gt;, researchers from University of California, Berkeley, dissect the brain circuits that control growth hormone release during sleep and report a novel feedback mechanism in the brain that keeps growth hormone levels finely balanced.&lt;/p&gt;
&lt;p&gt;The findings provide a map for understanding how sleep and hormone regulation interact. The new feedback mechanism could open avenues for treating people with sleep disorders tied to metabolic conditions like diabetes, as well as degenerative diseases like Parkinson's and Alzheimer's.&lt;/p&gt;
&lt;p&gt;"People know that growth hormone release is tightly related to sleep, but only through drawing blood and checking growth hormone levels during sleep," said study first author Xinlu Ding, a postdoctoral fellow in UC Berkeley's Department of Neuroscience and the Helen Wills Neuroscience Institute. "We're actually directly recording neural activity in mice to see what's going on. We are providing a basic circuit to work on in the future to develop different treatments."&lt;/p&gt;
&lt;p&gt;Because growth hormone regulates glucose and fat metabolism, insufficient sleep can also worsen risks for obesity, diabetes and cardiovascular disease.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;The sleep-wake cycle&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The neurons that orchestrate growth hormone release during the sleep-wake cycle -- growth hormone releasing hormone (GHRH) neurons and two types of somatostatin neurons -- are buried deep in the hypothalamus, an ancient brain hub conserved in all mammals. Once released, growth hormone increases the activity of neurons in the locus coeruleus, an area in the brainstem involved in arousal, attention, cognition and novelty seeking. Dysregulation of locus coeruleus neurons is implicated in numerous psychiatric and neurological disorders.&lt;/p&gt;

&lt;p id="insertion_middle"&gt;&lt;/p&gt;
&lt;p&gt;"Understanding the neural circuit for growth hormone release could eventually point toward new hormonal therapies to improve sleep quality or restore normal growth hormone balance," said Daniel Silverman, a UC Berkeley postdoctoral fellow and study co-author. "There are some experimental gene therapies where you target a specific cell type. This circuit could be a novel handle to try to dial back the excitability of the locus coeruleus, which hasn't been talked about before."&lt;/p&gt;
&lt;p&gt;The researchers, working in the lab of Yang Dan, a professor of neuroscience and of molecular and cell biology, explored the neuroendocrine circuit by inserting electrodes in the brains of mice and measuring changes in activity after stimulating neurons in the hypothalamus with light. Mice sleep for short periods -- several minutes at a time -- throughout the day and night, providing many opportunities to study growth hormone changes during sleep-wake cycles.&lt;/p&gt;
&lt;p&gt;Using state-of-the-art circuit tracing, the team found that the two small-peptide hormones that control the release of growth hormone in the brain -- GHRH, which promotes release, and somatostatin, which inhibits release -- operate differently during REM and non-REM sleep. Somatostatin and GHRH surge during REM sleep to boost growth hormone, but somatostatin decreases and GHRH increases only moderately during non-REM sleep to boost growth hormone.&lt;/p&gt;
&lt;p&gt;Released growth hormone regulates locus coeruleus activity, as a feedback mechanism to help create a homeostatic yin-yang effect. During sleep, growth hormone slowly accumulates to stimulate the locus coeruleus and promote wakefulness, the new study found. But when the locus coeruleus becomes overexcited, it paradoxically promotes sleepiness, as Silverman showed in a study published earlier this year.&lt;/p&gt;
&lt;p&gt;"This suggests that sleep and growth hormone form a tightly balanced system: Too little sleep reduces growth hormone release, and too much growth hormone can in turn push the brain toward wakefulness," Silverman said. "Sleep drives growth hormone release, and growth hormone feeds back to regulate wakefulness, and this balance is essential for growth, repair and metabolic health."&lt;/p&gt;
&lt;p&gt;Because growth hormone acts in part through the locus coeruleus, which governs overall brain arousal during wakefulness, a proper balance could have a broader impact on attention and thinking.&lt;/p&gt;
&lt;p&gt;"Growth hormone not only helps you build your muscle and bones and reduce your fat tissue, but may also have cognitive benefits, promoting your overall arousal level when you wake up," Ding said.&lt;/p&gt;
&lt;p&gt;The work was funded by the Howard Hughes Medical Institute (HHMI), which until this year supported Dan as an HHMI investigator, and the Pivotal Life Sciences Chancellor's Chair fund. Dan is the Pivotal Life Sciences Chancellor's Chair in Neuroscience. Other co-authors of the paper are Peng Zhong, Bing Li, Chenyan Ma, Lihui Lu, Grace Jiang, Zhe Zhang, Xiaolin Huang, Xun Tu and Zhiyu Melissa Tian of UC Berkeley; and Fuu-Jiun Hwang and Jun Ding of Stanford University.&lt;/p&gt;
&lt;/div&gt;

					&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>ScienceDaily</author><pubDate>Tue, 09 Sep 2025 03:24:38 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMib0FVX3lxTE9UY0g3UEJiRHJ2REtOeGhKYXUtMEp2ZzQ3cld5NV9ZSklQemNvajExU3BCZGhGN0JBbjRvQWxZNkctSGRGWndfS3pjbks4UDRYQkNCSDRTeWVlSEh0ZktYNjE2Yl9FX3pGN2VEWGlaVQ</guid></item><item><title>莱姆病在密歇根州激增，促使一些县采取行动-底特律新闻</title><link>https://www.detroitnews.com/story/news/local/michigan/2025/09/08/lyme-disease-surges-michigan-prompting-some-counties-take-action-tick-surveillance/85970119007/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="gnt_ar_b"&gt;&lt;p class="gnt_ar_b_p"&gt;As Lyme disease spikes in Michigan, public health workers across the state are conducting what is called tick "surveillance" to see where different tick species are and which diseases they may be carrying to better inform the public, though it can't expand without more funding.&lt;/p&gt;&lt;p class="gnt_ar_b_p"&gt;Of Michigan's 83 counties, health departments in 26 of those did tick surveillance this year as part of a Michigan Department of Health and Human Services project, which started in 2018. Each of these counties does tick dragging, which helps the department find ticks in new areas.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Detroit News</author><pubDate>Tue, 09 Sep 2025 03:02:38 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMi8gFBVV95cUxPVE9tTWdZTmtIVHRtUHd3SlpwbFBYZHhxa1Q3el9YbTRISXotRWR5QlpWRzBlTUYtLXdJWWJNa2ZpSi14TTNjcXhab2lFZVkwZHcxQXlpQTMzMXNPQ1hQSkFNeXRmN0E1TmZTUEtkMHRYMzJOMkVPSTRaNkltdF96ZTBwSUlTcWJQVjdmdmEtdGV3bG90QWQ1WHl6SGx4cTN6RHhFbWtyWTJ6V0toeWVPQzl1cVVSbFFvaGp0dG9XNXhINEp3Y1lnLU9BajNLRkRNZU50V0liRmhRdzVsLUsxV3ZLWGpNUklHTWlFdi1TRE1mdw</guid></item><item><title>酒精相关性肝病：饮酒如何使肠道细菌严重损害肝脏，以及原因-印度时报</title><link>https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/alcohol-associated-liver-disease-how-drinking-allows-gut-bacteria-to-severely-harm-the-liver-and-why-it-is-so-dangerous/articleshow/123776808.cms</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="_s30J clearfix  "&gt;&lt;p&gt;For decades, we have heard that excessive drinking creates liver disease that is mostly irreversible. However, the exact mechanisms through which alcohol accelerates liver damage remained unclear to scientists, that is till now. However, a 2025 research study discovered a fresh gut–liver pathway, which explains how chronic alcohol consumption damages liver tissue.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="3"&gt;&lt;/span&gt;&lt;p class="cdatainfo modify_cdata_list_style id-r-component " data-pos="4"&gt;&lt;h2&gt;A new find&lt;br&gt;&lt;/h2&gt;&lt;/p&gt;&lt;p&gt;The research team of Nature (PMID: 40836099), discovered that long-term alcohol consumption decreases the presence of muscarinic acetylcholine receptor M4 (mAChR4) in the small intestine. The receptor mAChR4 plays a vital role in maintaining gut bacterial control through its function in goblet cells, which line the intestinal tract.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="7"&gt;&lt;/span&gt;&lt;div class="lOvcW vdo_embedd"&gt;&lt;div class="k7lcu"&gt;&lt;p class="efT4r"&gt;Critical signs that indicate the onset of a liver disease&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;span class="id-r-component br" data-pos="9"&gt;&lt;/span&gt;&lt;span class="id-r-component br" data-pos="12"&gt;&lt;/span&gt;&lt;p&gt;The gut lining contains goblet cells which produce GAPs (goblet cell-associated antigen passages). The immune system receives training through GAPs, to identify and regulate gut bacteria. The reduction of mAChR4 by alcohol consumption prevents goblet cells from creating proper GAPs. Because of this, the immune system becomes less capable of handling gut bacteria because of this condition.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="14"&gt;&lt;/span&gt;&lt;p class="cdatainfo modify_cdata_list_style id-r-component " data-pos="15"&gt;&lt;h2&gt;What happens as a result&lt;br&gt;&lt;/h2&gt;&lt;/p&gt;&lt;p&gt;The absence of GAPs creates an environment where bacteria from the gut can escape through the gut barrier, to reach the liver. The liver becomes more susceptible to damage, when bacteria enters its tissue after reaching this organ. The research demonstrated this process occurred in both human liver biopsy samples and laboratory animal experiments. The research demonstrated that alcohol consumption resulted in decreased mAChR4 expression, which led to impaired defense mechanisms against harmful gut bacteria entering the &lt;/p&gt;&lt;a href="https://www.niaaa.nih.gov/alcohols-effects-health/alcohol-liver-disease" rel="noopener nofollow noreferrer" styleobj="[object Object]" class="" target="" commonstate="[object Object]" frmappuse="1"&gt;liver&lt;/a&gt;&lt;p&gt;.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="20"&gt;&lt;/span&gt;&lt;p&gt;The research established a direct link between alcohol consumption and liver damage through the following sequence of events.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="22"&gt;&lt;/span&gt;&lt;p&gt;The small intestine contains lower levels of mAChR4, when people consume alcohol.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="24"&gt;&lt;/span&gt;&lt;p&gt;The decrease in mAChR4 expression results in reduced goblet cell GAP production.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="26"&gt;&lt;/span&gt;&lt;p&gt;The immune system loses its ability to control gut bacteria when GAPs become scarce.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="28"&gt;&lt;/span&gt;&lt;p&gt;Bacteria from the gut escape through the damaged gut wall to enter the liver.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="31"&gt;&lt;/span&gt;&lt;p&gt;The bacteria entering the liver through this process intensify both alcohol-induced liver inflammation, and steatohepatitis.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="33"&gt;&lt;/span&gt;&lt;span class="id-r-component br" data-pos="35"&gt;&lt;/span&gt;&lt;p class="cdatainfo modify_cdata_list_style id-r-component " data-pos="36"&gt;&lt;h2&gt;Related diseases&lt;br&gt;&lt;/h2&gt;&lt;/p&gt;&lt;p&gt;The condition known as alcohol-associated liver disease, (ALD) encompasses different liver conditions which develop from prolonged alcohol consumption. The first stage of fatty liver disease known as steatosis, develops when liver cells store fat, but usually produces no noticeable symptoms. The progression of alcohol consumption leads to alcoholic steatohepatitis, which causes liver inflammation together with tissue damage. The progression of liver damage through fibrosis (scarring) eventually results in cirrhosis, which severely impairs liver function. The progression of cirrhosis results in liver failure, which creates dangerous complications that may require patients to receive a liver transplant. The research reveals how bacterial gut invasion leads to worsened inflammation and tissue damage in steatohepatitis and ALD stages, which creates new therapeutic possibilities to stop this destructive process.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="43"&gt;&lt;/span&gt;&lt;p class="cdatainfo modify_cdata_list_style id-r-component " data-pos="44"&gt;&lt;h2&gt;Potential for new treatments&lt;br&gt;&lt;/h2&gt;&lt;/p&gt;&lt;p&gt;The research demonstrated that GAP signaling restoration enables the immune system to fight bacterial infections effectively. The direct activation of mAChR4 in goblet cells of mice, protected their livers from alcohol-related damage. The discovery indicates that future medical treatments for alcohol-associated liver disease could focus on mAChR4, and its associated signaling pathways.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="48"&gt;&lt;/span&gt;&lt;p class="cdatainfo modify_cdata_list_style id-r-component " data-pos="49"&gt;&lt;h2&gt;Requires further testing&lt;br&gt;&lt;/h2&gt;&lt;/p&gt;&lt;p&gt;Most of the research data however, stems from animal experiments together with limited human biopsy tissue analysis. The medical field lacks evidence about using mAChR4 or gp130 immune pathway treatments for patients with alcohol-related liver damage. Additional clinical trials must be conducted to determine if these innovative methods will work safely and effectively for liver protection in patients.&lt;/p&gt;&lt;span class="id-r-component br" data-pos="53"&gt;&lt;/span&gt;&lt;p class="cdatainfo modify_cdata_list_style id-r-component " data-pos="54"&gt;&lt;h2&gt;What can one do&lt;br&gt;&lt;/h2&gt;&lt;/p&gt;&lt;p&gt;Doctors around the world say that no amount of alcohol is safe, and one should not drink at all. If you however, enjoy drinking, keep it extemely occasional, ranging from once a week (1-2 drinks only) to a couple of times in a year. Any amount greater than this can increase your dependence on alcohol, which can lead to long-term alcohol-associated liver disease. &lt;/p&gt;&lt;span class="id-r-component br" data-pos="56"&gt;&lt;/span&gt;&lt;span class="id-r-component br" data-pos="58"&gt;&lt;/span&gt;&lt;span class="id-r-component br" data-pos="60"&gt;&lt;/span&gt;&lt;p class="cdatainfo modify_cdata_list_style id-r-component " data-pos="61"&gt;&lt;br&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Times of India</author><pubDate>Tue, 09 Sep 2025 02:47:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiwAJBVV95cUxOMm1rcXZMTW1zc05rS2dHbWd5dVhfUk5zY0NlZWJjQWg1UVJVSkRiVWg3M2pQR0RGdTM4WTZCZk4tNFowVGZBOGFJVTNLVFdyM2JKQW9jUmJscVZuSnNrbTdrdU9Cb0xJN1puemdjTWZibnk3a0d6VnFHdGVnZEJXWl9vYWlFcG1Td0NVa3Mya2xWZUx6Y3I2emlmT1pTQTlpTjVvczdGLWhBeUk2QkM3RjVyeFRZTVFOc3hvZF85aThYcDdLdWU3WThWd1lSSXB6UXEtMlBVbXBaNFlhV0M3NzB4TlFjNXo5WV9wV2Vibmszb1d6bWh0ZUZ5bENPaGRNOEpiZHNvUS1UOXA3dkZxSEU2MjFsUVl2SnFJalhKSHFZMGI5RHdpX1F4eWxxdDFDUW1mQk9tdE9LT1RGcjNxYg</guid></item><item><title>新研究发现，近一半的糖尿病患者不知道自己患有糖尿病- KHBS</title><link>https://www.4029tv.com/article/undiagnosed-diabetes-global-study/66017606</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;p class="article-content--body-text-raw"&gt;
						When was the last time you had your blood sugar checked? It might be worth looking into, a new study says.Forty-four percent of people age 15 and older living with diabetes are undiagnosed, so they don’t know they have it, according to data analysis published Monday in the journal The Lancet Diabetes &amp;amp; Endocrinology.The study looked at data from 204 countries and territories from 2000 to 2023 in a systematic review of published literature and surveys. The findings at the global level are for people age 15 and older.“The majority of people with diabetes that we report on in the study have type 2 diabetes,” said Lauryn Stafford, the lead author of the study.Around 1 in 9 adults live with diabetes worldwide, according to the International Diabetes Foundation. In the United States, 11.6% of Americans have diabetes, according to 2021 data from the American Diabetes Association.“We found that 56% of people with diabetes are aware that they have the condition,” said Stafford, a researcher for the Institute for Health Metrics and Evaluation. “Globally, there’s a lot of variation geographically, and also by age. So, generally, higher-income countries were doing better at diagnosing people than low- and middle-income countries.”Younger people don’t know they have diabetesPeople under 35 years were much less likely to be diagnosed if they had diabetes than people in middle age or older. Just “20% of young adults with diabetes were aware of their condition,” Stafford said.Routine screenings aren’t promoted as much for young adults as for older adults. Many larger organizations, like the American Diabetes Association, suggest annual routine screenings for adults 35 and older.“You can survive with elevated glucose levels for many, many years,” Stafford said. “People end up getting diagnosed with diabetes only at the point where they have complications,” which are more common in older adults.Depending on how long a person has had diabetes before it’s discovered, the health impacts may vary.“Diagnosing diabetes early is important because it allows for timely management to prevent or delay long-term complications such as heart disease, kidney failure, nerve damage, and vision loss,” said Rita Kalyani, chief scientific and medical officer at the American Diabetes Association. She was not involved in the study.Around one-third of adults are diagnosed with diabetes later than their earliest symptom, according to a 2018 study.What symptoms should you look for?“Symptoms of diabetes include increased thirst or hunger, frequent urination, blurry vision, unexpected weight loss, and fatigue. However, in the early stages, most people with diabetes are asymptomatic, which highlights the importance of screening and diagnosis,” said Kalyani, a professor of medicine in the division of endocrinology, diabetes and metabolism at Johns Hopkins University.If you experience any of these symptoms or have a history of diabetes in your family, experts recommend you get a glucose screening.Globally, in 2023, about 40% of people with treated diabetes were getting optimal results and lowering their blood sugar, said Stafford. That’s why it’s important that future efforts focus on ensuring that more people receive and follow proper treatment post-diagnosis.That only 4 in 10 patients were seeing optimal results was surprising, as several well-established treatments, including insulin, Metformin and other drugs like GLP-1s, are available.People with diabetes likely also have other health issues, such as hypertension or chronic kidney disease, which can make treatment complex, Stafford added.Can you prevent diabetes?It depends.While there is no known way to prevent type 1 diabetes, there are many ways to prevent the more common form of type 2 diabetes.Reducing the amount of red and processed meats you eat can help lower your risk of type 2 diabetes, as previously reported by CNN. You could do this with a Mediterranean diet or by introducing more plant-based foods to your meals.In addition, limit the amount of ultraprocessed foods you eat, adding more whole foods, like fruits and nuts, instead.Incorporating physical activity into your regular routine can also decrease your risk of developing not only diabetes but also other chronic diseases. Fast walking for at least 15 minutes a day is just one form of exercise you can do.“I think, ultimately, if we can also focus more on the risk factors for developing diabetes — preventing people from needing to be diagnosed in the first place — that is also critical,” Stafford said.
					&lt;/p&gt;
	
					&lt;div class="article-content--body-text"&gt;
																			&lt;p&gt;When was the last time you had your blood sugar checked? It might be worth looking into, a new study says.&lt;/p&gt;&lt;p&gt;Forty-four percent of people age 15 and older living with diabetes are undiagnosed, so they don’t know they have it, according to data analysis published Monday in the journal &lt;a href="https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00217-7/abstract" rel="nofollow"&gt;The Lancet Diabetes &amp;amp; Endocrinology&lt;/a&gt;.&lt;/p&gt;



&lt;p&gt;The study looked at data from 204 countries and territories from 2000 to 2023 in a systematic review of published literature and surveys. The findings at the global level are for people age 15 and older.&lt;/p&gt;&lt;p&gt;“The majority of people with diabetes that we report on in the study have type 2 diabetes,” said Lauryn Stafford, the lead author of the study.&lt;/p&gt;&lt;p&gt;Around &lt;a href="https://idf.org/about-diabetes/diabetes-facts-figures/" rel="nofollow"&gt;1 in 9 adults&lt;/a&gt; live with diabetes worldwide, according to the International Diabetes Foundation. In the United States, 11.6% of Americans have diabetes, according to 2021 data from the &lt;a href="https://diabetes.org/about-diabetes/statistics/about-diabetes" rel="nofollow"&gt;American Diabetes Association&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;“We found that 56% of people with diabetes are aware that they have the condition,” said Stafford, a researcher for the Institute for Health Metrics and Evaluation. “Globally, there’s a lot of variation geographically, and also by age. So, generally, higher-income countries were doing better at diagnosing people than low- and middle-income countries.”&lt;/p&gt;


&lt;h2 id="younger-people-dont-know-they-have-diabetes" class="body-h2"&gt;Younger people don’t know they have diabetes&lt;/h2&gt;&lt;p id="cream-inline-rec" class="cream-inline hidden"&gt;
&lt;/p&gt;
&lt;p&gt;People under 35 years were much less likely to be diagnosed if they had diabetes than people in middle age or older. Just “20% of young adults with diabetes were aware of their condition,” Stafford said.&lt;/p&gt;&lt;p&gt;Routine screenings aren’t promoted as much for young adults as for older adults. Many larger organizations, like the &lt;a href="https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/diagnosis-treatment/drc-20351199#:~:text=Screening.,diabetes%20or%20other%20risk%20factors." rel="nofollow"&gt;American Diabetes Association&lt;/a&gt;, suggest annual routine screenings for adults 35 and older.&lt;/p&gt;&lt;p&gt;“You can survive with elevated glucose levels for many, many years,” Stafford said. “People end up getting diagnosed with diabetes only at the point where they have complications,” which are more common in older adults.&lt;/p&gt;&lt;p&gt;Depending on how long a person has had diabetes before it’s discovered, the health impacts may vary.&lt;/p&gt;&lt;p&gt;“Diagnosing diabetes early is important because it allows for timely management to prevent or delay long-term complications such as heart disease, kidney failure, nerve damage, and vision loss,” said Rita Kalyani, chief scientific and medical officer at the American Diabetes Association. She was not involved in the study.&lt;/p&gt;&lt;p&gt;Around one-third of adults are diagnosed with diabetes later than their earliest symptom, according to a &lt;a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6481650/" rel="nofollow"&gt;2018 study&lt;/a&gt;.&lt;/p&gt;&lt;h2 id="what-symptoms-should-you-look-for" class="body-h2"&gt;What symptoms should you look for?&lt;/h2&gt;&lt;p&gt;“Symptoms of diabetes include increased thirst or hunger, frequent urination, blurry vision, unexpected weight loss, and fatigue. However, in the early stages, most people with diabetes are asymptomatic, which highlights the importance of screening and diagnosis,” said Kalyani, a professor of medicine in the division of endocrinology, diabetes and metabolism at Johns Hopkins University.&lt;/p&gt;&lt;p&gt;If you experience any of these &lt;a href="https://diabetes.org/about-diabetes/warning-signs-symptoms" rel="nofollow"&gt;symptoms&lt;/a&gt; or have a history of diabetes in your family, experts recommend you get a glucose screening.&lt;/p&gt;&lt;p&gt;Globally, in 2023, about 40% of people with treated diabetes were getting optimal results and lowering their blood sugar, said Stafford. That’s why it’s important that future efforts focus on ensuring that more people receive and follow proper treatment post-diagnosis.&lt;/p&gt;&lt;p&gt;That only 4 in 10 patients were seeing optimal results was surprising, as several well-established treatments, including &lt;a href="https://my.clevelandclinic.org/health/body/22601-insulin" rel="nofollow"&gt;insulin&lt;/a&gt;, &lt;a href="https://www.mayoclinic.org/drugs-supplements/metformin-oral-route/description/drg-20067074" rel="nofollow"&gt;Metformin&lt;/a&gt; and other drugs like &lt;a href="https://www.cnn.com/2025/04/17/health/eli-lilly-weight-loss-glp-1-pill-orforglipron" rel="nofollow"&gt;GLP-1s&lt;/a&gt;, are available.&lt;/p&gt;&lt;p&gt;People with diabetes likely also have other health issues, such as hypertension or chronic kidney disease, which can make treatment complex, Stafford added.&lt;/p&gt;&lt;h2 id="can-you-prevent-diabetes" class="body-h2"&gt;Can you prevent diabetes?&lt;/h2&gt;&lt;p&gt;It depends.&lt;/p&gt;&lt;p&gt;While there is no known way to prevent &lt;a href="https://www.cdc.gov/diabetes/about/about-type-1-diabetes.html" rel="nofollow"&gt;type 1 diabetes&lt;/a&gt;, there are many ways to prevent the more common form of &lt;a href="https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/in-depth/diabetes-prevention/art-20047639" rel="nofollow"&gt;type 2 diabetes&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;Reducing the amount of red and processed meats you eat can help lower your risk of type 2 diabetes, as &lt;a href="https://www.cnn.com/2024/08/20/health/meat-red-processed-diabetes-wellness" rel="nofollow"&gt;previously reported by CNN&lt;/a&gt;. You could do this with a Mediterranean diet or by introducing more plant-based foods to your meals.&lt;/p&gt;
&lt;p&gt;In addition, limit the amount of ultraprocessed foods you eat, adding more whole foods, like fruits and nuts, instead.&lt;/p&gt;&lt;p&gt;Incorporating physical activity into your regular routine can also decrease your risk of developing not only diabetes but also other chronic diseases. Fast walking for at least 15 minutes a day is just one form of exercise you can do.&lt;/p&gt;&lt;p&gt;“I think, ultimately, if we can also focus more on the risk factors for developing diabetes — preventing people from needing to be diagnosed in the first place — that is also critical,” Stafford said.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;

							
											&lt;/div&gt;
	
	
						
						
																			

																				&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>KHBS</author><pubDate>Tue, 09 Sep 2025 02:28:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMifkFVX3lxTE9rbGZObkQxR2tnRHJ1NWhycEI5VDRFZTItOF9HSERqSHNqellZRklMMXRmX1lscUdCY3pXNmppbWRmdURvV0ZOWmc0aklvaW9HdjZhNXhWYUhzTFc2RGlxdkwxQ0JHTGw5d0lZSmxmR2lRYkJ6QUFtWFJKOVpqdw</guid></item><item><title>新研究发现，近一半的糖尿病患者不知道自己患有糖尿病- WPTZ</title><link>https://www.mynbc5.com/article/undiagnosed-diabetes-global-study/66017606</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;p class="article-content--body-text-raw"&gt;
						When was the last time you had your blood sugar checked? It might be worth looking into, a new study says.Forty-four percent of people age 15 and older living with diabetes are undiagnosed, so they don’t know they have it, according to data analysis published Monday in the journal The Lancet Diabetes &amp;amp; Endocrinology.The study looked at data from 204 countries and territories from 2000 to 2023 in a systematic review of published literature and surveys. The findings at the global level are for people age 15 and older.“The majority of people with diabetes that we report on in the study have type 2 diabetes,” said Lauryn Stafford, the lead author of the study.Around 1 in 9 adults live with diabetes worldwide, according to the International Diabetes Foundation. In the United States, 11.6% of Americans have diabetes, according to 2021 data from the American Diabetes Association.“We found that 56% of people with diabetes are aware that they have the condition,” said Stafford, a researcher for the Institute for Health Metrics and Evaluation. “Globally, there’s a lot of variation geographically, and also by age. So, generally, higher-income countries were doing better at diagnosing people than low- and middle-income countries.”Younger people don’t know they have diabetesPeople under 35 years were much less likely to be diagnosed if they had diabetes than people in middle age or older. Just “20% of young adults with diabetes were aware of their condition,” Stafford said.Routine screenings aren’t promoted as much for young adults as for older adults. Many larger organizations, like the American Diabetes Association, suggest annual routine screenings for adults 35 and older.“You can survive with elevated glucose levels for many, many years,” Stafford said. “People end up getting diagnosed with diabetes only at the point where they have complications,” which are more common in older adults.Depending on how long a person has had diabetes before it’s discovered, the health impacts may vary.“Diagnosing diabetes early is important because it allows for timely management to prevent or delay long-term complications such as heart disease, kidney failure, nerve damage, and vision loss,” said Rita Kalyani, chief scientific and medical officer at the American Diabetes Association. She was not involved in the study.Around one-third of adults are diagnosed with diabetes later than their earliest symptom, according to a 2018 study.What symptoms should you look for?“Symptoms of diabetes include increased thirst or hunger, frequent urination, blurry vision, unexpected weight loss, and fatigue. However, in the early stages, most people with diabetes are asymptomatic, which highlights the importance of screening and diagnosis,” said Kalyani, a professor of medicine in the division of endocrinology, diabetes and metabolism at Johns Hopkins University.If you experience any of these symptoms or have a history of diabetes in your family, experts recommend you get a glucose screening.Globally, in 2023, about 40% of people with treated diabetes were getting optimal results and lowering their blood sugar, said Stafford. That’s why it’s important that future efforts focus on ensuring that more people receive and follow proper treatment post-diagnosis.That only 4 in 10 patients were seeing optimal results was surprising, as several well-established treatments, including insulin, Metformin and other drugs like GLP-1s, are available.People with diabetes likely also have other health issues, such as hypertension or chronic kidney disease, which can make treatment complex, Stafford added.Can you prevent diabetes?It depends.While there is no known way to prevent type 1 diabetes, there are many ways to prevent the more common form of type 2 diabetes.Reducing the amount of red and processed meats you eat can help lower your risk of type 2 diabetes, as previously reported by CNN. You could do this with a Mediterranean diet or by introducing more plant-based foods to your meals.In addition, limit the amount of ultraprocessed foods you eat, adding more whole foods, like fruits and nuts, instead.Incorporating physical activity into your regular routine can also decrease your risk of developing not only diabetes but also other chronic diseases. Fast walking for at least 15 minutes a day is just one form of exercise you can do.“I think, ultimately, if we can also focus more on the risk factors for developing diabetes — preventing people from needing to be diagnosed in the first place — that is also critical,” Stafford said.
					&lt;/p&gt;
	
					&lt;div class="article-content--body-text"&gt;
																			&lt;p&gt;When was the last time you had your blood sugar checked? It might be worth looking into, a new study says.&lt;/p&gt;&lt;p&gt;Forty-four percent of people age 15 and older living with diabetes are undiagnosed, so they don’t know they have it, according to data analysis published Monday in the journal &lt;a href="https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00217-7/abstract" rel="nofollow"&gt;The Lancet Diabetes &amp;amp; Endocrinology&lt;/a&gt;.&lt;/p&gt;



&lt;p&gt;The study looked at data from 204 countries and territories from 2000 to 2023 in a systematic review of published literature and surveys. The findings at the global level are for people age 15 and older.&lt;/p&gt;&lt;p&gt;“The majority of people with diabetes that we report on in the study have type 2 diabetes,” said Lauryn Stafford, the lead author of the study.&lt;/p&gt;&lt;p&gt;Around &lt;a href="https://idf.org/about-diabetes/diabetes-facts-figures/" rel="nofollow"&gt;1 in 9 adults&lt;/a&gt; live with diabetes worldwide, according to the International Diabetes Foundation. In the United States, 11.6% of Americans have diabetes, according to 2021 data from the &lt;a href="https://diabetes.org/about-diabetes/statistics/about-diabetes" rel="nofollow"&gt;American Diabetes Association&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;“We found that 56% of people with diabetes are aware that they have the condition,” said Stafford, a researcher for the Institute for Health Metrics and Evaluation. “Globally, there’s a lot of variation geographically, and also by age. So, generally, higher-income countries were doing better at diagnosing people than low- and middle-income countries.”&lt;/p&gt;


&lt;h2 id="younger-people-dont-know-they-have-diabetes" class="body-h2"&gt;Younger people don’t know they have diabetes&lt;/h2&gt;&lt;p id="cream-inline-rec" class="cream-inline hidden"&gt;
&lt;/p&gt;
&lt;p&gt;People under 35 years were much less likely to be diagnosed if they had diabetes than people in middle age or older. Just “20% of young adults with diabetes were aware of their condition,” Stafford said.&lt;/p&gt;&lt;p&gt;Routine screenings aren’t promoted as much for young adults as for older adults. Many larger organizations, like the &lt;a href="https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/diagnosis-treatment/drc-20351199#:~:text=Screening.,diabetes%20or%20other%20risk%20factors." rel="nofollow"&gt;American Diabetes Association&lt;/a&gt;, suggest annual routine screenings for adults 35 and older.&lt;/p&gt;&lt;p&gt;“You can survive with elevated glucose levels for many, many years,” Stafford said. “People end up getting diagnosed with diabetes only at the point where they have complications,” which are more common in older adults.&lt;/p&gt;&lt;p&gt;Depending on how long a person has had diabetes before it’s discovered, the health impacts may vary.&lt;/p&gt;&lt;p&gt;“Diagnosing diabetes early is important because it allows for timely management to prevent or delay long-term complications such as heart disease, kidney failure, nerve damage, and vision loss,” said Rita Kalyani, chief scientific and medical officer at the American Diabetes Association. She was not involved in the study.&lt;/p&gt;&lt;p&gt;Around one-third of adults are diagnosed with diabetes later than their earliest symptom, according to a &lt;a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6481650/" rel="nofollow"&gt;2018 study&lt;/a&gt;.&lt;/p&gt;&lt;h2 id="what-symptoms-should-you-look-for" class="body-h2"&gt;What symptoms should you look for?&lt;/h2&gt;&lt;p&gt;“Symptoms of diabetes include increased thirst or hunger, frequent urination, blurry vision, unexpected weight loss, and fatigue. However, in the early stages, most people with diabetes are asymptomatic, which highlights the importance of screening and diagnosis,” said Kalyani, a professor of medicine in the division of endocrinology, diabetes and metabolism at Johns Hopkins University.&lt;/p&gt;&lt;p&gt;If you experience any of these &lt;a href="https://diabetes.org/about-diabetes/warning-signs-symptoms" rel="nofollow"&gt;symptoms&lt;/a&gt; or have a history of diabetes in your family, experts recommend you get a glucose screening.&lt;/p&gt;&lt;p&gt;Globally, in 2023, about 40% of people with treated diabetes were getting optimal results and lowering their blood sugar, said Stafford. That’s why it’s important that future efforts focus on ensuring that more people receive and follow proper treatment post-diagnosis.&lt;/p&gt;&lt;p&gt;That only 4 in 10 patients were seeing optimal results was surprising, as several well-established treatments, including &lt;a href="https://my.clevelandclinic.org/health/body/22601-insulin" rel="nofollow"&gt;insulin&lt;/a&gt;, &lt;a href="https://www.mayoclinic.org/drugs-supplements/metformin-oral-route/description/drg-20067074" rel="nofollow"&gt;Metformin&lt;/a&gt; and other drugs like &lt;a href="https://www.cnn.com/2025/04/17/health/eli-lilly-weight-loss-glp-1-pill-orforglipron" rel="nofollow"&gt;GLP-1s&lt;/a&gt;, are available.&lt;/p&gt;&lt;p&gt;People with diabetes likely also have other health issues, such as hypertension or chronic kidney disease, which can make treatment complex, Stafford added.&lt;/p&gt;&lt;h2 id="can-you-prevent-diabetes" class="body-h2"&gt;Can you prevent diabetes?&lt;/h2&gt;&lt;p&gt;It depends.&lt;/p&gt;&lt;p&gt;While there is no known way to prevent &lt;a href="https://www.cdc.gov/diabetes/about/about-type-1-diabetes.html" rel="nofollow"&gt;type 1 diabetes&lt;/a&gt;, there are many ways to prevent the more common form of &lt;a href="https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/in-depth/diabetes-prevention/art-20047639" rel="nofollow"&gt;type 2 diabetes&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;Reducing the amount of red and processed meats you eat can help lower your risk of type 2 diabetes, as &lt;a href="https://www.cnn.com/2024/08/20/health/meat-red-processed-diabetes-wellness" rel="nofollow"&gt;previously reported by CNN&lt;/a&gt;. You could do this with a Mediterranean diet or by introducing more plant-based foods to your meals.&lt;/p&gt;
&lt;p&gt;In addition, limit the amount of ultraprocessed foods you eat, adding more whole foods, like fruits and nuts, instead.&lt;/p&gt;&lt;p&gt;Incorporating physical activity into your regular routine can also decrease your risk of developing not only diabetes but also other chronic diseases. Fast walking for at least 15 minutes a day is just one form of exercise you can do.&lt;/p&gt;&lt;p&gt;“I think, ultimately, if we can also focus more on the risk factors for developing diabetes — preventing people from needing to be diagnosed in the first place — that is also critical,” Stafford said.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;

							
											&lt;/div&gt;
	
	
						
						
																			

																				&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>WPTZ</author><pubDate>Tue, 09 Sep 2025 02:28:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMifkFVX3lxTE13Z19ZaEJfUHY1eEVOV0d6RlV0Q2hxWDMzR1RhZXdKODlHNnhKdjk4Y1J0S0VBMnpud2F4TFRaSWZSdXprRTBxX3BkU0gwLVNMTUlLTzFjNU9yUW9BVEhWeXl0UUcydDJjcDBkWEtDbGFvWkt4YXNBZ2NzdDRGZw</guid></item><item><title>武士日常生活可以降低老年人跌倒的风险- ScienceAlert</title><link>https://www.sciencealert.com/daily-samurai-routine-could-reduce-risk-of-falls-in-seniors</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="post-content"&gt;
			&lt;p&gt;&lt;a href="https://en.wikipedia.org/wiki/Samurai"&gt;Ancient Japanese samurai&lt;/a&gt; were warriors of distinction, with a reputation for discipline and mastery of precision. Their deliberate and composed approach to movement could be an effective strength training method for elderly individuals.&lt;/p&gt;&lt;p&gt;A randomized controlled trial by researchers from Tohoku University in Japan shows the daily practice of Rei-ho – a mindful practice of physical etiquette involving slow and careful sitting, standing, and walking movements – can boost strength in the knees, potentially protecting seniors against &lt;a href="https://www.sciencealert.com/shockingly-common-injury-linked-with-increased-risk-of-dementia"&gt;falls and injuries&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;It's easy to do, requires no equipment, and takes just five minutes a day to see the effects.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Related: &lt;a href="https://www.sciencealert.com/brain-boost-linked-to-exercise-can-last-several-years-scientists-find"&gt;Brain Boost Linked to Exercise Can Last Several Years, Scientists Find&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;"Knee extension strength – the force used to straighten knees – is a key measure of mobility and daily functioning," &lt;a href="https://www.tohoku.ac.jp/en/press/traditional_japanese_samurai_daily_behavior_improves_leg_strength.html"&gt;says&lt;/a&gt; exercise physiologist Ayaka Ogasawara. "These exciting results suggest that Rei-ho may help seniors maintain their independence."&lt;/p&gt;&lt;p&gt;The researchers recruited 34 healthy adults aged over 20 with no experience in Rei-ho, and split them into two groups. One group was instructed to continue their &lt;a href="https://www.sciencealert.com/supercharge-your-daily-walk-with-these-5-simple-changes"&gt;daily activities&lt;/a&gt;, while the other was asked to spend five minutes following between 20 and 22 Rei-ho squats and sit-to-stand exercises once a day, four days a week.&lt;/p&gt;&lt;figure id="attachment_173468" aria-describedby="caption-attachment-173468" class="wp-caption alignnone"&gt;&lt;img decoding="async" src="https://www.sciencealert.com/images/2025/09/StudyExercises.jpg" alt="Rei-ho exercises" class="wp-image-173468 size-full" srcset="https://www.sciencealert.com/images/2025/09/StudyExercises.jpg 642w, https://www.sciencealert.com/images/2025/09/StudyExercises-321x415.jpg 321w, https://www.sciencealert.com/images/2025/09/StudyExercises-600x775.jpg 600w" sizes="(max-width: 642px) 100vw, 642px" loading="lazy"&gt;&lt;figcaption id="caption-attachment-173468" class="wp-caption-text"&gt;Typical sitting and standing motions (b and d), compared with body positions in Rei-ho (a and c). (Ogasawara et al., &lt;em&gt;Tohoku J. Exp. Med.&lt;/em&gt;, 2025)&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;After three months of Rei-ho, the group using the exercises showed an average 25.9 percent increase in &lt;a href="https://www.physio-pedia.com/Knee_Extensors"&gt;knee extension strength&lt;/a&gt;, compared to an increase of just 2.5 percent in the control group – a significant difference in a short space of time.&lt;/p&gt;&lt;p&gt;While the volunteers involved in the study weren't seniors, the researchers speculate that older individuals may benefit most from the findings.&lt;/p&gt;&lt;p&gt;"In recent years, the decline in muscle strength and physical fitness has become a significant public health concern," &lt;a href="https://dx.doi.org/10.1620/tjem.2025.J099"&gt;write&lt;/a&gt; the researchers in their published paper.&lt;/p&gt;&lt;p&gt;"Muscle strength naturally diminishes with age, often leading to conditions such as sarcopenia and frailty."&lt;/p&gt;&lt;p&gt;"This decline is further aggravated by the widespread prevalence of sedentary lifestyles. Importantly, the reduction in strength tends to be more pronounced in the lower limbs than in the upper limbs."&lt;/p&gt;&lt;p&gt;Importantly, the exercise routine used in the research relies solely on the body's own weight, and is slow and deliberate, reducing the risk of injury and common consequences of &lt;a href="https://doi.org/10.1159/000094530"&gt;other exercises&lt;/a&gt;, &lt;span&gt;such as increased blood pressure&lt;/span&gt;&lt;span&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p&gt;Though the number of people involved in the study was relatively small, and participants were trusted to perform the tasks without supervision, other studies have &lt;a href="https://doi.org/10.1016/j.exger.2018.12.016"&gt;reached similar conclusions&lt;/a&gt;, and in older people.&lt;/p&gt;&lt;p&gt;This is far from the first time that traditional approaches to health have been &lt;a href="https://www.sciencealert.com/this-traditional-african-diet-appears-to-boost-the-immune-system"&gt;shown to be beneficial&lt;/a&gt; – perhaps something to bear in mind in the fast-changing modern world, where much of our focus is on the future.&lt;/p&gt;&lt;p&gt;"We think it's also valuable that those outside of Japan who want to try Rei-ho would also be able to experience a unique aspect of ancient Japanese tradition in addition to the health benefits," &lt;a href="https://www.tohoku.ac.jp/en/press/traditional_japanese_samurai_daily_behavior_improves_leg_strength.html"&gt;says&lt;/a&gt; exercise physiologist Akira Sato.&lt;/p&gt;&lt;p&gt;The research has been published in the &lt;a href="https://dx.doi.org/10.1620/tjem.2025.J099"&gt;&lt;em&gt;Tohoku Journal of Experimental Medicine&lt;/em&gt;&lt;/a&gt;.&lt;/p&gt;
		&lt;/div&gt;
	&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>ScienceAlert</author><pubDate>Tue, 09 Sep 2025 02:03:08 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMikgFBVV95cUxQSUVJSlVzLU1nNHdWY191bEtSRFJTb1dFWXNGUDJtRHlOR3lBU0lfbmtmZzRCTDVBQm9nNWdpbVR5V0Q3NzExY3ZTZFQ5ak40UENyYTFhU3hPYU9Qc0FZUGFQbHVWamxEOXZtQ1JMeXZhcjJDWkJvcjNNQy1LRHpuQ2NzSGVpSThiemRCSXZqSWE0dw</guid></item><item><title>内华达人现在可以在零售药店无需处方即可获得最新的COVID疫苗- KTVN</title><link>https://www.2news.com/townnews/pharmacy/nevadans-can-now-get-updated-covid-vaccine-at-retail-pharmacies-without-a-prescription/article_3b7617f5-8c52-4c0c-b5d6-eb80e82dfce3.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div dir="ltr"&gt;&lt;p&gt;Nevadans can now receive the updated COVID-19 vaccine at retail pharmacies statewide without a prescription.&lt;/p&gt;&lt;p&gt;The update comes in a statement from a spokesperson for the office of Governor Joe Lombardo.&lt;/p&gt;&lt;p&gt;According to the Governor’s Office, on September 5, the Nevada Board of Pharmacy issued clarifying guidance on a state regulation that temporarily stopped the distribution of the updated COVID-19 vaccine at retail pharmacies statewide. The Governor’s Office says with the guidance in place, Nevadans can now receive the update COVID-19 vaccine at retail pharmacies statewide, if they choose to do so.&lt;/p&gt;&lt;p&gt;Reached for comment, CVS replied with the following statement.&lt;/p&gt;&lt;p class="gmail-xmsonormal"&gt;&lt;em&gt;State pharmacy laws govern where we can currently vaccinate. Based on FDA approval, we currently can offer COVID-19 vaccines in the following states: AK, AL, AR, CA, CO, CT, DE, HI, IA, ID, IL, IN, KS, KY, MA, MD, MI, MN, MO, MS, MT, NE, ND, NH, NJ, NM, NV, NY, PA, OH, OK, RI, SC, SD, TN, TX, VT, WA, WI, and WY. Prescriptions are not needed. &lt;/em&gt;&lt;/p&gt;&lt;p class="gmail-xmsonormal"&gt;&lt;em&gt;Once ACIP acts on the updated COVID-19 vaccines or states take additional action to authorize pharmacy dispensing prior to ACIP recommendations, we’ll be able to offer the FDA-approved COVID-19 vaccines – without a prescription – in the remaining states. Right now, we can offer the updated COVID-19 vaccines to patients, prior to ACIP action, if they present an authorized prescriber’s prescription. Those states are AZ, DC, FL, GA, LA, ME, NC, OR, UT, VA, WV. &lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;Appointments can be scheduled online via &lt;strong&gt;&lt;span&gt;&lt;a href="https://link.edgepilot.com/s/15029339/0SKn33U_60uNNvvHgKVJkA?u=http://cvs.com/"&gt;CVS.com&lt;/a&gt;&lt;/span&gt;&lt;/strong&gt;, through the CVS Health app, or patients can walk into our pharmacies and clinics.&lt;/em&gt;&lt;/p&gt;&lt;p&gt;We have reached out to Walgreens for comment on the issue, and have yet to hear back.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>KTVN</author><pubDate>Tue, 09 Sep 2025 01:20:46 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMihwJBVV95cUxPZG5ldl9sazJON3NiSUUzUVNLZlVyLXh2aWdhQnNSRlJwQkY4dXlWSjVsUnZLNmp5SlZER240Ni1YUEhzTXJCVGlzUG4wRmZMQzNocnpVU2M4cU9WZXBQMFFCSjM4SERBVDJySExsdlNaVTB6OERSYTUzbGpJNVcxaHpLU1FyNkJFX3Izb2FxOUtnZkVFS3djX2tDdlBfYnVvUlNTS21qUVdiZjVFdWs2WVBnRXdBNjhrdVZtNElPaVFXWk1FdHNxNHFHcHZzc05wYzZoVmQ3UWtyeVhVWG1SOUN4UHQyN2hXbm00Y1RpTjBmclFNb3E0eFpnUVlrZ3NiYnU5VmRNSQ</guid></item><item><title>在处方混乱中，弗吉尼亚州家庭面临获得更新的COVID-19疫苗的障碍- WTOP</title><link>https://wtop.com/virginia/2025/09/virginia-families-face-hurdles-getting-updated-covid-19-vaccine-amid-prescription-confusion-2/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;p class="schema-summary"&gt;Virginia families are hitting roadblocks getting the new COVID-19 vaccine, as shifting federal rules spark confusion over pharmacy prescription requirements.&lt;/p&gt;

            &lt;div id="Entry-content" class="entry-content Entry-content "&gt;
                                                
                                
                &lt;p&gt;Virginia families are hitting roadblocks while getting the new COVID-19 vaccine, as shifting federal rules spark confusion over pharmacy prescription requirements.&lt;/p&gt;


&lt;p&gt;According to &lt;a href="https://www.vdh.virginia.gov/blog/2025/09/05/statement-from-the-virginia-department-of-health-regarding-the-2025-26-covid-19-vaccine/" target="_blank" rel="noopener"&gt;the Virginia Department of Health&lt;/a&gt;, pharmacists can give vaccines in two ways: with a prescription from a medical provider, or under statewide protocols that allow vaccinations without a prescription — as long as they follow the immunization schedule from the Centers for Disease Control and Prevention.&lt;/p&gt;
&lt;p&gt;The CDC’s current immunization schedule lists the 2024-25 COVID-19 vaccine, but not the 2025-26 version, which is why a prescription is now required for the newer shots.&lt;/p&gt;
&lt;p&gt;Jim Hardin, a 75-year-old resident of Haymarket, told WTOP he was asked to present a prescription recently when he tried to get a vaccination at a Giant Foods Pharmacy near his home. He said he’s never been asked for a prescription.&lt;/p&gt;
&lt;p&gt;“To me, this is kind of a federal bureaucracy … that’s really useless,” Hardin said. “If you think about it, what doctor is going to say, ‘No, I’m not going to give you a prescription for a COVID shot?’ I mean, they’ll all give it to you.”&lt;/p&gt;
&lt;p&gt;Hardin said he is retired veteran and can get a shot at a local military base. But he said that’s at least 20 miles away and not at all convenient.&lt;/p&gt;
&lt;p&gt;Several states have already acted on similar concerns. In Colorado, Massachusetts, New York and Pennsylvania, pharmacists can give COVID-19 vaccines without a prescription.&lt;/p&gt;
&lt;p&gt;The CDC’s vaccine advisory committee meets Sept. 18 and 19 to vote on updated COVID-19 shots. If approved, pharmacists could give the vaccines without a prescription.&lt;/p&gt;
&lt;p&gt;“I just think the government is trying to dissuade citizens from getting a shot,” Hardin said. “I think that’s wrong.”&lt;/p&gt;
                
                
                &lt;p class="After-content"&gt;
                                    &lt;/p&gt;

            &lt;p class="single-page__signature bottom"&gt;&lt;em&gt;Get breaking news and daily headlines delivered to your email inbox by signing up &lt;a href="https://wtop.com/newsletter-signup/" target="_blank" rel="noopener"&gt;here&lt;/a&gt;.&lt;/em&gt;&lt;/p&gt;
&lt;p class="single-page__signature bottom"&gt;© 2025 WTOP. All Rights Reserved. This website is not intended for users located within the European Economic Area.&lt;/p&gt;
            &lt;/div&gt;
            
            &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>WTOP</author><pubDate>Tue, 09 Sep 2025 00:38:41 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMixwFBVV95cUxNRGNiN0JXTWFKTndsZUJGMmotUUlUbGNXdVpFeGV5djFoOVltWEYzVGgwaWtXY1JXTDJNcXk1ck9aeU5mOTI4TVQ0M2tsODVsdDl6VXZORnFJN2k3N1ZiX3hVN3YwQ215UXdzWlpadHJaYTY0d2h3N3A3MDZYZElxQWVpRm9iSklrUTNvcGc5R3g1eklwM2UyYnJkZS1lYXoySFg1QlJHZzJOY3pPZmFmY0ZGVmpqeHNvUlBiUkI5T3ZRLUpIMklj</guid></item><item><title>17名年龄较大的女性正在揭示60年前与今天的分娩有多么不同- BuzzFeed</title><link>https://www.buzzfeed.com/carleysuthers/moms-share-birth-experiences-from-60s</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="subbuzz buzz-width--standard__subbuzz buzz-type--list__subbuzz subbuzz-text
  subbuzz-index-4
  
  
  
  
  " data-module="subbuzz-text"&gt;
  
  &lt;p id="139254104" class="subbuzz-anchor"&gt;&lt;/p&gt;



  &lt;h2 class="subbuzz__header subbuzz__header--standard subbuzz__title "&gt;
    
      &lt;span class="subbuzz__number"&gt;2.&lt;/span&gt;
    

    
      &lt;span class="js-subbuzz__title-text"&gt;"I was born in '68. Induction wasn't a thing, as the popular thinking was that the baby would come when it was time. My mom's due date was mid-April, yet I was born the last week of May."&lt;/span&gt;
    
  &lt;/h2&gt;



&lt;p&gt;"She told me she had to get weekly blood tests to make sure everything was okay, which confused me at first, until I figured out it was due to RH incompatibility. Nowadays, this is solved by a single injection, but it apparently wasn't available then.&lt;/p&gt;&lt;p&gt;Because of the RH incompatibility, there was a chance I wouldn't survive, so she and my father didn't buy anything for me, thinking that if the worst happened, they wouldn't have to go home to a house filled with painful reminders.&lt;/p&gt;&lt;p&gt;After I was born healthy, she gave her friend some money to go and buy all the basics a newborn would need. The amount she gave the friend? $20."&lt;/p&gt;&lt;p&gt;—&lt;a href="https://www.reddit.com/r/AskOldPeople/comments/1myvthm/comment/nahrbs2/?utm_source=share&amp;amp;utm_medium=web3x&amp;amp;utm_name=web3xcss&amp;amp;utm_term=1&amp;amp;utm_content=share_button" target="_blank"&gt;u/Cuddles_McRampage&lt;/a&gt;&lt;/p&gt;

&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>BuzzFeed</author><pubDate>Tue, 09 Sep 2025 00:31:02 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiggFBVV95cUxQVzFSY2t4enljNUhZSWlYLXJkUFVEZ1ZXWU1hZVdMazItS1hHYzkta2dyMjgxdVhCTEl6RjdYaGxnY09ic2dheGdEeWg2V3czc1JlVnZtaF9IdnhXZjdWLU5EVmVGd2E3TFIyOVJoNnJTRDBHMzlzUHM0OXFMdUk0bWpn</guid></item><item><title>为什么越来越多的老年人转向使用大麻- CBS新闻</title><link>https://www.cbsnews.com/news/seniors-older-americans-marijuana-cannabis/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;section class="content__body"&gt;
    &lt;p&gt;When Don Searles went to a recent party, he didn't want to show up empty-handed. So he made peanut brittle using an old family recipe — with a modern-day twist.&lt;/p&gt;&lt;p&gt;"We added the marijuana," he said.&lt;/p&gt;&lt;p&gt;The party was hosted by 74-year-old Gayle Crawley at the Trilogy retirement community an hour east of San Francisco, where lately the golf course has a new competitor for popularity.&lt;/p&gt;&lt;p&gt;Between 2021 and 2023, cannabis use among Americans 65 and older went up 46%, according to a study &lt;a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2834781?guestAccessKey=6fb7097a-4590-4b78-b8a5-b21f5b00def4&amp;amp;utm_source=For_The_Media&amp;amp;utm_medium=referral&amp;amp;utm_campaign=ftm_links&amp;amp;utm_content=tfl&amp;amp;utm_term=060225" target="_blank" rel="nofollow noopener"&gt;published&lt;/a&gt; in JAMA Internal Medicine.&lt;/p&gt;&lt;p&gt;Crawley said those numbers reflect that marijuana is a "good solution to a lot of medicinal issues." &lt;/p&gt;

    
&lt;p id="mpu-plus-outstream-middle" data-ad="mpu-plus-outstream-middle" class="ad-mpu-plus-outstream-middle ad-wrapper " data-ad-unit='"mpu-plus-outstream-middle"'&gt;
    &lt;/p&gt;
&lt;p&gt;And with cannabis now legal in 40 states for medical use and 24 for recreational, according to the &lt;a href="https://www.ncsl.org/health/state-medical-cannabis-laws" target="_blank" rel="nofollow noopener"&gt;National Conference of State Legislatures&lt;/a&gt;, the stigma is quickly diminishing.&lt;/p&gt;&lt;p&gt;Steven Clarke, another attendee at Crawley's party, said he's never smoked and prefers edibles. &lt;/p&gt;&lt;p&gt;When asked why he's drawn to the drug, Clarke told CBS News that "it does work on PTSD, pain issues, relaxation issues, brain disorders, heart disease." &lt;/p&gt;&lt;p&gt;But some medical professionals disagree. &lt;/p&gt;

    
    
&lt;p id="mpu-flex-inc3" data-ad="mpu-flex-inc" class="ad-mpu-flex-inc ad-wrapper " data-ad-unit='["mpu-flex-inc",3]'&gt;
    &lt;/p&gt;
&lt;p&gt;Matt Springer, a professor at UC San Francisco, warns that THC, the main psychoactive compound in marijuana, may carry health risks, no matter how seniors ingest it. &lt;/p&gt;&lt;p&gt;"If they are smoking marijuana, we can be pretty confident that they're harming their cardiovascular system," Springer told CBS News, adding that if they're eating THC, "they're not without risk."&lt;/p&gt;&lt;p&gt;Other researchers found cannabis use is linked to a doubled risk of dying from cardiovascular disease, a 29% higher risk for acute coronary syndrome and 20% higher risk for stroke, &lt;span class="link"&gt;&lt;a href="https://www.cbsnews.com/news/cannabis-cardiovascular-heart-disease-death-risk-study/" target="_blank" data-invalid-url-rewritten-http=""&gt;according to a study&lt;/a&gt;&lt;/span&gt; published in June. The authors analyzed data from 24 studies published from 2016 to 2023.&lt;/p&gt;&lt;p&gt;Searles, who suffers from chronic pain after a motorcycle accident five years ago, said he isn't surprised by the findings.&lt;/p&gt;&lt;p&gt;"I go to my doctor and he says, geez, quit drinking milk. Uh, stay away from the sugar. What isn't bad for you nowadays?" Searles said.&lt;/p&gt;

      

                    
        
      
        
    

    



    
      
    
  

          
  
        
      &lt;div class="content-author"&gt;
      &lt;a href="https://www.cbsnews.com/team/jim-axelrod/" class="content-author__name" data-invalid-url-rewritten-http=""&gt;Jim  Axelrod&lt;/a&gt;

      &lt;div class="content-author__bio"&gt;
        &lt;div class="content-author__full-information"&gt;
          &lt;p class="content-author__text"&gt;Jim Axelrod is the chief correspondent and executive editor for CBS News' "Eye on America" franchise, part of the "CBS Evening News." He also reports for "CBS Mornings," "CBS News Sunday Morning," and CBS News 24/7.&lt;/p&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
        &lt;/section&gt;

  
  

  &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>CBS News</author><pubDate>Tue, 09 Sep 2025 00:06:34 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMifEFVX3lxTE11cDAwUllTWHZ6Z2IxNnVHeWdWWUwtWS01M1BVUngyUk5OVmlRd1VsNTFFUHJ4T1VUQ1JOOFFQRnNuT00tLTk1dGUzSnZ6X3ZhSUVlblFfa1JJS2F0WDB4czdTQVZyTkp0ZzB4UzlRYTJsSjlHREtTRHVrWHrSAYIBQVVfeXFMTjdoOVAtMmxxZmJydW11MTNUMHIwMjNXM3BjTndDVnczblVuS2dGemxJMEtsdzZYN1pwUDRTLTIzXy0wbTdzWU1HTkJETG5xSF90MVZ5b1J0S3BsYTJHZ1g2UERuenlpRTJNNmRMX3BpMlBodGVwdERJenktZW1HYWRwdw</guid></item></channel></rss>